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 Pref ace 
 Public health ethics can be seen both as the application of principles and norms to 
guide the practice of public health and as a process for identifying, analyzing, and 
resolving ethical issues inherent in the practice of public health. Public health ethics 
helps us decide what we should do and why. Although the practice of public health 
has always considered ethical issues, the emergence of public health ethics as a 
discipline is relatively new. Although rooted in bioethics and clinical and research 
ethics, public health ethics has many characteristics that set it apart. The defi ning 
characteristics are its focus on achieving social goods for populations while respect-
ing individual rights and recognizing the interdependence of people. 
 Currently there are few practical training resources for public health practitio-
ners that consider ethical issues and dilemmas likely to arise in the practice of pub-
lic health. In public health ethics training, we have found it advantageous to use 
cases to illustrate how ethical principles can be applied in practical ways to decision 
 making. The use of cases encourages refl ection and discussion of ethics, reinforces 
basic ethical concepts through application to concrete examples, highlights practi-
cal decision making, allows learners to consider different perspectives, and sensi-
tizes learners to the complex, multidimensional context of issues in public health 
practice. The case-based approach (known as casuistry) contrasts with the theoreti-
cal approach to considering moral principles, rules, and theories. By describing 
scenarios, cases allow the learner to use ethical principles in the context of a realis-
tic situation that sheds light on ethical challenges and illustrates how ethical prin-
ciples can help in making practical decisions. 
 This casebook comprises a broad range of cases from around the globe to high-
light the ethical challenges of public health. For those new to public health ethics, 
Section I introduces public health ethics. Chapter  1 , “Public Health Ethics: Global 
Cases, Practice, and Context” by Ortmann and colleagues, summarizes basic 
 concepts and describes how public health ethics differ from bioethics, clinical 
 ethics, and research ethics. The chapter also includes an approach for conducting an 
ethical analysis in public health. In Chap.  2 , “Essential Cases in the Development of 
Public Health Ethics,” Lee, Spector-Bagdady, and Sakhuja highlight important 
viii
events that shaped the practice of public health and explain how practitioners 
address and prevent ethical challenges. 
 Section II is organized into chapters that discuss the following public health 
topics:
•  Resource allocation and priority setting 
•  Disease prevention and control 
•  Chronic disease prevention and health promotion 
•  Environmental and occupational public health 
•  Vulnerability and marginalized populations 
•  International collaboration for global public health 
•  Public health research 
 We have invited some of the leading writers and thinkers in public health ethics 
to provide an overview of the major ethical considerations associated with each 
topic. The topic overviews offer the authors’ perspectives about applicable ethical 
theories, frameworks, and tools and draw attention to the cases that follow. The 
cases are meant to highlight the ethical issues in practice. Each represents the work 
of authors from around the globe who responded to a solicitation from the U.S. 
Centers for Disease Control and Prevention. We worked with the authors to ensure 
that each case included a concise articulation of a public health situation that raises 
ethical tensions, challenges, or concerns that require decisions or recommendations 
from public health offi cials or practitioners. The cases are presented in a standard 
format that includes a background, case description, discussion questions, and ref-
erences. However, we also allowed for variation in the amount of detail provided in 
each section and the approach used to set up the case. Our goal was to include just 
enough contextual information to orient the reader who is not an expert in the case 
topic. We include the case setting, population, or intervention in question, legal or 
regulatory landscape, and questions to stimulate discussion on core ethical issues. 
Each case—although fi ctionalized—is as realistic as possible to refl ect the ethical 
challenges that public health practitioners face daily. Sometimes the cases were 
based on actual or composite events. In these instances, the case details were modi-
fi ed to exclude identifying information that could be considered private, sensitive, 
or disputable by others involved in the case. 
 We deliberately did not attempt to provide a resolution or solution for the cases. 
Often in public health practice, there is no single correct answer. Instead, ethical 
analysis in public health is a process to identify the ethical dimensions of the options 
available and to arrive at a decision that is ethically justifi able, through deliberation 
and consideration of relevant facts, values, and contexts. 
 The cases and other writings in this book represent the opinions, fi ndings, and 
conclusions of the authors and do not necessarily refl ect the offi cial position, views, 
or policies of the editors, the editors’ host institutions, or the authors’ host institu-
tions. We decided which topic category to place the case in to best distribute the 
cases across chapters. However, you may note that some cases cross topic areas and 
could just as easily have been included in another chapter. 
Preface
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 This casebook is written for public health practitioners, including frontline work-
ers, fi eld epidemiology trainers and trainees, and managers, planners, and decision 
 makers with an interest in learning about how to integrate ethical analysis in their 
day-to-day public health practice. However, the casebook will also be useful to 
instructors in schools of public health and public health students as well as to aca-
demic ethicists who can use the book to teach public health ethics and distinguish it 
from clinical and research ethics. 
 Our hope is that the casebook will increase awareness and understanding of pub-
lic health ethics and the value of ethical analysis in public health practice in all of its 
forms. This includes applied public health research; public health policy develop-
ment, implementation, and evaluation; and public health decision making in national 
and international fi eld settings and training programs. By emphasizing prospective 
practical decision making, rather than just presenting a theoretical academic discus-
sion of ethical principles, we hope this casebook will serve as a useful tool to sup-
port instruction, debate, and dialogue about the nature of ethical challenges 
encountered in public health practice and how to resolve these challenges. We rec-
ommend discussing the cases in small groups and using the discussion questions, 
the ethical framework described in Chap.  1 , and the information provided in the 
topic area overview sections as a starting place for exploring the ethical issues 
refl ected in the cases. The ultimate goal of case-based learning is to develop skills 
in ethical analysis and decision making in daily public health practice. The ethical 
framework provides a convenient tool for putting our ideas into practice. 
 Atlanta ,  GA ,  USA  Drue  H.  Barrett, PhD 
Atlanta, GA, USA   Leonard  W.  Ortmann, PhD 
 Sydney ,  Australia  Angus  Dawson, PhD 
 Washington ,  DC ,  USA  Carla  Saenz, PhD 
 Geneva ,  Switzerland  Andreas  Reis, MD 
 Atlanta ,  GA ,  USA  Gail  Bolan, MD 
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 Chapter 1 
 Public Health Ethics: Global Cases, Practice, 
and Context 
 Leonard  W.  Ortmann ,  Drue  H.  Barrett ,  Carla  Saenz ,  Ruth  Gaare  Bernheim , 
 Angus  Dawson ,  Jo  A.  Valentine , and  Andreas  Reis 
1.1  Introduction 
 Introducing  public health ethics poses two special challenges. First, it is a relatively 
new fi eld that combines public health and  practical ethics . Its unfamiliarity requires 
considerable explanation, yet its scope and emergent qualities make delineation dif-
fi cult. Moreover, while the early development of public health ethics occurred in a 
Western context, its reach, like public health itself, has become global. A second 
challenge, then, is to articulate an approach specifi c enough to provide clear 
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4guidance yet suffi ciently fl exible and encompassing to adapt to global contexts. 
Broadly speaking, public health ethics helps guide practical decisions affecting 
 population or  community health based on scientifi c evidence and in accordance 
with accepted  values and  standards of right and wrong. In these ways, public health 
ethics builds on its  parent disciplines of public health and ethics. This dual inheri-
tance plays out in the defi nition the U.S.  Centers for Disease Control and Prevention 
(CDC) offers of public health ethics: “A systematic process to clarify,  prioritize , and 
justify possible courses of public health action based on ethical  principles , values 
and beliefs of  stakeholders , and scientifi c and other  information ” (CDC  2011 ). 
Public health ethics shares with other fi elds of practical and professional ethics both 
the general theories of ethics and a common store of ethical principles,  values , and 
beliefs. It differs from these other fi elds largely in the nature of challenges that pub-
lic health offi cials typically encounter and in the ethical frameworks it employs to 
address these challenges. Frameworks provide methodical approaches or proce-
dures that tailor general ethical theories,  principles , values, and beliefs to the spe-
cifi c ethical challenges that arise in a particular fi eld. Although no framework is 
defi nitive, many are useful, and some are especially effective in particular contexts. 
This chapter will conclude by setting forth a straightforward, stepwise  ethics frame-
work that provides a tool for analyzing the cases in this volume and, more impor-
tantly, one that public health practitioners have found useful in a range of contexts. 
For a public health practitioner, knowing how to employ an ethics framework to 
address a range of ethical challenges in public health—a know-how that depends on 
practice—is the ultimate take-home message. 
 We learn new things more readily when we can relate them to familiar things, 
and we understand complex things by breaking them into their components. 
Accordingly, throughout this introductory chapter, we will relate public health eth-
ics to more familiar concepts and better-known related fi elds, while the immediately 
following section will explore the components of public health ethics that derive 
from its  parent disciplines of public health and ethics. After describing public 
health’s core activities, goals, and  values , we will explain why ethical concepts like 
the  right to health ,  social justice , and health  equity directly follow as central con-
cerns of public health. After defi ning ethics broadly in everyday terms, we will 
examine the complementary roles facts and values play in public health. This exam-
ination is important because the respective bases of the two parent disciplines differ 
considerably; public health science rests on the logic of scientifi c discovery, whereas 
ethics rests on the logic of right action and good decision making. We will then 
contrast the more familiar, everyday understanding of  morality with the formal dis-
cipline of ethics as a prelude to considering three well-known ethical theories rele-
vant to public health. Because both  laws and ethical rules establish parameters for 
public health practice, their similarity and difference need to be clarifi ed. This 
extended account, fi rst of  parent disciplines, then of kindred concepts, and fi nally of 
family resemblances between the related fi elds of  clinical ethics ,  bioethics , and 
 research ethics , will culminate in an effort to characterize what is distinctive about 
public health ethics. 
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51.2  Public Health 
 There are many defi nitions of public health. They often begin as descriptions of cur-
rent practice but once established become prescriptions for subsequent practice. It 
is important, then, to consider defi nitions, because they shape not only public health 
practice, but also how we conceive of public health ethics (Dawson and Verweij 
 2007 ). The same logic applies to how we think about the individual concepts of 
health and the public. Defi ning health as the absence of disease or symptoms, for 
example, more readily fi ts allopathic medicine, which focuses on negating symp-
toms to treat disease. But it hardly fi ts public health’s emphasis on preventive mea-
sures that address root causes rather than symptoms. Nor does it cover public 
health’s promotion of health and well-being across a range of interventions. In this 
regard, the  World Health Organization (WHO) offers  a  defi nition of health more 
suitable to public health: “A state of complete physical, mental, and social well- 
being and not merely the absence of disease or infi rmity” (WHO  2006 ). But even 
this more holistic defi nition does not suffi ciently clarify the meaning of “public” in 
public health. Dawson and Verweij ( 2007 ) identify two primary meanings of “pub-
lic” in public health, each of which they break down into three senses. Public can 
mean population-wide and refer to (1) the epidemiologically measured health of a 
 population or group, (2) the distribution of health in a population, or (3) the underly-
ing social and environmental conditions impacting everyone’s health. Public also 
can mean collectively accomplished and requiring (1) the concerted actions of many 
people and institutions whether governmental or nongovernmental; (2) the coopera-
tion or involvement of the public, or (3) the public’s joint  participation to realize the 
health improvement. 
 In a practical fi eld like public health,  defi nition  often takes the form of enumerat-
ing key activities, such as  surveillance ,  sanitation , maintaining food and workplace 
 safety , disease  prevention and  control , and promoting healthy behavior. The identi-
fi cation of the ten essential services of public health illustrates this enumerative 
approach (Fig.  1.1 ) (Public Health Functions Steering Committee  1994 ). These ser-
vices fall under three overarching functions of assessment, policy development, and 
assurance that constitute an integrated cyclic process. The delivery of these services 
in local, regional, or national public health agencies accordingly defi nes public 
health practice. In this schema,  research is a distinct practical service but also 
 integral to all public health activities, providing insights and innovative solutions at 
every point. Public health ethics addresses the entire spectrum of ethical issues that 
arise in any area of public health practice but especially in those areas where no 
specifi c  guidelines govern practice.
 Such lists have the advantage of concretely specifying current activities but lack 
criteria that defi nitions normally provide for including or excluding additional activ-
ities as a fi eld develops. In 1920, Charles Edward A. Winslow, an infl uential public 
health theorist and leader, pioneered  a  defi nition of public health that still informs 
many European and international public health institutions, including WHO (Marks 
et al.  2011 ).
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6 Public health is the science and the art of preventing disease, prolonging life, and promoting 
physical health and  effi ciency through organized community efforts … and the  development 
of the social machinery which will ensure to every individual in the community a  standard 
of living adequate for the maintenance of health (Winslow  1920 ). 
 Even more succinctly, the  U.S. Institute of Medicine (IOM) defi nes public health 
as “what we, as a society, do collectively to assure the conditions for people to be 
healthy” (IOM  1988 ). 
 These two defi nitions highlight the importance of collective action to address the 
health needs of  populations . Public health’s population focus distinguishes it from 
clinical medicine’s focus on individual patients, though examples like  vaccination 
indicate that the two fi elds can overlap. Epidemiologists statistically aggregate the 
health data of individuals to provide a picture of  population health , but populations 
ultimately originate from  communities of individuals who constitute social wholes. 
 Fig. 1.1  Essential Public Health  Services . (1) Monitor health status to identify  community health 
problems. (2) Diagnose and investigate health problems and health hazards in the community. (3) 
Inform, educate, and empower people about health issues. (4) Mobilize community partnerships 
and action to identify and solve health problems. (5) Develop policies and plans that support indi-
vidual and community health efforts. (6) Enforce  laws and  regulations that protect health and 
ensure  safety . (7) Link people to needed personal health services and assure the provision of health 
care when otherwise unavailable. (8) Assure competent public and personal health care workforce. 
(9) Evaluate  effectiveness , accessibility, and quality of personal and population-based health ser-
vices. (10) Research for new insights and innovative solutions to health problems (From Public 
Health Functions Steering Committee  1994 .  Essential Public Health Services . Available at  http://
www.cdc.gov/nphpsp/essentialServices.html ) 
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7Individuals in society stand in complex relations of  interdependence , competition, 
and  solidarity that can impact health in ways that transcend the individual. Thus, in 
addition to aggregating individual medical data, epidemiologists need to measure 
the impact of various social factors on health. To tackle the complex, often compet-
ing health needs of social groups, public health practitioners need to dialogue and 
partner with their communities. At a higher administrative level, public health offi -
cials need to manage  intersectoral  collaborations , navigate political processes, and 
formulate public health law. Four distinguishing features of public health practice—
the pursuit of the collective good, a focus on  prevention , the use of  government or 
collective action, and an emphasis on an outcome-based (utilitarian) approach—
generate most of the ethical challenges public health practitioners typically face 
(Faden and Shebaya  2010 ). 
1.2.1  Core  Values 
 People value many things such as friends and family, material goods and resources, 
knowledge, and art. Some things people value are ethical virtues like courage or 
honesty, whereas others are ethical  principles like  justice and equality. People gen-
erally value what they consider important, what matters to them, and what gives 
their lives meaning. Public health’s primary goals and commitments refl ect its core 
values, which are rooted in health, science, and the community (Public Health 
Leadership Society  2002 ).  Everyone recognizes the value of health, but public 
health approaches health in relation to science and the community in its endeavor to 
prevent disease and injury, protect the public from harm, and promote health and 
well-being. But seeing how science and community represent values requires a 
word of explanation. 
 The commitment to science as a value stance often becomes apparent only in 
relation to people who distrust science or  prioritize other value commitments such 
as economic interests or religion. Public health values science by endeavoring to 
base interventions and policies on the best available data and evidence-based prac-
tices. That endeavor entails a commitment to conduct  surveillance and  research , 
because only by understanding the social burden of disease and its underlying or 
structural causes can public health impact the health of the entire  population . The 
qualifi er “best available” is a reminder of the need to continuously improve practice 
and not rely on tradition or current practices. It also reminds us that during emergen-
cies, time and resource constraints limit the ability to gather evidence. 
 Public health  values community in two obvious senses. First, it recognizes that 
the success of most  health interventions depends on a community’s acceptance, 
cooperation, or  participation . Second, it recognizes that to be successful, public 
health must  respect the community’s values and gain the  trust of its members. Yet 
there is a third, deeper sense in which community represents a value. A community 
is, to emphasize again, neither a statistical abstraction nor a mere aggregate of indi-
viduals but rather a network of relationships and emotional bonds between people 
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8sharing a life in common organized through a  political and moral order (Jennings 
 2007 ). The value that best refl ects this fundamental, relational character of social 
life is  solidarity .  Solidarity can remain unspoken yet operative because it forms the 
basis of social life and collective action. Just as communities are not mere aggre-
gates of individuals, neither are the agencies or organizations that make the collec-
tive decisions that affect the community. Personal interests, to be sure, can motivate 
individuals, but the felt recognition of a common plight, that we are all in it together, 
underlies the collective decisions society and public health must make to solve col-
lective problems. To say that public health values community means that it values 
solidarity, even when solidarity remains unacknowledged as is often the case 
(Dawson and Jennings  2012 ). 
1.2.2  Health  Equity , Social Justice,  and Social Determinants 
of Health 
 As the foregoing goals, defi nitions, core  values , and commitments of public health 
clearly suggest, the  right to health and health equity are central, not peripheral, to 
public health’s mission. Chapter  8 on  international collaboration will examine some 
practical challenges in addressing the right to health and social determinants of 
health, so the emphasis here will be on the rationale for achieving health equity as a 
matter of social justice. 
 Despite greater individual access to health care and advances in public health, 
high burdens of disease remain across much of the globe. Some differences in  dis-
ease burden result from genetics and some from variable  risks of exposure to infec-
tious agents and other threats, but most of the differential burden arises from social, 
economic, and political  conditions . These conditions include poverty, lack of educa-
tion, and  discrimination against particular social groups and often refl ect historical 
injustices or long-standing systemic, structural defi ciencies. Collectively, these con-
ditions have come to be known as  social determinants of health (Blane  1999 ). 
Greater access to individual health care can mitigate their effect, but an adequate 
response to them requires concerted public action to address their underlying causes. 
 Whether comparing countries or groups within countries, social stratifi cation by 
 social determinants correlates with differences in health status (Marmot  2007 ). 
These health differences have aroused widespread concern, but how one defi nes 
them signifi cantly affects public health practice (Braveman  2006 ). In particular, dis-
tinguishing  health disparity from health in equity is critical. As a comparative indi-
cator of health status, health disparity is a neutral, epidemiologic term that need not 
imply an ethical  obligation to remedy. Health  disparities , however, can and fre-
quently do refl ect underlying inequities. WHO defi nes  health inequities as health 
differences that are “socially produced; systematic in their distribution across the 
 population ; and unfair” (WHO  2007 ). Terms like “inequity” and “unfair” are ethical 
terms that imply an obligation to redress an in justice. Justice has a range of mean-
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9ings that include giving people what they deserve or are owed and distributing 
goods and services fairly. Justice in a medical context often involves the individual’s 
access to health services. In public health, discussions of health  equity usually 
involve questions of how to distribute health benefi ts fairly or how to achieve better 
 health outcomes among communities or groups that suffer  health inequities . 
Attaining greater  equity might involve the politically controversial strategy of dis-
proportionally distributing resources within a  population , by, for example, distribut-
ing more to those most in need.  A less-controversial strategy is to improve  health 
outcomes for all, even while devoting special efforts to those most in need. WHO 
defi nes  health equity as “the absence of unfair and avoidable or remediable differ-
ences in health among population groups defi ned socially, economically, demo-
graphically, or geographically” (WHO  2007 ). 
 Achieving health  equity is most urgent for groups who have experienced histo-
ries of marginalization and  discrimination and who continue to experience higher 
rates of illness and premature deaths than members of the mainstream  population . 
Especially for these groups, “social injustice is killing people on a grand scale” 
(WHO  2008 ). Realizing the goal of social justice with  respect to health means 
achieving health equity. Doing so requires not only a fair distribution of  health out-
comes , it also means that “ideally everyone should have a fair opportunity to attain 
their full health potential” and that “no one should be disadvantaged from achieving 
this potential, if it can be avoided” (Whitehead  1992 ). For many, these goals imply 
that social justice obligates public health to improve any social condition that pre-
vents people from maintaining a  standard of life adequate to maintain health (Powers 
and Faden  2006 ). Although some believe that improving  social conditions that 
affect health overextends public health’s mandate, such a broad mandate is arguably 
consistent with both Winslow’s and IOM’s defi nitions of public health. Moreover, 
such a broad mandate has both nineteenth century precursors in the social medicine 
movement and more recent  precedents in the “Health for All” strategy that empha-
sizes  health promotion and the “Health in All Policies” strategy (Kickbusch  2003 ; 
Freiler et al.  2013 ). But a major milestone was reached with the 2008 report of the 
WHO Commission on Social Determinants of Health that sought to “marshal the 
evidence on what can be done to promote health  equity , and to foster a global move-
ment to achieve it” (WHO  2008 ).  Although  governments can guarantee  human 
rights and essential services, establish policies that provide an equitable basis for 
health improvement, and gather and monitor data on  health equity , achieving equity 
ultimately will depend  on the cooperation of government and civil society (Blas 
et al.  2008 ). 
1.3  Ethics 
 People strive to be “good,” to do the “right” thing and to lead a “good life,” but where 
do such basic, familiar moral  values as good and right originate? Throughout his-
tory, religious people have explained these ideas as revelations of divine command. 
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Anthropologists, however, view morals as customs that govern social interactions, 
and because all cultures display such customs, interpret moral practices in terms of 
a survival function rooted in human nature. By contrast, many social and  political 
thinkers emphasize that moral concepts result from social conventions or agree-
ments that are subject to deliberation and change.  Governments today often consult 
social scientists and health experts who empirically investigate what fosters or 
improves human life, health, and happiness. Where science informs  law and  policy , 
it helps defi ne in a conventional sense what we mean by good and right. In particu-
lar, public health science helps establish what is considered good for the health of 
 populations and communities. Further below we will examine three ethical theories 
prominent in public health ethics that offer contrasting perspectives on the nature 
and basis of  morality . In the meantime, we will address three general questions that 
a public health practitioner fi rst approaching the study of ethics might well ask: how 
does science relate to ethics, what is the difference between ethics and  mora lity, and 
what sort of things count as  principles or basic concepts in ethics? 
1.3.1  Scientifi c Facts and Ethical  Values 
 Public health practice increasingly requires appreciation of the complementary 
roles facts and values play in making and justifying decisions. Observation reveals 
facts, while scientifi c research controls and manipulates the experimental context to 
discover causation or correlation. Data on  disease burden , research on intervention 
 effectiveness , and estimates of the resultant health benefi ts for the  population gener-
ally inform public  health interventions . Health messaging can often inform the pub-
lic about the scientifi c rationale underlying public health interventions. Nevertheless, 
in the mind of the public, scientifi c evidence does not always invalidate or outweigh 
other sources of evidence or appeals to emotions, interests, and values. While public 
health practitioners give more weight to  community health and scientifi c evidence, 
they also need to consider how the public will respond to an intervention. 
Successfully implementing public health actions, then, will often entail weighing 
the public’s attitudes, interests, and values in relation to public health’s core 
values. 
 Two mundane features of public health practice often serve to conceal value 
assumptions: shared core values and  standard practice. First, sharing values can 
render them invisible as assumptions, until they unexpectedly become contested. 
Unwelcome surprises occur when interventions that presuppose core  values affect 
 stakeholders who do not share those values, as when  parents refuse to have  children 
vaccinated based on media hearsay or individuals reject a highly effective program 
as governmental intrusion. Avoiding such surprises begins with becoming aware of 
one’s own value presuppositions in relation to those of other stakeholders and com-
munity members. Second, routine use of evidence-based standards can conceal 
underlying value assumptions. If developed and tested to address a known health 
problem, as is common, an intervention’s purpose and effectiveness is taken for 
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granted. Standard interventions, then, generally require no more justifi cation than 
noting their standard status or seeing that “the facts dictated” their use. “Dictating” 
facts are indicators that trigger use of a standard intervention (e.g., meeting the cri-
teria of a case defi nition or documenting exposure to a dangerous level of a contami-
nant). Such “dictating facts,” more properly speaking, only  indicate the appropriate 
intervention but cannot literally  dictate that anything be done. What in the end dic-
tate actions are the values, goals, and  obligations that the standard intervention pre-
supposes and that practitioners tacitly ratify each time they apply the standard. In 
other words, values, goals, and  obligations , even when tacit, form a necessary bridge 
between knowledge and action. 
 Though  standard practices tacitly incorporate ethical  principles , they seldom 
raise ethical challenges. Challenges more typically arise in unusual or extreme situ-
ations where standards are not yet in place, are changing, or are competing. These 
situations include emergency operations, foreign cultural settings, emergent fi elds 
with innovative interventions, or periods of severe budget constraints that force pri-
oritization of programs. In such challenging situations where no value consensus 
exists or where evidence does not point to a single course of action, public health 
ethics provides a process to determine and justify a course of action. That justifi ca-
tion can incorporate a number of factors: evidence base for the intervention, 
 cost effectiveness , analysis of relevant ethical rules and  stakeholder  values , a cre-
ative design of options or alternatives that embody these values, and a fair and trans-
parent  decision-making process that incorporates stakeholder contributions. 
 Recognizing one’s own value assumptions in relation to those of the public will 
be critical for implementing new interventions wherever success depends on public 
acceptance. The public will not embrace interventions that embody or presuppose 
values that clash with community values or whose relative importance is low com-
pared to other community values. Members of the public generally are more com-
mitted to their  political views, ethical and religious values, and an intervention’s 
impact on them personally than to scientifi c evidence or community impact. Public 
health practitioners need to recognize that no matter how compelling to them, com-
munity impact and scientifi c rationale seldom resonate as deeply with the public. 
Consequently, in communicating, public health practitioners need to supplement 
scientifi c messaging with dialogue, an appeal to common values, or enlistment of 
spokespersons who share the value orientation of the relevant  stakeholder s or com-
munity. Regarding some controversial matters, ultimate success in implementing an 
intervention may require building a  social consensus (Ortmann and Iskander  2013 ). 
 In certain situations, untangling factual claims based on science from value judg-
ments is critical for success. For example, suppose independent investigators have 
scientifi cally verifi ed the level of worker exposure to a toxic chemical used in indus-
try. Determining what level of exposure would be safe, however, remains a value 
judgment that depends on the degree of concern that people have about  safety . 
Placing a higher value on safety might result in stricter controls that decrease  risk 
for workers, but the fi nancial  costs of decreasing risks could cut industry profi ts or 
jobs, even as health costs fall.  Stakeholders representing industry, workers, or public 
health practitioners might have different positions regarding a safe level of  exposure. 
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To make a good decision about a safe exposure level, the value of safety might have 
to be discussed and weighed in relation to business, employment, and health consid-
erations. However, these varying positions regarding safety need not imply disre-
gard for safety or disagreement on the underlying facts. Rather, they illustrate that 
confl icting value judgments can coexist despite a consensus on both the underlying 
facts and the importance of a particular value such as  safety . 
 Directly addressing the value  confl icts in such situations through ethical delib-
eration makes more sense than calling into question the underlying facts and can 
lead to better, fairer, and more transparent decisions. It is also important to recog-
nize that doubting the science often represents an underlying value dispute mas-
querading as a scientifi c dispute (Brunk et al.  1991 ). Sowing doubt on scientifi c 
assessments merely as a tactic to oppose an evidence-based  policy or recommenda-
tion undermines science. This doubt can exert pressure to test and retest results, 
raising the bar for scientifi c validity ever higher (Michaels  2008 ). The solution is 
not to litigate, as it were, the science, but to recognize that communicating  risk is a 
social process that goes beyond science messaging and must take cultural attitudes, 
perceptions, and symbolic meanings into account (Krimsky and Plough  1988 ). 
Where profound value disagreements prevail, public health legitimately  prioritizes 
its core  values but cannot speak for everyone.  Stakeholder views require a fair hear-
ing, whether through media  research , stakeholder analysis, or direct solicitation of 
input from individuals, focus groups, or public meetings. By design, a fair, transpar-
ent ethical decision-making procedure can help determine what value tradeoffs are 
feasible and what values may be nonnegotiable. Such a deliberative procedure can 
help to gain public acceptance and become part of the justifi cation for a course of 
action. 
 To those accustomed to rigorous research methods and evidence-based  standards 
of practice, navigating the world of ethical values and rules can be perplexing. 
Values, as the term itself implies, manifest valences, that is, variable degrees of 
commitment or estimations of importance along a continuum. Individuals rank  val-
ues differently, change their rankings, and will alter their relative ranking of values 
in different contexts. The range of options for ethical rules are far more limited, 
namely, to obey or not obey. Nevertheless, the ethical rules governing particular 
situations also vary from country to country or even from jurisdiction to jurisdiction 
within a country. Despite this variability in values and ethical rules, reducing ethical 
judgment to mere opinion or to a consensus of opinion relative only to personal or 
cultural preferences would be a mistake. Ethical values and rules enjoy the approval 
of history, custom,  law , and religious tradition, but they also fi nd anchor biologi-
cally, psychologically, and socially in human life. Value judgments and ethical 
determinations, then, are not relative as much as correlative; that is, they correlate 
and resonate with these deeper roots of human life that we share. If humans indeed 
share a set of fundamental values, then ethical  confl icts primarily refl ect differences 
in prioritizing  values in a particular context, rather than a fundamental disagreement 
about values. This point of view provides grounds for optimism about the possibil-
ity of fi nding a deeper basis for understanding and mutual  respect , if not agreement, 
when ethical tensions surface. 
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1.3.2  Ethics  and  Morality 
 Although many use the terms ethics and morality interchangeably, we will distin-
guish the formal discipline of ethics from the common morality that guides every-
day actions and behavior. Morality refers to a society’s shared, stable beliefs about 
what is good and bad, right and wrong. Through upbringing and socialization, each 
generation passes this common morality to the next. Common morality envelopes 
the individual like an ecosphere of shared customs, rules, and  values . For most cir-
cumstances, people habitually rely on this common morality to guide their conduct, 
and it serves them well, just as  standard practice generally serves  professional prac-
titioners well. Still, common morality can fall short where its rules  confl ict , where 
it inadequately illuminates novel moral problems, or where intense disagreement 
prevails among rival  stakeholder s. In such instances, the formal discipline of ethics 
offers a deliberate, systematic way of addressing troubling moral issues,  confl icts , 
and  dilemmas . Ethics can assist in:
•  Recognizing ethical issues and distinguishing them from factual issues; 
•  Providing a vocabulary to systematically discuss ethics; 
•  Identifying appropriate ethical  principles to guide action in a particular context; 
•  Using these principles to analyze actions in regard to their ethical acceptability; 
•  Understanding the competing moral claims and  values of  stakeholders ; 
•  Designing alternative courses of action that incorporate these claims and 
values; 
•  Evaluating which alternative best fi ts a given context, all things considered 
•  Establishing a procedurally just, transparent process for decision making; and 
•  Justifying decisions regarding recommendations, policies,  or  intervention s. 
1.3.3  Ethical  Principles 
 Principles are general categories, rules, or  guidelines that form the basis of a disci-
pline. In ethics, there are various kinds of principles and many examples of each 
kind. The kinds include basic ethical categories (e.g., virtues,  values , or rights), ethi-
cal commands or rules of conduct (e.g., not stealing, not harming, or treating others 
with  respect ), and  guidelines for weighing outcomes (e.g., achieving the greatest 
good for the greatest number, distributing burdens and benefi ts fairly, or properly 
proportioning benefi t to harm). Ethical principles like  justice or respect for  auton-
omy are simultaneously values, ideals, and the basis for deriving rules of conduct. 
Such rules serve as  ethical standards to evaluate past and pending actions, programs, 
and policy  recommendations . When addressing complex or controversial issues or 
issues involving numerous  stakeholders , many different principles can come into 
play. But because ethical decision making depends on context (e.g., on local circum-
stances, community stakeholders, and decision makers), no formula can determine 
the most relevant ethical principles. Nevertheless, most ethicists and practitioners 
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working in a fi eld would agree that certain principles, theories, or frameworks pro-
vide more helpful guidance for that fi eld. Given the need for fl exibility, some prefer 
to speak not of ethical principles but of “general moral considerations” that can 
provide guidance in public health practice (Childress et al.  2002 ). At any rate, a 
complex ethical challenge involving stakeholders with competing moral claims fre-
quently demands consideration of a variety of ethical  principles and theories to 
address the situation and justify a proposed intervention. For these reasons, it will 
be useful both to examine below several ethical theories used in public health ethics 
and to provide at the end of the chapter a framework that is generally applicable to 
ethical issues that arise in public health. 
1.3.4  Ethical Theories 
 As used here, an ethical framework refers to a tool or approach for practically 
addressing ethical challenges that often includes a stepwise procedure. An ethical 
framework may rely heavily on just one ethical theory, but frameworks generally 
take a pragmatic approach that procedurally allows for using a variety of theories or 
principles as the issue or context demands. Whereas an ethical framework has a 
practical orientation, an ethical theory also addresses more fundamental questions, 
so-called “metaethical” questions. Does  morality originate in divine command, 
human nature, or human convention? Is it essentially a habit, intuition, form of rea-
soning, or a quality or purpose of an action? An ethical theory will offer a distinct, 
coherent understanding of the source and nature  of  morality that will shape how one 
reasons about moral issues and determine which  principles are most important. Two 
persons employing the same theory, however, will not necessarily reach the same 
conclusion about an ethical issue; much will depend on which aspects of the issue 
they deem most important and on how they weigh different factors. Nevertheless, 
because a particular ethical theory tends to favor certain principles or types of prin-
ciples, using the same theoretical approach will lead to similar lines of reasoning 
and selection of  principles . 
 The  diversity of ethical theories does not imply their mutual opposition so much 
as points to the extensive range of the moral landscape and the need to illuminate its 
various contours. A helpful way of illuminating this landscape is to distinguish 
theories depending on whether they focus on the actor, the action, or the results of 
action. To illustrate this particular way of carving up the moral landscape, Table  1.1 
describes some well-known ethical theories.
 Aristotle’s virtue ethics is an ethical theory that focuses on the moral character of 
the actor or agent (Bartlett and Collins  2011 ). Classic virtues are dispositions or 
stable patterns of behavior that lie between extremes of vice; courage, for example, 
lies between the extremes of cowardice and foolhardiness in taking risks. Habit and 
practice are necessary to develop virtues whose possession we equate with good 
character and that equip a person to be effective in society or an organization. 
Because good character translates into virtuous action that others aspire to emulate, 
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we tacitly invoke virtue ethics whenever we ask how an outstanding public fi gure or 
health leader would handle a situation. In a modern  professional context, virtues 
also include the skills the profession has identifi ed that lead to success in that pro-
fession and which professional education and training instill in practitioners. Once 
established, virtues readily become the  standards of  obligation and  accountability to 
evaluate professional performance and function similarly to the rules and  principles 
of  duty discussed below. Holding public health institutions accountable for the pro-
fessional competence of their employees illustrates virtue ethics (Public Health 
leadership Society  2002 ). More recently,  th e capabilities approach has exploited the 
potential of virtue ethics to guide decisions about  policy or interventions in a way 
that goes beyond matters of professional training and responsibilities. This approach 
takes a broader developmental view of human agency and capacity building. It con-
ceives health as a fundamental capability necessary for individuals to succeed in 
society, one on which many further capabilities depend (Sen  2009 ; Ruger  2010 ). 
 An ethical theory that focuses on action or, more properly, the rules governing 
action, is deontology. The word deontology comes from the ancient Greek word, 
 deontos , which means duty. Because duties oblige us to obey rules that govern 
actions or conduct, they bind or constrain the will ahead of action. In judging 
whether an action is right or wrong, deontology ignores consideration of harmful or 
benefi cial consequences and relies on these rules of  duty to serve as the  standard of 
judgment. People usually have rules of duty or  obligation in mind when they speak 
of  ethical standards or worry that standards are breaking down. Examples of these 
rules include religious commandments to honor  parents , not lie, or not steal and 
 Table 1.1  Ethical theories 
 Theory  Agent-centered  Deontology  Utilitarianism 
 Focus  Agent  Action  Result of action 
 Key fi gure  Aristotle  Immanuel Kant  John  Stuart Mill 
 Main 
concept 
 Virtues : Acquired habits, 
skills, or dispositions that 
make people effective in 
social or professional 
settings 
 Duties : Ethical rules or 
commands that constrain 
one’s action or defi ne 
 obligations owed to 
others 
 Results : Good or bad 
outcomes of actions and 
policies or their 
benefi cial or harmful 
effects on individuals 
and society 
 Examples  Honesty, courage, 
modesty, trustworthiness, 
transparency, reliability, 
and perseverance 
 Ethical and religious 
commandments, 
obligations to seek justice 
or respect persons and 
their rights 
 Burdens, risks, harms, 
or  costs versus the 
benefi ts, advantages, or 
savings resulting from 
interventions or policies 
 Ethical 
action 
 Doing what a virtuous 
person would do in a 
given situation 
 Fulfi lling an obligation or 
 duty owed to oneself or 
society 
 Maximizing the net 
balance of benefi ts over 
harms 
 Uses  Assessing skills and 
capacities needed for 
success in a community, 
organization, or 
profession 
 Establishing  compliance 
rules and regulations, and 
setting standards for 
evaluating actions and 
behavior 
 Conducting population- 
level cost-benefi t, 
risk-benefi t, or 
 cost-effectiveness 
analyses 
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rules of social interaction such as treating people fairly, doing them no harm, or 
respecting their rights. Rights often are said to stand in reciprocal relation to duties. 
Thus, the right to free speech presupposes a duty to  respect the right of others to 
speak or the public health  obligation to ensure conditions for maintaining health 
presupposes a  right to health . 
 Deontology as a theory owes most to  Im manuel Kant’s view of the “good will” 
and his closely linked account of  autonomy . A person of morally good will does the 
right thing for its own sake, which means acting purely for the sake of duty.  Duties 
are moral rules or  laws that bind the will and limit the scope of action. For Kant, 
basing decision for one’s action solely on duty without regard to the potential good 
or bad consequences of the action is the only legitimate basis for moral action. Kant 
even goes so far as to say that “a free will and a will under moral laws are one and 
the same” (Gregor et al.  2012 ). 
 Kant conceives duty as the quintessential expression of  autonomy , which may 
come as a surprise to those who equate autonomy with rational free choice or even 
just following one’s preferences without interference. However, the meaning of 
autonomy for Kant derives from its literal meaning in Greek,  autos (self) and  nomos 
( law) ; namely, self-legislating. Autonomy enacts from within the moral rules and 
 principles that bind the will and guide action. However, not every self-originating 
impulse should be obeyed; only actions conceivable as universal laws morally bind 
the will. Morally laying down the law for oneself entails legislating for everyone, 
but universally legislating does not mean asserting one’s will over others. Nor does 
it mean that the ethical content of a moral law or duty is valid eternally and every-
where. Rather, it refers to the “categorical imperative” an unconditional require-
ment for an action to be moral. To qualify as a duty, a rule that commands action 
must apply to every rational person. Stealing, for example, could never qualify as a 
 duty , because a situation where everyone steals from everyone else would undercut 
the one-sided advantage of stealing that the thief hopes to exploit. Although self- 
directed, autonomous action is necessarily other-regarding. 
 Kant maintains that the categorical imperative can be expressed in two other 
ways equivalent to universality, namely, “respect for humanity” and a “kingdom of 
ends” (Gregor et al.  2012 ). In each, this other-regarding dimension of autonomy is 
evident. Respecting humanity means never treating persons as mere means or 
objects but always treating them as ends, that is, regarding them as fellow autono-
mous agents. Autonomously agreeing on actions, interventions, or policies requires 
that decision makers mutually consider and understand their reasons for action and 
be willing to abide by the rules derived from these reasons as  laws they collectively 
impose upon themselves (O’Neill  2002 ). 
 The idea of a fellowship of mutual consideration comes out most clearly in 
Kant’s concept of a kingdom of ends. This concept is really the ideal of a systematic 
union or commonwealth of autonomous individuals making  law s that apply to 
everyone. This ideal presupposes that ethical deliberation places  respect for others 
as ends, as autonomous agents, above self-interest. The core idea is that we only 
consider actions that could gain acceptance by a community in which all see them-
selves as sovereigns who lay down universal laws binding on themselves and others. 
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The hope is that the body of  law governing society progressively embodies this 
ideal. Such mutual regard in laying down the moral laws that will bind one’s actions 
differs signifi cantly from insistence on noninterference with individual free choice, 
let alone with personal preferences. Conversely, the aspiration behind Kant’s view 
of  autonomy harmonizes well with the public health  obligation to address collective 
problems through collective action. 
 For  utilitarianism , judging the rightness of an action depends on an estimation of 
its subsequent practical outcome or result rather than on its conformity to  principles 
of  duty . Utilitarianism considers ethically best that course of action that will result 
in the greatest  net benefi ts over harms. A utilitarian approach underlies cost-benefi t 
analyses that weigh an intervention’s  costs ( risks , harms, burdens, or disadvantages) 
against its benefi ts (advantages, utility, improvements, cost savings). In addition to 
its focus on consequences, utilitarianism is egalitarian, communitarian, and scien-
tifi c in outlook. It is egalitarian in considering everyone’s benefi t and equally 
weighting each person’s good, as opposed to privileging certain people. It is com-
munitarian in attempting to increase benefi ts to society rather than individuals, 
seeking the “greatest good for the greatest number.” It endeavors to be scientifi c by 
quantifying harms and benefi ts, accounting for probability, and calculating net ben-
efi t. Calculating net benefi ts over harms is less problematic when relevant factors 
employ a common scale of measurement, for example, weighing the fi nancial costs 
of treating a disease with the cost savings from preventing that disease. Comparing 
different outcomes (e.g., fi nancial costs versus quality-adjusted life  years ) some-
times involves diffi cult judgments about the relative value of each outcome. Because 
the utilitarian approach seeks to determine and promote the collective good based 
on aggregate measures, it readily lends itself to justifying public  health 
interventions . 
1.3.5  Law Versus Ethics 
 Laws share certain deontological features with ethical  principles of action (and with 
religious commandments). They all defi ne one’s  obligations or  duties and typically 
take the form of rules or commands regarding what one should or should not do. 
They can lay down positive requirements to fulfi ll but more commonly establish 
parameters that prohibit certain actions or constrain  liberty in some way. Laws do 
not differ from ethical rules primarily based on content, because an ethical rule can 
become a law without changing the rule’s content. For Kant, at least, the crucial 
difference between ethics and law concerns one’s reason for obeying; namely, 
whether one acts purely voluntarily out of a sense of  duty or merely in external 
conformity with duty, either to appear to be moral or out of fear of penalty or pun-
ishment. Laws are rules enforced by penalty or punishment, which many people 
might otherwise break. Society can tolerate the fl outing of some rules, but disobedi-
ence of more important rules can disrupt society or create danger. For these reasons, 
society establishes and enforces laws regarding socially important matters, not 
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leaving their  compliance up to individual prerogative. An ethical rule’s enactment as 
law, therefore, implies agreement by society or the law’s enactors on the importance 
of strictly regulating the behavior the law governs. Law can be a blunt instrument 
that effectively compels compliance, which suffi ces to satisfy the reasons for its 
enactment, even if it cannot coax  voluntary obedience from an inward sense of duty. 
 In theory, deontologically evaluating a past or proposed action is a straightfor-
ward binary determination of compliance or noncompliance with a legal or ethical 
rule. In practice, however, defi ning a rule’s scope or determining exactly which 
actions fall under it can prove diffi cult. Moreover, when different rules apply, deter-
mining which should take precedence often becomes problematic, especially when 
they  confl ict . Lying to protect a relative, for example, can put the  duty to speak 
truthfully into confl ict with familial  obligations . Determining which rule takes pre-
cedence can involve reasoning clearly from ethical  principles , weighing the under-
lying  values embodied in the  law , or considering the practical impact of the 
intervention in context. Because laws demand  compliance , they are more rigid. 
Additional legal stipulations can  prioritize or specify how to apply laws in certain 
situations, but doing so increases their complexity. Ethical  guidelines operate more 
fl exibly than rigid, compulsory laws and more readily accommodate compromise. 
With ethical guidelines, decision makers can consider and rank the underlying val-
ues the ethical rules serve to promote. Doing so allows for trade-offs between com-
peting ethical considerations and for deciding which values it makes sense to 
prioritize in the given context. Conversely, law’s comparative rigidity can be a virtue 
where only stricter oversight and  enforcement will ensure compliance and establish 
order. 
 Across cultures, legal, ethical, and religious rules prohibiting basic offenses such 
as lying, theft and murder show considerable overlap. However, cultures vary in 
exactly which rules are matters of individual choice and which are matters of legal 
enforcement and punishment. This variability also applies to the status of rules and 
standards governing  research on human subjects. Even within a country, signifi cant 
variability can prevail in whether human subjects’ research rules and  standards are 
legal  regulations or ethical  guidelines (U.S. Department of Health and Human 
Services  2015 ). Some  se e the lack of legal regulation as a breach in protections, but 
others prefer guidelines, arguing that regulations tie reviewer hands, making it more 
diffi cult to make trade-offs or nuanced judgments based on moral discernment of 
the particulars of each case (Verweij and Dawson  2009 ). Because each approach 
offers advantages and disadvantages,  political culture and local context must ulti-
mately decide whether human subjects’ research rules exist as enforceable regula-
tions or ethical  guidelines . 
 Regardless of whether it takes the form of guidelines or  law ,  research ethics will 
govern only a fraction of the ethical issues that the fi eld of public health must 
address. In many areas of public health practice, there are no specifi c ethical  guide-
lines or  regulations . To address ethical challenges in these areas or to address emer-
gent challenges, the ethical practice of public health therefore requires the ability to 
use general ethical frameworks. Such frameworks can employ checklists of ques-
tions and stepwise procedures. However, because novel challenges continually 
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emerge and changing contexts introduce nuances no set of rules can anticipate, pub-
lic health  professionals ultimately need to practice ethical decision making over 
time in order to cultivate moral judgment and discernment. 
 By laying down and enforcing what may, must, or cannot be done, legal rules 
function as boundaries of acceptable behavior. Ethics, science, budgets or politics, 
each in its own way, also can restrict the scope of action. Public health practitioners 
and offi cials therefore fi rst need to conduct a feasibility analysis to determine the 
relevant limits on possible interventions or policies. Determining these limits sel-
dom will restrict the scope of action to a single possible course. Given multiple 
possibilities, most people will aspire to the best course of action beyond the legal 
fl oor of minimally acceptable behavior yet within the other relevant limits. As a 
result, the ethical challenges public health practitioners face seldom involve stark 
choices between right or wrong, good or evil. A good feasibility analysis will have 
ruled out any unethical or illegal options or alternative courses of action in advance. 
Rather, the tough choices more frequently involve selecting the best alternative 
from among competing goods, each of which to a greater or lesser degree realizes 
the public health goal and embodies relevant  stakeholder values. 
 Whereas determining and complying with the various limits on action is largely an 
analytic process, designing alternatives is a synthetic, creative process. Alternatives 
should all realize the public health goal and incorporate the perspectives and  values 
of subject matter experts and relevant stakeholders. Deciding upon the best alterna-
tive must take into account how it will realize the public health goal in a particular 
context and with  respect to the stakeholders. For example, advocating contraceptives 
to reduce unwanted teen  pregnancy might seem to promise success based on effi -
cacy studies, but ethical controversy could render such a program less than optimal 
in some contexts.  Political culture  or  social  norms can confer partisan advantage or 
disadvantage to some alternatives, while other alternatives may enjoy an advantage 
because of the experience and expertise of a health department. Whatever alterna-
tive practitioners fi nally choose, their choice will presuppose a prioritizing of val-
ues. The foregoing account highlights why public health practitioners need to see 
ethics as something more than a  compliance matter. It transcends compliance 
because public health ethics also involves practical decision making, which should 
include stakeholder analysis, the incorporation of stakeholder values in the design 
of alternatives, and a fair, transparent deliberative process to evaluate alternatives. 
1.4  Public Health Ethics 
 Compared with more established fi elds of  practical ethics such as  clinical ethics , 
 research ethics , and  bioethics , the fi eld of public health ethics is relatively new. 
Consequently, many public health practitioners may be better acquainted with these 
more established fi elds than with public health ethics. In particular, practitioners 
may already be acquainted with the four  principles these fi elds rely on for ethical 
evaluation:  benefi cence ,  nonmalefi cence ,  respect for  persons ( autonomy ), and 
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 justice (U.S. Department of Health, Education, and Welfare  1979 ; Beauchamp and 
Childress  2012 ). Being applicable to health and  research , these four principles also 
are relevant to public health, but having arisen to address issues in other fi elds, they 
need to be adapted to a public health context. Even then, they still fall short in 
addressing the ethical challenges that arise in public health. Examining these related 
ethics fi elds and showing how the four principles fi t into a public health context can 
serve by way of contrast to indicate what is distinctive about public health ethics. 
1.4.1  Research Ethics , Clinical Ethics, and  Bioethics : 
 Principlism and the Four  Principles 
 Research ethics  entails the wider notion of scientifi c integrity but is best known and 
most developed in relation to medical research involving human subjects. The 
development of human subjects’ research ethics  guidelines can neither be divorced 
from breaches of ethical conduct in human subjects’ research nor wholly reduced to 
a reaction to these events. But beginning with the  Nuremberg Code ( 1947 ), balanc-
ing  risks and benefi ts to research subjects and getting their  informed consent have 
been cornerstones of international  research ethics guidelines. Far more infl uential 
than the  Nuremberg Code , the  Declaration of Helsinki from the World Medical 
Association (WMA) is a fundamental document in international human subjects’ 
research ethics  guidelines . Its initial 1964 version included provisions for proxy 
 consent for those with diminished  autonomy . Its 1975 revision called for review of 
 research by an independent committee, now known as an  ethics review committee 
(WMA  1964 , 1975, 2013). The use of such committees began spreading under the 
aegis of WHO and then in response to the  HIV/AIDS pandemic, as the number of 
large-scale  vaccine and  drug trials grew in developing countries. In the  United 
States , research  regulations set forth in the  Common Rule govern  ethics 
review committees as well as all human subjects’  research that receives U.S. 
government funding (U.S. Department of Health and Human Services  2009 ). In  the 
 United States, a standing ethics review committee generally functions within a 
specifi c governmental or university institution and therefore is referred to as  an 
 institutional review board (IRB). Beginning in 1982, the  Council for International 
Organizations of Medical Sciences (CIOMS) , in  collaboration with WHO, proposed 
 i nternational ethical  guidelines for  biomedical research involving human subjects 
(CIOMS  2002 ). 
 Our discussion of these documents has only highlighted key provisions of what 
is required to ensure the safety of human subjects. CIOMS’s most recent research 
 guidelines ( 2002 ), for example, contain more than 60 pages of text, explanation, and 
commentary. But ensuring ethical conduct and scientifi c integrity in  research 
requires more than the oversight function of  ethical review committees. It also 
requires extensive training not only in  research ethics but also in a number of related 
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areas. Training and guidelines should cover, among other things, mentoring of 
junior researchers, authorship and publications  policy ,  confl icts of  interest that arise 
in partnerships and collaborative science, and data acquisition, management, shar-
ing and ownership. Ethics training can help develop moral judgment. The hope is 
that training and application will enable practitioners to reason about new, diffi cult, 
or ambiguous cases in morally discerning ways. 
 Clinical ethics address the ethical issues that arise in clinical practice. Until the 
advent of  bioethics , medical professionalism emphasized the health care provider’s 
 obligation to  prioritize the patient’s welfare, the health care provider’s professional 
judgment about what would most benefi t the patient, and the importance of estab-
lishing patient  trust . The traditional model of  clinical ethics was frankly  paternalis-
tic . Under the infl uence of bioethics, many health care providers began embracing a 
more patient-centered model of care that emphasized patient  autonomy and 
 informed consent . This patient-centered model conceives care as a contract between 
patient and provider. The emphasis on contracts strikes some as an inappropriate 
consumerist model that undervalues  professional judgment and undermines patient 
trust in the medical profession. Tensions between these two models have led to a 
compromise that reasserts the importance of medical professionalism and clinical 
judgment, while acknowledging the importance of respecting patient autonomy 
(ABIM Foundation et al.  2002 ). 
 Bioethics has a range of meanings, the fi rst of which applies to ethical issues 
brought about by advances in biomedicine and  biotechnology . Ethical issues that 
arise from using life-sustaining technologies in end-of-life and beginning-of-life 
care  epitomize  this sense of bioethics. But bioethics also arose in response to medi-
cal  paternalism and to the abuse of human subjects in medical  research . Bioethics 
has championed  informed consent , patient autonomy in doctor-patient relationships 
and the  safety of human subjects in research. However, many bioethicists think the 
focus on  clinical ethics and on  personal autonomy unduly restricts bioethics’ pur-
view. They advocate a more holistic,  social justice approach in bioethics, which has 
been referred to as “population-based bioethics” or “integrative bioethics” (Sodeke 
 2012 ). It can be argued that this expansion of bioethics beyond  clinical ethics into 
population issues moves bioethics into the arena of public health ethics (Callahan 
and Jennings  2002 ). 
 Principlism came into being in a 1979 document called the  Belmont Report 
(U.S. Department of Health, Education, and Welfare  1979 ). The report was the work 
of the U.S. National Commission for the Protection of Human Subjects of 
Biomedical and Behavioral  Research , which convened in 1974 partly in response to 
the exposé of the  U.S. Public Health Service Tuskegee  Syphilis Study. The  Belmont 
Report became the basis for revising 45 CFR 46, the so-called  Common Rule , part 
of the legally binding U.S. Code of Federal Regulations, governing the protection of 
human subjects (U.S. Department of Health and Human Services  2009 ). The 
 Belmont Report clearly explained the underlying ethical  principles that informed 
existing  regulations and provided an ethical framework for thinking about subse-
quent regulations. Principlism has remained the predominant ethical framework in 
biomedical ethics (Beauchamp and Childress  2012 ). Its explanatory groundwork 
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accounts for much of its success, but its relevance to medicine and  research , the 
prestige that attaches to these fi elds, and its compatibility with liberal  individualism 
also have played a role. 
 Benefi cence (doing good) and  nonmalefi cence (doing no harm) date back to the 
Hippocratic Oath as medical principles. Collapsing them both into benefi cence, as 
the  Belmont Report does, underscores the practical consideration that  biomedical 
decisions generally aim to optimize  net benefi t over harm, rather than to maximize 
only benefi ts or minimize only harms or  risks . However, these  principles are dis-
tinct, not mere opposites. Not doing harm has a certain priority (fi rst, do no harm), 
because not benefi tting someone seems a less serious offense than doing that person 
harm. That priority partly refl ects the human tendency more readily to forgive over-
looked benefi ts (errors of omission) than deliberate actions resulting in harm (errors 
of commission). 
 Justice has several meanings that include due process and fair deliberative proce-
dure, properly assessing what people are owed or due, and equitable distribution of 
burdens and benefi ts. According to philosophic tradition, justice has always func-
tioned dually, applying to individuals but more importantly serving as an overarch-
ing principle for adjudicating competing claims in relation to the group or to other 
members of society. The phrase, “ social justice ,” then, is redundant but in  political 
contexts marked by  individualism serves as a reminder of justice’s social dimen-
sion. In fact, this phrase came into vogue in public health circles to counter the 
ideology of “market justice,” which views the equal access of individuals to the free 
market as a valid, reliable, and preferred means for sorting out issues of economic 
and social justice (Beauchamp  1976 ). The notion of health  equity , which compares 
different groups, primarily refers to this social dimension of  justice , although denial 
of access to health care, a contributing factor to  health inequity , violates what the 
individual is owed. 
 Respect for persons emphasizes that individuals, as agents in charge of their own 
lives and bodies, have the right to make decisions and choices free from undue 
interference.  Respect for persons forms the basis of  informed consent , namely, the 
right of patients and human  research subjects to be informed of, and to  assent to, 
medical or research procedures they might undergo, especially procedures that pose 
potential harm or  risk . Conducting research  on  human subjects or performing medi-
cal procedures on patients without their prior knowledge or  consent in most cases 
violates their  personal autonomy . However, health  professionals have a special (i.e., 
paternal)  obligation to look out for the welfare of people with diminished decisional 
capacity—such as those in a coma or the very young—and to protect them from 
harm. 
 These four  principles were originally conceived as  prima facie principles, that is, 
each expressed a self-evident though not absolutely binding  obligation and none 
had an inherent priority over another. However, in many  Western countries and in 
the  United States in particular,  respect for persons has dominated discussion in  bio-
ethics , clinical ethics, and  research ethics where it often takes precedence as a moral 
consideration over the other principles. This ascendancy most likely refl ects the 
high value that these countries place on  liberty and  freedom . At any rate, in public 
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discourse generally and in public debate about public  health interventions ,  respect 
for persons often amounts to an insistence on noninterference with individual free 
choice or with personal preferences. Although Kant’s other-regarding idea of moral 
 autonomy , harmonizes well with collective decision making, the insistence on non-
interference with personal  choice often creates impediments to the implementation 
of public  health interventions . In part for this reason, the  social justice movement 
has had to challenge the emphasis on respect for persons in order to  promote the 
public good and health  equity . 
1.4.2  Contrast between  Clinical Ethics and Public Health 
Ethics 
 Table  1.2 contrasts the individual focus of clinical ethics with the community/
 population focus of public health ethics. Because public health and clinical practice 
can overlap, the items in the respective columns represent tendencies along a con-
tinuum rather than stark opposites. Where separate agencies carry out  public health 
services and medical care, these contrasts may be more pronounced. The overlap 
between public health and clinical practice makes it even more important to high-
light their differences to bring out distinctive features of public health ethics.
 The table makes clear that the Belmont principles of  benefi cence (seeking ben-
efi ts),  nonmalefi cence (avoiding harm),  respect for persons , and  justice remain 
important in public health, but must be extended to accommodate the broader scope 
 Table 1.2  Comparison of areas of focus/tendency in  clinical ethics and public health ethics 
 Clinical ethics focus/tendency  Public health ethics focus/tendency 
 Treatment of disease and injury  Prevention of disease and injury 
 Medical interventions by clinical 
professionals 
 Range of interventions by various professionals 
 Individual benefi t seeking and harm 
avoidance based on health care provider’s 
fi duciary relation to a patient 
 Social, community, or  population benefi t 
seeking and harm avoidance based on collective 
action 
 Respect for individual patients  Relational  autonomy of interdependent citizens 
 Professional  duty to place the interests of the 
patient over that of provider 
 Duty to the community to address health 
concerns that individuals cannot solve and that 
require collective action 
 Authority based on the prestige and 
trustworthiness of the physician and the 
medical profession as a whole 
 Authority based on  law , which is a principal tool 
of  public health policy for creating health 
 regulations 
 Informed consent sought from an individual 
patient for specifi c medical interventions 
 Community  consent and building a  social 
consensus through ongoing dialogue and 
 collaboration with the public 
 Justice concerns largely limited to treating 
patients equally and ensuring  universal 
access to health care 
 Central concern with  social justice regarding 
health and achieving  health equity 
1 Public Health Ethics: Global Cases, Practice, and Context
24
of public  health interventions . This broader scope entails many types of  profession-
als , interventions and policies that display a  political and social dimension, and a 
wider range of activities such as community engagement,  intersectoral  collabora-
tion , collective decision making, and governmental administration. As a result, pre-
vailing political philosophies and culture will necessarily shape the way public 
health functions. The crucial point is that differences of scale that produce a higher 
order of complexity also produce qualitative differences that introduce different pat-
terns of causation. Among other things, this means that social factors do not merely 
represent aggregated individual factors and so cannot always be addressed in the 
same way as individual factors. 
1.4.3  Individual Versus Relational  Autonomy 
 For understanding what is qualitatively distinct about public health, the contrast 
between  respect for individual persons and the relational autonomy of community 
members is key.  Respect for persons upholds an individual’s right to make  indepen-
dent decisions free from undue pressure, but relational autonomy emphasizes that 
individual actions occur in the context of other people whom these actions will 
affect. The potential harmful impact of individual action on the welfare of others 
sets a limit to individual action. Relational autonomy draws attention, then, to the 
 interdependence of people living in communities and to the  solidarity that arises 
from the emotional bonds that shared lives create. Anthropology teaches that people 
always fi nd themselves in a network of social relations, while evolutionary biology 
has shown how profoundly people are built from the physiological ground up as 
sociopolitical beings. Because it presupposes the social context of language and 
reasoning ability, individual autonomy also depends developmentally on relational 
autonomy. That is, people only become autonomous through relations and interac-
tions with others. As African humanism (ubuntu philosophy) epitomizes it,  umuntu 
ngumuntu ngabantu , “a person is a person through other persons” (Louw  2008 ). 
Familial and communal deliberate processes are foundational for the development 
of individual autonomy and provide an even deeper basis for collective decisions 
than the type of solidarity that comes to the fore in crises or in the face of common 
predicaments. Kant would reject any suggestion that developmental context, emo-
tional bonds or feelings of solidarity underpin moral autonomy. Nevertheless, moral 
autonomy and relational autonomy both display an inner-directed, but other- oriented 
feature that readily aligns with collective decision making. 
 These points about the foundational character of social relatedness,  solidarity , 
 interdependence , and communal decision making do not readily align with certain 
features of  social contract theory , on whose  principles liberal democracy is based. 
Whereas virtually every other  political tradition conceives the sociopolitical realm 
as a natural feature of human life,  social contract theory posits humankind’s original 
state, the state of nature, as one of solitary  individualism . In this view, society or at 
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least civil society come into existence voluntarily through a contract that creates 
 government through the  consent of the governed (Riley  1982 ). Although never seri-
ously advanced as a scientifi c account of society’s origins, social contract theory 
nevertheless has exerted a powerful infl uence as a  political founding myth. As such, 
it has made personal  liberty , free choice, and consent of the governed presumptive 
 values of societies whose governing political philosophy rests on social contract 
theory. By “presumptive,” we mean that the value,  norm , or claim is assumed to be 
valid or have priority, so that the onus is on the person who objects to the presump-
tion to justify a different value, norm, or claim. 
1.4.4  Personal Autonomy as a  Presumptive Value of Liberal 
Democracy 
 Personal autonomy in a clinical and  research context generally means  respect for 
the patient’s right to receive an explanation of a medical procedure or research inter-
vention, to be informed of any potential benefi ts or harms, and to freely choose 
whether to accept the procedure or participate in the research. More generally and 
in other contexts, personal autonomy has come to mean an insistence on  liberty , free 
choice, and noninterference with personal preferences. Personal autonomy in this 
more general sense owes more to John Stuart  Mill’s nineteenth-century views on 
 liberty than to Kant’s eighteenth-century idea of autonomy (O’Neil  2002 ; Dawson 
 2011 ). An important aspect of Mill’s view of liberty is the “ harm principle ,” which 
holds that “the only purpose for which  power can be rightfully exercised over any 
member of a civilized community, against his will, is to prevent harm to others” 
(Mill  1989 ) . What people choose to do regarding themselves is no business of  gov-
ernment . Interfering with this private sphere of self-determination constitutes gov-
ernmental  paternalism . This interference diminishes the sphere of  liberty that 
affords individuals the chance to direct their own lives and develop their talents and 
character to the highest degree. A chief advantage of democratic society, one that 
benefi ts the entire society, is the creative social dynamism that emerges from the 
synergism between individuals who are developing their talents and abilities. 
 Arguably, the primary aim of the  harm principle is to promote the kind of indi-
vidual self-development that benefi ts society rather than to champion every exercise 
of free choice. At any rate, some have sought to distinguish this edifying version of 
 personal autonomy from an all-encompassing version that demands undue defer-
ence to any and all personal  choices and preferences merely because they are per-
sonal (O’Neill  2002 ; Dawson  2011 ; Powers et al.  2012 ). Presuming, or insisting on, 
the validity of  personal autonomy makes more sense in the delimited context of 
medicine and  biomedical research on human subjects where an individual’s body is 
the focus of activity. It makes less sense in the far wider sphere of public health 
activity where social interactions and the  interdependence of people come into play. 
Absolutizing  personal autonomy in the sphere of public health would give effective 
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veto  power over every collective decision aimed at the public good to any individual 
who felt constrained by that decision. A more moderate version might distinguish 
levels of importance of personal choices and exercises of  liberty . A collective deci-
sion concerning the public good could override some personal choices and limit 
liberty, even when they did not involve direct harm to others. Such decisions, when 
made in the context of a fair, transparent process of ethical deliberation involving 
 stakeholders , are more likely to get buy-in from a community and less likely to be 
labeled  paternalistic . 
 Because public health considers the relation between individuals and the collec-
tive good, it necessarily has a  political dimension. How a country’s political culture 
balances this relation will drive and constrain public health practice and so shape the 
nature of the ethical frameworks that are appropriate to a country’s politics (Hyder 
et al.  2008 ). In the brief history of public health ethics, the most important  ethics 
frameworks have emerged in the political context of liberal democracy. Many of 
these frameworks refl ect the tensions between public health’s  obligation to act col-
lectively for the common good and the  presumptive value of  personal autonomy . 
The  principle of  least infringement and Kass’s  code of restraint illustrate the effort 
to mediate such tensions (Kass  2001 ). The code of restraint strives to balance  auton-
omy claims against the  obligation to safeguard  community health by determining 
what intervention most effectively protects health while minimally infringing on 
 liberty . In a liberal political context that recognizes Mill’s  harm principle , this strat-
egy justifi es the trumping of  personal autonomy as long as imminent harm threatens 
the populace, for example, in a deadly outbreak of contagious disease. But where 
the threat of harm to others is indirect or not immediate, as with the  obesity epi-
demic, the  harm principle less readily justifi es a liberty-limiting intervention such as 
banning or taxing certain foods. Utilitarian approaches that weigh the health advan-
tages of intervention and the disadvantages of obesity clearly support obesity inter-
vention, but limiting interventions to those that do not restrict personal  choices also 
have limited  effectiveness . In Chap.  6 , Jennings considers the relative merits of 
these approaches in his overview of the ethical issues in environmental and occupa-
tional public health. His discussion raises the question of the extent to which an 
ethical framework should adapt itself to the presumptive  values of the  political con-
text or should refl ect the nature of the practical fi eld under investigation. To some 
extent, it must do both. 
 The three-step framework offered in the next section is designed to guide deci-
sion makers, through questions, to assess the ethical dimensions of a case, including 
which moral considerations (e.g.,  population utility or  liberty ) may have more 
weight than others, given the issue or context. This contextual approach provides 
the fl exibility and starting point for deliberation to accommodate the issues globally 
and to uncover the varying perspectives of  stakeholders with potentially different 
presumptive moral  norms (e.g.,  solidarity versus  individual rights ). 
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1.5  Ethical Frameworks 
 What at fi rst glance demarcates public health ethics from related fi elds of health 
ethics are the ethical problems that public health  professionals typically encounter 
in their practice and the ethical frameworks used in practice to address these prob-
lems. Regarding these ethical problems, this casebook offers a representative, but 
not exhaustive, sample. Regarding ethical frameworks, this chapter has suggested 
two competing criteria for choosing. On the one hand, ethical frameworks should be 
grounded in their topics. Dawson ( 2011 ) expresses the point succinctly by arguing 
that public health should be the foundation of public health ethics. Accordingly, we 
have presented a view of public health ethics that builds on the defi nitions of public, 
health, and public health, and on the goals of public health practice. But we have 
also defi ned ethics and indicated how public health ethics draws on numerous ethical 
theories and can provide a moral guide grounded in the  norms of benefi ting others, 
preventing harms, and providing utility. We have pointed out its distinguishing 
 principles based on the facts of community and  interdependence . Lastly, we have 
situated public health ethics within the process of ethical decision making about 
which options are the most justifi able means to achieve public health goals in a 
particular context. In the end, grounding public health ethics in public health may 
require public health leaders to have the courage to advocate public health  values 
and goals, even when that position is unpopular. Such a stance may be justifi ed, for 
example, where the feasibility of a much-needed public  health intervention requires 
a long- range strategy to change social  norms or build  social consensus . 
 On the other hand, precisely because public health itself is practical, pragmatic, 
and community oriented, an ethical framework designed for it must accommodate 
itself to a country’s  presumptive values and  political culture. This consideration 
illustrates that the feasibility of public  health interventions usually depends on their 
alignment with the political culture, while their success usually implies public 
acceptance. Many established frameworks, like that of Kass, seem designed with a 
liberal political context in mind that gives presumptive weight to  individual liberty , 
which may limit the range of interventions that can be justifi ed. Newer approaches 
to ethical analysis in public health place more emphasis on social values like  equity 
and  solidarity , although these newer approaches often are diffi cult to put into practice 
(Lee  2012 ). In addition, while newer approaches may offer clear reasons to justify 
a broader range of interventions, the reasons may be less persuasive if they do not 
consider the presumptive  values in context. For example, in Chap.  3 , Daniels dis-
cusses the ethical  confl icts that arise during  pandemics between the  standard goal of 
improving  population health and emergency contexts that demand allocating scarce 
resources in a way that treats people fairly. He asks, if in the pandemic context we 
believe that saving the most lives trumps giving priority to those who are sickest, 
can we justify revising the usual priority given to the sickest in health care? 
 Arguably, what would be most useful is not a set of frameworks designed for 
specifi c presumptive  values , but, rather, a framework that can accommodate any 
presumptive values and consider them in relation to values rooted in public health 
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or in context. The three-step framework that follows is a straightforward tool to help 
practitioners analyze the ethical tensions in a particular context. It addresses 
Daniels’ tough question directly by considering health care’s presumptive prioriti-
zation of the sickest in relation to the public health value of saving the most lives in 
a  pandemic . 
1.6  A Three-Step Approach to Public Health Decision 
Making 
 We offer the following framework, drawn from public health practice and described 
by Bernheim et al. ( 2007 ), as an example of an analytic tool that can guide decision 
makers through reasoning and deliberation. It is not meant to introduce a rigid 
application of ethical principles, nor does it presume that any one moral  norm has 
greater weight that trumps other norms. Instead, the questions are designed to help 
decision makers clarify whether a particular moral norm (e.g.,  solidarity or  liberty 
or  equity ) is weightier than others in context, and if so, then strong reasons must be 
offered to override the presumptive moral  norm . For example, during an epidemic, 
equity may carry presumptive weight and trump other moral  norms in some con-
texts. Ethicists at the Joint Centre for  Bioethics offered the following insight from 
the SARS experience:
 In the case of an epidemic, it is important to control the spread of the disease, but as much 
attention should be paid to the rights of the noninfected patients who need urgent medical 
care. There may be as many people who died from other illnesses and could not get into 
hospital as there were who died from SARS.  Equity is required in the amount of attention 
given to a wide array of people, including patients with and without SARS. Accountability 
for making  reasonable decisions, transparency and  fairness are expected …. (Singer et al. 
 2003 ) 
 The questions clarify the relevant factors, such as stakeholder claims, alternative 
actions, and possible justifi cations for deciding on one course of action. 
1.6.1  An Approach to Ethical Analysis and Justifi cation 
in Context 
 Step I: Analyze the Ethical Dimensions of the Public Health Issue and Context
•  What are the  risks , harms, or concerns? 
•  What are the appropriate public health goals in this context? 
•  What is the scope and legitimacy of legal authority, and which  laws and  regu-
lations apply? 
•  What are the moral  norms and claims of  stakeholders , and how strong are 
they? 
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•  Are  precedent legal or ethical cases relevant for identifying the presumptive 
moral  norms ? 
•  Which features of the social-cultural-historical context apply? 
•  Do professional codes of ethics provide guidance? 
 Step II: Formulate Alternative Courses of Action and Evaluate their Ethical 
Dimensions
•  What are the short- and long-term options, given the assessment of the public 
health issue and context in Step I? 
•  What are the ethical dimensions and tensions of each option?
 –  Utility: Does the public health action produce the best balance of benefi ts 
over harms and other  costs ? 
 –  Equity and  Justice : Is  health equity advanced? Are the benefi ts and bur-
dens distributed fairly ( distributive justice )? Is there appropriate public 
 participation , including the participation of affected parties ( procedural 
justice )? 
 –  Respect for Individual and Community Interests: Does the public health 
action respect  self-determination and  human rights , as well as civic roles 
and community values (e.g., trustworthiness,  solidarity ) (Dawson and 
Jennings  2012 )? 
•  Other Moral Considerations in Public Health: Are there other moral consider-
ations in public health that are important to consider? (For example, reciproc-
ity, solidarity, protecting  privacy and confi dentiality; keeping promises and 
commitments; or disclosing  information and speaking honestly, sometimes 
grouped as transparency.) 
 Step III: Provide Justifi cation for a Particular Public Health Decision
•  Effectiveness : Is the public health action likely to be effective? 
•  Proportionality : Will the probable benefi ts of the action outweigh the infringed 
moral considerations? 
•  Necessity: Is the action necessary (i.e., will overriding a confl icting ethical 
 norm achieve an important public health goal)? 
•  Least Infringement : Is the public health action the least restrictive means 
available? 
•  Public Justifi cation: Can decision makers offer public justifi cation in the 
 political and cultural context that  stakeholders , the public, and those most 
affected fi nd acceptable? 
 Consider the following scenario described by Melnick ( 2015a ). A family adopted 
several  children from a developing country with a high  tuberculosis (TB) preva-
lence, including  multidrug-resistant TB (MDR-TB) .  Screening on arrival revealed 
that the children were infected with TB but did not have active disease and were not 
contagious. The family has strong religious beliefs about medical care and refused 
 treatment , immunizations, and other preventive care. The children were home- 
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schooled, but they did attend community activities. Soon after arrival one of the 
teenage children developed TB symptoms, and after several months the family con-
sulted a pediatrician who diagnosed active pulmonary TB. Cultures revealed that 
the child had MDR-TB. Directly observed treatment (DOT) is part of the  standard 
of care for active TB in the  United States , and the local health department nurse 
visited the family to provide DOT. The  parents objected to the home visit, stating 
that DOT was an invasion of their  privacy and parental rights. The health depart-
ment has the statutory authority to require in-person DOT and even impose isolation 
of the case and removal from the family to protect the public’s health. What should 
health offi cials do? Drawing on questions in Step I, health offi cials might fi rst clar-
ify the harms and  risks and the goals of public health action. The public health goals 
are to prevent TB transmission and ensure the child receives appropriate care. 
Requiring DOT creates risks for the child such as side effects from treatment and 
social and behavioral harms associated with isolation and loss of  privacy during 
visits, and potential community harm, by driving cases underground. Who are the 
 stakeholders , and what are their moral claims?
 There are several stakeholders: the child, the child’s family (including  parents but also sev-
eral siblings), and the public, which expects the health department to protect the community 
from TB. Regarding moral claims, the child has some expectations of  freedom of move-
ment, and  privacy ; the family has similar expectations regarding privacy,  respect for paren-
tal rights, and the  freedom to administer  medications to their child at a convenient time and 
place. However, these claims are not absolute, and competing moral claims can outweigh 
them. The child has a moral claim that could compete with her parent’s claim, specifi cally, 
that receiving DOT will reduce the  risk of inappropriate  treatment and relapse compared to 
having her  parents administer the medications. In addition, the public has a moral claim 
based on two expectations: ( 1 ) that the health department will protect the community from 
TB, and ( 2 ) that people contagious for TB and other  infectious diseases will protect others 
by behaving in an appropriate manner, including staying home when  contagious and coop-
erating with treatment recommendations. This is especially concerning in this case because 
the  immigration health offi cials had discussed the risks with the parents, warning them to 
seek treatment as soon as the child developed symptoms, yet the parents waited several 
months before taking the child to a pediatrician (Melnick  2015a , 175). 
 Consider another short scenario that illustrates the value of exploring options 
under Step II. A new  policy is being considered that would require  parental consent 
for newborn  screening .  Parental consent currently is not required, although newborn 
testing is not conducted if there are parental objections. The health department has 
been asked to take a position on the pending policy. What position should the health 
department take? What are the options? 
 Options include mandatory  screening without  consent , routine screening with 
advance notifi cation (Opt In), routine screening without advance notifi cation (Opt Out) 
(i.e., screening and testing done unless the  parents object),  voluntary screening (i.e., 
screening requires full consent and might also include a pre- and post- counseling 
session with each new mother). Some arguments that might be offered against 
requiring  parental consent focus on the fact that (1) the benefi ts of screening are 
obvious and substantial, relative to potential harms; (2)  parents have few good rea-
sons to justify parental refusal and place their child at  risk for harm; (3) obtaining 
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consent from each parent is diffi cult, costly, and an unwarranted expenditure of time 
and money; and (4) the history of  newborn screening has become acceptable and 
routine. Some arguments that may be raised for requiring  parental consent include 
(1) parental consent is necessary because refusal of newborn  screening is reasonable 
given the increasing list of diseases included in the battery of newborn tests and the 
low probability of many of these diseases; (2)  newborn screening can have adverse 
consequences such as psychological harms associated with false positive tests; (3) 
long-term parental caretaking is enhanced when parents are included in all clinical 
decisions about their  children ; and (4) the process of obtaining  consent need not be 
time-consuming or burdensome but rather can help enhance the health professional- 
patient relationship (CDC  2012 ) . Which arguments are stronger, and which of the 
options are the most ethically justifi able? The answer may depend on the social and 
 political context in which the issue is considered, and which ethical  values carry 
weight in that context. Whether there were  presumptive values in place would be 
explored through the questions in Step I, which examines previous cases, the appli-
cable  laws and policies, and  stakeholder claims in context. So, for example, in a 
society that has a strong moral  norm or presumption for  solidarity , there could be a 
presumption for continuing  population newborn  screening without  parental con-
sent . On the other hand, for a society that has a liberal political context that has a 
presumption for  individual liberty , there may be a presumption for an option that 
seeks more explicit  consent from  parents . In either context, the presumptive moral 
 norms are not determinative but are rebuttable, so the arguments or reasons to over-
ride those norms must be stronger. 
 Consider a third case from public health practice in which a person (the index 
case) infected with primary  syphilis and  HIV refuses to provide contact  information 
for his wife, insisting that he and his wife had not had sexual relations for several 
years. Contact tracing and partner notifi cation have been important tools historically 
for public health offi cials, although these interventions can involve thorny ethical 
tensions, requiring health offi cials to justify their decisions. In this type of situation, 
health offi cers will consider several options, starting with those that infringe least on 
the index case’s choices. For example, they might fi rst provide to the index case 
additional  information and assurance about confi dentiality while allowing him to 
notify his wife voluntarily, either alone or with the help of public health workers. If 
this proves unsuccessful, other interventions might be considered, such as incen-
tives, the threat of restrictions such as isolation, or attempts to notify the wife with-
out his knowledge or  consent . Each of these options would be determined in context, 
using the questions in Step III. Questions considered may include (1) Would the 
options likely accomplish the goal of warning and testing the wife without risking 
greater harm or possible adverse outcomes for the wife (e.g., domestic violence, 
loss of income, or loss of housing)? (2) Is there signifi cant concern about a  risk of 
harm to others, such as family members or  children , so that the burdens and benefi ts 
of the action would not be distributed fairly? (3) Is the action the least restrictive of 
the important moral claims of the  stakeholders ? (4) Is it necessary now to override 
 confl icting claims to achieve the public health goal? Answering the questions in 
Step III helps decision makers consider whether actions are justifi able. As one 
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health offi cer explains, “Public health offi cials should justify their decisions with 
deliberations that build not only community support and  trust , but also build support 
and trust from the individuals and families directly affected” (Melnick  2015b ). 
 As the scenarios illustrate, public health is a social and  political undertaking. 
Thus, making diffi cult choices in public health implicates important social, cultural, 
and political  norms embedded in a particular context and community of  stakehold-
ers (Childress and Bernheim  2008 ). Regardless of whether decision makers work in 
a  government public health agency, community nonprofi t,  nongovernmental organi-
zation (NGO) from another country, or a global organization, decision makers must 
rigorously assess the public health issue  in context , to minimally be able to act “in 
ways that preserve the moral foundations of social collaboration” at the core of  col-
lective health activity (Calabresi and Bobbitt  1978 ). 
 The context specifi cally includes attention to  stakeholders and relationships 
among public health stakeholders and community members, including the common 
understanding of their roles,  obligations , and  collaborations . Especially in  global 
public health , it is important to note that even the decision makers are stakeholders, 
in some sense, and often, when they are health  professionals , they have their own 
social-cultural norms and their own professional codes that can provide guidance. 
Appeals to the codes of particular professions, however, do not provide a suffi cient 
justifi cation for a public health decision, since justifi cations should be grounded in 
a society’s widely shared ethical values and  norms . 
 Engaging stakeholders and addressing claims, especially those of the people 
most affected by a public health issue, in ethical analysis, is especially important 
and can sometimes support and strengthen the  collaboration and cohesion needed 
for public acceptance of a decision. The ways to engage and reason with  stakehold-
ers in an ethical analysis will vary in different settings and communities, depending 
on community  values , cohesion, and expectations, and can range from establishing 
an ethics board for deliberation, to gathering  information from focus groups or 
social media, to including stakeholder representatives on the decision-making team. 
 Stakeholder  norms and claims are a critical feature for an ethical analysis in order 
to achieve a primary goal in public health—the development and maintenance of 
relationships of  trust , defi ned in a report from IOM as “the belief that those with 
whom one interacts will take one’s interests into account, even in situations in which 
one is not in a position to recognize, evaluate, or thwart a potentially negative course 
of action by those trusted” (IOM  1996 ). 
 Ethical analysis is a dynamic process and, particularly for the practice of public 
health, is best accomplished through group deliberations that involve understanding 
others’ perspectives and thinking independently and imaginatively. Public health 
 professionals often have to decide how best to realize numerous important societal 
 norms and  values when pursuing public health goals. Ethical tensions do occur in 
public health and at times require overriding an important  principle , value, or moral 
consideration to undertake a justifi able public health action. However, a structured 
ethical analysis can often lead to imaginative alternatives that transcend or mini-
mize ethical tensions and to decisions that most or many stakeholders fi nd 
acceptable. 
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 Chapter 2 
 Essential Cases in the Development of Public 
Health Ethics 
 Lisa  M.  Lee ,  Kayte  Spector-Bagdady , and  Maneesha  Sakhuja 
2.1  Introduction 
 While “public health” has been defi ned as what society does to “assure the condi-
tions for people to be healthy” (Institute of Medicine  2003 , xi), public health  ethics 
is a “systematic process to clarify,  prioritize , and justify possible courses of public 
health action based on ethical  principles ,  values and beliefs of  stakeholders , and 
scientifi c and other  information ” ( Schools of Public Health Application Service 
 2013 ). Despite several important characteristics that distinguish public health from 
clinical medicine, at its start public health ethics borrowed heavily from  clinical 
ethics and  research ethics (see Chap.  1 ). In the 1980s, with the onset of the AIDS 
epidemic and unprecedented advances in biomedicine, the inability of clinical eth-
ics to accommodate the ethical challenges in public health from existing frame-
works led pioneering ethicists to reframe and adapt clinical ethics from an individual 
and  autonomy focused approach to one that better refl ected the tension between 
 individual rights and the health of a group or  population (Bayer et al.  1986 ; 
Beauchamp  1988 ; Kass  2001 ; Childress et al.  2002 ; Upshur  2002 ). Others called for 
public health ethics to emphasize relational ethics and  political philosophy (Jennings 
 2007 ). More recently, some authors have suggested outlining foundational  values 
from which operating principles for public health ethics can be articulated only after 
careful consideration of the goals and purpose of public health. This approach 
would require us to establish a clear defi nition  of the moral endeavor of public 
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tion, views, or policies of the editors, the editors’ host institutions, or the authors’ host 
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health as a fi eld (Lee  2012 ) and construct an ethical framework stemming from the 
nature of it (Dawson  2011 ). 
 A versatile framework for public health ethics must accommodate public health 
in practice and  research . In public health practice, an  ethics framework must guide 
decisions about activities like  infectious disease control, primary  prevention , and 
 environmental health , as well as newer expectations of public health such as  chronic 
disease control and preparedness. In  public health research , biomedical and behav-
ioral  research ethics provide a great deal of guidance—but  research that focuses on 
population-based outcomes and community concerns reveals additional ethical 
considerations. 
 A fundamental tension in public health is one between individual- and population- 
based interests. Various  political traditions place different value on each, and these 
 values can fl uctuate within the same political structure over time. When authorities 
intervene to affect  population health , they must fi nd an equilibrium between indi-
vidual and population interests in all political contexts, whether authoritarian, 
socialist, or liberal individualist. To consider individual interests as well as popula-
tion interests, regardless of the philosophical tradition within which these interests 
are valued, is a challenge for a public health  ethics framework . The cases we present 
in this chapter illustrate how this equilibrium between individual and population 
interests has been established in the context of dynamic political and historical 
infl uences. 
 One way of approaching public health ethics deliberation is through the method 
of  casuistry , defi ned as “the interpretation of moral issues, using procedures of 
reasoning based on paradigms and analogies, leading to the formulation of expert 
opinion about the existence and stringency of particular moral  obligations , framed 
in terms of rules or maxims that are general but not universal or invariable, since 
they hold good with certainty only in the typical conditions of the agent and the 
circumstances of action” (Jonsen and Toulmin  1988 , 297). Consideration of case 
studies and the use of casuistic methods of resolution of morally similar cases 
through interpretation of ethical  principles have played important roles in the devel-
opment of public health ethics—particularly before public health ethics was viewed 
as distinct from  clinical ethics . Individual case studies enable discussions about 
which ethical  norms we should adopt for the practice of public health and how pub-
lic health  professionals should deliberate to resolve ethical problems in practice 
(Centers for Disease Control and Prevention [CDC]  2012 ) . In this chapter, we 
review several seminal cases that shaped the ethics of public health research and 
 practice over the past century to provide the foundation of current public health eth-
ics and lay the groundwork for a casebook to enable casuist analysis. 
 Our fi rst case example is  Jacobson v Massachusetts , set in the beginning of the 
twentieth century.  Jacobson  is  a foundational U.S. public health legal case that sup-
ports states’ rights to create and enforce  laws and  regulations that limit individual 
 autonomy to protect the public’s health and stop the spread of communicable dis-
ease. Our second case study, from the mid-1900s, looks at two ethically troubling 
 U.S. Public Health Service ( PHS ) protocols for studying sexually transmitted dis-
eases (STDs) in the U.S. state of  Alabama and  Guatemala . These experiments, like 
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most  research protocols, were not intended to benefi t the subjects; rather their intent 
was the broader benefi t of the public’s health. They show however, that researchers, 
despite the apparent motivation to advance public health, can breach public health 
 research ethics and  harm research subjects. The fi nal case, a contemporary example 
of the New York City  A1C Registry to monitor and address the  diabetes epidemic in 
the city, demonstrates how addressing the ethical dimensions of public health inter-
ventions can facilitate their implementation. This case moves our focus from public 
 health interventions targeting communicable diseases to those supporting second-
ary  prevention of  noncommunicable diseases . It focuses on the ethical dimensions 
that can arise when technological advances in communication might affect indi-
vidual  privacy . Unlike the consistent movement forward with which  casuistry has 
moved  clinical ethics , (Jonsen  1991 ), the outcomes in the cases we describe here 
shaped, and sometimes jolted, the nascent fi eld of public health ethics. 
 These three case studies, occurring within the same  political structure over the 
span of a century, illustrate the tension between individual  autonomy and protection 
of public health in very different ways. The fi rst case depicts a situation where the 
balance tipped in favor of protection of the public’s health in the context of  infec-
tious diseases . The second case demonstrates unconscionable exploitation of vul-
nerable  research subjects for the benefi t of other communities. Finally, the third case 
presents a situation in which solutions to public health problems based on techno-
logical advances and access to data can strike a balance with individual health  pri-
vacy concerns. Each case illustrates the quest for equilibrium between individual 
and  population interests . 
2.2  Case Study:  Jacobson v. Massachusetts 
 The earliest activities associated with modern public health are  sanitation and  infec-
tious disease control. From the fi rst  public health surveillance system in colonial 
America that required tavern keepers in Rhode Island to report contagious disease, 
to John Snow removing the Broad Street pump handle in London to end the 1854 
cholera epidemic, control of communicable diseases has been fi rmly in the jurisdic-
tion of public health (Thacker  2010 ). Discovery of the physiological mechanisms of 
 vaccines in the eighteenth century gave us new tools to control  infectious diseases 
but also raised critical questions about how to carry out—effectively and ethically—
 policies and plans that support individual and  community health . 
2.2.1  Background 
 By the turn of the twentieth century, public health campaigns—including improved 
hygiene, sanitation, and access to safer food and water—had already extended the 
average life expectancy in the  United States (CDC  1999 ). But  infectious diseases 
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were still the leading cause of mortality, with  tuberculosis , pneumonia, and  diar-
rheal disease accounting for 30 % of U.S. citizen deaths (Cohen  2000 ). Evolving 
support for the  government’s involvement in protecting public health led to the 
establishment of hygienic laboratories in 1887 (Kass  1986 ). These laboratories con-
tinue today to provide essential services such as diagnostics,  public health surveil-
lance ,  research , and  vaccine development. 
 Edward  Jenner , who discovered that a  vaccine for smallpox could be created 
using cowpox lesions, sent his vaccine from England to Benjamin  Waterhouse at 
Harvard University in 1800 (Riedel  2005 ). After successfully vaccinating the mem-
bers of his household, Waterhouse began selling the vaccine in Boston, Massachusetts 
(Kass  1986 ). Not all physicians vaccinated as meticulously as Waterhouse however, 
and in one unfortunate incident, adulterated smallpox vaccine caused an epidemic 
in the Boston area (Kass  1986 ). 
 As interest in and concern about the  vaccine grew, the Board of Health of Boston 
decided to perform one of the fi rst controlled  clinical trials in U.S. history, which 
eventually demonstrated  effectiveness of the vaccine (Kass  1986 ). A century later, 
Massachusetts had established  vaccination campaigns, but smallpox persisted: One 
hundred cases were reported in Massachusetts in 1900 with 2314 cases by 1902 
(Parmet et al.  2005 ). The Board of Health had originally promoted a  voluntary vac-
cination scheme until January 1902 when two  children , one in Boston, died of post-
vaccination complications within a month of each other (Willrich  2011 ). After 
voluntary efforts stalled, the Board ordered  mandatory vaccination in February, but 
did not enforce the order. After an outbreak sent another 50 adults and children to 
the hospital and caused seven deaths, the Board voted that the  regulations needed to 
be enforced (Willrich  2011 ). 
 Local public health offi cials employed creative ways to follow enforcement 
orders, “many of which were scientifi cally sound but not all of which were apt to 
inspire public  trust ” (Parmet et al.  2005 , 653). The Boston Herald, for example, 
reported in March 1902 that public health doctors and guards forcibly vaccinated 
“Italians, negroes and other employees” (Parmet et al.  2005 , 653). Despite the suc-
cess of the smallpox  vaccine in curtailing disease, anti-vaccinationists described 
compulsory  vaccination as “the greatest crime of the age” and as “more important 
than the slavery question, because it is debilitating the whole human race” 
(Washington Post  1905 ; Gostin  2008 , 122). Pro-vaccinationists were as polarizing, 
describing the debate as “a  confl ict between intelligence and ignorance, civilization 
and barbarism” (New York Times  1885 ; Gostin  2008 , 122). 
2.2.2  Case Description 
 It was in this context that the U.S. Supreme Court heard  Jacobson v. Massachusetts , 
which despite, and perhaps because of, the vastly different ways it has been inter-
preted and applied since then, is arguably the most important legal public health 
case ever decided in the  United States (Gostin  2005 ). Under the doctrine of “police 
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power,” it had already been established in the late 1800s that states had the authority 
to enforce “sanitary  laws , laws for the protection of life,  liberty , health or property 
within its limits [and] laws to prevent persons and animals suffering under conta-
gious or  infectious diseases …” within their own boundaries (R. R. Co. v. Husen 
 1877 , 465, 472). In 1885, the Supreme Court confi rmed that this included ensuring 
conditions essential to the “ safety , health, peace, good order and morals of the com-
munity” as “even  liberty itself… is only  freedom from restraint under conditions 
essential to the equal enjoyment of the same right by others” (Crowley v. Christensen 
 1890 , 86, 89). 
 In 1902, in response to the increase in smallpox cases discussed above, the 
Cambridge,  Massachusetts Board of Health issued an order, which became  law , 
requiring citizens be vaccinated against smallpox or pay a $5 fi ne (the equivalent of 
about $135 in 2015) (Massachusetts Revised Laws  1902 ; Commonwealth v. 
Henning Jacobson  1903 ; Mariner et al.  2005 ). Henning  Jacobson , a Cambridge 
minister, refused both the  vaccination  and to pay the fi ne. He argued he had previ-
ously received the smallpox vaccination in  Sweden as a child and had experienced 
“great and extreme suffering, for a long period” as a result and that one of his sons 
had experienced  adverse events from vaccination as well (Commonwealth v. 
Henning Jacobson  1903 , 246).  Jacobson argued that the  law was thus “hostile to the 
inherent right of every freeman to care for his own body and health in such way as 
to him seems best ....” (Jacobson v. Massachusetts  1905 , 26) . The case went to trial. 
 At trial,  Jacobson argued that his history of adverse reaction to the smallpox  vac-
cine should grant him an exception from the  law . However, the law did not actually 
provide for such exceptions for adults (as it did for  children ). Jacobson was found 
guilty of “the crime of refusing  vaccination ” (Willrich  2011 , 285). He appealed to 
the superior court, where the judge again ruled that Jacobson’s medical history was 
“immaterial” to his legal violation. The judge also refused Jacobson’s plea to tell the 
jury that the law was a violation of the constitutions of Massachusetts and the  United 
States because it offered no such exception. The court again found  Jacobson guilty 
(Willrich  2011 ) . 
 Jacobson fared no better in the Massachusetts Supreme Court. It too rejected 
Jacobson’s evidence of his prior adverse experience with the  vaccination as well as 
his son’s as “matters depending upon his personal opinion, which could not be taken 
as correct, or given effect, merely because he made it a ground of refusal to comply 
with the requirement” (Commonwealth v. Henning Jacobson  1903 , 246). Moreover, 
it pointed out that even if Jacobson  could prove that he would suffer adverse effects 
from the  vaccine , the statute did not offer an exception for such a case. In response 
to Jacobson’s argument that this defi ciency rendered the statute unconstitutional, the 
court responded that the “theoretical possibility of an injury in an individual case as 
a result of its  enforcement does not show that as a whole it is unreasonable. The 
application of a good  law to an exceptional case may work hardship” (Commonwealth 
v. Henning Jacobson  1903 , 247). However, the Massachusetts court held that if citi-
zens refused to be vaccinated it was not within the  power of public health authorities 
to vaccinate them by force (as the Boston Herald had reported occurring) 
(Commonwealth v. Henning Jacobson  1903 ; Parmet et al.  2005 ) . 
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 When the  Jacobson  case fi nally made its way to the U.S. Supreme Court, the 
Court found that the  vaccination statute was generally a reasonable protection of the 
public health while maintaining  individual liberty . The Supreme Court did conclude 
that to subject someone to vaccination who was unfi t because of a health condition 
“would be cruel and inhuman in the last degree;” it stipulated that “we are not 
inclined to hold that the statute establishes the absolute rule that an adult must be 
vaccinated if it be apparent or can be shown with reasonable certainty that he is not 
at the time a fi t subject of vaccination or that vaccination, by reason of his then 
condition, would seriously impair his health or probably cause his death” (Jacobson 
v. Massachusetts  1905 , 38–39) . However, the Court found that  Jacobson was “in 
perfect health and a fi t subject of vaccination” and that he simply “refused to obey 
the statute and the  regulation adopted in execution of its provisions for the protec-
tion of the public health and the public  safety , confessedly endangered by the pres-
ence of a dangerous disease” (Jacobson v. Massachusetts  1905 , 39) . The Court 
ordered Jacobson to submit to vaccination or pay the fi ne (Jacobson v. Massachusetts 
 1905 ). Three years after his legal fi ght began,  Jacobson paid the $5 penalty (Willrich 
 2011 ). 
2.2.3  Discussion 
 Legal cases since 1890 had allowed states to require citizens be vaccinated, but 
around the turn of the century, limits to that right began appearing that included a 
“present danger”  standard requiring a real and immediate threat and adherence to 
the harm avoidance  principle protecting citizens from undue burden as much as pos-
sible (Willrich  2011 ).  Jacobson has endured as a fundamental philosophical foun-
dation of the reconciliation of individual interests with those of the public’s health 
in a  political system emphasizing liberal  individualism . 
 Despite the limitations of the facts in  Jacobson , it has been interpreted in many 
ways to support numerous public health activities over the past century. Notably, the 
Supreme Court did not require that otherwise healthy citizens submit to  vaccination , 
only that it was constitutional to require citizens to be vaccinated  or pay a fi ne. Also, 
while the Court found that a lack of a health exception to the vaccination mandate 
would be unconstitutional, it did not grant Jacobson this exception for himself. 
 However, as with so many examples in the lexicon of medical ethics, one of the 
most important practical effects of historical cases is how they have been interpreted 
and applied to future circumstances. Part of  Jacobson ’ s legacy has been the Court’s 
“community oriented philosophy” based in social-contract (or compact) theory 
(Gostin  2005 , 578): “a fundamental  principle of the social compact [is] that the 
whole people covenants with each citizen, and each citizen with the whole people, 
that all shall be governed by certain  laws for ‘the common good ….’” (Jacobson v. 
Massachusetts  1905 , 26) . While the Court recognized  individual liberty interests 
protected by the Constitution, it found that these interests did not impart an absolute 
right of  freedom from restraint because “on any other basis organized society could 
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not exist with  safety to its members” (Jacobson v. Massachusetts  1905 , 26) . It noted 
that no citizen could enjoy full  liberty in a society that recognized “the right of each 
individual person to use his own [liberty] … regardless of the injury that may be 
done to others” (Jacobson v. Massachusetts  1905 , 26). 
 The Court also found that reasonable  regulations to protect the public health and 
 safety were among these constitutional limits on  liberty (Jacobson v. Massachusetts 
 1905 ). Despite the fact that  Jacobson found  mandatory vaccination distressing and 
objectionable, it was the responsibility of the city board of health to “not permit the 
interests of the many to be subordinated to the wishes or convenience of the few” 
(Jacobson v. Massachusetts  1905 , 29) . As discussed above, the Court found that 
exceptions were needed for citizens with established concerns for their health—but 
did not apply this exception in Jacobson’s case. 
 The social contract implied in this case also needed to be reconciled with limits 
on  government and constitutional protections of  individual liberty . While the Court 
had already established a  standard of fair application of public  health interventions 
(e.g., not targeting a specifi c race-based group) (Jew Ho v. Williamson  1900 ; Gostin 
 2008 ),  Jacobson  built on several cases to further explain  standards of constitutional 
protections (i.e., there must be a public health threat to the community, and the state 
or board of health must design the public  health intervention to combat that threat). 
The Court found that the intervention must be proportionately tailored to that threat 
creating a “reasonable balance … between the public good and the degree of per-
sonal invasion ” and should not  harm citizens in and of itself (Gostin  2008 , 
126–127). 
 While it is hard to reconcile some of the facts of  Jacobson with its lofty consti-
tutional deliberation, it is the Court’s desire to reconcile individual interests with 
those of the public health in a society that  values liberal  individualism that has 
become its enduring legacy. Many court decisions following  Jacobson reaffi rmed 
states’ use of police  power for the public health (Gostin  2005 ), and in 1922 the 
Supreme Court agreed that states could require vaccinations for  children who attend 
 school (Zucht v. King  1922 ).  Jacobson was an important step in the lengthy public 
health battle against smallpox, culminating in its eradication in 1977 (Cohen  2000 ). 
 The legal and ethical boundaries between the individual and public health remain 
mobile in public health  law and  policy despite the  Jacobson decision. 
Notwithstanding its rejection of forced vaccination, coercion—as opposed to the 
modern emphasis on education—continued as a public health tactic, employed fre-
quently and often directed toward vulnerable citizens (e.g., quarantined sex work-
ers during World War I) (Colgrove and Bayer  2005 ). And despite the  liberty 
protections it carved out, the Court itself struggled with upholding both  individual 
rights and constitutional liberties. In 1927, citing  Jacobson , the Court upheld a 
forced-sterilization  law in Virginia of “mental defectives.” The  Buck v. Bell deci-
sion reasoned that “[i]t is better for all the world, if instead of waiting to execute 
degenerate offspring for crime, or to let them starve for their imbecility, society can 
prevent those who are manifestly unfi t from continuing their kind. The  principle 
that sustains compulsory vaccination is broad enough to cover cutting the fallopian 
tubes” (Buck v. Bell  1927 , 207). 
2 Essential Cases in the Development of Public Health Ethics
44
 In more communitarian-leaning societies,  Jacobson ’ s value serves less as a map 
for navigating public good in an individualist context, and more as an illustration of 
how individual and community interests can be balanced within the  political and 
social structure. Even within the  United States , however,  Jacobson has been inter-
preted over the decades to be a foundation for diverse legal opinions supporting 
remarkable expansions of federal  power —including warrantless entry into homes in 
time-sensitive circumstances of compelling need and a defense of the federal  govern-
ment’s right to detain U.S. citizens without due process as “enemy combatants” (in a 
dissenting opinion) (Willrich  2011 ). Many of these cases, and certainly  Buck v. Bell  
serve as a stark reminder that federal  powers ostensibly in the public interest cannot 
be used solely to maximize perceived public benefi t—they must be tempered by  jus-
tice and  fairness to both communities and individuals (Lombardo  2008 ). But as the 
legal community continued to struggle with what the implications and contours of 
what  Jacobson should be in the  United States , offi cials continued to press on in what 
was then an unregulated fi eld—that of  public health research . 
2.3  Case Study:  U.S. Public Health Service Research 
on Sexually Transmitted Disease:  Alabama 
and  Guatemala 
 Since the 1940s, contemporary  research ethics has developed rapidly through a 
desire to protect human participants in research. Internationally, the Nuremberg 
Trials for Nazi war criminals, including the trial of Nazi physicians who conducted 
torturous medical experiments on subjects, resulted in the  Nuremberg Code ( 1947 ), 
a compilation of  guidelines for conducting research with human participants. In 
1964, the World Medical Association’s (WMA)  Declaration of Helsinki further 
refi ned ethical guidance for research with humans, and in particular the  participa-
tion of vulnerable  populations (WMA  1964 ). 
 The next case study focuses on two separate mid-century U.S. PHS experiments 
on sexually transmitted diseases in the U.S. state of Alabama and  Guatemala . While 
one of the ten  essential public health services is to “conduct research to attain new 
insights and innovative solutions to health problems” (CDC  2013b ; Harrell et al. 
 1994 , 29), these experiments demonstrate how an imbalance of population and indi-
vidual interests—coupled with disregard for respect for persons—can lead to tragic 
results. 
2.3.1  Background 
 In the early 1900s, STDs—and  syphilis in particular—were major concerns for 
public health. Conservative estimates suggested that syphilis affected 10–15 % of 
the U.S.  population (Jabbour  2000 ) with symptoms ranging from sores to paralysis, 
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blindness, and  death  (CDC  2013a ). One leading expert at the time described syphi-
lis as a plague “which, in these times of public enlightenment, is still shrouded in 
obscurity, entrenched behind a barrier of silence, and armed, by our own ignorance 
and false shame, with a thousand times its actual  power to destroy…” (Stokes 
 1920 , 7). In 1905, German scientists isolated the microbe that caused syphilis, and 
in 1910 other scientists proposed salvarsan (a preparation of arsenic) as the cure 
(Jones  1993 ). Salvarsan  treatment involved a painful set of injections over a long 
period and ultimately turned out to be highly toxic (Jones  1993 ). 
 In 1912, the U.S.  government established PHS to join other federal public health 
efforts to improve administration and distribution of public health aid to the states, 
to oversee interstate  infectious diseases and  sanitation , and to conduct  public health 
research (Jones  1993 ). In 1918, PHS established a  Division of Venereal Disease to 
organize and support state prophylactic and  treatment work (Jones  1993 ). World 
War I had highlighted the harmful effect of STDs on the U.S. armed forces, but after 
interest in the disease from a wartime perspective abated, public health workers 
focused on  syphilis as a poverty-linked disease—and a disease that reportedly 
affected  African Americans in particular. Some physicians even argued that syphilis 
was a “quintessential black disease” and African Americans a “notoriously syphilis-
soaked race” (Jones  1993 , 24, 27). 
 Funding for and interest in preventing and treating STDs waned during peace-
time, though they remained a public health problem. With World War II on the 
horizon, the director of the PHS Venereal Disease Research  Laboratory argued that 
“[t]he  prevention of the primary invasion of the male by the  syphilis spirochete, as 
a means of minimizing the loss of  effectiveness which is incident to established 
disease, still constitutes one of the most pressing problems of military medicine” 
(Mahoney  1936 , 78–79). When the  United States became involved in World War II, 
public health offi cials once again became concerned about STD rates in American 
troops and predicted “approximately 350,000 fresh infections with gonorrhea [in 
the armed forces], [which] will account for 7,000,000 lost man days per year, the 
equivalent of putting out of action for a full year the entire strength of two full 
armored divisions or of ten aircraft carriers” (Presidential Commission for the 
Study of Bioethical Issues [PCSBI]  2011 , 12). The  cost of treating the anticipated 
infections was $34 million (about $465 million in 2015, adjusted for infl ation) 
(PCSBI  2011 , 12) . 
2.3.2  Case Description 
 In search of a more effective  treatment for syphilis, U.S. PHS researchers in the 
1930s had turned to  African-American communities for  public health research in 
part because of the perception of high rates of infection, as discussed above. PHS 
surveyed six southern counties and found the highest syphilis rates among black 
men in Macon County, Alabama, where the city of Tuskegee serves as the county 
seat. Created in part by a confl uence of economic, social, and clinical 
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factors—including the Great Depression, lack of public and private funds for con-
tinuation of development projects, pervasive  racism in American medicine, and 
failed attempts in the pre-penicillin era to treat  syphilis with heavy metals—public 
health researchers decided to conduct a study to observe the “natural progression” 
of untreated syphilis (Brandt  1978 ; U.S. Department of Health, Education, and 
Welfare [HEW]  1973 ). 
 The Tuskegee syphilis study or, more accurately, the  U.S. Public Health Service 
 Study of Untreated Syphilis in the Male Negro ,  Macon County ,  Alabama , was an 
observational study of 399 men with syphilis, and 201 men without, conducted from 
1932 through 1972. After 40 years, it fi nally ended when a PHS STD investigator, 
Peter Buxton, went to the press with allegations of gross ethical violations, includ-
ing a lack of  informed consent for  participation , deception, withholding  treatment , 
as well as racism and lack of scientifi c soundness (Jones  1993 ; Brandt  1978 ). 
 During this study,  public health researchers posed as physicians and told the 
men, who were already infected with  syphilis , that they were going to  treat them for 
“bad blood” (which, in common vernacular referred to a range of chronic conditions 
of unknown origin that could have included anything from syphilis to anemia). In 
reality, the researchers were not treating the subjects for any of these diseases. 
While during the salvarsan-era, nontreatment would not necessarily have made a 
large difference  clinically , once the Venereal Disease Research Laboratory estab-
lished that penicillin was a safe, effective, and inexpensive cure for syphilis in 1943, 
the profound clinical detriment of being a study participant became clear. After 
1943, the researchers actively kept subjects from receiving penicillin for other ail-
ments so as not to interfere with their ability to analyze the primary outcome of 
interest, which was the natural progression of untreated  syphilis (CDC  2013c ). 
 Throughout the study, the public health researchers practiced active deceit result-
ing in 399 infected men being kept from penicillin  treatment until their death or 
1972 when the study was stopped. The Assistant Secretary for Health and Scientifi c 
Affairs, under the then U.S. Department of Health, Education, and Welfare, char-
tered an advisory panel to investigate the circumstances surrounding the study. The 
panel later issued the Final Report of the Tuskegee Study Ad Hoc Advisory Panel in 
April 1973 (HEW  1973 ). 
 Meanwhile, the experience of soldiers during World War II had confi rmed the 
need for improved diagnosis and  treatment of STDs. After the war, these efforts 
were revitalized by animal studies that demonstrated the  effectiveness of a new 
post-exposure prophylaxis called “orvus-mapharsen.” PHS was interested in 
whether this solution would be effective in humans, and it was believed that 
 establishing effi cacy in humans required controlled intentional exposure in 
humans—preferably via the “natural method” of sexual intercourse. Because, in 
part,  commercial sex work was legal in the prison in Guatemala City, Guatemala, 
the researchers planned to conduct prophylaxis experiments there. The plan was to 
intentionally expose  prisoners to STDs through sexual intercourse with  commercial 
sex workers carrying  infection (PCSBI  2011 ). 
 As a result, from 1946 through 1948, the U.S.  government funded, via a federal 
grant from the National Institutes of Health and approved by the highest echelons of 
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PHS (including Surgeon General Thomas Parran) , STD, serological, and inocula-
tion experiments in Guatemala (Spector-Bagdady and Lombardo  2013 ). The 
researchers, led on the ground by a senior surgeon in the PHS, John C.  Cutler , soon 
discovered that they could not reliably infect prison subjects with STDs through 
sexual intercourse with  commercial sex workers ; the researchers were thus unable 
to compare the  effectiveness of the prophylaxis regimen they were testing. In an 
effort to increase infection rates, researchers expanded to other vulnerable  popula-
tions , such as soldiers and psychiatric patients, and engaged in more invasive meth-
ods of intentional exposure, such as abrasion of genitals and manually applying 
syphilitic emulsion—despite objections of their PHS supervisors that the latter 
methods of inoculation were scientifi cally  unsound (PCSBI  2011 ). 
 By the end of these experiments, considered by some at the time to be “ethically 
impossible” in design (Kaempffert  1947 ), public health researchers intentionally 
exposed approximately 1300 Guatemalan  prisoners , soldiers,  commercial sex work-
ers , and psychiatric patients to  syphilis , gonorrhea, and/or chancroid without 
 informed consent . The researchers documented some form of  treatment for only 
half of the subjects they exposed to infection (PCSBI  2011 ). 
 The Guatemala STD  experiments ended in 1948 when the researchers decided 
not to apply for a continuation of funding due to concerns about reporting project 
activities to the approving study section and the new surgeon general in the  United 
States (PCSBI  2011 ) . The Guatemala STD experiments remained undiscovered for 
nearly 65 years until Cutler’s  papers , uncovered in 2003, were brought to the atten-
tion of the U.S.  government and presented at a  professional meeting in 2010 (PCSBI 
 2011 ; Reverby  2011 ). Upon learning of the experiments, President Barack Obama 
requested that his Presidential Commission for the Study of Bioethical  Issues 
(Bioethics Commission) conduct a historical review and ethical analysis of the stud-
ies in Guatemala. The Bioethics  Commission concluded its analyses and reported 
its results to President Obama in September 2011 (PCSBI  2011 ). 
2.3.3  Discussion 
 The U.S. PHS Study of Untreated  Syphilis in the Negro Male unmasked a range of 
important ethical issues that fi t into three fi elds of  bioethics we now call  profes-
sional ethics, public health ethics, and  research ethics . Through the lens of profes-
sional ethics, the untreated syphilis study calls into question what it means to be an 
ethical scientist, an ethical physician, and an ethical  government steward of public 
 trust . Through the public health ethics lens, it raises issues of imposing the  risk of 
 harm to individuals to benefi t the community, appropriate engagement with the 
affected community, and  justice and  fairness . 
 Far and away, however, the untreated  syphilis study in Tuskegee had the most 
substantial impact on  research ethics . It was not the fi rst study to egregiously 
 disrespect  personal autonomy and grossly exploit vulnerable  populations . Indeed, 
by 1966, Henry Beecher had outlined 22 such studies in clinical research, some 
2 Essential Cases in the Development of Public Health Ethics
48
involving  children , mentally and physically compromised patients, and incarcerated 
individuals (Beecher  1966 ). Nor was it the fi rst instance of African Americans being 
mistreated by the medical establishment (Gamble  1997 ), but it was the fi rst unethi-
cal study of this magnitude scandalously exposed by the mainstream media involv-
ing and funded by the U.S. federal government. While the original intent of the 
untreated  syphilis study in Tuskegee was to contribute to the greater and seemingly 
more urgent social good, it has been remembered for withholding  treatment from a 
socially and politically vulnerable  group by actively deceiving them. 
 Comprehensive scholarship has examined the legacy of the untreated syphilis 
study. Its impact is as deep as it is broad in the  bioethics community and the social 
culture of the  United States . This case study examines only the  policy outcomes that 
resulted from the  ethical review and analysis of the untreated  syphilis study, which 
is but a small slice of its legacy, yet one that has profoundly shaped the way clinical 
and  public health research is conducted in the United States. 
 The Tuskegee Study Ad Hoc Advisory Panel (Advisory Panel) submitted its fi nal 
report to then Assistant Secretary for Health, Charles C. Edwards, in April 1973 
(HEW  1973 ). The Advisory Panel found that the study was ethically unjustifi ed in 
1932 due to the lack of evidence that any  consent was obtained from participants, 
breaking “… one fundamental ethical rule…that a person should not be subjected to 
avoidable  risk of death or physical  harm unless he freely and intelligently consents” 
(HEW  1973 , 7). Also, the lack of a study protocol or plan left the study’s scientifi c 
soundness highly suspect, especially in light of the “disproportionately meager” 
scientifi c data it produced (HEW  1973 , 8). 
 Besides the lack of  informed consent , other important ethical violations noted by 
the Advisory Panel included researchers lying and withholding penicillin even after 
it was established to be effective as a  treatment for syphilis. The insults to basic 
dignity and  respect for  persons forced on the men in the study convinced the 
Advisory Panel to recommend a permanent body to regulate all federally supported 
 research involving human participants. This permanent body was to formulate  poli-
cies for establishing institutional review boards (IRBs) , compensating research par-
ticipants who suffer research-related injury, and reviewing protocols at local 
institutions before beginning  research studies . It also called for creating local sub-
ject advisory groups to monitor  consent procedures (HEW  1973 ). While the 
U.S. Department of Health, Education, and Welfare (now the  U.S. Department of 
Health and Human Services ) had  guidelines for  research grants and contracts, the 
Advisory Panel recommended “… that serious consideration should be given to 
developing, through Congressional action, rules and procedures which apply to the 
entire human research enterprise without reference to the source of funding” (HEW 
 1973 , 37). 
 The Advisory Panel report paved the way for creation of the fi rst congressionally 
formed national  bioethics committee : the  National Commission for the Protection of 
Human Subjects of Biomedical and Behavioral Research (National Commission) . 
As a direct consequence of the ethical investigation into the untreated  syphilis study, 
and acknowledgment that this was not an isolated incident, the National Commission 
began work in 1974 developing national  guidelines for  research involving human 
participants. 
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 The National Commission’s most cited work, the  Belmont Report , outlined three 
ethical  principles for research still in use today:  respect for persons ,  benefi cence , 
and  justice (National Commission for the Protection of Human Subjects of 
Biomedical and Behavioral Research  1979 ) . It also provided guidance on  informed 
consent , special rules for  vulnerable populations , and requirements for review of 
protocols by  IRBs . These recommendations, later codifi ed into federal  regulations 
that govern federally funded research with human participants, continue to infl u-
ence human research today—helping ensure the respectful and ethical  treatment of 
participants in biomedical and  public health research (U.S. Department of Health 
and Human Services  2009 ). 
 A more subtle, but enduring impact of the National Commission’s efforts spe-
cifi c to public health  research was its focus on engaging the community in which 
research is to be conducted. Although only anecdotally reported, a lack of  trust in 
 government , health care, and research is widely believed to be a lasting consequence 
of the untreated  syphilis study (Gamble  1993 ; Swanson and Ward  1995 ). Empirical 
data suggest, however, that the untreated syphilis study itself did not deter  participa-
tion (Katz et al.  2008 ), but rather a lack of trust stemming from a larger social legacy 
of  racism and fears of exploitation originating in the era of slavery in the  United 
States (Gamble  1993 ). In recent times, these fears resurfaced at the onset of the 
AIDS epidemic in the 1980s in the form of suspicion of intentional infection and 
genocide (Jones  1993 ). This mistrust resulted in the distribution of misinformation 
and diffi culties in delivering education and care for those at high  risk for  HIV 
(Thomas and Quinn  1991 ). Since then, methods and best practices for community 
engagement have been developed and published both in the United States (Barnett 
 2012 ; U.S. Department of Health and Human Services  2011 )  and  internationally 
(World Health Organization [WHO]  2012 ; UNAIDS  2011 ). 
 When analyzing the effect of the Guatemala STD  experiments on public health 
ethics, it is important to note that while the experiments took place in the 1940s, 
they were critically investigated only recently—65 years after their occurrence. 
Despite the stark contrast of today’s regulated research context with  research con-
ducted in the 1940s, scholars continue to examine the original research documents, 
and our ability to learn from past errors continues. That the U.S. government, at 
least, had learned lessons from the Tuskegee study is evident by the swiftness of its 
response to the discovery of the Guatemala STD experiments. While it took 25 years 
for a U.S. president to apologize to the Tuskegee  syphilis study participants, fami-
lies, and community (The White House  1997 ), President Barack Obama called 
President Alvaro  Colom of Guatemala to apologize for the STD research immedi-
ately following the announcement of its discovery to the public in 2010. 
 The PHS  research studies in Tuskegee and Guatemala demonstrate the serious 
consequences that can result when the relative interests of the individual and the 
 population are inappropriately reconciled. Indeed, these abuses of individual 
research subjects have created an enduring legacy of cautionary tales that, together 
with an orientation toward liberal  individualism , have provided a lasting and 
powerful check on public health authority in the  United States . Major  policy 
changes were put into practice after the discovery of the syphilis studies in  Alabama . 
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These policies were intended to protect research participants from being treated as 
mere means to an end, to bring back into equilibrium the individual and population 
interests that public health must reconcile. Still, public  health interventions continue 
to face resistance to actions perceived to limit individual choice—making substan-
tive engagement of the relevant community even more critical for turn-of-the-cen-
tury public health campaigns. The case that follows describing the New York City 
 A1C Registry highlights how, even after all of the regulatory and ethical work 
accomplished over the past four decades, innovative approaches to public health 
advances interpreted to curtail some  individual liberty can still inspire debate about 
the optimal role of  government in promoting public health. 
2.4  Case Study:  The New York City  A1C Registry 
 Public health increasingly has focused on  secondary prevention , or the prevention 
of disability from disease. As the burden of disease in the  United States has shifted 
from communicable diseases like smallpox and STDs to  noncommunicable 
diseases , public health  professionals face new ethical challenges related to 
monitoring chronic conditions and inspiring individuals to improve their health. 
The following case illustrates how new technologies affect public  health 
interventions and can limit the  precedent set by  Jacobson  when health  risks are 
neither communicable nor imminent. Such cases call for a recalibration of  population 
and individual interests when considering dramatically different health and social 
settings. 
2.4.1  Background 
 Although  infectious diseases accounted for more than 80 % of deaths in the  United 
States in the 1900s (Steinbrook  2006 ), in 2011, WHO estimated that  noncommuni-
cable diseases were responsible for 66 % of deaths worldwide (WHO  2013 ). These 
changes in the causes of morbidity and mortality are typical of an “epidemiologic 
transition,” a  population health phenomenon that occurs when populations carry out 
public health measures such as  sanitation and immunization, which decrease death 
rates from  infectious diseases , increase life expectancy, and simultaneously begin to 
increase  risk for noncommunicable conditions (McKeown  2009 ). 
 Of  noncommunicable disease deaths worldwide in 2008, deaths from  diabetes 
alone accounted for 1.3 million (WHO  2011 ). In the  United States , 8.3 % of the 
population (about 25.8 million people) had diabetes in 2011 (CDC  2011 ) . Because 
of the signifi cant impact that  noncommunicable diseases , such as diabetes, have on 
health systems, WHO has promoted  lifestyle modifi cations and other public  health 
interventions (WHO  2011 ). 
 Several interventions, such as providing advice about physical activity and a 
healthy diet to people with impaired glucose tolerance, have lowered rates of  diabe-
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tes (Dornhorst and Merrin  1994 ; Ramachandran et al.  2006 ).  Research also has 
shown that controlling blood sugar levels (measured by A1C levels), blood pres-
sure, and LDL cholesterol can reduce the  risk of long-term complications and death 
among people with diabetes (Chamany et al.  2009 ). Some evidence suggests 
improvements from educating patients in diabetes management, but more evidence 
is needed (Chamany et al.  2009 ). 
 Although there are effective ways of controlling risk factors for complications 
once diabetes is diagnosed, management of these  risk factors across the  United 
States has been deemed inadequate (Chamany et al.  2009 ). In New York City the 
percentage of adults who reported having  diabetes more than doubled from 3.7 % in 
1994 to 9.2 % in 2004 (Chamany et al.  2009 ). A 2005 report of the  New York City 
Department of Health and Mental Hygiene (NCY DOHMH) showed that diabetes 
prevalence was higher among non-white residents (NCY DOHMH  2007 ; NCY 
DOHMH  2006a ). In 2004, NCY DOHMH found that diabetes was the fourth lead-
ing cause of death in the city’s population (NCY DOHMH  2004 ), and a survey of 
New York City adults in 2004 showed that fewer than 10 % of those with diabetes 
were able to manage blood sugar, blood pressure, and cholesterol satisfactorily 
according to city public health  standards (Chamany et al.  2009 ). In New York City, 
37 % of  diabetes patients on state and federally funded  Medicaid had an A1C level 
(refl ecting average blood sugar) greater than 9 %—which suggests poor glycemic 
control (Barnes et al.  2007 ). WHO has found that  policies that promote manage-
ment of these  risk factors have potential to reduce spending for individuals and the 
public (WHO  2011 ). 
2.4.2  Case Description 
 In December 2005, the NCY DOHMH submitted a proposal to the New York City 
Board of Health that would require laboratories with electronic reporting capabili-
ties to submit A1C test results for New York City residents to the NCY DOHMH 
(NCY DOHMH  2005a ). After a period for public comment, the New York City 
Board of Health approved this proposal, creating the fi rst U.S. program requiring 
public health reporting of A1C results. Supported by evidence from the success of 
other disease control programs (such as programs targeting lead poisoning and 
 tuberculosis ), this program established a  public health surveillance system to track 
 diabetes in the  population and to support those who could benefi t from diabetes 
control (Chamany et al.  2009 ). 
 The mandate required applicable laboratories to submit A1C test results to the 
NCY DOHMH within 24 h of completion. Data to be reported included date of 
the test; name of the testing facility; name and address of the ordering facility or 
provider; and name, address, and date of birth of the individual tested (Chamany 
et al.  2009 ). The NCY DOHMH proposed to use the reported A1C results to gener-
ate a registry to monitor glycemic control in the New York City  population and to 
provide mechanisms to support patients and physicians in controlling diabetes 
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(NCY DOHMH  2005a ). The data in the registry were analyzed by various factors 
including age, location, and type of health care facility to determine distinctions in 
testing patterns, health care usage, and glycemic control. However, race and ethnic-
ity data were not reported and therefore not included in the longitudinal analysis 
(Chamany et al.  2009 ). 
 After the A1C test results reached the NCY DOHMH, if the average blood sugar 
level exceeded a predetermined threshold, the patient and provider were notifi ed. 
Providers were mailed a roster of their patients ordered from highest to lowest A1C 
level, listing the patients’ two most recent test results calling special attention to 
A1C levels greater than 9 % (NCY DOHMH  2006b ). Patients at least 18 years of 
age with an A1C level greater than 9 % or who were overdue for testing also received 
a letter informing them of their test results, advising them on how to control their 
A1C level, and specifi cally recommending a follow-up appointment with their pro-
vider. The letter was printed in English and Spanish (NCY DOHMH  2005a ). 
 The goals of the provider and patient notifi cation program were to increase pro-
viders’ knowledge about glycemic control in their patient  population , facilitate pro-
viders in assisting and guiding patients at high  risk for complications, and inform 
and aid patients at high risk for devastating sequelae (NCY DOHMH  2012 ). While 
patients had the option to opt- out of the provider and patient notifi cation program, 
laboratories were still required to report their data to the registry (NCY DOHMH 
 2005b ). Reported data were held confi dentially and were unavailable to insurers, 
licensure organization, or employers (NCY DOHMH  2005c ). In 2009, 3 years after 
initiation of the program, 4.2 million A1C test results for almost 1.8 million indi-
viduals were registered with the NCY DOHMH (Chamany et al.  2009 ). 
2.4.3  Discussion 
 The mandated reporting of A1C results in New York City and the interventions that 
followed stimulated discussion about the role of  government in preventing  noncom-
municable diseases . Mandated communicable disease reporting is a longstanding 
and widely accepted essential public health practice, but the modern technology 
available to collect, analyze, and respond to health data today is unprecedented. 
While there are clear  population interests in controlling the sequelae of  diabetes —
preventing limb amputations and reducing care disparities, for example—there are 
also individual interests such as  privacy and  self-determination at stake. Current 
public health  ethics frameworks must consider the tension between individual and 
population interests in conjunction with the social, epidemiologic, technologic, and 
economic context of the case. 
 Proponents of the  A1C Registry argued that outreach for  noncommunicable dis-
ease is an integral part of public health practice and indeed is an  obligation of public 
health agencies, especially for a disease deemed epidemic (WHO  2011 ). They 
argued that the  A1C Registry allowed practitioners to identify patients in greatest 
need of follow-up or referral—often patients with fewest resources—and develop 
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disease management strategies (Chamany et al.  2009 ). One of the program’s goals 
in mailing test results to patients was to enable them to better manage their own 
 diabetes (e.g., only 10 % of people with diabetes know their own A1C level) (Berger 
and Silver  2008 ). 
 Others criticized some of New York City  Mayor  Michael Bloomberg’s  public 
health policies and interventions as creating a “ nanny state ” (characterized by being 
overly controlling of the lives of its citizens) (Magnusson  2014 ). Some patients 
believed that the  A1C Registry represented an unwarranted invasion of  privacy 
(Barnes et al.  2007 ), and some providers considered it an intrusion in the provider–
patient relationship (Goldman et al.  2008 ). Many who argued against public  health 
interventions such as the A1C Registry view choices about food and health—even 
when damaging—as choices that should enjoy a high degree of  autonomy uninfl u-
enced by  government (although they generally are silent about the infl uence of food 
and beverage industry  advertising ). A public health entity with fi scal and moral 
interests in the well-being of its citizenry should also work to ensure that individuals 
have accurate and actionable  information with which to make their health decisions 
(Thaler and Sunstein  2008 ). 
 Unlike the early 1900s when  Jacobson was decided, or the 1940s when the U.S. 
PHS STD  research was conducted in  Alabama and Guatemala, we now have several 
public health  ethics frameworks that help us approach ethical issues more system-
atically (Kass  2001 ; Childress et al.  2002 ; Baum et al.  2007 ; Bernheim et al.  2007 ). 
These frameworks refl ect attempts to reconcile individual and  population interests 
outlined by the  Jacobson Court. For example, the  A1C Registry case raised issues 
relating to  principles of  least infringement ,  social justice ,  health equity , and evi-
dence of benefi t. 
 When applying these ethical precepts to the  A1C Registry case, the  principle of 
 least infringement requires that public health pursue the least intrusive course of 
action that still achieves the public health goals. The A1C Registry attempted to 
accommodate this principle by allowing people to opt  out , which prevented NCY 
DOHMH from contacting patients and their clinicians, but did not relieve the labora-
tory from submitting reports to the registry. While the opt- out mechanism gives indi-
viduals some control over how their data are used, it can still allow a public health 
entity to seek to improve constituents’ well-being with minimal infringement. 
 Policy makers must also explain the aims of the program and whether benefi ts 
and burdens are expected to be distributed equitably throughout the population. In 
the  A1C Registry case, these foundational  values of  social justice and  health equity 
in large part motivated the reporting system. In New York City, substantial differ-
ences in morbidity and mortality by race/ethnicity and neighborhood income level 
were evident. NCY DOHMH use of the data to identify and then reduce these dif-
ferences promoted public health goals. One challenge in addressing such disparities 
is to ensure efforts do not inadvertently increase disparities or cause other social 
 harms , including stigma or loss of social capital. 
 Finally, policy makers have a  duty to ensure public health programs are effective, 
including empirically evaluating programs to provide evidence of this  effectiveness . 
In developing the  A1C Registry , policy makers compiled evidence from effective 
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public health programs to help explain the need and potential effectiveness of this 
program. As the NCY DOHMH evaluates the program and collects evidence of the 
A1C Registry’s effect on  diabetes in the city, it might alter  policies and procedures. 
Empirical data on the effectiveness of the registry are pending, and those results will 
certainly play an important role in assessing the program’s scientifi c and ethical 
rationale. As this brief analysis demonstrates, contemporary frameworks to guide 
ethical public health decision making offer additional nuance to the foundational 
tension between individual and  population interests. 
 The case of the A1C Registry draws attention to important implications of the 
 Jacobson  precedent and the continued infl uence of major historic breaches of public 
health ethics. The current agreed-upon equilibrium in the  United States emphasizes 
 individualism , even as similar  noncommunicable disease public health campaigns 
continue to be established (e.g., attempting to control the addition of trans fats to 
foods and the size of sugar-sweetened beverages) (Gostin  2013 ). These contempo-
rary cases in the United States are being established and deliberated in a climate of 
changing health care  policy and in the absence of an agreed-upon framework for 
public health ethics. The challenges they elucidate, however, are likely to have an 
important impact on the future role of public health in health care. 
2.5  Conclusions and Implications 
 The cases discussed here demonstrate how providing  essential public health ser-
vices requires ethical  principles and analysis as varied as the goals they hope to 
achieve. Clinical and  research ethics play a role, but are not suffi cient for the con-
sideration of competing public health  values . More substantial limits on  liberty and 
 privacy can be justifi ed as public health ethics aims to alleviate the “collective haz-
ard,” as opposed to individual  risk , for both motivation and validation of interven-
tions (Bayer and Fairchild  2004 ). However, as the cases in  Alabama and Guatemala 
underscore, limitations on  power are as important as justifi cations. 
 In different ways, the cases outlined here shaped public health practices and ethi-
cal expectations in the  United States . However, as our world grows more connected 
and our work increasingly crosses jurisdictional boundaries, it is clear that there are 
common values that motivate public health ethics even in vastly different  political , 
social, and economic contexts. The global setting in which many public health  pro-
fessionals work requires attention to such contextual factors. 
 Many of the cases outlined in the chapters that follow uncover additional ethical 
considerations affecting daily public health practice wherever that practice occurs. 
Whether it is social  duty or  political feasibility of the negative right to noninterfer-
ence, case studies can clarify ethical dimensions, help us examine alternatives for 
approaching decisions, and remind us that ethical decision making in public health 
is not an optional endeavor in  any case. These case studies underscore the need to 
identify decision-making frameworks that lead to careful consideration of individ-
ual and public interests, as a disregard for one or the other is perilous to both. 
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 Chapter 3 
 Resource Allocation and Priority Setting 
 Norman  Daniels 
3.1  Resource Allocation in Public Health 
 There has been much discussion of resource  allocation in medical systems, in the 
 United States and elsewhere. In large part, the discussion is driven by rising  cost s 
and the resulting budget pressures felt by publicly funded systems and by both 
 public and private components of mixed health systems. In some publicly funded 
systems, resource allocation is a pressing issue because resources expended on one 
disease or person cannot be spent on another disease or person. Some of the same 
concern arises in mixed medical systems with multiple funding sources. 
 Although much has been written on resource  allocation issues in medicine, there 
has been less discussion about how resource allocation affects public health. Federal, 
state, and local public health budgets in the United  State s constrain investments in 
health at those levels. In this regard, they are more like some foreign medical 
 systems than the more fragmented and mixed public-private medical system of the 
United States. In the context of budget cuts domestically and in many countries 
responding to an economic downturn, how to invest (and allocate) public health 
resources is a pressing issue. 
 Most investments in public health aim to reduce  population health  risk s, but 
some risks are greater than others, and  resource allocation decisions must respond 
to risks. Sometimes resource allocation decisions focus on the immediate payoff of 
reducing risks from a specifi c disease, whereas other resource allocation decisions 
affect the infrastructure needed to respond to health risks over time. In addition, 
resource allocation decisions may determine who faces risks—the distribution of 
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risks matters, not just the aggregate impact. Resource allocation in public health 
thus focuses on deciding  what risks to reduce—which depends in part on their 
 seriousness as  population factors and who faces them—and  how to reduce risks. 
 The cases in this chapter that discuss resource allocation force us to contemplate 
decisions about priorities in public health as opposed to the more frequently 
 discussed medical issues about health care priorities. Later we suggest that making 
decisions about these issues should be part of a deliberative process that emphasizes 
transparency,  stakeholder  participation , and clear, relevant reasoning. 
3.2  Collective Lessons from the Cases 
 Collectively, these resource allocation cases bring out several important points. 
Separately, they raise other central issues. It is worth noting these general issues 
before commenting on the more specifi c problems raised by each case. 
 The  fi rst  point the cases collectively make is that  effi ciency has ethical and not 
just economic importance (Daniels et al.  1996 ). If one health system is more  effi cient 
than another, it can meet more health needs per dollar spent than the less effi cient 
one. If we want systems to meet more health needs, and we should, then we prefer 
more effi cient health systems. Specifi cally, if we think we have  obligations to meet 
more health needs, or if we think meeting more “does more good,” and we ought to 
do as much good as we can with the resources we have, then we have an ethical 
basis for seeking more effi cient health systems. The economic pursuit of effi ciency 
should not, then, be dismissed as something that has no ethical rationale. 
 A second point the cases collectively make is that  effi ciency is not the only goal of 
health  policy , for we have concerns about how health benefi ts are  distributed as well as 
how they add up. Health policy is not only concerned with  improving  population health 
as a whole, but also with aiming to distribute that health fairly (Daniels  2008 ). That 
means many  resource allocation decisions involve competing health policy goals. 
 The point about competing goals is illustrated by a problem often encountered in 
policy decisions: should we always favor getting the best outcome from the use of a 
resource, or should we give people “fair” chances to get a benefi t if it is at least 
signifi cant (Brock  1988 )? For example, during an  i nfl uenza pandemic, should we 
allocate ventilators to those with the best chance of survival, or should we give 
 signifi cant but lesser chances to a broader group? 
 Reasonable people often disagree about when the difference in expected benefi ts 
means we should favor best outcomes over fair chances, or even about what counts 
as a fair chance. Hence, a third point emerges from the cases taken collectively: 
 reasonable people often disagree about the choice, and it is not possible to simply 
dismiss one side as irrational or insensitive to evidence and argument (Daniels and 
Sabin  2008 ). Indeed, reasonable people will disagree about how much priority to 
give to the sickest (or worst off) patients. They may think we have to weigh the 
seriousness of an illness against the potential benefi t that we know how to deliver, 
they may disagree about how to trade off those considerations, or they may disagree 
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about when modest benefi ts to larger numbers of people outweigh greater benefi ts 
 delivered to fewer people. Together these “unsolved rationing” problems—the best 
outcome versus fair chances problem (when to prefer best outcomes to fair chances), 
the priorities problem (how much priority to give to those who are worst off), and 
the aggregation problem (when do modest benefi ts to more people outweigh signifi -
cant benefi ts to fewer people)—mean that there is pervasive ethical disagreement 
underlying many  resou rce allocation problems (Daniels  1993 ). 
 There are other common sources of disagreement. One of the most common 
sources of controversy in  resource allocation decisions arises when a particular inter-
vention is seen as the last chance to extend life by some—a necessity if we are to act 
compassionately—and when it is seen primarily as an unproven intervention by others 
that we have no  obligation to provide it. Denials of such interventions in last-chance 
cases have been considered the “third rail”  of resource allocation  decisions (Daniels 
and Sabin  2008 ). Here we have two competing public  value s—compassion and stew-
ardship—and most public offi cials would prefer to be seen by the public as commit-
ted to saving lives rather than as  ha rd-nosed stewards of collective resources. 
 The cases taken collectively bring out one fi nal point: our  main analytic tools for 
aiding  resource allocation decision  making are limited in several ways, particularly 
by insensitivity to various ethical issues, especially issues of distribution. In short, 
these tools may take the fi rst point, about the importance of  effi ciency , seriously, yet 
fail to help us with the second and third lessons the cases collectively bring out, that 
we are also interested in distributing effi ciently produced health fairly, and that rea-
sonable people disagree about how to do that. To see this, consider two widely used 
tools:  comparative effectiveness research (CER) , which has been given prominence 
as a  r esearch focus in the Patient Protection and Affordable Care Act of  2010 , and 
 cost-effectiveness analysis (CEA) . Both help to answer policy- making questions. For 
example, a typical use of CER compares the  effectiveness of two interventions 
(drugs, procedures, or even two methods of delivery), and  policy makers may want 
to know if a new technology is more effective than older technologies. 
 Of course, they may also want to know if the new technology provides additional 
effectiveness at a reasonable  cost , which points to a shortcoming of much CER in 
the United  State s, where considerations of cost are generally avoided. Similarly, if 
there is only one effective  treatment for a condition, CER tells us nothing useful. It 
also tells us nothing about whether a more effective intervention is worth its extra 
cost. And, CER cannot help us compare intervention outcomes across different 
 disease conditions, since it uses no measure of health that permits a comparison of 
effectiveness. Indeed, decision makers face many resource allocation questions that 
cannot be answered by CER, even if CER can help avoid wasteful investments in 
interventions that do not work or that offer no improvement  ov er others. 
 In Germany, however, CER is combined with an  economic analysis that takes cost 
into account and that allows the calculation of “ effi ciency frontiers ” for different classes 
of drugs (Caro et al.  2010 ). Presumably, this method could be extended to different 
classes of public  health interventions if they are grouped appropriately. To calculate an 
effi ciency frontier, the effect of each drug in a class in producing some  health outcome 
is plotted against its  cost , and the curve is the effi ciency frontier for that class of drugs. 
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It is then possible to calculate if a new intervention in that drug class improves  effec-
tiveness at a price more or less effi cient than what is projected from  the existing effi -
ciency frontier. This use of CER allows German decision  makers to negotiate the price 
of treatments with manufacturers, rejecting payments that yield ineffi cient improve-
ments. German  policy makers can then cover every effective intervention sold at a price 
that makes it reasonably effi cient. Still, because German use of CER cannot make 
comparisons across diseases, it allows vast differences in  effi ciency across conditions. 
 CEA aims for greater scope  than  CER. It deploys a common unit for measuring 
 health outcomes , either a  disability-adjusted life year (DALY) or a  quality-adjusted 
life year (QALY) . This unit purports to combine duration with quality, permitting us 
to compare health states across a range of disease conditions. With this measure of 
health effects, we can construct a ratio (the incremental  cost-effectiveness ratio, or 
 IC ER) of the change in costs that results from the new intervention with the change 
in health effects (as measured by QALYs or DALYs). We can then calculate the cost 
per QALY (or  DAL Y) and arrive at an effi ciency measure for a range of interven-
tions that apply to different  condi tions. 
 Critics have noted  p roblematic ethical assumptions in the construction of the 
 health-adjusted life-year measures and in the use of CEA (Nord  1999 ; Brock  2004 ). 
To see some of these problems, consider the following table:
 Rationing problem  CEA  Fairness 
 Priorities  No priority to worst off  Some priority to worst off 
 Aggregation  Any  agg regation is OK  Some aggregations OK 
 Best outcomes/Fair  ch ances  Best  outcome s  Fair chances 
 CEA systematically departs from judgments many people will make about what 
is fair. The priorities problem asks how much priority we should give to people who 
are worse off. By constructing a unit of health  effectiveness , such as  the QALY, 
CEA assumes this unit has the same  value , regardless of who gets it or wherever it 
goes in a life (“A QALY is a QALY” is the slogan). But intuitively, many people 
think that a unit of health is worth more if someone who is relatively worse off 
(sicker) gets it rather than someone who is better off (less sick) (Brock  2002 ). At the 
same time, people generally do not think we should give complete priority to those 
who are worse off. We may be able to do little for them, so giving them priority 
means we would have to forego doing more good for others. Few would defend 
creating a bottomless pit out of those unfortunate enough to be the worst off. 
 Similarly, CEA assumes that we should aggregate even small benefi ts. Then, if 
enough people get small benefi ts, it outweighs giving large benefi ts to a few. But 
intuitively, most people think some benefi ts are trivial goods that should not be 
aggregated to outweigh larger benefi ts to a few (Kamm  1993 ). Curing many  people’s 
colds, for example, does not  outwei gh saving a single life. 
 Finally, CEA favors putting resources where we get a best outcome, whereas 
people intuitively favor giving people a fair (if not equal) chance at a benefi t. 
Locating an  HIV/AIDS  treatment clinic in an urban area may save more lives than 
placing a clinic in a rural area, but in doing so, we may deny many people a fair 
chance at a signifi cant benefi t (Daniels  2004 ). 
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 In all three of these examples of rationing problems, CEA favors  a  maximizing 
strategy, whereas people making judgments about  fairness are generally willing to sac-
rifi ce some  aggregate  population  health to treat people fairly. In each example, whether 
it is giving some priority to those who are worse off, viewing some benefi ts as not 
worth aggregating, or giving people fair chances at some benefi t,  fairness deviates from 
the health maximization that CEA favors. Yet we lack agreement on  principle s that tell 
us how to trade off goals of maximization and fairness in these cases. People disagree 
about what  trades they are willing to make, and this ethical disagreement is pervasive. 
 Determining priorities primarily by seeing whether an intervention achieves  some 
 cost/QALY  standard is adopting a health maximization approach. This approach departs 
from widely held judgments about fairness, even where people differ in these judg-
ments. Thus, the  National Institute of Clinical and Health Excellence (NICE) in the 
 United Kingdom has had to modify its more rigid practice of  approving new inter-
ventions only if they met a cost/ QALY  standard in the face of recommendations from 
its Citizens Council. This council, intended to refl ect representative social and ethical 
judgments among British citizens, has proposed relaxing NICE’s threshold in vari-
ous cases where judgments about  fairness differed from concerns about health maxi-
mization. The judgments of the Citizens Council in  this  regard agree with what the 
social science literature suggests are widely held views in a range of cultures and 
contexts (Dolan et al.  2005 ; Menzel et al.  1999 ; Nord  1999 ; Ubel et al.  1999 ,  2001 ). 
 There are, of course, those who criticize departures from the NICE threshold of 
the sort that the Citizens Council recommended. Compromising the maximization 
of health that CEA promotes may be seen as a moral error, perhaps the result of 
elevating the rescue of an “identifi ed” victim (say, a cancer patient whose life might 
be extended modestly by a new drug)  ove r benefi ts to “statistical” lives (using the 
resources to provide greater benefi ts to others). The reasonable disagreement about 
how to proceed suggests that we should view CEA as an input into a discussion 
about  reso urce allocation, not as an algorithm for making decisions. This “aid to 
decision making” role was proposed by the  Public Health Service in its recommen-
dations about the use of CEA (Gold et al.  1996 ). In short, controversial ethical 
 positions are embedded in CEA, and using CEA uncritically commits one to these 
views, even though many disagree with them. 
3.3  Specifi c Ethical Issues in Resource Allocation 
 We have already noted that the  effi ciency of a health system has ethical  consequences. 
But what should we count as  effi ciency ? Should we use our resources to generate 
more revenues for a unit of the health system—say, a hospital? Doing so would 
defi ne effi ciency the way most businesses do: other things being equal, an allocation 
that produces a greater return on investment is a more effi cient use of stockholder or 
owner resources. Alternatively, we might narrow the range of effects to health effects 
on the covered  population . Then we have greater effi ciency when an allocation pro-
duces more positive health effects in that population than an alternative allocation. 
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 The case Guzmán brings from  Colombia raises this issue forcefully. Should 
 hospitals, or a specifi c health plan, allocate resources favoring services (certain 
 treatment s) that raise more revenues than an alternative allocation (certain preven-
tive measures)? Perhaps the gains from the treatments will involve fewer  population 
health gains over time than those obtained by the preventive or  health promotional 
measures, even if they show their improvement more quickly and so look better 
sooner. Which plan should the  policy maker adopt? 
 This issue examines our purpose in designing a health system. Is it to meet the 
health needs of a population or is it to provide a good return on investment for those 
who invest in health services? We might think that this question is easier to answer in 
a system where health care delivery is seen largely as a public undertaking aimed at 
improving population health. In such a system, it might seem that there is only one 
purpose behind the health care system. Return on  investment  for the taxpayer  funding 
such a system should be measured by how effi ciently the system  improves  popula-
tion health. In systems where resources are owned privately (and there are many of 
these), however, it seems we must consider at least two goals. Even if the private 
sector must in part seek to improve  population health , which may be a requirement 
of state-imposed health care  regulation or, in some people’s opinions, a social respon-
sibility of corporations, private health-care organizations still must deliver a reason-
able return on investment for owners. Thus,  policy makers within private health-care 
organizations have a dual task. Balancing return on investment with improvement in 
 populatio n health thus becomes the central issue in the Colombian case study. 
 The Chilean case written by Gómez and Luco raises a similar issue, but this case 
focuses on measurable differences in the  cost effectiveness of certain services and 
in the severity of two conditions. If we consider only cost effectiveness, we view 
 effi ciency in one way—the best  health outcomes in the aggregate for the population 
for an investment in health. If we take severity of condition into account, we might 
view this as an  equity demand—in which case, we have an effi ciency-equity  confl ict 
and must make a trade-off. Or, we might think of effi ciency as a ranking of needs by 
severity of condition. In the latter, the resource allocation case turns on how we 
defi ne effi ciency. Specifi cally, the Chilean category of Guaranteed  Health Interventions 
could include  cataract surgery (the leading cause of blindness in the Chilean population), 
but not  multiple sclerosis (MS)  treatment s, which might be viewed as maximizing 
effi ciency in a  standard sense. Or, the Guaranteed Health Interventions scheme 
could include the less cost-effective treatment of MS but not cataract surgery, since 
MS is viewed as a more severe condition (because it can be life threatening and lead 
to premature death), even if it is far less prevalent than cataracts. If this were the 
case, the more effi cient system, in this nonstandard view, would rank treating more 
severe conditions as more effi cient than treating less severe conditions. If budget 
limitations mean only one should be included in the Guaranteed  Health Interventions 
program, either  M S or cataract surgery, which should it be? 
 The  cataract surgery intervention delivers a signifi cant benefi t in terms  of QALYs 
to a larger part of the  population than does the intervention package for MS, but the 
greater severity of premature death seems to be an important reason for favoring 
MS. If this reason is given priority over  cost effectiveness and over the standard 
view of  effi ciency , then are less effective treatments for more severe conditions 
N. Daniels
67
 supposed to have priority over more effective and cost-effective treatments for less 
severe conditions? If so, what kind of a health system does that produce if all needs 
can not be  met  given resource limits? Alternatively, do we want a system that always 
 we ighs cost  effectiveness more highly than the severity of a condition that some 
people have? That too seems  problem atic. 
 Suppose we think improving  population health is a worthwhile and defensible 
goal of a health system, we favor improving population health over increasing 
 revenues for the private sector (in the Guzmán case), and we also favor giving prior-
ity to cost effectiveness over severity of a condition (in the Gómez and Luco case). 
A  confl ict still remains between health maximization in the aggregate and concerns 
about  equity , as illustrated in the Blacksher and Goold case (and arguably in the 
case about  triage in  pand emics by Smith and Viens). 
 In the case that Blacksher and Goold describe, the task is to decide whether to 
 reallocate resources from a program focused on  maternal-child health and reduction 
of  b lack-white  in fant mortality  dis parities to a program that may get more health per 
dollar spent through other interventions.  Infant mortality among blacks and whites 
has declined rapidly in the United  State s; and in absolute terms, the decline has been 
more rapid for blacks. Still, the ratio of black infant mortality to white infant mortal-
ity has increased. Because the public health department is in a highly segregated 
city, this shift in program focus might seem to require viewing the remaining  bl ack- 
white health  d isparities as morally  a cceptable (especially given the high rate of 
improvement that past programs gave to black infant mortality rates). When should 
we view  health disparities as morally acceptable? When should we weigh reducing 
health disparities as more important than some aggregate gains in health that we 
know how to produce in a  population ? If public health has two goals—improving 
 population health and distributing that health fairly—how should we weigh the 
goals when they confl ict? 
 One important feature of the Blacksher and Goold case, namely the opinions 
within the community whose  inequalities are at issue, is really a feature to which 
nearly all cases warrant attending. People affected by a  policy ought to have some 
 infl uence in determining that policy. Some people might believe this is what  democ-
racy  requires. A diffi culty this view of democracy faces, however, is that those who 
speak for the community may not appropriately represent the community affected 
by the decision. Nevertheless, the opinions of a broader range of  stakeh olders may 
improve deliberation (depending on how those opinions are managed). It may also 
improve the acceptance of the decisions, which arguably enhances the legitimacy of 
the  decision-making process . 
 Resistance to including a broader range of  stakeholder s in decision making about 
health priorities may come from a concern that they bring with them “partiality.” 
This resistance may come from the view that greater impartiality leads to better 
deliberation. Arguably, this concern about partiality ignores the positive gains that 
partiality often brings to deliberation, especially if we know how to manage such 
deliberation so that we minimize the  risk s that partiality sometimes brings. We need 
such management skills in any case since partiality is unavoidable in most contexts. 
Rather than banning what cannot be eliminated, managing partiality in deliberations 
is the best way to improve decision making in contexts of reasonable disagreement. 
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 The  confl ict between improving  population health and treating people fairly can 
arise in other contexts. Arguably, the problem raised by Smith and Viens about the 
 principle that should govern  triage in  pande mics can be viewed as a confl ict between 
health maximization, in this case, saving the most lives, versus recognizing the 
claims that the sickest people have on us for assistance. Ordinarily, health systems 
give some priority to those who are sickest, but should that priority disappear in favor 
of saving lives when scarce resources, such as ventilators, are allocated in pandemic 
conditions? If we allocate our ventilators to the sickest patients, we may save fewer 
lives than if we allocate them to those whose lives we can better expect to save. Even 
if we think we should give priority to those worst off, do we ordinarily think that 
concern for them should govern triage  policy in pandemics? If we believe saving the 
most lives trumps concerns about helping those who are sickest in  pandemics, can we 
justify why the priority we give to the sickest should be revised in pandemics? 
 Suppose we have an acceptable way of measuring the burden of disease in a  popu-
lation , and according to this measure, mental illness is not given the priority it ought 
to have. That is, it contributes more to the burden of disease than is normally recog-
nized in  standard health systems, which provide too few services to meet  mental 
health needs. This is the problem upon which Rentmeester et al.’s case focuses. 
Specifi cally, some mental health conditions require signifi cant resources for what 
 Medicaid terms as “behavioral management,” which is seen as a social support 
 service not a medical  treatment . As a result, these services, to the extent they are 
provided, fall to state-funded social service budgets. The services place a burden on 
state fi nances that would be diminished if they were instead included in Medicaid 
 bud gets (50 % of which are fi nanced by each state). Arguably, the  stigma that attaches 
to  mental health issues is one important reason for this underprovision of social sup-
ports for people with mental health issues. In Nebraska, the  political opposition to 
 expanded  Medicaid coverage through the Affordable Care Act  ad ds to the burden on 
state budgets and the potential under-servicing of these mental-health induced needs. 
 It takes resources to meet public health needs. Suppose we can increase the resources 
to meet some of those needs by accepting a  pu blic-private partnership that improves a 
compromised private partner’s image? Should we meet health  n eeds at this price? 
 That is the issue posed by the Hernández-Aguado case from  Spain . Specifi cally, 
should public health authorities put their stamp of approval, in the form of their 
logo, on fl u epidemic notices printed on soft drink labels? The  inclusion of the logo 
is a requirement of the private entities that are willing to donate space on the labels 
of their products. Obviously, this provides a form of public support for soft drinks 
that arguably contribute to  obesity in a population and thus to the prevalence of 
 noncommunicable diseases associated with obesity. But in view of the low budgets 
available for fl u warnings, is this a price worth paying? What would the decision 
maker have to know about the effects of such labels to decide this case, or is the 
decision something that can be made independently of the specifi c payoffs of imple-
menting the warning system? Is there a way to consider  the  cost and assess whether 
the outcome of the warning is worth this price? Is this simply an  effi ciency calcula-
tion about the  cost effectiveness of reducing a  disease burden in this way? 
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3.4  Decision-Making Process 
 One fi nal crosscutting issue lurks behind all the cases in the resource allocation 
chapter (perhaps all the cases in the volume)—namely, the nature of the decision- 
making process that addresses the issues they raise. Public health decisions about 
resource allocation—judging from the cases on that topic in this volume—face 
 reasonable ethical disagreement. That is because the tradeoffs involved in the two 
main goals of  public health policy — improving  population health and distributing 
health fairly—are trade-offs about which people often reasonably disagree. How 
can public health decisions be made in real time, given these ethical disagreements, 
in ways that enhance their legitimacy and are arguably fair to all parties? 
 One approach to the problem is to construct a fair process for making those  decisions 
and to rely on the outcomes of such a process. People will judge the outcomes of a fair 
process to be fair (Daniels and Sabin  2008 ). What  conditions  should such a decision-
making process meet if it is to be considered fair? Four conditions are arguably neces-
sary (even if some may think they are not suffi cient and want to add others):  (1) The 
decisions and the rationales for them should be made  public. (2) They should be based 
on reasons all think are  relevant. (3) They should be  revisable in light of new evidence 
and arguments. And  (4) , these conditions should be  enforced so that the public can see 
that they obtain. Some explanation is needed for these conditions. 
 The publicity condition is widely embraced, even if it is fairly strong. It calls for 
the grounds for decisions—not just the content of the decisions—to be transparent. 
People have a right to know why decisions that affect their health are made the 
way they are. Moreover, making the reasoning for such decisions public is a way of 
exposing them to scrutiny so errors in reasoning or evidence can be detected and 
decisions improved. Even though we may not be able to be explicit  in  advance about 
all criteria we use to decide such cases, that is, we may work out our reasons through 
deliberation, we can explain on what we base our decisions. And that gives people 
affected by our decisions the knowledge they have a right to possess. 
 The search for reasons that all consider relevant to making a reasonable public 
health decision about resource allocation can narrow disagreement considerably. 
Even if people can agree on what reasons they think are relevant—in the spirit of 
fi nding mutually justifi able grounds for their decisions—they may not agree about 
the weight they give these reasons. One way to test the relevance of such reasons is 
to subject them to scrutiny by an appropriate range of  stakeholder s. What counts as 
appropriate may vary with the case. Who should be heard in deliberations is itself 
worthy of deliberation. Stakeholders raise different arguments that should be heard, 
and including their voices improves buy-in to decisions. Since stakeholders may not 
in many instances be elected representatives, we may be skeptical about whether the 
democratic process is improved by including them, but, if the deliberation is well 
managed, the quality of the discussion may improve greatly. 
 The  revisability condition , requiring that decisions be modifi able in light of new 
evidence and argument, is also widely embraced and not considered controversial. 
Decisions are made on the basis of evidence and arguments, and better evidence and 
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arguments may emerge that require revisiting some decisions. Some  decisions  can 
then be modifi ed, though it may be too late for others, and our consolation is that we 
made the best choices we could, given the evidence and arguments. 
 The intent of the  enforcement condition is to ensure that the other, more substan-
tive, conditions are met. Sometimes enforcement is a matter of state  regulation . 
Sometimes it can be the result of  vol untary conformance with a process. 
 Since  ethical disagreements abound in  resource allocation decisions , we need a 
process that enhances legitimacy. But can we claim that a decision-making process that 
is fair yields fair outcomes? One view is that we may ultimately become persuaded by 
a good argument that  fairness requires a different decision than one that emerged from 
a fair process. We can in this way defeat the  fairness we might ordinarily attribute to the 
outcome of a fair process. Does the prospect of defeating the fairness of a decision 
emerging from a fair process mean that we should not attribute fairness to the out-
comes? Alternatively, we can admit that the  fai rness that comes from a deliberation is 
only “defeasible” fairness, but it is  the  fairest conclusion we  ca n reach at the time. 
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 This case is presented for instructional purposes only. The ideas and opinions 
expressed are the author’s own. The case is not meant to refl ect the offi cial position, 
views, or policies of the editors, the editors’ host institutions, or the author’s host 
institution. 
3.5.1  Background 
 During the 1990s, many  Latin American countries began reforming their health sys-
tems according to a neoliberal development model that emphasizes free markets 
(Homedes and Ugalde  2005 ; Stocker et al.  1999 ). Approved in 1993,  health reform in 
Colombia was supposed to overcome problems such as low coverage, inequality in 
access and use of health care services, and ineffi ciency in the allocation and distribu-
tion of resources. But the reform also hoped to encourage more focus on illness  pre-
vention and  health promotion and more  community participation in health 
decision- making processes. The reformers advocated predominantly for neoliberal 
 value s like effi ciency, free choice, universality, and quality. Although they were also 
committed to the  communitarian values of  solidarity ,  equity , and social  participation . 
 The Colombian  health reform was one of the fi rst examples of implementing 
 managed competition in the developing world (Plaza et al.  2001 ). To stimulate com-
petition among insurers and health service providers, both public and private, health 
reformers applied the theory of managed competition (Enthoven  1993 ).  According 
to this theory, competition achieves effi ciency and reduces  cost , making health care 
services responsive to  consumer needs (Londoño and Frenk  1997 ). Hospitals 
become responsive when they are able to sell services and become fi nancially sus-
tainable. To achieve sustainability, supply subsidies (direct transfers from the state 
to hospitals) had to replace demand subsidies (transfers directed to the poor through 
a subsided  s ecurity plan). 
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 The Colombian reform established a General Social Security System in Health 
that featured two insurance plans:  (1) The Contributory Plan, fi nanced by manda-
tory contributions (formal employees and employers from the public and private 
sectors).  (2) The Subsidized Plan, funded by resources from the Contributory Plan 
and from taxes and other sources, which covered people unable to pay (Vargas et al. 
 2010 ). The actors of the system are the insurance companies, the health service 
providers, and the state regulatory organizations. Insurance companies contract 
with health service providers, and the regulatory organizations control  compliance 
with the defi ned basic health packages. 
 To optimize resources, the reform placed controls on medical practitioners and 
established explicit priority criteria based on  clinical guidelines that defi ned benefi t 
packages. From 1993, some adjustments to the reform have been introduced, such 
as the creation, in 2012, of the Institute for Health Technology Assessment to 
 provide  a n evidence base for health decisions. The Institute recommends which 
medical technologies should be paid with public resources on the basis of which 
technologies optimally improve the quality and  cost effectiveness of medical care. 
To determine these technologies, it conducts  health outcomes  research that guides 
technology development, evaluation,   and use (Giedion et al.  2012 ). 
 Nevertheless, 20 years later, the promise of reform lies unfulfi lled and many 
patients still experience high out-of-pocket costs, long wait times, or denial of  services. 
To access health services, frustrated citizens are turning to the legal system as a last 
resort and, by so doing, congesting the courts (Defensoría del Pueblo  2012 ).  Physicians 
are responding to economic incentives and  penalties by restricting hospitalization 
time and decreasing the use of expensive diagnostic tests and specialist referrals 
(Abadía and Oviedo  2009 ). To further reduce labor costs,  service providers have 
increased the workload of health  profession als and the number of patients seen per 
day,  whi le reducing the time spent with each patient (Defensoría del Pueblo  2007 ). 
 Insurance companies often take a long time to pay health service providers, and 
they also contract their own service network (a process known as vertical integration), 
so many  public hospitals are in serious fi nancial diffi culties. Meanwhile, hospital 
workers frequently disrupt the normal operation of hospitals as they strike to improve 
work conditions and have their paychecks issued more promptly. Should hospitals 
fail—40 % of the 968 public hospitals in Colombia are classifi ed as being at medium 
or high fi nancial  risk —nearly ten million people could be left without health service 
(Ministerio de Salud y Protección Social  2012 ; Quintana  2002 ). Add to that, the 
reforms have increased inequity, as more affl uent patients can more  easily access 
quality health care services than can low-income patients (Vargas et al.  2010 ). 
 The described problems refl ect a complex situation that requires profound 
 structural reform . As one way to address the immediate problems of  effi ciency and 
quality, Colombia in 2012 instituted  public hospital accreditation. Accreditation 
requires hospital directors to reach goals in service delivery related to fi nancial 
 viability, quality, and effi ciency. Hospital boards can now fi re directors who fail to 
meet these  g oals within a specifi ed period (Rodríguez  2012 ). Given the imbalances 
between budgets, service demands, and  ongoing  costs, hospital directors face enor-
mous challenges and ethical  dilemmas in formulating and executing their 
 mana gem ent plans. 
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3.5.2  Case Description 
 You are a director of a  public hospital that focuses on  health promotion and  prevention 
activities, such as general practice, dentistry, clinical laboratory, hospitalization, 
and emergency care. In developing your management plan, you must make deci-
sions about which services to  prioritize . If you prioritize services that represent 
higher revenues and lower costs as a way of conserving resources, you may have to 
reduce priority for some services. To guide your decision making, you conducted a 
retrospective study of service billing in the past 2 years and learned that the clinical 
laboratory and external medical consultation yielded higher incomes. The lowest 
yielding programs in the short term— vaccination , educational programs to improve 
 lifestyles , and provision of micronutrient  supplements to  children and pregnant 
women—were associated with the best long-term health results. 
 Taking seriously your fi duciary responsibilities, you try to guarantee fi nancial 
sustainability by containing labor costs,  restricting  consultation times, and shorten-
ing hospital stays. Your challenge is to do these things without diminishing the 
quality of patient care. But because you compete with other institutions, you must 
also assure suffi cient reserves to maintain and update medical equipment that will 
improve the “sale of services.” Knowing that every management decision you make 
will affect the  population you serve, you begin to refl ect on the  factors  affecting 
your  h ospital  man agement  plan. 
3.5.3  Discussion Questions 
 1.  Who are the major  stakeholder s in this case and what are their interests,  value s, 
and moral claims? Between which of them are there ethical  confl ict s or 
tensions? 
 2.  Which of these interests, values, and moral claims should be prioritized? How 
would you justify your priorities? 
 3.  Would you prioritize programs that in the short term brought in needed revenues 
or those programs that had highest impact long term? 
 4.  How can tensions between the goals of effi ciency, fi nancial viability, and quality 
be resolved? What weight should be assigned to each goal by the hospital board 
when evaluating your performance? 
 5.  At least in the short run, the new reforms seem to be prioritizing effi ciency, via-
bility, and quality over  equity . Should a health system attain the former goals 
before tackling the problem of equity, or should it insist on equity from the start? 
 6.  Can equity in health care be achieved without doing something about wealth 
inequity and other social determinants of health? 
 7.  Should you justify your decisions by emphasizing solidarity with other hospital 
directors and seeking community support? 
 8.  How could collaborations between public health, communities and the health care 
system begin to address neoliberal  concern s with effi ciency, viability, and quality? 
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 This case is presented for instructional purposes only. The ideas and opinions expressed 
are the authors’ own. The case is not meant to refl ect the offi cial position, views, or 
policies of the editors, the editors’ host institutions, or the authors’ host institutions. 
3.6.1  Background 
 The Global Burden of Disease (GBD) compares disease burdens based on epidemio-
logical measures of prevalence, mortality, disability, and associated  cost s. The GBD 
for mental illness amounts to 14 % of the world’s total disease burden (World Health 
Organization  2005 ).  I n the United  State s alone, every fi fth child suffers from a mental 
disorder (Perou et al.  2013 ). Although mental illness clearly causes disabilities (Prince 
et al.  2007 ), underservice to those with mental illness is commonplace. Lack of access 
to mental health services counts as the fi rst of many hurdles facing families who have 
a child with a mental illness.  Stigma and the lack of parity in health coverage for 
physical and mental illness are other hurdles for these families. Not surprisingly, these 
hurdles can critically affect the development  of  children with mental illness. 
 Lack of access to mental and behavioral health services  for  children 5 years and 
younger especially threatens their development. Rapid brain growth occurs in the 
fi rst 5 years of life, which lays the foundation for cognitive, emotional, and moral 
development. Exposure to chronic stress can prompt the release of hormones in the 
brain that can have enduring consequences for how the adult brain is organized and 
how it functions (Shonkoff and Phillips  2000 ). Because poor health can show up in 
children as developmental delay, access to mental and behavioral health services is 
critical. Longitudinal studies demonstrate positive and long-acting effects of early 
childhood interventions, such as environmental enrichment programs, on a range of 
cognitive and noncognitive skills, social behaviors, academic achievement, and 
adult job performance (Heckman  2008 ). The  esti mated annual rate of return on 
investment from targeted early childhood development programs is 7 %, and early 
intervention reduces the predictable need for higher, more costly levels of care in 
later life (Heckman et al.  2010 ). 
 In the United  State s, Medicaid is a government-funded program that provides 
health coverage to people with certain disabilities and to low-income adults and 
their children. The Federal Medicaid Act (FMA) requires states participating in 
Medicaid programs to provide  medically necessary  treatment to eligible children. 
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Under federal Medicaid  law , states must provide “early and periodic  screening , 
diagnostics, and treatment,” also known as EPSDT services, to eligible Medicaid 
recipients under age 21 (U.S.C. § 1396d(a)(4)(B)). The defi nition of EPSDT 
includes  necessary health care , diagnostic services, treatment, and other measures 
described in the Medical Assistance subchapter for the United States Code (42 
U.S.C. § 1396d (a)) (2012) that correct or ameliorate defects and physical and men-
tal illnesses and conditions discovered by the screening services, regardless of 
whether such services are covered under the state plan (42 U.S.C. § 1396d (r)(5)) 
(2013). The  medical necessity  standard , which is based on clinical standards of care, 
refers to interventions that may be justifi ed as reasonable, necessary, or appropriate. 
States must comply with the FMA standard to cover all treatments for a Medicaid-
eligible child’s physical or mental condition, even if service coverage is optional for 
adults covered by Medicaid. FMA also bars states from arbitrarily denying or reducing 
the amount, duration, or scope of a required service to an otherwise eligible recipient 
solely because of the diagnosis, illness, or condition (Nebraska Legislature  2012 ). 
 Despite the provisions of FMA, the U.S. Department of Health and Human 
Services, which oversees the Medicaid program, excludes certain behavioral health 
treatments for children with developmental disabilities and autism (National Health 
Law Program  2012 ; Autism Society of Nebraska  2012 ). In addition, some states’ 
Medicaid contracts allow insurers more  freedom than other states to deny payment 
for services. States also vary in who—the claimant or the insurer—must prove 
whether coverage provisions are adequate or fall short of federal Medicaid legal 
standards (Rosenbaum and Teitelbaum  1998 ). Differences among states in approval 
of payment for specifi c treatments, including mental and behavioral health treat-
ment, illustrate the need for more consistency in Medicaid coverage provisions and 
the lack of parity between mental and physical health coverage. Mental health ben-
efi ts must be offered at parity with medical services to newly eligible recipients as 
part of the 2010 Patient Protection and Affordable Care Act (ACA), and Medicaid 
expansion controversy is clear evidence that parity is a work  in progress (Mental 
Health America  2013 ; U.S. Department of Labor  2008 ). 
 Because of inadequate coverage for mental and behavioral health services for 
Medicaid-eligible  children , some  parents have no option other than to surrender their 
child to the child welfare system so that the child will receive full coverage for neces-
sary mental and behavioral health care services. This results in signifi cant cost-shift-
ing from Medicaid to the state’s child welfare system. That is, when a state provides 
federally mandated services to Medicaid-eligible children, it receives a fi nancial 
match from the federal  government to pay the  cost s. When a state denies federally 
mandated Medicaid services and a family surrenders a child to state custody so the 
child can receive care, the state pays the expense of the previously denied Medicaid 
costs plus the expense of entitlements the child acquires as a ward of the state. 
 The ACA Medicaid expansion offers a window of opportunity to increase cover-
age for behavioral health  treatment for children with mental illnesses. Although the 
federal government will bear the primary fi nancial burden of Medicaid expansion, 
some states have elected, for  political reasons, not to participate in this expansion. 
For participating states, ACA Medicaid expansion will replace state and local men-
tal health services funds with federal Medicaid money that will cover a wider range 
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of home and community-based services for mental illness treatment (Bazelon 
Center for Mental Health Law  2012 ). 
 Public health agencies and leaders often provide input for the Medicaid system, 
helping to develop protocols, criteria, and rules about which treatments are defi ned 
as  medically necessary . Such decisions about medical necessity affect clinicians, 
patients, and families because they determine which treatments get recommended at 
the clinical level and infl uence which treatments insurers cover. 
3.6.2  Case Description 
 You are the Medicaid director of a state with the country’s highest percentage of 
 children in the child welfare system. Twenty-fi ve percent of children in the state’s 
foster care system are there not because of abuse or neglect, but because of behav-
ioral problems and mental illnesses. As a state offi cial, you are aware that this results 
 in  signifi cant cost-shifting from Medicaid to the state’s child welfare system. 
 Recently, the case of 4-year-old Sam has come to your attention. Sam’s family 
cannot afford mental and behavioral health care for Sam, although he is Medicaid- 
eligible and insured through Magiscare (a private company with a state contract to 
administer Medicaid for mental and behavioral health services). Sam’s  parent s are 
considering surrendering their boy to become a state ward to get him the mental 
health services he needs. 
 Sam, you learn, eats random objects and dirt, throws tantrums, bangs his head on 
the ground, hits and bites himself and others, and often runs away. Recently diag-
nosed by his physician as having autism, Sam was referred to a psychologist who 
recommended outpatient behavioral therapy. Both the physician and the psycholo-
gist expect this therapy to be covered through the family’s Magiscare plan. 
 Magiscare denied the psychologist’s requests for payment on the grounds that, 
for children of Sam’s age, behavioral management is not covered under state  law 
because it is not “medically necessary.” Magiscare substantiated their denial of 
 payment because Sam’s behaviors primarily refl ect developmental disabilities 
related to autism, which are not covered under their contract with the state. When 
you ask the Magiscare executive director about this case, she suggests that Sam’s 
 parent s could attend therapy sessions to help them cope with their son’s behaviors, 
but she reasserts that behavioral management is not covered for children as young 
as Sam under state law because it is not medically necessary. 
 Members of the state legislature and child mental health advocacy groups are try-
ing to expand access to home-based and community-based mental health services. 
They have asked you to support their efforts. You also consider that your governor, 
who is your boss, has publically stated his fi rm opposition to ACA Medicaid expan-
sion, thus denying the state the opportunity to expand coverage for children’s mental 
and behavioral health  treatment through the ACA. At present, you know that your 
state is offering limited mental and behavioral health  service s and that narrow defi ni-
tions of  medical necessity are used to limit access to those services. 
 As the state Medicaid director, which steps should you take? 
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3.6.3  Discussion Questions 
 1.  Who are the main  stakeholder s in this case, and what are their primary interests? 
 2.  “Passing” the expense of coverage denied by Medicaid to other components of pub-
lic service, such as the  child  welfare system, has fi scal and social implications.
 (a)  What are some of these implications? 
 (b)  How should prevalence, mortality, disability,  and  cost be factored into think-
ing about ways to balance short- and long-term  risk s and benefi ts to indi-
viduals and to the public in this case? 
 3.  Suppose a  policy advisor warns that expanding behavioral health care for  chil-
dren will strain the Medicaid budget and require cuts in services for adults or 
reduce their eligibility.
 (a)  How should you respond? 
 (b)  Which considerations or priorities would guide your funding allocations? 
 4.  What role should ethical  principle s such as  stewardship ,  public health leader-
ship , and  moral courage play in this case? 
 5.  Medical necessity implies an acute care model of health service delivery and 
refl ects a clinical perspective. How well does this idea apply to a public health 
 prevention model of health service delivery? Are there better alternatives? 
 6.  Parity in insurance coverage for mental health is federally mandated for private 
insurers, which covers most citizens, but has proven to be an elusive goal for 
people who do not have private insurance or do not have enough coverage. 
 Medicaid is a public ( government funded) insurance program, not a private one. 
Although Medicaid benefi ciaries receive coverage for medically necessary men-
tal health services,  e ach state defi nes  medical necessity uniquely.
 (a)  Should a federal mandate defi ne  medical necessity for mental and behavioral 
services? 
 (b)  What fi nancial implications would such a mandate have from a state per-
spective and from an overall perspective? 
 7.  The term  principle-policy gap can be used to characterize situations in which 
most people support health coverage in  principle ; but in practice, they are unable 
to pay for coverage or unwilling to take the  political , social, cultural, or fi scal 
 risk s necessary to enable such coverage. What do such gaps tell us about which 
 value s the majority favors, and how might the term  principle-policy gap help us 
understand the dynamics in this case? What roles should public health leaders 
play in responding to principle-policy gaps? 
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3.7  Case 3: Public-Private Partnerships: Role of Corporate 
Sponsorship in Public Health 
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 Department of Public Health, History of Science and Gynecology 
 Universidad Miguel Hernández and CIBER de Epidemiología y Salud Pública 
 San Juan, Alicante ,  Spain 
 e-mail: ihernandez@umh.es 
 This case is presented for instructional purposes only. The ideas and opinions 
expressed are the authors’ own. The case is not meant to refl ect the offi cial position, 
views, or policies of the editors, the editors’ host institutions, or the authors’ host 
institutions. 
3.7.1  Background 
 Public health systems are usually underfunded in comparison with health care sys-
tems. In fact, the Organisation for Economic Co-operation and Development 
(OECD) countries allocate on average only 3 % of their health spending to  pub lic 
health and  prevention activities (OECD  2011 ). This low funding of public health 
programs hinders the capacity to implement effective public health policies (Robert 
Wood Johnson Foundation  2011 ). 
 Population health challenges, such as infl uenza pandemics, are increasingly 
complex, and tackling them involves urgently executing a wide array of public 
health measures to prevent disease transmission. In the case of infl uenza pandemics, 
measures can vary from border quarantine, social distancing, provision of antivirals 
and  vaccine s, and personal hygiene strategies. Recommendations often need to be 
made quickly even when knowledge about the seriousness and potential health and 
social effects are incomplete. The target for preventive interventions is the entire 
population. However, resources for intense and sustained health campaigns through 
mass communications are expensive. In addition, the social determinants of the dis-
ease must be understood and considered (Crowcroft and Rosella  2012 ). This typi-
cally involves the need for policies that engage the health and non-health sectors, 
such as educational policies and social or economic factors (Savoia et al.  2012 ). 
This complexity, together with decreasing funds and other factors, has contributed 
to increasing private sector involvement in health care. 
 According to  the  World Health Organization (WHO), a public-private partner-
ship gathers a set of actors for the common goal of improving  population health 
through agreed roles and  principle s. This may also be described as public sector 
programs with private sector participation (WHO  2013 ). WHO has described sev-
eral types of partnerships, including philanthropic, transactional, and transforma-
tional. Sponsorship is a form of a public-private partnership defi ned as “any form of 
monetary or in-kind payment or contribution to an event, activity, or individual that 
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directly or indirectly promotes a company’s name, brand, products, or services” 
(Kraak et al.  2012 ). In this sense, sponsorship is a commercial transaction, not type 
of philanthropy. 
 Public-private partnerships have become increasingly common for public health 
campaigns. Some transnational companies and their corporate foundations collabo-
rate with public institutions, such as United  Nation s agencies and  government s, to 
tackle complex public health problems, such as  treatment of diarrhea in developing 
countries (Torjesen  2011 ),  tuberculosis , and malaria (Ridley et al.  2001 ). These  col-
laboration s have been encouraged by international institutions and experts as a way 
to mobilize resources and expertise, which could complement the public sector. 
WHO has also encouraged using public-private partnerships to deliver health ser-
vices for a range of health problems, including HIV infection,  malaria ,  tuberculosis , 
trachoma, and vaccine-preventable diseases (Buse and Walt  2000a ,  b ). However, 
corporations’ increasing role in public health has been criticized as jeopardizing the 
mission of public health and its commitment to population health (Hastings  2012 ; 
Ludwig and Nestle  2008 ). Some corporations have used tactics that discredit public 
health actions, such as distorting scientifi c information and using fi nancial tactics 
and  political infl uence to avoid unfavorable regulations (Wiist  2011 ). 
 Public health  profession als, public health agencies, and governments often must 
decide whether to collaborate with the private sector to improve population health. 
These decisions are increasingly frequent as health department budgets shrink and 
public-private partnerships are seen as a way to secure funds for core public health 
programs. Ethical considerations can help us decide whether and when to form such 
partnerships. However, the available public health ethics frameworks (e.g., Public 
Health Leadership Society  2002 ; Nuffi eld Council on  Bioethics  2007 ; Kass  2001 ) 
do not specifi cally discuss public-private partnerships. Only the Public Health 
Leadership Society provides guidance for  such  collaborations.  Principle 10 pro-
poses that, “Public health institutions and their employees should engage in collabo-
rations and affi liations in ways that build the public’s trust and the institution’s 
effectiveness.” Continued discussion about the ethical implications of private-public 
partnerships is needed. 
3.7.2  Case Description 
 Top health offi cials in an industrialized country have declared a public health emer-
gency due to an infl uenza pandemic. The head of the country’s health department 
receives a call from the president of a multinational company that produces sugary, 
high-calorie drinks. The company president expresses his concern about the pan-
demic and wants to collaborate with the  government to prevent the spread of fl u. 
The company offers the health department a considerable amount of space, one- 
third of each can, on its star product (a soft drink) free of charge, to include mes-
sages on fl u  prevention . The company insists that the health department logo be 
included on the can along with the preventive messages. For them, the association 
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between the health department (through the logo) and their product is essential for 
the  collaboration as it would be an acknowledgement by the health department of 
the company’s social responsibility. 
 The head of the health department arranges a meeting with several health authori-
ties and offi cials to consider the offer. On one side, some members of the group sup-
port the proposal because of the need to carry out far-reaching public health 
campaigns to limit the impact of pandemic fl u. At that stage, the incidence of pan-
demic fl u is increasing quickly and the number of new outbreaks in  schools is wor-
rying the health authorities and the  population . There have been recent budget cuts to 
the health department, and some offi cials argue the company’s contribution may be 
the best option to ensure a far-reaching campaign on prevention measures to benefi t 
the population. They see sponsorship as a form of social responsibility because the 
company does not have any apparent economic interest in fl u-related activities. They 
also note that there are no other companies offering a similar collaboration. 
 But other offi cials say the company’s soft drink products contribute to the  obe-
sity and diabetes epidemic and that the company’s use of the health department logo 
would label it a pro-health industry with the backing of the highest health authority 
in the country. They also raise concerns about risking the independence of the health 
department in future regulatory action on sugar-rich beverages. 
 As the  hea d of the health department, you must decide if you should collaborate 
with the company. 
3.7.3  Discussion Questions 
 1.  What considerations should the health department director weigh when deciding 
whether to collaborate with the beverage company? 
 2.  Who are the major  stakeholder s the health department should consider, and what 
 value s might each of these stakeholders bring to this decision? 
 3.  In making your decision, what values should be prioritized? 
 4.  What positive or negative impacts would displaying the health department logo 
on the soft drink cans have on health department operations? 
 5.  How might sponsorship by a company that produces sugary beverages affect 
public trust in the health department and the institution’s effectiveness? 
 6.  Would the decision be different if the company produced healthy foods and the 
department’s logo was placed on a healthy product? 
 7.   Would community involvement facilitate decision making and the consideration 
of the ethical questions? What ethical criteria or guidance should be established 
to accept or reject a future donations or sponsorship of a public health program 
by a company? 
 Acknowledgements  We thank Mr. Jonathan Whitehead for language editing. 
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3.8  Case 4: Black-White Infant Mortality: Disparities, 
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 This case is presented for instructional purposes only. The ideas and opinions expressed 
are the authors’ own. The case is not meant to refl ect the offi cial position, views, or 
policies of the editors, the editors’ host institutions, or the authors’ host institutions. 
3.8.1  Background 
 Preterm births, the leading cause of infant mortality, are increasing annually worldwide 
(World Health Organization  2012 ).  The United  State s shares company with Nigeria, 
India, and Brazil among the top ten  countri es with the highest numbers of preterm births 
and ranks 31st among Organisation for Economic Co-operation and Development (OECD) 
nations in infant mortality (OECD  2010 ). Within the United States, racial and ethnic 
disparities in infant mortality remain entrenched and have increased (MacDorman and 
Mathews  2009 ). U.S. health  policy leaders have made the elimination of health dispari-
ties a top public health priority (Centers for Disease Control and Prevention  2011 ; 
U.S. Department of Health and Human Services  2011 ). Infant mortality is an important 
area of focus for  eliminating  disparities, both in its own right and because the rate of 
infant mortality serves as an indicator of the nation’s health due to its association with 
maternal health, social and economic conditions, racial discrimination, access to health 
care, and public health practices (MacDorman and Mathews  2009 ). 
 During the twentieth century, U.S. infant mortality declined 93 % (MacDorman 
 2011 ). In 1900, about 100 infants died per 1000 live births. By 2000, that number 
fell to 6.89. During the last half of the twentieth century, the rate of black infant 
mortality dropped dramatically. In 1950, black infant mortality was 43.9 deaths per 
1000 live births compared with 26.8 deaths per 1000 live births among whites 
(Mechanic  2002 ). But by 1998 black infant mortality fell to 13.8 deaths per 1000 
live births compared with 6.0 deaths per 1000 live births among whites. As these 
numbers show, both groups made signifi cant absolute gains, with blacks gaining 
more in absolute terms—a reduction of 30.1 for blacks and 20.8 for whites. Yet, 
black infant mortality still remained about twice that of whites. 
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 These disparities have persisted in the twenty-fi rst century. In 2006, non- Hispanic 
black women experienced the highest  rate of infant mortality, with 13.4 infant 
deaths per 1000 live births, while non-Hispanic white women had a considerably 
lower rate, with 5.6 infant deaths per 1000 live births. Citing a 2006 report from the 
National Healthy Start Association, MacDorman and Mathews ( 2009 ) report that 
programmatic efforts to reduce disparities in black-white infant mortality have had 
some successes at local levels, but eliminating the disparities is diffi cult. 
 The U.S. Centers for Disease Control and Prevention and the U.S. Department of 
Health and Human Services have prioritized both the elimination of health dispari-
ties and improvement in overall  population health. These twin goals—one distribu-
tive, the other aggregative—are separate and sometimes  confl ict (Anand  2004 ). 
Increases in health disparities often accompany advances in aggregate gains in popu-
lation health (Mechanic  2007 ). Although this case is specifi c to the United  State s, the 
dilemma is not. Data show that signifi cant progress on child mortality has been made 
in many countries but that this overall success is often coupled with increased 
inequalities between advantaged and disadvantaged groups (Chopra et al.  2012 ). In 
China and India, for example, disparities in mortality persist between boys and girls 
younger than 5 years, a function of entrenched gender discrimination (You et al. 
 2010 ). These examples raise challenging questions about how ethically to assess 
such cases and set priorities for the allocation of scarce public health resources. 
3.8.2  Case Description 
 You serve as the director for the local health department in a racially segregated 
urban city in the Midwest with one of the greatest concentrations of African 
Americans in the United States. The city has a long history of civil rights activism 
that led to protests and marches that ultimately empowered and mobilized black 
communities and organizations. Your health department has a history of prioritizing 
maternal-child health and the elimination of black-white disparities in infant mor-
tality in its programs, an investment of resources affi rmed by the city residents 
through the department’s community outreach program and planning processes. 
 Chronic  underfunding  of public health, made worse by the economic downturn, 
has resulted in drastic and unprecedented reductions in the public health budget. In 
consultation with your staff and community board of health, you have raised the 
possibility of redirecting resources from maternal-child health into other programs 
based on a number of practical and ethical considerations. As with national statis-
tics, the city has seen signifi cant declines in black infant mortality, even as black- 
white disparities remain. You note that although the maternal-child health programs 
are cost-effective, their impact on reducing black-white disparities seems to have 
stalled. Other programs appear to meet targets more consistently. To help support 
these other programs, you note that allocating resources to more effective programs 
provides more “health” per dollar, thus meeting the utilitarian demand to maximize 
overall health, which many view as the primary goal of public health and health 
 policy (Powers and Faden  2006 ). In addition, although black-white disparities in 
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infant mortality persist, blacks have made signifi cant gains, declining more than 
whites in some decades. You note that remaining inequalities could be deemed ethi-
cally acceptable by some  standard s of  equity , such as the “maximin”  principle . 
Although this distributive principle is subject to interpretation (Van Parijs  2003 ), it 
is generally understood to require that social and economic inequalities work to 
benefi t society’s least advantaged groups. Thus, inequalities (even signifi cant ones) 
are morally acceptable as long as the least advantaged have signifi cantly benefi ted 
(Powers and Faden  2006 ). 
 The director of community outreach proposes that the health department not 
make this decision unilaterally, but instead listen to community opinions on these 
questions of priorities and fairness. He suggests that the health department collabo-
rate with community partners to host a series of public forums. He insists that a 
topic of such historic and contemporary concern to the community must be subject 
to public deliberation. Despite having a history of supporting community discus-
sions, you are concerned about  the  cost of community forums, noting that they will 
drain resources from an already slim budget. 
3.8.3  Discussion Questions 
 1.  Have local health departments met their ethical obligations when community 
health improves overall, but health disparities persist? If not, why not? If so, on 
what grounds? 
 2.  Is there something about infant mortality that makes it special in considerations 
of fairness? If so, what is it? 
 3.  Should the role of race and racism in infant mortality shape priority setting and 
the allocation of resources in public health? If so, why? 
 4.  On what grounds and how should you as the local health department director 
make resource allocation decisions? What  standard s—evidence,  principle s of 
 justice , public opinion—should infl uence priority setting? 
 5.   Should the community have a role in identifying community health priorities or, 
more specifi cally, in providing input into allocation decisions that directly affect 
them? If so, how should the community be involved and who represents the 
community? 
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3.9  Case 5: Priority Setting in  Healt h Care: Ethical Issues 
 M.  Inés  Gómez and  Lorna  Luco 
 Centro de Bioética, Facultad de Medicina 
 Clínica Alemana–Universidad del Desarrollo 
 Santiago ,  Chile 
 e-mail: migomezb@gmail.com 
 This case is presented for instructional purposes only. The ideas and opinions 
expressed are the authors’ own. The case is not meant to refl ect the offi cial position, 
views, or policies of the editors, the editors’ host institutions, or the authors’ host 
institutions. 
3.9.1  Background 
 The Chilean  Sy stem of Guarantees in Health—created by  law in 2004—aims to 
establish guaranteed health care interventions in health promotion, disease and 
injury  prevention , diagnosis and  treatment , rehabilitation and palliative care 
(Ministerio de Salud  2004 ). The law mandates that public and private insurers pro-
vide the resources needed to protect the public against excessive health-related 
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spending and guarantee timely and universal access to authorized interventions 
based on  standard s of care. 1 
 National health objectives, established by the Ministry of Health, determine the 
list of guaranteed interventions. This list, however, is reviewed every 3 years and 
amended as new scientifi c and health information emerges. As of 2013, the System 
 o f Guarantees in Health included interventions for 80 health-related conditions 
(Ministerio de Salud  2013 ), accounting for almost 60 % of the Chilean burden of 
disease. The System of Guarantees in Health is a priority system based on acknowl-
edged criteria, namely scientifi c evidence and socially shared  value s. For the system 
to be effective, the criteria must be transparent, publicly accepted, and open to 
review and modifi cation. 
 The  law that created the System of Guarantees in Health also mandated a proce-
dure for selecting the guaranteed interventions (Ministerio de Salud  2004 ). The 
procedure factors in public opinion  research to identify social consensus on health 
priorities, studies to identify effective interventions that prolong and improve qual-
ity of life, and assessments of interventions’ cost effectiveness (Burrows  2008 ). The 
procedure determines priorities with an algorithm that includes these factors and 
information on disease burden and health system capacity (Missoni and Solimano 
 2010 ). After choosing the health interventions, the health ministry elaborates on a 
package of interventions related to specifi c health conditions and develops clinical 
 guide lines  for  such interventions. 
3.9.2  Case Description 
 You direct a team within the Ministry of Health that is responsible for recommend-
ing priorities for guaranteed health interventions. The priority ranking system 
emphasizes the selection of cost-effective interventions for conditions with the 
greatest burden. However, the health ministry also has authorized including expen-
sive interventions that are less effective or treating health conditions with low prev-
alence, if that condition or those interventions signifi cantly impact health. Because 
of budget reductions, a number of interventions are under review. Your team has 
been asked to recommend funding interventions for two health 
conditions—cataract (a common condition with highly effective  treatment ) and 
multiple sclerosis (a less prevalent condition but one with signifi cant health and 
social impact). 
1  Law 19.966 for the System of Guarantees in Health includes the following defi nitions for guaran-
tees:  Guaranteed Access —Public and private health insurers must grant the resources to provide 
guaranteed interventions;  Guaranteed Opportunity —Guaranteed interventions must be delivered 
within a deadline established in the protocols elaborated by the Ministry of Health;  Guaranteed 
Quality: Interventions must be delivered by registered and accredited health care providers; 
 Financial Protection —A maximum copayment is established to avoid the insured falling into 
fi nancial insolvency. 
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 Cataract, the main  cause  of blindness, primarily affects people over 40. This 
health problem has a high impact as measured by quality-adjusted life years 
(QALYs) (Ministerio de Salud  2007 ). Its surgical treatment is effective for 80–95 % 
of patients. The package of guaranteed interventions includes diagnostic confi rma-
tion within 180 days after suspected diagnosis and surgical treatment 90 days after 
confi rmation. In 2013, it was expected that 48,424 cataract surgeries would be 
performed in Chilean public hospitals and 416 in private institutions. 
 Multiple sclerosis , an autoimmune infl ammatory disease leading to demyelin-
ation in the central nervous system, produces a progressive deterioration of health 
and quality of life. It represents a minimal disease burden at the  population level, 
mainly due to premature death. In Chile, it is estimated that 385 patients are treated 
for multiple sclerosis each year. The package of guaranteed interventions includes 
diagnostic confi rmation within 60 days; confi rmed cases must receive treatment 
within 30 days. Treatment includes pharmacological therapy and  p hysiotherapy. 
3.9.3  Discussion Questions 
 1.  What are some of the ethical, scientifi c, and social considerations that should be 
weighed in deciding if interventions for both cataract and multiple sclerosis 
should be covered by the System of Guarantees in Health? 
 2.  Is there an obligation for health systems to cover all health problems affecting a 
population? Are there limits? 
 3.  How should health problems be prioritized and who should have the authority to 
make these decisions? Which criteria should receive the most weight in ranking 
priorities? 
 4.  How should resources be distributed among health conditions affecting many 
people versus health conditions affecting few people? 
 5.  How should resources be distributed among procedures that are preventive ver-
sus treatments for existing conditions? 
 6.  How does taking a public health perspective versus a clinical medicine perspec-
tive affect your thinking about including these two conditions in the System of 
Guarantees in Health? 
 7.  What role should transparency play in the selection procedure? 
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views, or policies of the editors, the editors’ host institutions, or the authors’ host 
institutions. 
3.10.1  Back ground 
 Infectious diseases such as pandemic infl uenza and severe acute respiratory syn-
drome (SARS) have attuned the attention of  policy makers and health practitioners 
to the importance of protecting and promoting the public’s health in the face of 
increased care needs and extreme resource scarcity. In particular, acute care needs 
for the critically ill and discussions of  treatment priorities have been the subject of 
much debate in pandemic planning (Hick et al.  2007 ; Melnychuk and Kenny  2006 ; 
Uscher-Pines et al.  2006 ). This is not surprising, as it has been estimated that more 
than 700,000 Americans may require mechanical ventilation during a pandemic, far 
outnumbering available ventilators (Rubinson et al.  2010 ; U.S. Department of 
Health and Human Services  2005 ). Additionally, shortages of hospital beds, person-
nel, and other equipment can be expected during a pandemic, which may limit the 
ability to meet an expected increase in patient  volu me (World Health Organization 
 2008 ). 
 Prudentially planning for the public’s increased care needs during a pandemic 
requires assessing surge capacity, especially in critical care units (CCU). However, 
as pandemics increase in severity, they can overwhelm critical care capacity and 
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contingency arrangements. To make the best use of resources and personnel (even 
in the absence of a pandemic), patients are triaged—evaluated to determine the type 
and priority of care to be received. While medical information informs the develop-
ment of triage criteria, ethical considerations about triage goals—whether explicit 
or implicit—also play a role. For public health emergencies that overwhelm capac-
ity, some propose adjusting critical care triage criteria to emphasize certain public 
health goals, like saving the most lives possible (Christian et al.  2006 ; Silva et al. 
 2010 ). 
 Some contend that utilitarian reasoning should predominate in critical care tri-
age, based on the intuition that, when resources are scarce, allocation decisions 
should produce the greatest good for the greatest number (Charlesworth  1993 ; 
Childress  2004 ). Critics of  utilitariani sm reply that it requires coercion or covert-
ness to succeed, because the public will not voluntarily sacrifi ce their lives or their 
loved ones for the greater good (Baker and Strosberg  1992 ). Utilitarian triage may 
be unpalatable to the public on the further ground that it quantifi es and judges the 
 value of one life over another, which could disproportionally impact particular pop-
ulation groups (Hoffman  2009 ). Others therefore would base triage decisions on 
egalitarian considerations, for instance, by giving everyone an equal chance at 
obtaining a scarce good, an approach for which historical precedent exists (Baker 
and Strosberg  1992 ). 
 Whatever approach is adopted, prior arrangements between  policy makers, prac-
titioners, and the public based on thoughtful,  transparent deliberation about the 
most ethical approach to CCU triage usually will improve the legitimacy of  d eci-
sions. Those who promote an approach based on  fairness  and  equity need to con-
sider that, during public health emergencies, the goal of saving lives may force a 
retreat to utilitarian ethics (Kirkwood  2010 ; Veatch  2005 ). While not necessarily 
unethical in itself, a retreat that overturns prior arrangements lays itself open to 
charges of illegitimacy. 
 Variability in the frameworks used to allocate public health resources illustrates 
the importance of refl ecting upon the  value s that undergird policy decisions and 
individual practices, like critical care triage. Appealing spontaneously in the heat of 
the moment to values that have not been adequately refl ected upon or discussed in a 
 transparent and deliberative manner may lead to undesirable outcomes and accusa-
tions of unethical practices. While discussions of CCU triage criteria ultimately 
concern institutional clinical policy and practice, they refl ect a larger discussion 
about the overarching public health goals in the face of large-scale, widespread 
public health emergencies, like pandemics. 
3.10.2  Case Description 
 An outbreak of a novel infl uenza virus has progressed to the point that  the  World 
Health Organization has declared a pandemic. In the pandemic’s fi rst wave, hospital 
capacities were suffi cient to handle the infl ux of pandemic infl uenza patients, whose 
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morbidity and mortality rates mirrored rates for seasonal infl uenza. However, 
despite a  vaccination campaign and other measures, such as ensuring surge capac-
ity, rates of morbidity and mortality associated with the virus have increased drasti-
cally during the pandemic’s second wave. 
 The resulting increased number of patients needing hospital beds has over-
whelmed even the surge capacity of the CCUs of a metropolitan city’s tertiary care 
hospitals. To meet this challenge, a teleconference has been scheduled between sev-
eral members of the hospitals’ administration, the CCU directors from each hospi-
tal, and public health offi cials involved in leading the jurisdiction’s pandemic 
response. As a public health offi cial who played a central role in developing the 
pandemic plan for your jurisdiction, you have been included on the call to provide 
guidance for the pandemic response. 
 During the meeting, a number of CCU directors report that their physicians and 
nurses are concerned about the type of patients  bein g admitted into the CCU. Some 
of the directors see a trend that they suggest is ultimately undermining the effi ciency 
of the pandemic response. They argue that, as the severity of the pandemic contin-
ues to increase, their triage criteria should be modifi ed so as to use CCU resources 
to save the most lives possible. They worry that admitting those who present with 
the most need is preventing  treatment of those who will benefi t most from CCU 
admission. “So long as our triage scheme saves the most lives, it is ethically justifi -
able” a number of them declare. 
 The group takes up the proposal of a CCU director to triage according to 
Sequential Organ Failure Assessment (SOFA) scores—which are derived using a 
tool that determines a patient’s organ function and failure rate to predict outcomes 
(Vincent et al.  2000 ). Were the pandemic’s severity to increase, the group suggests 
that, in addition to the CCU director’s proposal to use SOFA criteria, even more 
inclusion, exclusion, and priority criteria could be added with the goal of saving as 
many lives as possible. They’ve proposed exclusion criteria for CCU admittance 
that include patients with a poor prognosis, patients with other known health issues, 
and some mention of age cut-offs, to name a few. 
 Others involved in the teleconference question whether this is the right approach 
to take. They argue that, by aiming to save the most lives possible, those who may 
benefi t less from CCU admission, like older adults or individuals with disabilities, 
will be unfairly affected. They say, “we should not just aim to save lives, but rather 
save lives  fairly .” As you and your public health colleagues are leading the pan-
demic response, the hospital administrators and CCU  di rectors look to you for a 
recommendation or decision about how to proceed. 
3.10.3  Discussion Questions 
 1.  Ensuring that the CCU has surge capacity is a common strategy to accommodate 
an infl ux of patients who have been infected with pandemic infl uenza.
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 (a)  Does surge capability require alternative critical care triage criteria? 
 (b)  If the population’s health needs exceed contingency arrangements, should 
alternative critical care triage criteria be used? 
 (c)  How should these decisions be made? 
 (d)  What principles,  value s, or processes should infl uence these decisions? 
 2.  What considerations might exist during a pandemic that do not exist in everyday 
critical care and critical care triage that do or do not support the modifi cation of 
triage criteria? If pandemic critical care triage requires a unique conceptual 
framework, what principles ought to be valued in such a framework (e.g. need, 
equality, utility, effi ciency)? 
 3.  Would the severity of a pandemic ever warrant the use of a utilitarian scheme for 
critical care triage, given that the public generally fi nds it unpalatable and carry-
ing out such a plan could require coercion? How could an adverse public reac-
tion to coercive or covert measures be mitigated? 
 4.  In a pandemic, the most seriously ill patients with the lowest probability of being 
saved might be left untreated because their care would require too many resources 
with little prospect of recovery. This illustrates a  confl ict between the common 
good and the best interests of individual patients. What other confl icts might 
arise when triaging in a pandemic? 
 5.  Triage can be used to maximize the number of lives saved with available 
resources. Should we aim to maximize the number of lives or, alternatively, the 
number of life years saved? This can also give rise to questions about the quality 
of those lives and years lived. Is it ever appropriate to make allocation decisions 
based on quality of life or life years? 
 Acknowledgements  MJS is supported by a Canadian Institutes of Health Research Frederick 
Banting and Charles Best Canada Graduate Scholarship and the Canadian Institutes of Health 
Research Douglas Kinsella Doctoral Award for Research in Bioethics. AMV is supported by the 
Faculty of Medicine, Ruhr-University Bochum. 
 Open Access  This chapter is distributed under the terms of the Creative Commons Attribution-
NonCommercial 2.5 License ( http://creativecommons.org/licenses/by-nc/2.5/ ), which permits 
any noncommercial use, duplication, adaptation, distribution, and reproduction in any medium 
or format, as long as you give appropriate credit to the original author(s) and the source, a link 
is provided to the Creative Commons license, and any changes made are indicated.
The images or other third party material in this chapter are included in the work’s Creative 
Commons license, unless indicated otherwise in the credit line; if such material is not included 
in the work’s Creative Commons license and the respective action is not permitted by statutory 
regulation, users will need to obtain permission from the license holder to duplicate, adapt, or 
reproduce the material. 
 References 
 Baker, R., and M. Strosberg. 1992. Triage and equality: An historical reassessment of utilitarian 
analyses of triage.  Kennedy Institute of Ethics Journal 2(2): 103–123. 
 Charlesworth, M. 1993.  Bioethics in a liberal society. New York: Cambridge University Press. 
3 Resource Allocation and Priority Setting
94
 Childress, J. F. 2004. Disaster triage.  Virtual Mentor 6(5).  http://journalofethics.ama-assn.
org/2004/05/ccas2-0405.html (accessed on 20 Nov 2015). 
 Christian, M.D., L. Hawryluck, R.S. Wax, et al. 2006. Development of a triage protocol for critical 
care during an infl uenza pandemic.  Canadian Medical Association Journal 175(11): 
1377–1381. 
 Hick, J., L. Rubinson, D. O’Laughlin, and J. Farmer. 2007. Allocating ventilators during largescale 
disasters—Problem, planning, and process.  Critical Care 11(3): 217–226. 
 Hoffman, S. 2009. Preparing for disaster: Protecting the most vulnerable in emergencies.  UC 
Davis Law Review 42: 1491–1547. 
 Kirkwood, K. 2010. In the name of the greater good?  Emerging Health Threats Journal 2(E12): 
1–3. 
 Melnychuk, R.M., and N.P. Kenny. 2006. Pandemic triage: The ethical challenge.  Canadian 
Medical Association Journal 175(11): 1393–1394. 
 Rubinson, L., F. Vaughn, S. Nelson, et al. 2010. Mechanical ventilators in US acute care hospitals. 
 Disaster Medicine and Public Health Preparedness 4(3): 199–206. 
 Silva, D.S., J.X. Nie, K. Rossiter, S. Sahni, and R.E. Upshur. 2010. Contextualizing ethics: 
Ventilators, H1N1 and marginalized populations.  Healthcare Quarterly 13(1): 32–36. 
 U.S. Department of Health and Human Services. 2005.  HHS pandemic infl uenza plan.  http://www.
fl u.gov/planning-preparedness/federal/hhspandemicinfl uenzaplan.pdf . Accessed 7 Jan 2013. 
 Uscher-Pines, L., S.B. Omer, D.J. Barnett, T.A. Burke, and R.D. Balicer. 2006. Priority setting for 
pandemic infl uenza: An analysis of national preparedness plans.  PLoS Medicine 3(10): 
1721–1727. 
 Veatch, R.M. 2005. Disaster preparedness and triage: Justice and the common good.  The Mount 
Sinai Journal of Medicine 72(4): 236–241. 
 Vincent, J.L., F. Ferreira, and R. Moreno. 2000. Scoring systems for assessing organ dysfunction 
and survival.  Critical Care Clinics 16(2): 353–366. 
 World Health Organization (WHO). 2008.  Addressing ethical issues in pandemic infl uenza plan-
ning: Discussion papers.  http://www.who.int/csr/resources/publications/cds_fl u_ethics_5web.
pdf . Accessed 2 July 2013. 
N. Daniels
95© The Author(s) 2016 
D.H. Barrett et al. (eds.), Public Health Ethics: Cases Spanning the Globe, 
Public Health Ethics Analysis 3, DOI 10.1007/978-3-319-23847-0_4
 Chapter 4 
 Disease Prevention and Control 
 Michael  J.  Selgelid 
4.1  Introduction 
 Ethical issues surrounding  public health policy and practice regarding disease pre-
vention and control often involve confl icting rights and values. Such confl icts partly 
arise from tension between individual and community interests or tension involving 
cultural beliefs and practices. This chapter outlines how such confl icts and tensions 
arise in the context of disease prevention and control by exploring ethical issues 
associated with  mandatory treatment and vaccination,  disease screening and  sur-
veillance , diseases prone to stigma,  access to care ,  health promotion incentives , and 
 emergency response . 
4.2  Mandatory Treatment and Vaccination 
 In standard biomedical ethics (as opposed to public health ethics) discourse, the 
patient’s right to  informed consent to medical intervention is often considered sac-
rosanct. A primary aim of informed consent is to avoid medical  paternalism , such as 
coercing a patient to do something for his or her own benefi t. The transition in clini-
cal practice from medical paternalism to informed consent was largely based on the 
ideas that (1) a well-informed patient is better placed than the doctor to determine 
which actions are in the patient’s best interests (Goldman  1980 ) and (2) that a 
patient’s  autonomy should, in any case, be respected. 
 The opinions ,  fi ndings ,  and conclusions of the author do not necessarily refl ect the offi cial posi-
tion ,  views ,  or policies of the editors ,  the editors ’  host institutions ,  or the author ’ s host 
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 In public health, however, treatment and vaccination may, in addition to the health 
of the individual, be important to  population health . As such, individual patients are 
not the only stakeholders whose interests must be considered. In the context of  tuber-
culosis (TB) , coercive treatment is common—in so far as, in many jurisdictions, 
patients with active TB are required to undergo (often directly observed) treatment 
under threat of confi nement if they refuse. While TB treatment usually benefi ts those 
subjected to this kind of coercion, the primary motive for such policies is the protec-
tion of public health rather than  paternalism . Because patients with untreated active 
TB remain contagious, their treatment is essential to prevent infection of others. 
Though objections to paternalism are not as relevant to mandatory treatment in this 
context, ethical issues remain. Because mandatory treatment (aimed at protection of 
others) confl icts with individual liberty, there is a  confl ict between legitimate values—
i.e.,  individual liberty versus public health. There are also confl icting rights—i.e., the 
right of coerced individuals to  autonomy versus the rights of others to health (or their 
rights not to be harmed by being infected). Each of these values and rights is legiti-
mate; and, arguably, none should be given absolute priority over the others. A key 
ethical question about mandatory treatment is, thus, how great the  thr eat to others (and 
public health in general) would need to be in order for mandatory treatment to be 
justifi ed. 1 It is noteworthy that TB is relatively exceptional—i.e., there are not many 
other cases of  infectious diseases for which treatment is routinely required. 
 Similar issues arise in the context of vaccination. While vaccination usually benefi ts 
the vaccinated, it also benefi ts others via contribution to herd immunity (Verweij and 
Dawson  2004 ). Mandatory vaccination is also more common than mandatory treat-
ment. In some jurisdictions, for example, vaccination of  children is required for school 
attendance. The case presented by Simón-Lorda et al. considers the scenario of a  mea-
sles outbreak, resulting from a low rate of vaccination uptake, at a school in  Spain . In 
the scenario, the confl icting rights associated with mandatory medical intervention 
again come into play. The suggestion that unvaccinated children should not be permit-
ted to attend school, for example, is initially rejected by health authorities on the 
grounds that this would confl ict with their right to education. Unvaccinated children’s 
right to education, thus, confl icts with the rights of other children not to be infected. 
How should such a confl ict of rights be resolved? In the case presented by Simón-
Lorda et al., the outbreak fi nally becomes so widespread that mandatory vaccination is 
called for as an emergency measure. Assuming such a decision would be legitimate in 
the scenario under consideration, it might be grounded on the belief that public health 
outweighs individual liberty when the stakes are suffi ciently high (rather than the belief 
that the value of public health outweighs the value of  liberty in general). 
 A  complicating factor regarding mandatory vaccination is that when one unvac-
cinated child ends up becoming infected with a disease (such as  measles ) and then 
goes on to infect others, it could be argued that those others who become infected 
do not in fact have their rights violated because they could have avoided infection 
1  With respect to the public health  ethics framework discussed in Chap.  1 , the question here is what, 
exactly, the  proportionality requirement should be thought to consist in. For further discussion of 
this issue, see Selgelid ( 2009 ). 
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by getting vaccinated themselves. It would usually be parents, rather than  children , 
however, who make decisions about  childhood vaccination . This raises the question 
of who (e.g., parents or the government) should have  authority to make decisions 
about children’s health and well-being—and vaccination in particular. Assuming 
that parents should usually retain decision-making authority about childhood vac-
cination, the relevance of cultural differences to public health ethics is highlighted 
by the fact that some parents may refuse vaccination of their children for what are 
ultimately cultural reasons (e.g., religious beliefs). This leads to questions (also 
raised by other cases presented in this chapter) about whether, and to what extent, 
 cultural beliefs and practices should infl uence  public health policy and practice. 
4.3  Disease Screening  and Surveillance 
 As in the cases of treatment and vaccination,  informed consent to diagnostic testing is 
usually considered essential in standard biomedical ethics discourse regarding doctor-
patient relationships. In public health, however, diagnostic testing is sometimes 
required, for example as a condition of employment (such as tuberculin skin testing of 
restaurant and hospital employees) or  immigration (for which both TB and  HIV test-
ing are common). Testing of tissues or other biological samples also sometimes takes 
place, for research or surveillance purposes, without patients’ or donors’ awareness or 
consent (e.g., testing of stored sputum samples to determine TB  drug resistance preva-
lence). Cases such as these may pose confl ict between the goal to promote public 
health, on the one hand, and the goals to respect individual  autonomy and  privacy , on 
the other. As with  mandatory treatment and  vacc ination, however, such practices are 
arguably justifi able in cases where public health benefi ts are suffi ciently high (which 
is not to say that public health generally trumps autonomy and  privacy ). 
 As with vaccination, questions about parental authority in decision making 
regarding childhood health arise in the context of disease screening. The case pre-
sented by Nicholls et al., raises such issues.  Bloodspot screening is commonly used 
to test newborns for numerous serious health conditions, and stored bloodspots are 
sometimes later used for research and surveillance that lead to important public 
health benefi ts. Given the potential importance of such practices for a child’s health, 
and to public health more generally, to what extent is parental informed consent to 
bloodspot screening or secondary use of stored bloodspots essential? The case pre-
sented by Nicholls et al. raises the worry that more parents, out of privacy concerns, 
might refuse  n ewborn bloodspot screening if a thoroughgoing  informed consent 
process (as opposed to the current opt-out model) were required, and that this could 
have adverse effects for both newborns and, given the benefi ts of research and 
 surveillance with stored bloodspots, public health more generally. Among other 
important questions, Nicholls et al. ask, “How should clinically actionable results 
[of secondary investigations involving bloodspots] be dealt with?” When surveil-
lance testing of stored bloodspots  or  other stored tissues leads to identifi cation of 
not-previously- recognized disease (or predispositions thereto), for example, to what 
extent do investigators have  duties to track down and inform individuals from whom 
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bloodspots or other stored tissues were originally obtained? Like research, surveil-
lance raises ethical issues about  standards of care (Selgelid  2012 ). 
 Ethical issues concerning testing and surveillance are also highlighted in the case 
presented by Bhattacharya. In this case, the  criminalization of  HIV transmission 
and mandatory name-based reporting requirements (in the case of  HIV diagnosis) 
are portrayed as deterrents to sex workers’ seeking of  HIV testing . In the case of 
criminalized transmission, the  disincentive to testing is that criminal  penalties asso-
ciated with prostitution are greater (in some jurisdictions) for those who have tested 
HIV positive. Among other things, criminalizing HIV makes it diffi cult for public 
health workers to promote HIV testing of sex workers (who are an especially vul-
nerable group, and for whom testing is especially important—for their own sake and 
for public health more generally) while adhering to mandatory reporting require-
ments. This challenge is further exacerbated by socio-economic and cultural factors 
that promote prostitution to begin with. 
 This case also raises more general issues about the  criminalization of infectious 
disease transmission . Many argue that there is a moral  obligation to avoid infecting 
others, based on a duty not to harm others (Harris and Holm  1995 ). Criminalizing 
 infectious disease transmission involves the legal  enforcement of such a moral  duty . 
Given that  HIV transmission usually involves consenting adults knowingly taking 
risks, one might question whether criminalization of HIV transmission, in particu-
lar, is necessary. It should be noted, however, that it is usually  intentional transmis-
sion of HIV that is criminalized. In any case, criminalization of HIV transmission 
raises questions about the extent to which intentional transmission of other diseases 
should also be criminalized and whether, or why,  negligent transmission (of  HIV or 
other diseases) should also be subject to legal  penalties . 
 The  case  by Bhattacharya also raises ethical questions about name-based report-
ing, which is legally required upon positive diagnosis of numerous diseases of pub-
lic health importance (Fairchild et al.  2007 ). As a surveillance measure, the purpose 
of name-based reporting pertains to contact tracing and, among other issues, estima-
tions of disease incidence or prevalence, which are used to inform  public health 
policy and practice (Lee et al.  2010 ). While mandatory name-based reporting may 
have important public health benefi ts, it confl icts with  privacy and  informed 
consent . It may also have adverse effects upon public health if it ends up driving 
epidemics underground, when those especially in need of testing and treatment are 
reluctant to seek care due to concerns about privacy or lack of  trust in health care 
providers. What the overall public health consequences of name-based reporting 
actually are,  with   any reportable disease, is ultimately an empirical question. 
4.4  Stigma 
 Related to the  privacy issues considered above is the problem of disease stigmatiza-
tion, which can lead to  discrimination and other abuses of those known (or, perhaps 
wrongly, believed) to be affected. The extent and nature of disease stigmatization, and 
the effects thereof, are often largely related to cultural factors or misunderstanding of 
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the diseases in question. The unjust discrimination and abuse commonly associated 
with disease stigmatization are especially problematic because they make matters 
worse for those who are already badly off (by virtue of health status). As in the case 
considered above, stigma can also deter those in need from seeking testing or health 
care to begin with. The problem of stigma could be reduced via better public educa-
tion about the nature of stigmatized diseases and better legal protections against unjust 
discrimination and other abuses associated with stigma. 
 Ways in which stigmatization can interfere with individual and public health is 
illustrated in the case presented by Henning and Nair. While risks of vertical  HIV 
transmission from infected mother to newborn can be reduced by replacing breast-
feeding with formula and providing antiretrovirals to the mother, in some southern 
African countries  HIV is so heavily stigmatized that women may be reluctant to 
pursue such measures in fear they will suffer violence or be abandoned by their 
husbands (if such measures reveal, or raise suspicions about, their HIV status). In 
the case presented by Henning and Nair, such fears on the part of a mother create a 
 dilemma for her doctor, who, based on best medical practice and concern for the 
baby (and public health), would presumably want to encourage such measures, but, 
based on concern for the mother’s  privacy and well-being, might not want to insist 
on them. While there is no obvious answer to the question of what the doctor should 
immediately do in this poignant case presented by Henning and Nair, the long-term 
solution to this kind of problem would presumably require cultural change involv-
ing reduction of HIV stigma via public engagement and awareness-raising, and 
greater  empowerment and protection of women in general. 
4.5  Access to Care 
 It is commonly believed that there is a universal human  right to health and/or health 
care, and such rights are enshrined by the  Un iversal Declaration of Human Rights 
and other human rights instruments (Selgelid and Pogge  2010 ). In addition  to  being 
a matter of  human rights and justice, access to care is also important for public 
health. In the context of infectious diseases, for example, lack of access to care 
results in perpetuation of epidemics when those left untreated remain contagious. 
This is one reason the burden of  infectious disease is more heavily shouldered by 
impoverished developing nations, where access to care is limited, largely due to 
resource constraints. When such diseases run rampant in developing countries, this 
poses threats to  global health more generally—because infectious diseases show no 
respect for international borders. This points to self-interested reasons, in addition 
to egalitarian and human rights reasons, for wealthy countries to do more to pro-
mote health care improvement in developing countries. 
 Although the  right to health care is widely recognized (if not always well respected 
and protected) it is questionable whether such a right should be considered absolute. 
Some means of health care may be too expensive, even in wealthy countries, to be 
routinely provided. In other cases, providing health care to individual patients might 
itself have adverse effects on public health. When patients fail to complete a full 
4 Disease Prevention and Control
100
course of antimicrobial treatment, for example, this promotes emergence of  drug 
resistance (which increases danger to others who might be infected). Luco et al. pres-
ent a case involving a TB patient who repeatedly fails to complete his prescribed 
course of  m edication and ends up with drug-resistant TB as a result. In light of this 
patient’s history of noncompliance, his adherence to further courses of treatment 
might be considered unlikely. The patient nonetheless pleads for a new course of 
treatment and promises to adhere to the prescribed regimen. Whether providing addi-
tional treatment in a case like this would be warranted depends at least partly on 
whether there is a decent chance the treatment will succeed (assuming the patient 
does in fact adhere) in light of the current level of drug resistance. If the patient’s TB 
is already resistant to all available treatments, then further treatment (even if the 
patient adheres) might at best be futile or at  wor st lead to greater  drug resistance . 
 If, on the other hand, the patient’s TB remains susceptible to treatment then 
deciding whether to provide additional  medicatio n might partly depend on the like-
lihood that the patient will comply with treatment in the future. One might argue 
that a doctor’s decision to withhold treatment based on predictions about continued 
noncompliance would involve unjust  discrimination based on the doctors’ judgment 
of the patient’s character, and that doctors, in general, have no special expertise for 
making such judgments or predicting patients’ behavior in the fi rst place (World 
Health Organization [WHO]  2010 ). If the patient is left untreated, then this would 
arguably infringe on his right to health care and threaten public health (i.e., if the 
patient remains infectious and at large in the community). On the other hand, based 
on past experience, there appears to be a legitimate concern that providing care (or 
respecting the patient’s right to care) may confl ict with others’  right to health and 
public health more generally (i.e., as continued noncompliance may lead to increased 
drug resistance). Consideration of this case motivates further refl ection on  manda-
tory treatment (discussed above) because if treatment  compliance was  better 
 enforced to begin with, then  dilemmas posed by cases like this might be avoided. 
4.6  Health Promotion Incentives 
 Public health policies often involve incentivizing health promoting behaviors (e.g., 
provision of fi nancial benefi ts to parents when children are vaccinated) and/or dis-
incentivizing unhealthy behavior (e.g., heavy taxation of things like cigarettes and 
alcohol). While such policies might be considered manipulative or  paternalistic in 
spirit, they do not rely on outright coercion if people are still ultimately free to 
behave as they wish, and so  autonomy is largely respected. Their legitimate aim is 
health improvement. Such policies, however, may sometimes involve tension with 
cultural beliefs and practices. In the case presented by Bhati, for example, cash 
incentives are used to encourage  childbirth in health care institutions in  India , where 
homebirth remains traditional. This situation leads to a tragic conclusion in the case 
of a mother who resists her in-laws’ pressure (apparently based on monetary motive) 
toward institutional delivery. She ends up losing her child due to delivery 
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complications while traveling to her home village where she planned to give birth 
and is then faced with “the wrath of her husband and in-laws.” While the cash incen-
tive aims to promote the health of mothers and  children , and public health more 
generally, the point of this case is to show how this kind of health promotion incen-
tive might exacerbate pressures on women who, in the cultural milieu of India, 
already suffer diminished autonomy. The warning is that, despite good intentions, 
 health promotion incentives  can backfi re if they lack adequate cultural sensitivity. 
4.7  Emergency Response 
 Emergencies are extreme situations (Viens and Selgelid  2012 ) where threats to pub-
lic health can be exceptionally severe. Examples include epidemics, other natural 
disasters (e.g., fl oods, hurricanes, earthquakes), and manmade disasters (e.g., war, 
 terrorism , severe environmental damage). As noted in cases previously discussed, 
 public health policies and practices often give rise to confl icts between the rights and 
liberties of individuals, on the one hand, and the goal to promote public health, on the 
other. It has also been repeatedly suggested (above) that the importance of public 
health protection is more likely (than would otherwise be the case) to outweigh the 
importance of protecting/respecting  individual rights and liberties in cases where the 
magnitude of threat to public health is especially great. During emergencies, there-
fore, it may be more necessary than in other contexts to resort to  liberty infringing 
measures. In the case of a severe epidemic, for example, social distancing measures 
such as isolation and quarantine might be justifi ed despite the fact that they interfere 
with one of the most basic human  righ ts,  freedom of movement. 
 Emergencies also often put unprecedented pressure on limited resources and 
thus require diffi cult ethical decisions regarding resource  allocation . Given the 
spectre of a future severe  infl uenza  pandemic, for example, there has been much 
debate about who should be given priority for resources like antivirals, vaccines, 
and ventilators if (as may be expected) need outstrips supply (Verweij  2009 ). 
 Emergencies, fi nally, also often call for urgent action. So, decisions must be 
made quickly, and other time-saving measures may be needed to mitigate harm. 
While urgent research might be needed to understand and control an epidemic 
caused by a novel pathogen, for example, it has been argued that the usual proce-
dures for ethical clearance of research (which can be very slow) might need to be 
altered in the case of emergency research in particular (WHO  2009 ). 
 The issue of urgency is well illustrated by the case presented by Peacock and col-
leagues. In the event of a major bioterrorist attack involving anthrax, it might be nec-
essary to vaccinate large numbers of people quickly. Administration of vaccine shortly 
after exposure is important because  anthrax vaccine provides prophylactic protection. 
Because anthrax vaccine has not been tested in children, however, its use in children 
would require  informed consent of parents according to U.S. law. In a scenario where 
huge numbers of children would need to be vaccinated quickly, however, going 
through usual informed consent processes might take too much time (and perhaps 
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lead to unrest among those waiting to be vaccinated). This motivates examination of 
possible ways to hasten the consent process, for example, via group  information ses-
sions rather than the usual one-on-one consent process. While group consent proce-
dures may facilitate more timely vaccination of children, the question is whether, or 
the extent to which, group sessions would ultimately compromise informed consent 
and whether such compromise would be justifi ed by public health benefi ts. As with 
other cases presented in this chapter, the case presented by Peacock et al. illustrates 
how cultural factors may pose special diffi culties. For example, quick consent would 
be especially challenging in cases where children’s parents do not speak English. 
Quick consent (to a vaccine that has not been studied in children) may likewise be 
diffi cult in cases where parents are generally skeptical about vaccine safety. 
 The case presented by Viens and Smith explores a range of ethical challenges 
associated with  mass evacuation that might be called for in an emergency scenario 
involving a major hurricane. Among other issues, this case raises questions about 
when evacuation should be voluntary or mandatory (while the latter, like isolation 
and quarantine, would involve interference with  freedom of movement); whether, or 
how, mandatory evacuation should be enforced; whether there are  duties to rescue 
those who refuse to comply with calls for evacuation; whether such people should 
be fi nancially sanctioned if they are in fact rescued; who should be given special 
assistance with evacuation efforts, and how those in need of assistance should be 
prioritized; whether it might be acceptable to abandon unstable patients who  cannot 
 be moved (or for whom movement would be excessively expensive); whether  com-
pensation might be due to those who suffer fi nancial (or other) loss as a result of 
 compliance with calls for voluntary  or  mandatory evacuation; and whether there 
should be legal protections against price gouging  of  commodities like gasoline. 
4.8  Conclusion 
 This chapter has illustrated ways in which ethical issues associated with disease 
prevention and control involve confl icting rights and values, tensions between indi-
vidual and community interests, and tensions involving cultural beliefs and prac-
tices. While the cases discussed in this chapter provide a good overview of many of 
the most important and diffi cult ethical issues associated with disease prevention 
and control, the discussion above reveals that their resolution would require resolu-
tion of both empirical questions (about the extent to which alternative values would 
likely be promoted or compromised by one practice or policy or another) and philo-
sophical questions (about how to balance legitimate values in cases of confl ict). It is 
also important to recognize that resolution of any of the specifi c issues in the cases 
discussed above would not necessarily imply resolution of the more general issues 
raised by these cases. Resolving the question of whether or not there should be 
mandatory  measles vaccination in  Spain , for example, would not resolve the ques-
tion of whether there should be  mandatory vaccination of measles in other coun-
tries, or whether there should be mandatory vaccination against other diseases (in 
Spain or elsewhere). A virtue of case studies is that context is crucial to the empiri-
cal questions that ethical issues (partly)  turn on. 
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4.9.1  Background 
 In 2005, the  European Regional Offi ce of the World Health Organization (WHO- 
EUR), which includes 53 countries, set the goal of eliminating measles in Europe in 
2010 (WHO  2005 ). The  Pan American Health Organization (PAHO) declared the 
WHO Region of the Americas free from endemic measles in 2002 (Castillo- 
Solorzano et al.  2011 ). Nevertheless, that region has continued to experience peri-
odic outbreaks, probably due to importation of measles from other parts of the 
world. In 2008, WHO’s Executive Board (EB) began to determine whether to extend 
the goal of eradicating measles to the rest of the world (WHO  2010a ). 
 The decrease in measles cases after a vaccine was introduced in the 1980s made 
the WHO-EUR goal of eliminating measles in Europe realistic. However, in 2006–
2007, the  vaccine coverage rates remained below 90 % in many European countries, 
and although the number of cases continued to fall, epidemic outbreaks still occurred 
periodically (Muscat et al.  2009 ). At the end of 2009, an explosion of outbreaks was 
recorded and the number of cases began to increase sharply. This upward trend con-
tinued throughout 2010, when 30,639 measles cases were reported (WHO  2011 ). 
This forced WHO-EUR to postpone its eradication goal until 2015 (WHO  2010b ). 
 The increase in measles cases can be attributed to the inability to achieve appro-
priate levels of vaccine coverage (>90 %) either because people cannot access health 
services, or because they hold personal beliefs against vaccination (Muscat  2011 ). 
The latter group includes members of the  anti-vaccination movement , which makes 
extensive use of the Internet and social networks to share ideas (Kata  2010 ). After 
rumors spread about an association between measles vaccination and  autism , vaccine 
coverage rates decreased in countries such as the United Kingdom, where “anti-
vaccination” sentiment has gradually grown during the past 10 years (Flaherty  2011 ). 
 Measles is a notifi able disease in the 53 WHO-EUR countries, all of which 
employ a two-dose regimen for immunization. However, measles vaccination is 
not mandatory in all WHO-EUR countries. A study of 29 of the 53 WHO EUR 
member countries showed that, in 2010, vaccination against measles was only 
obligatory for children in 8 of  t he 29 (Haverkate et al.  2012 ). Within the 21 remain-
ing countries, vaccination was recommended but voluntary. The debate about 
which of the two positions, voluntary or compulsory  vaccination , is better from an 
ethical point of view, remains open (Moran et al.  2008 ; Schröder-Bäck et al.  2009 ). 
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 Spain is one of the European countries where measles has reappeared. The fi rst 
childhood immunization schedule (CIS) was introduced in Spain in 1975. In 1978, 
Spain began to vaccinate against measles (one dose at 15 months) which beginning in 
1981 was administered as a measles-mumps-rubella (MMR) vaccine. Starting in 1990, 
a second dose at 11 years of age was introduced. In 2004, the age at which the second 
dose was administered was revised to 8 years of age. As a result, the illness almost 
disappeared over the course of a 20-year period: 220,096 cases in 1986, but only 17 
cases in 2005. However, since that time, cases have increased, with periodic local out-
breaks: 2006 (349 cases), 2007 (260 cases), 2008 (305 cases), 2009 (43 cases), 2010 
(285 cases) and 2011 (3507 cases) (WHO  2012 ). In 2011, an infected person died. 
 In contrast with countries such as the United States,  Spain has made  childhood vac-
cination voluntary and not a requirement for attending school (Colgrove  2006 ; Stadlin 
et al.  2012 ). However, the average  vaccine coverage rates are high (>90 %) (Masa et al. 
 2010 ). This can be attributed largely to the public health system’s primary care teams, 
distributed throughout the country and composed of family doctors, pediatricians and 
nurses. Even so, there are still places where coverage is less extensive, particularly in 
poor parts of large cities with low levels of socioeconomic development. 
 In  Spain , health professionals document administration of  childhood vaccines in 
handwriting in a paper booklet maintained by the parents. They also register this 
 information in the child’s medical record, which is commonly computer based. 
 However, discrepancies can occur between the two vaccine registration systems. 
4.9.2  Case Description 
 You are the chief public health offi cer in a province of Spain. One day, a pediatrician 
tells you about a 13-year-old who is suspected to have measles. The child and his 
family attended a wedding the week before. Within 10 days, six more people who 
also attended the wedding were diagnosed with measles and nine secondary cases 
are confi rmed. Of the secondary cases, seven were thought to have been exposed at 
school and two were in the hospital emergency  wa rd. 
 All cases occurred in a historic quarter of the city with a large degree of cultural, 
economic, religious, ethnic, and social  diversity . This multicultural identity diverges 
from the relative homogeneity of the rest of the city. 
 The public primary school of the historic quarter is now the focal point of the 
outbreak. There are 216  students enrolled in the school. You order two initial 
public health measures outlined in the regional health ministry’s Alert Protocol 
for  Measles : (1) that a letter be sent to parents asking them to bring their child’s 
vaccination booklet to the school, and (2) that a meeting be held with the parents 
to have health professionals inform them about the disease and the immunization 
process. 
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 As a result of the letter, the parents of 137 children take the vaccine booklet to 
the school, which shows a low degree of  measles  vaccine coverage (60 %). Those 
children not immunized are then vaccinated with their parents’ consent. However, 
the parents of 79 children fail to bring the vaccine booklet to the school. 
 In the parent meeting, some of the parents express their support for the anti- 
vaccination movement. They express sentiments such as “the disease is a natu-
ral process, so we prefer to organize measles parties;” “risk of measles is very 
low, but vaccines are toxic poisons;” “a lot of hidden complications of vaccines 
exist, for example,  autism ;” and “Big Pharma and politicians are looking out for 
profi ts, not for the welfare of our kids.” They also allege, “vaccination is not 
obligatory in  Spain , and we have a right to educate our children in accordance 
with our values.” These remarks generated a heated dispute between parents for 
and against vaccination. The majority of parents seem misinformed about the 
risks and benefi ts of vaccination and do not even know the immunization status 
of their own children. 
 The next day, the measles outbreak at the school comes to the attention of the 
local and national media. Alarmist messages and negative stories about 
 anti- vaccination groups grab headlines. There are stories that seem to blame the 
outbreak on the cultural  diversity of the historic quarter. You worry that the negative 
media reports may stigmatize the people living in this quarter or, even more worri-
some, blame specifi c religious or ethnic groups. 
 Therefore,   you consider adopting additional public health measures such as 
maximizing  surveillance in the city, controlling emergency rooms to decrease (or 
eliminate) transmission, and vaccinating health professionals and children under 
6 months. You also consider having unvaccinated children stay home, but health 
authorities reject the idea, alleging it would violate the right to education. Little by 
little, a number of parents consent to having their children vaccinated, or the chil-
dren are stricken and become immune. 
 Nevertheless, new cases linked to the school continue to occur. In the regional 
health ministry, attention is turned to the possibility of requiring vaccination via a 
court order, citing a fundamental law that enables such exceptional actions in  public 
health emergencies . 
 Finally, a request is put to the judge to authorize the enforced vaccination of 35 
children. He does and you inform the parents. Two nurses, accompanied by a police 
offi cer, visit the houses one by one. The majority of the parents give consent to the 
vaccination. Ten days later, only nine children remain unvaccinated as a result of the 
refusal of their parents. You inform the judge that the number is so low that the situ-
ation of special risk generated has now been overcome. You suspend compulsory 
vaccinations. 
 Since the fi rst case was diagnosed, 10 months have elapsed. A total of 308 cases 
have been confi rmed, 96 in minors younger than 1 year old. And 71 patients required 
hospitalisation (23 %), including fi ve adults. 
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4.9.3  Discussion Questions 
 1.  What are the values, ethical principles, and rights that come into confl ict in this 
case? If it is not possible to respect all of them, how should they be 
prioritized? 
 2.  Is the decision to allow unvaccinated children to attend the school justifi ed? 
 3.  Think of a solution that adequately balances the  freedom of choice of parents 
who are against vaccination with the protection of the health of a community 
where vaccination is not compulsory. 
 4.  Was there suffi cient epidemiological risk to justify the court order? Were there 
other possible solutions? Once the judicial measure had been adopted, why was 
it not pursued to its conclusion? Does the argument to suspend administering 
vaccines provide suffi cient grounds for this decision? 
 5.  Once the outbreak has subsided, what measures should be introduced to avoid 
further outbreaks? If the vaccination rate in the country later falls and new out-
breaks occur, should the  government  consider mandatory vaccination? 
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4.10.1  Background 
 The pursuit of  global public health  takes place in an unjust world ,  demanding that its prac-
titioners judge when and to what extent to compromise their ideals and standards in order 
to remain effective. (Wikler and Cash 2009) 
 Mother-to-child transmission (MTCT)—also known as  vertical transmission —is 
the primary cause of  HIV infection in children under 10 years of age (Interagency 
Coalition on AIDS and Development  2011 ). Each year, more than 600,000  infants 
become infected with  HIV from prenatal transmission during  pregnancy , labor and 
delivery, or breastfeeding, primarily in under-resourced countries ( Centers for 
Disease Control and Prevention  2012 ; Interagency Coalition on AIDS and 
Development  2011 ; Mnyani and McIntyre  2009 ). 
 For  wo men who are HIV-negative, breastfeeding is the preferred child survival 
strategy. It is linked to a lower risk of various health problems for babies, including a 
reduction in the risk of death from diarrhea and malnutrition (World Health 
Organization  2007 ; O’Reilly et al.  2012 ). However, the risk of an HIV-positive woman 
transmitting the virus to her baby in the absence of any intervention ranges from 15 to 
45 % (De Cock et al.  2000 ; World Health Organization  2015 ). Avoidance of breast-
feeding (use of replacement feeding) reduces the risk of neonatal transmission to 
20 % (Interagency Coalition on AIDS and Development  2011 ). Modifi ed feeding, 
also known as mixed feeding (liquids or solids), results in a risk of  transmission of 
about 30–35 % (Coutsoudis et al.  1999 ). The safety of replacing breastfeeding depends 
on access to clean water, a reliable supply of formula, and availability of instruction. 
Thus, use of mixed feeding techniques can be a challenge in many middle- or low-
income countries (World Health Organization  2007 ; O’Reilly et al.  2012 ). 
 To help reduce the risk of babies becoming infected with  HIV and to ensure quality 
services across the different levels of the health system, the World Health Organization 
(WHO) released revised guidelines in 2010 for use by managers of national HIV and 
AIDS programmers, as well as local managers and health care providers. The guide-
lines emphasize treatment for pregnant, HIV-infected women. Those with stage 3 or 
stage 4 disease (CD4 count ≤350 cells/μL) require lifelong three-drug  antiretroviral 
therapy (ART) to treat their own  HIV infections and for  pre vention of  m other-to-child 
transmission of HIV (PMTCT). For women with less- advanced disease, WHO rec-
ommends a country- or program-level choice between Option A (maternal zidovudine 
during  pregnancy and  infant nevirapine [NVP] throughout breastfeeding), and Option 
B (maternal three-drug ART regimens throughout pregnancy and breastfeeding) 
(WHO  2010 ). Mutations of the virus can occur when the required course of treatment 
is not followed (Interagency Coalition on AIDS and Development  2011 ). 
 In many countries, social stigma, fear of the risk of  discrimination , rejection, and 
violence can thwart a woman’s intention to have an  HIV  test, take antiretroviral 
drugs, or substitute breast milk (Interagency Coalition on AIDS and Development 
 2011 ). Such obstacles arise in part from traditional beliefs  and  values and from 
unfamiliarity with the practice of biomedicine. In some cultures, a woman is viewed 
as responsible for her own  HIV infection and that of her child, and she may suffer 
emotional or physical abuse at the hands of her family if her  HIV status is  discovered. 
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However, it can be important for her family to be aware of her HIV status, as they 
are often the ones who advise her on child feeding practices. Dealing with a wom-
an’s fear of being exposed as an HIV-positive mother is a challenge inherent in 
programs that focus  on PMTCT. 
4.10.2  Case Description 
 In a  sub-Saharan African country, Dr. Charles directs a rural health clinic that an 
international organization funds. Funding requires the clinic to follow new WHO 
guidelines for the PMTCT. The guidelines specifi cally recommend using antiretro-
viral drugs throughout the breastfeeding period by HIV-positive women (WHO 
 2010 ). The district health offi ce is also requiring Dr. Charles to develop guidance 
for his clinical staff on how to carry out the guidelines in a way that takes the values 
and beliefs of the community into account. Implementing the guidelines poses a 
major challenge for Dr. Charles because of the country’s weak health infrastructure, 
the small number of paid staff in his clinic, and an inadequate facility with limited 
general supplies. However, his facility boasts a lab, and he has received some fund-
ing to support the PMTCT program. 
 Recently, a woman in labor came to the clinic and told Dr. Charles she was HIV 
positive. She wanted to know how she could breastfeed without awakening suspi-
cions of her HIV status. She was worried that if neighbors or family found out, her 
husband would abandon her, and she would have to support herself and the child in 
a  hostile  environme nt. 
4.10.3  Discussion Questions 
 1.  How should this patient’s plight infl uence Dr. Charles as he helps his clinic carry 
out the WHO guidelines? From a public health perspective, what confl icts does 
Dr. Charles have in meeting his patient’s needs? 
 2.  Who are the stakeholders Dr. Charles should consider as he develops his guid-
ance and what information does he need to ensure success in reducing mother-
to- child transmission of HIV in this community? 
 3.  What procedures can he put in place to decrease the risk of HIV-positive women 
being stigmatized by their partners, family, or community? 
 4.  How should the infant’s well-being be balanced with maintaining the mother’s 
health, social welfare, and survival? 
 5.  To what extent should Dr. Charles consider the culture of his community in which 
family decision making and traditions about infant feeding often hamper mothers’ 
efforts to decrease the risk for HIV transmission? How can public health programs 
build fl exibility that anticipates cultural diversity in beliefs, values, and practice? 
 6.  Instead of just focusing on his patients, should Dr. Charles consider holding struc-
tured conversations with people in the community to infl uence social norms or with 
village elders as a way to infl uence social norms counterproductive to program aims? 
M.J. Selgelid
111
 References 
 Centers for Disease Control and Prevention. 2012.  HIV for women.  http://www.cdc.gov/HIV/risk/
gender/women/facts/index.html . Accessed 23 May 2013. 
 Coutsoudis, A., K. Pillay, E. Spooner, L. Kuhn, and H.M. Coovadia. 1999. Infl uence of infant-
feeding patterns on early mother-to-child transmission of HIV-1 in Durban, South-Africa: A 
prospective cohort study.  Lancet 354(9177): 471–476. 
 De Cock, K.M., M. Fowler, E. Mercier, et al. 2000. Prevention of mother-to-child HIV transmis-
sion in resource-poor countries: Translating research into policy and practice.  JAMA 283(9): 
1175–1182. doi: 10.1001/jama.283.9.1175 . 
 Interagency Coalition on AIDS and Development. 2011.  HIV/AIDS: Mother-to-child transmission. 
 http://www.icad-cisd.com/ . Accessed 23 May 2013. 
 Mnyani, C., and J. McIntyre. 2009. Preventing mother-to-child transmission of HIV.  BJOG: An 
International Journal of Obstetrics & Gynaecology 116(suppl 1): 71–76. 
 O’Reilly, C.E., P. Jaron, B. Ochieng, et al. 2012. Risk factors for death among children less than 5 
years old hospitalized with diarrhea in rural western Kenya, 2005–2007: A cohort study.  PLoS 
Medicine 9(7): e1001256. doi: 10.1371/journal.pmed.1001256 . 
 Wikler, D., and R. Cash. 2009. Ethical issues. In  Global public health: A new era , ed. R. Beaglehole 
and R. Bonita, 249–266. Oxford: Oxford University Press. 
 World Health Organization (WHO). 2007.  HIV transmission through breastfeeding: A review of 
available evidence.  http://whqlibdoc.who.int/publications/2008/9789241596596_eng.pdf . 
Accessed 1 May 2013. 
 World Health Organization (WHO). 2010.  Antiretroviral drugs for treating pregnant women and 
preventing HIV infection in infants.  http://www.who.int/hiv/pub/mtct/guidelines/en/ . Accessed 
1 May 2013. 
 World Health Organization (WHO). 2015.  Mother-to-child transmission of HIV.  http://www.who.
int/hiv/topics/mtct/en/ . Accessed 1 June 2015. 
4.11  Case 3:  Newborn  Bloodspot Screening: Personal Choice 
or Public Health Necessity? Storage and Ownership 
of  Newborn  Bloodspots 
 Stuart  G.  Nicholls 
 School of Epidemiology, Public Health and Preventive Medicine 
 University of Ottawa 
 Ottawa ,  ON ,  Canada 
 e-mail: snicholl@uottawa.ca 
 Jennifer  Milburn 
 Newborn Screening Ontario 
 Children’s Hospital of Eastern Ontario 
 Ottawa ,  ON ,  Canada 
 Daryl  Pullman 
 Division of Community Health and Humanities, Faculty of Medicine 
 Memorial University 
 St. John’s ,  NL ,  Canada 
4 Disease Prevention and Control
112
 This case is presented for instructional purposes only. The ideas and opinions 
expressed are the authors ’  own. The case is not meant to refl ect the offi cial position , 
 views ,  or policies of the editors ,  the editors ’  host institutions ,  or the authors ’  host 
institutions . 
4.11.1  Background 
 Newborn bloodspot screening (NBS) is the process in which a small blood sample is 
collected from the heel of a newborn, sent to a laboratory, and tested for serious and 
life-limiting conditions. If diseases are detected in the newborn period, treatment can 
begin immediately. NBS is conducted on almost 100 % of the newborn population in 
North America, roughly four million  infants per year in the United States (Botkin 
et al.  2012 ). Screening panels have steadily increased the number of conditions tested, 
with upward of 40 conditions included in some NBS programs. This momentum to 
include more conditions in screening panels refl ects a transition away from an ‘emer-
gency’  model to a ‘public health  service ’ model. In the emergency model, testing 
identifi es conditions amenable to treatment or associated with catastrophic morbidity 
or mortality. In contrast, a key goal of the public health service model is to inform 
decision making or avoid a “diagnostic odyssey” (Bailey et al.  2006 ; Buchbinder and 
Timmermans  2011 ; Metcalfe et al.  2012 ). Advances in newborn screening have 
 increased   our ability to detect previously unidentifi able conditions. However, they 
have also raised a number of ethical challenges about how to best use the  information . 
For example, testing can now reveal someone’s carrier status (i.e., the person carries a 
recessive copy of a genetic disorder without being affected by the condition). Knowing 
a child’s carrier status can inform future reproductive decision making but may induce 
 anxiety , lead to potential stigma, or reveal non-paternity (Hayeems et al.  2008 ). 
 Newborn screening is a routine practice in many states. In the U.S. state of 
Nebraska, for example, screening is mandatory without exception (Schweers  2012 ; 
Foral  2006 ). In other U.S. states, screening proceeds on an  o pt-out basis, although 
studies indicate that often parents are not afforded the opportunity to consent or are 
poorly informed about the opt-out option (Botkin et al.  2012 ). This may even be the 
case where screening proceeds in an ostensibly  informed choice manner, such as in 
the United  Kingdom (Nicholls  2012 ; Nicholls and Southern  2012 ). 
 Dried bloodspot samples are often stored for a number of years after collection, 
but the length of storage varies by jurisdiction (Botkin et al.  2012 ). Samples are 
retained for various reasons including repeat testing, quality control of testing proce-
dures, or as part of diagnosis. In addition, samples also may be used (anonymously) 
for external  quality assurance and research. While there is no consensus, a recent 
expert panel recommended a minimum storage period of about 3 months to allow for 
quality assurance, and indefi nite storage when initial positive (i.e., disease suspected) 
results are confi rmed by diagnostic testing (Botkin et al.  2012 ). In fi ve U.S. states, a 
parent has the legal right to request destruction or release of dried bloodspot samples, 
and in three states children may do so when they reach the age of majority (Lewis 
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et al.  2011 ).  A  number of other jurisdictions have followed suit with similar proce-
dures (Newborn Screening Ontario  2011 ). In most cases, release or destruction of the 
bloodspot requires a signed formal request by a parent or legal guardian. 
 Research to date has provided important fi ndings for both clinical decision making 
and public health. For example, studies exploring childhood leukemia have used 
bloodspots to identify whether genetic changes are present at birth, or have accumu-
lated over time, helping to clarify how the disease is caused. Others have considered 
 the   effects of  public health policies , such as the removal of perfl uorinated compounds, 
and examined the levels of these in bloodspot samples, noting signifi cant declines in 
analyte levels following the phasing out of these compounds (Spliethoff et al.  2008 ). 
As such, bloodspots may provide a useful resource for evaluating public health policy. 
Bloodspot samples may also be requested by the coroner’s offi ce or be used in foren-
sic investigations as was proposed, for example, in the  Netherlands following an 
explosion at a fi reworks factory (Couzin-Frankel  2009 ; Douglas et al.  2012 ). 
 However, there has been a great deal of media discussion regarding the retention, 
storage, and use of dried bloodspots due to public concerns about  privacy (Couzin- 
Frankel  2009 ; Muchamore et al.  2006 ; Bombard et al.  2012 ). In particular, there has 
been debate regarding the secondary use of stored bloodspots for research, which 
are seen as having tremendous research value (Tarini  2011 ). This has  cu lminated in 
several lawsuits in the United States and Canada (Lewis et al.  2012 ; Armstrong 
 2010 ) that have led to changes in storage policy and the destruction of millions of 
dried bloodspot samples (Lewis et al.  2012 ). 
4.11.2  Case Description 
 As manager of a newborn screening program, you are responsible for the daily 
operations of the program, as well as risk and resource management, program eval-
uation, and quality improvement initiatives. Your program screens approximately 
150,000 newborns annually for 28 conditions. Each year, on average, 140 babies are 
identifi ed as affected by at least one of the screened conditions. 
 Your program publishes a leafl et and hosts a website that provides  information 
for parents regarding the screening process, the conditions for which screening is 
conducted, and about storage. Your jurisdiction’s  regulations recommend that 
bloodspot samples be stored for a minimum of 5 years. Parents have the legal right 
to request destruction  or   release of a bloodspot sample at any time. To do so, the 
parents or legal guardian must complete a request form. 
 While parents are informed of the screening process and retention of bloodspots, 
consent is not required, and screening proceeds on an ‘opt-out’  b asis (i.e., screening 
proceeds unless parents explicitly object). There is no distinction between decisions 
for screening and decisions regarding retention of bloodspots. 
 The recent debate regarding the secondary use of stored bloodspots for research 
has increased researcher awareness of bloodspots as a resource and has put increased 
pressure on your offi ce to facilitate research requests. At the same time, you have 
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also received political pressure from the health ministry to review storage and con-
sent policy due to public concerns about  privacy . 
 In light of increasing media and researcher interest and political pressure, the 
health ministry has asked the standing advisory committee on newborn screening to 
convene a working group to review your jurisdictions’ policy on the retention of 
newborn bloodspots and the  information provided to parents. You have been charged 
with advising the committee regarding potential policy changes and the potential 
impacts of these on the screening  pro gram. 
 You are aware of the potential confl ict between public health benefi ts and  parental 
consent to the secondary use of bloodspots for research. However, you are concerned 
that providing too much information or raising concerns with parents  may   decrease 
uptake of what is an important population screening program. 
4.11.3  Discussion Questions 
 1.  Newborn bloodspot screening is both a public health program and a tool for 
individual clinical care. How should the public health gains from newborn 
screening weigh against individual privacy concerns? 
 2.  Given expressed concerns, how should participation in newborn screening be 
managed? Should the current opt-out policy be retained or would an informed 
consent model be ethically more justifi able? Should screening be distinguished 
from secondary use? If so, how should these two elements be handled? 
 3.  To what extent, if any, should the screening program attempt to persuade parents 
to withdraw their requests for return or destruction of bloodspots? 
 4.  Studies indicate that anonymized research data might be de-anonymised via sur-
name inference using genealogy databases (Gymrek et al.  2013 ) or based on date 
of birth, gender, and 5-digit ZIP code (Sweeney et al.  2013 ). Should parents have 
the right to consent or opt out of studies even in cases where only anonymised 
data is used, and which may provide improvements to population health? 
 5.  Should  residual dried bloodspots ever be made available to researchers? How 
should clinically actionable results be dealt with? 
 6.  One option is the indefi nite storage of residual bloodspots. Is this permissible, 
and if so, should the consent of the child be sought when they reach the age of 
majority? 
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 This case is presented for instructional purposes only. The ideas and opinions expressed 
are the author ’ s own. The case is not meant to refl ect the offi cial position ,  views ,  or 
policies of the editors ,  the editors ’  host institutions ,  or the author ’ s host institution . 
4.12.1  Background 
 The domestic sphere of home and family defi nes the lives of most women in India, 
where they assume the role of caregiver, either as wife or mother. Overall, age and 
sex govern the household’s hierarchy of authority, older over younger, men over 
women. Women, especially those living in northern India, experience decreased 
 autonomy and increased  inequalities in all areas of life (Iyengar et al.  2009 ; Bloom 
et al.  2001 ). Limited autonomy harms women’s maternal  health outcomes , restrict-
ing their ability to choose safe  childbirth options. In India, most births still occur in 
the home; less than 41 % occur in an institutional setting (International Institute for 
 Population  Sciences  2007 ). 
 Worldwide, more than half a million women die each year from complications 
during  pregnancy and childbirth (UNICEF  2009 ). About 99 % of these deaths occur 
in developing countries. Based on  maternal mortality trends from 1990 to 2008, 
developing countries, especially India, contribute about 18 % of the global burden 
of maternal deaths (Dikid et al.  2013 ). Data during 2007 through 2009 indicated that 
India’s maternal mortality ratio (MMR) was 212 per 100,000 live births (Registrar 
General of India  2011 ). Regional differences in MMR are found in India; during 
2007 through 2009 the MMR in northern states was 308/100,000 compared with 
207/100,000 in the southern states. 
 India has had a long history of redistributive  poverty-reduction programs, but few 
programs provide direct cash assistance to the needy (Mehrotra  2010 ). Cash incentive 
programs started in the 1990s predominantly in  Latin America where their success led 
to adoption in other parts of the world (Powell-Jackson et al.  2009b ).  These programs 
vary in size and scope; examples include programs that address vaccinations, educa-
tion, health care, safe  childbirth , sterilization, and poverty. An example from an Asian 
country is the Safe  Deliv ery Incentives Programme (SDIP), which was started in 
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2005 in Nepal with funds from the U.K. Department of International Development 
and the Nepalese government (Powell-Jackson et al.  2009a ; Karki  2012 ). The pro-
gram provided cash incentives to women who gave birth in health facilities and to 
health providers for each attended delivery (either in the woman’s home or in a facil-
ity). The program implementers or administrators expected that the cash incentive 
would reduce transportation barriers and delays in maternal care seeking (Bhandari 
and Dangal  2012 ). The program was most effective in changing health care-seeking 
behavior wherever women’s groups highlighted the importance of effective commu-
nication of the policy to the public (Powell- Jackson et al.  2008 ). Women exposed to 
the program were 24 % more likely to deliver in government health institutions, 5 % 
less likely to deliver at home, and 13 % more likely to have their delivery attended by 
a skilled health worker. Deliveries in government health institutions went from 34 % 
in the fi rst year (2005/2006) to 59 % in the third year (2007/2008). Overall, the pro-
gram was well received, however certain aspects of the policy were not accepted, 
including a condition that limited receipt of the cash incentive to  women  who had no 
more than two living children (Powell-Jackson et al.  2008 ). 
 India’s conditional cash transfer program, Janani Suraksha Yojana (JSY), is one 
of the largest programs of its kind in the world (Lim et al.  2010 ). JSY is funded 
through the central government, provides welfare to women living in indigent fami-
lies, and includes efforts to empower women to choose institutional childbirth rather 
than home delivery. 
 JSY represents a novel and useful way to ensure the  social welfare of women by 
integrating cash assistance with  childbirth delivery and post delivery care. The pro-
gram focuses on poor pregnant woman, especially those living in states with high 
MMRs and low institutional delivery rates. These low-performing states include Uttar 
Pradesh, Uttaranchal, Bihar, Jharkhand, Madhya Pradesh, Chhattisgarh, Assam, 
Rajasthan, Orissa, and Jammu and Kashmir (Tiwari  2013 ). An important component 
of this program is its focus on monitoring, evaluating, and providing,  health care for 
the mother and her baby (Lim et al.  2010 ). District-level household surveys have 
documented a decline in the proportion of home deliveries, which dropped from 59 % 
in the 2002–2004 survey (International Institute for Population Sciences  2006 ) to 
52 % in the 2007–2008 survey (International Institute for Population Sciences  2010 ). 
 Despite indicators of success, the JSY program has raised a number of concerns. 
One of the aims of JSY is equity in addition to coverage; the JSY program does not 
include private health care providers. The increased deliveries (from 35 % to 65 %) 
in public health care facilities may raise issues in the quality and standards of health 
care (MacDonald  2011 ). Another concern is that the lack of comprehensive emer-
gency obstetric care at many institutions compromises the safety of institutional 
deliveries (International Institute for Population Sciences  2010 ). A fi nal concern is 
that socioeconomic status, caste, and education create large inequities in access to 
the program’s cash incentives, while women who do gain access lack fi nancial con-
trol over the cash incentives (Gopichandran and Chetlapalli  2012 ). 
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4.12.2  Case Description 
 A 19-year-old woman from a poor area in India is pregnant for the fi rst time and 
only weeks from her delivery date. Wearing a long pardah to cover the lower half of 
her face and traditional maang tikka jewelry on her forehead to indicate married 
status, her attire refl ects the traditional values embedded in her culture. She wants to 
deliver her baby in her home village, which is an overnight’s journey away. But her 
husband and in-laws have other ideas. They have just learned of a government pro-
gram that provides a cash payment of 1000 rupees to women who opt for institu-
tional delivery over home delivery. Her mother-in-law insists that the delivery take 
place in their district institution. The woman’s parents,  believing the in-laws to be 
driven purely by greed, support their daughter. With encouragement from her par-
ents, the woman disobeys her husband and in-laws to travel to her parent’s home, 
but goes into labor on the road and loses her child due to complications in the deliv-
ery. The young woman not only is disconsolate over the loss of her child, she must 
now face the wrath of her husband and in-laws. 
 This is a poignant case, but only one in a dossier full of similar cases that you, as 
the state director for the maternal cash incentive program, have read that involve 
clashes between traditional ways and the incentive program. As a result, you have 
decided to convene an expert panel to consider recommendations to smooth not 
only the cultural friction the program is causing, but also the  program’s impact on 
the quality and safety of care, as well as access  to it. 
4.12.3  Discussion Questions 
 1.  Who are the main stakeholders in the case of the 19-year-old woman and what 
values and cultural perspectives does each stakeholder bring to this situation? 
 2.  How should you consider the issues about this and similar cases when deciding 
whether to revise the cash incentive program? 
 3.  What are the pros and cons of cash incentive programs from a public health 
perspective? 
 4.  What role should government play in improving the public’s health? 
 5.  In the context of inequities based on socioeconomic status, caste, and education, 
to what extent should you attempt to ensure that a woman’s autonomy is not 
violated? Should the same notion of autonomy be applied in India or other 
unique contexts as prevails in European and North American countries? 
 6.  Due to a fi nancial downturn, the state government is thinking about eliminating 
the maternal cash benefi t program. How can an ethical analysis assist in making 
this decision? What factors should be considered as part of this ethical analysis? 
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 This case is presented for instructional purposes only. The ideas and opinions expressed 
are the author ’ s own. The case is not meant to refl ect the offi cial position ,  views ,  or 
policies of the editors ,  the editors ’  host institutions ,  or the  author ’ s  host institution . 
4.13.1  Background 
 About 34.0 million people live with HIV worldwide, with 1.1 million residing in the 
United States (Centers for Disease Control and Prevention  2010 ).  The lack of a 
cure, coupled with the ailment’s debilitating and potentially fatal consequences, has 
prompted governments to enact structural interventions that, although well- 
intentioned, may be ineffective in preventing and controlling the spread of HIV. 
 HIV-specifi c criminal statutes are one example of a  structural intervention used in 
at least 63 countries, including the United States. In the United States, the initial fed-
eral response to HIV included potential criminal prosecution for people aware of their 
HIV-positive status who knowingly engaged in sexual activity with the intent to 
expose others to  HIV . Under the original text of the  Ryan White Care Act of 1990, no 
federal grant would be issued to a state unless it had  criminal laws under which to 
prosecute an HIV-infected person who knowingly engaged in sexual relations, donated 
blood (or semen or breast milk), or injected himself with a needle and provided the 
needle to another, with the intent to expose the other person to HIV (Public Law 
101–381  1990 ). The Ryan White Care Act of 1990 became a template for many states, 
leading to the passage of laws that included a determination of guilt for HIV-infected 
individuals who engaged in sexual activity or shared drug paraphernalia. Consent was 
a defense so long as the uninfected person knew of the partner’s HIV-positive status 
and provided  informed consent  before   engaging in the activity (i.e., sexual or drug-
related) (Public Law 101–381,  1990 ). Although the provision to award grants on the 
M.J. Selgelid
121
condition of having an HIV-criminal law in place was repealed in 2000, more than 33 
states currently have one or more HIV-specifi c  criminal laws in effect. 
 While the merits of using criminal law to prevent  HIV transmission remains 
questionable, there has not been enough thought given to the related effect of laws 
criminalizing  commercial sex work that, coupled with  HIV-criminalization laws, 
poses unique challenges for women and public health professionals. Together, these 
laws disproportionately affect women by virtue of their voluntary  participation in—
or coercion into—prostitution, and the harsher sentencing that may ensue upon con-
viction. In the state of Florida, for example, prostitutes who test positive for  HIV 
before committing a crime have their sentence increased from a misdemeanor (serv-
ing a term of imprisonment not exceeding 1 year) to a felony (serving a term of 
imprisonment not exceeding 5 years) (Fl. Stat. Ann. § 796.08(4)(2010)). Notably, a 
person convicted of prostitution in Florida must undergo mandatory  HIV testing . 
Consequently, the specter of criminal prosecution and up to 5 years imprisonment 
may deter many women from getting tested in the fi rst place, increasing the risk of 
acquiring and transmitting the virus. 
 Globally, women are at heightened risk of contracting HIV because of social, 
economic, and cultural factors stemming from  human rights violations,  gender 
inequality , and inadequate forums to pursue legal redress (Murthy and Bhattacharya 
 2010 ). An estimated 60 % of people infected with HIV in  sub-Saharan Africa are 
women; and females ages 15–24 years make up 75 % of those affl icted with the 
virus. Moreover, “male-to-female transmission during sex is about twice as likely to 
occur as female-to-male transmission, if no other  sexually transmitted infections are 
present” (Joint United Nations Programme on  HIV/AIDS [UNAIDS]  2004 ).  For 
 commercial sex workers , this disproportionate risk of exposure is exacerbated. 
Researchers have found that among female sex workers 15–49 years old, the preva-
lence of  HIV infection is 13.5 times higher than the prevalence among the general 
population of women (Kerrigan et al. 2013). 
 Public health practitioners are faced with a  dilemma of promoting  HIV testing 
and simultaneously adhering to mandatory reporting requirements. All states in the 
United States have enacted laws or  regulations requiring laboratory reporting of 
 HIV infection , with 32 states (and the District of Columbia) also enacting laws 
requiring reporting of CD4  levels   (white blood cells that protect against infection) 
and viral loads of people who test positive ( Centers for Disease Control and 
Prevention  2013 ). Nonexistent or inadequate  surveillance of commercial sex work-
ers, however, may prevent researchers from understanding the evolving nature of 
HIV and the burden it poses on this particular population. For example, a recent 
study found that a common CD4 gene variant (i.e. alteration of the gene sequence) 
is associated with an increased risk of HIV-1 infection in Kenyan female  commer-
cial sex workers (Oyugi et al.  2009 ). The researchers suggest that the effect of this 
variant on the epidemic in  Africa could be dramatic. 
 For many  human rights activists, laws criminalizing sex work discriminate 
against women and deny them their right to work. For others, prostitution is inher-
ently exploitative, with all commercial sex workers being victims who are denied 
legitimate (i.e., alternative) forms of employment. In most countries, however, the 
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law does not discriminate between these types of women or their reasons for engag-
ing in commercial sex work, compelling many women to avoid  HIV testing alto-
gether (UNAIDS  2012a ). By contrast, where  voluntary  counseling and testing have 
been extended to commercial sex workers, the results have been far more promis-
ing. A recent study found that voluntary counseling and treatment among a cohort 
of 421 commercial sex workers in Guinea resulted in 92 % of participants returning 
for their results (Aho et al.  2012 ). 
 The 35th anniversary of the international  Convention on the Elimination of All 
Forms of Discrimination against Women (CEDAW) affords an opportunity for gov-
ernments to affi rm that extending  HIV services to commercial sex workers and pro-
moting public health are not mutually exclusive endeavors. As the only treaty that 
rejects sex-discrimination in employment and in  health care access , CEDAW helps 
women show the link between health and  human rights , and particularly the  right to 
health and employment. The CEDAW Committee, which oversees the treaty’s exe-
cution, has advocated for the decriminalization of prostitution, in countries like 
China, where women are disproportionately prosecuted in lieu of the traffi ckers and 
pimps; and encourages governments to focus on rehabilitating and reintegrating 
women into society, enhancing opportunities, and providing support to ensure that 
their civil liberties are not violated (CEDAW  1981 , Committee on the Elimination of 
Discrimination Against Women  2006 ). As of 2013, 187 countries are parties to 
CEDAW,  but the United States has not ratifi ed it (United Nations  2013 ). 
4.13.2  Case Description 
 You are the  sexually transmitted infections (STI) program manager of the 
Communicable Disease Control Unit in a public health department in a large city. A 
recent news story of an HIV-positive commercial sex worker has prompted public 
concern.   While reviewing the county’s  HIV surveillance report for the last period of 
data collection, you note that the department does not conduct offi cial surveillance of 
commercial sex workers. Studies have found that the  HIV infection rate among 
female prostitutes has been as low as 12 % in Atlanta and as high as 57 % in northern 
New Jersey (Elifson et al.  1999 ). You are also aware of a UNAIDS report that found 
“where health and social services are provided and sex workers are actively engaged 
in efforts to provide  universal access to  HIV prevention , treatment, care and support, 
HIV incidence declines” (UNAIDS  2012b ). Therefore, you are eager to start an inter-
vention program that encourages commercial sex workers to undergo  HIV testing . 
You recall that an intervention in a neighboring state used caseworkers to offer pros-
titutes testing for STIs, including HIV. However, a number of challenges abound. 
 Prostitution is illegal in your state, with  penalties ranging from a Class A misde-
meanor (punishable by up to a year in prison) for fi rst-time offenders, to a Class 4 
felony (punishable by 1–3 years in prison) for repeat offenders. Moreover, state law 
requires that health care providers report to the Department of Health the names of 
patients who test HIV-positive. 
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 As an STI program manager, you are aware of the role of  social determinants of 
health and the need to think broadly about possible interventions and  collaboration s 
with other agencies. You have been infl uenced by a study on 222 commercial  sex 
workers  from the Center for Impact Research ( 2002 ) that  found   the following:
•  72 % of young commercial sex workers had run away from home and were likely 
to have used drugs or alcohol growing up; 
•  60 % reported domestic violence in the household; 
•  25 % had completed a high school education or passed a general educational 
development (GED) test; 
•  More than 50 % grew up in a household in which prostitution took place; 
•  87 % had someone suggest they engage in prostitution while they were growing up; 
•  22 % reported they were HIV-positive; 
•  21 % indicated being raped more than 10 times; 
•  50 % of women worked on behalf of another person (i.e., pimp), with 75 % 
reporting they believed the other person would harm them if they discontinued 
their services; 
•  More than 90 % increased their drug or alcohol use after becoming commercial 
sex workers; 
•  Almost 75 % of them had been arrested at least once, with close to 50 % of them 
reporting that the arrest took place before age 18; and 
•  More than 50 % were homeless. 
 Your  health department provides services related to homeless prevention and 
 substance abuse treatment, yet eligibility is dependent on an ability to meet mone-
tary  obligations (rent, utilities, etc.) after the assistance has been granted based on 
current or anticipated income. It is unlikely that  commercial sex work would satisfy 
this criterion. 
 You consider all of these issues as you think about how to begin an intervention 
program for commercial sex workers  to   encourage them to undergo  HIV testing . 
4.13.3  Discussion Questions 
 1.  Who are the main public and private stakeholders in this case? 
 2.  How should the criminal nature of commercial sex work infl uence the interven-
tion you develop to encourage commercial sex workers to undergo HIV testing? 
Should your intervention also target other risk factors for illness, such as home-
lessness, unemployment, and substance abuse? 
 3.  Are you obligated to seek help from law enforcement to carry out your 
intervention? 
 4.  What standard should you use to evaluate your intervention’s success? How would 
you treat empirical fi ndings alongside issues of equity and discrimination? 
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 5.  Given the many social determinants implicated by prostitution and its attendant 
health effects, what other agencies should you collaborate with and what other 
services should you consider providing along with, or instead of, HIV testing? 
 6.  Does the threat of prison ever get in the way of promoting healthy behaviors? If 
so, what criteria should be used to determine which activities and behaviors 
merit criminalization? Does reducing the number of women engaged in com-
mercial sex work or their incidence of HIV—or both—satisfy these criteria? 
 7.  Should the public health department conduct surveillance of the incidence of 
HIV among commercial sex workers? What challenges exist for the department 
in undertaking this task? 
 8.  Do you think ratifi cation of international laws like CEDAW can improve the 
health of commercial sex workers? 
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4.14.1  Background 
 Bacillus anthracis is a hardy, spore-forming bacterium that leads to  anthrax disease 
upon infection. The organism has long been considered a likely agent for biological 
warfare. A weaponized form of the agent would likely result in widespread inhala-
tion anthrax, a severe form of the disease that carries a high (>50 %) case fatality 
rate.  B. anthracis spores can last inside the body for weeks before germinating to 
induce infection and can persist for years in the environment. Anthrax disease is 
preventable if  antibiotics and vaccine are administered prophylactically before 
someone has symptoms. 
 T he U.S.  Centers for Disease Control and Prevention (CDC) and U.S. Department 
of Homeland Security are concerned about  B. anthracis as an agent of biological 
 terrorism due to its ease of dispersal, severe health impact, persistence in the envi-
ronment, and the special public health response it requires (CDC  2013 ). The U.S. 
anthrax attacks in 2001 infected 22 people, 5 of whom died, all from inhalation 
anthrax. The U.S.  Department of Health and Human Services prepares for a number 
of disaster scenarios, one of which is an aerosolized anthrax attack. In this scenario, 
 B. anthracis spores are released into the air in a densely populated area, potentially 
infecting thousands of people. 
 Children (<18 years) are given special considerations in an  anthrax attack sce-
nario, one of which involves receiving the anthrax vaccine,  Anthrax Vaccine 
Adsorbed (AVA) . The  U.S. Advisory Committee on Immunization Practices rec-
ommends giving AVA in conjunction with 60 days of  antibiotics for post-exposure 
prophylaxis of the exposed population against anthrax (Wright et al.  2010 ). This 
60-day antibiotic regimen covers the disease’s incubation period and allows for 
protection before the vaccine takes effect. The vaccine is likely to protect people 
longer than antibiotics alone and potentially protects against multiple strains of 
anthrax disease, including bioengineered strains that are resistant to antibiotics 
(Joellenbeck et al.  2002 ). 
 While most of the U.S. population can receive the anthrax vaccine under an 
 Emergency Use Authorization (EUA) , children must receive the vaccine under 
an  investigational new drug (IND) protocol as approved by the U.S.  Food and 
Drug Administration. The IND protocol requires  informed consent from parents, 
which is not required under an EUA. The informed consent requirement stems 
from the lack of safety or effi cacy data for AVA in children. Also, due to a 
requirement under the IND, a subset of the children with IND consent will be 
asked to enroll in a research IND so that safety and immunogenicity data in chil-
dren may be obtained during the emergency. The  President ial Commission for 
the Study of Bioethical Issues debated the study of AVA in children before the 
event, and has laid out a strict framework for approaching how best to ethically 
collect these data from a research  per spective (Presidential Commission for the 
Study of Bioethical Issues  2013 ). 
M.J. Selgelid
127
4.14.2  Case Description 
 A terrorist group has released an anthrax aerosol over a major city in the United 
States and in a country with a weak public health infrastructure. Of the more than 
9 million people in the U.S. metropolitan area at the time, 1.39 million people are 
exposed, 329,430 of whom are children (Kyriacou et al.  2012 ). All 1.39 million 
people exposed will need the vaccine and a 60-day supply of  antibiotics to pro-
tect them from developing disease. It is unclear what plans have been made to 
provide prophylaxis to the population living in the other country. In the United 
States, people thought to be exposed will receive antibiotics and vaccine at  points 
of dispensing (PODs) run by local health departments. The dispensing of antibi-
otics, which must begin within the fi rst 48 h and fi nish within 10 days, would 
require 20 sites providing medicine to 500 people per hour to achieve the goal for 
 the  exposed population. Vaccination routinely takes more time and involves 
additional staff and separate sites to care for the entire population. Additional 
steps will require more resources and time. Timeliness is essential to ensure 
those exposed are protected. 
 In the United States, children needing vaccine come to the vaccination clinic 
with their parents, slowing the lines to meet the  informed consent requirements. 
Unaccompanied children also show up, slowing the lines to a crawl, as staff 
attempt to contact parents. The complexity of different vaccine needs for different 
people, especially those who do not speak English, is overwhelming vaccination 
staff. To keep lines moving, the staff has created a separate line for families with 
children, but the slow pace of this line is challenging the clinic’s effort to achieve 
high  vaccine coverage rates among children. Tempers fl are as families watch 
adults without children move through the clinic quickly while the family lines 
grow ever longer. But the parents, who have lots of questions, cannot be rushed to 
provide their consent. They have been hearing disconcerting media stories high-
lighting issues related to anthrax vaccine side effects and the lack of testing and 
safety data. Many parents worry about immunizing their child with an untested 
vaccine never given to children and posing unknown risks. The vaccination clinic 
manager, who has had little time  to plan, quickly devises the following scenarios 
to speed decision making:
•  Provide parents with the  informed consent document and have a public health 
nurse meet with them to answer questions and discuss concerns about risks and 
benefi ts. 
•  Discuss the informed consent document with a group of families, answering 
questions and working through concerns about risks and benefi ts in the larger 
group, but having a nurse on call to answer confi dential questions and speak to 
families privately. 
•  Show a large group of families assembled in an auditorium a video produced 
by the local health department explaining the safety and effi cacy profi le of the 
vaccine in adults, and afterward have a nurse discuss with parents  t he  informa-
tion from the informed consent document and  allow  parents to ask questions. 
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4.14.3  Discussion Questions 
 1.  Of the options listed above, which should you choose? Justify your answer in 
terms of the benefi ts gained, harms avoided, respect for parental autonomy, pri-
vacy and confi dentiality, fairness, or other ethical values, such as trust and pro-
tecting vulnerable populations. 
 2.  Consider how placing families with children in separate lines affects the distribu-
tion of vaccine. Is this the fairest or optimal way to distribute the vaccine? Are 
there innovative or better options for administering the IND that adhere to FDA 
rules and achieve maximum vaccination coverage for children? Are these options 
ethically justifi able? 
 3.  If following the IND protocol for unaccompanied children makes vaccine cover-
age impossible, what should the vaccine clinic manager and staff do? How would 
you ethically justify your decision? Would this justifi cation hold if the group in 
question were all children, not just unaccompanied children? 
 4.  What roles will government trustworthiness and the public’s trust in the govern-
ment play in the vaccination campaign? 
 5.  What ethical concerns are presented by collecting data for research purposes 
during such an event? 
 6.  The other country under anthrax attack, which is resource poor and lacks public 
health infrastructure, has received vaccine from the United States, but is under 
no obligation to follow the mandated U.S. procedures through which antibiotics 
are administered. To ensure that vulnerable populations are protected against 
anthrax, what ethical principles, values, and concerns should this country con-
sider? Do these ethical principles, values, and concerns differ from those in the 
United States? If yes, how? If no, why not? 
 7.  A high percentage of the parents with young children do not speak English. 
Because the informed consent forms are only in English, translating them will 
take a lot longer, or an interpreter will need to be available. How would you bal-
ance the obligation to protect vulnerable populations with the obligation to maxi-
mize coverage? 
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4.15.1  Background 
 In  Chile , tuberculosis (TB) belongs to the list of “ mandatory notifi cation ” dis-
eases, a status that allows for the  confi dential  registration and monitoring of cases. 
Mandatory notifi cation, part of Chile’s  Communicable Disease Surveillances 
System, is legally authorized by the 1968 Sanitary Code of the Ministry of Health, 
specifi cally the  Regulation on Notifi cation of Communicable Diseases (Código 
Sanitario  1968 ). By the early 1970s, health authorities created the  Program for 
Control and Eradication of Tuberculosis (PROCET) , a model program in its tech-
nical conception and application of control measures. The program illustrates how 
to confront a public health care problem properly through systematically applied, 
adequate coverage and continuous quality evaluation (PROCET  2005 ). 
 Currently, TB prevalence is low in Chile, with the country signifi cantly reduc-
ing the disease’s mortality and morbidity rates in the closing decades of the twen-
tieth  cen tury (Pan American Health Organization  2006 ). By 2000, this reduction 
had allowed Chile to cross the eradication threshold (i.e., to reduce the incidence 
rate below 20 cases per 100,000 people). Over the fi rst decade of this century, 
however, the pace of reduction in the annual TB incidence rate slowed, decreasing 
from 7.5 % (1996–2000) to 4.2 % (2000–2005) to just 1.3 % (2005–2010). 
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This slowing resulted in a 2010 incidence rate of 13.2 cases per 100,000  people—
still below the eradication threshold—but  f alling short of the offi cial target of 10 
cases per 100,000 people. To explain the slowing pace, researchers have studied 
a number of variables, most notably, the role of treatment procedures (Herrero 
et al.  2011 ). 
 To meet the target of 10 TB cases per 100,000 people, PROCET established the 
following goals: (1) 90 % recovery rate for treated cases, (2) <5 % withdrawals from 
treatment, and (3) <3 % mortality rate for those undergoing treatment. Achieving 
these goals requires a stringent treatment regimen that consists of  health care work-
ers delivering TB  medication on an outpatient basis and directly observing patients 
while they take their medication. The medications are free for patients within the 
health care system, including those who have  multidrug-resistant TB (MDR-TB) . 
 Analysis of the treatment outcomes for the 2008–2010 cohort of TB patients 
indicates a recovery rate of 80 %, a withdrawal rate of 7 %, and a mortality rate of 
10 % (Ministerio de Salud  2012 ). Although the latter two numbers are high, analy-
sis reveals that TB treatment continues to be effective, given that the treatment fail-
ure percentage, less than 1 %, is quite small. However, the unsatisfactory withdrawal 
and mortality rates suggest  PROCET  needs to improve its performance in getting 
patients to adhere to treatment and in following up more quickly with patients to 
prevent mortality. 
4.15.2  Case Description 
 Pedro is a 42-year-old divorced father of two. He is a mechanic, but is unemployed 
and living with his parents. 
 Diagnosed in 2009 with sputum-smear positive pulmonary TB, Pedro received 
fi rst-line treatment at an outpatient primary care clinic in Santiago. In October 2009, 
he moved to the northern part of the country to work as a driver and withdrew from 
treatment for the fi rst time. While up north, his sputum-smear again tested positive. 
However, after fi ve attempts in 3 years, Pedro was unable to complete the daily 
phase of the treatment. As indicated by medical staff, he either refused to attend the 
local medical center for treatment or rejected the treatment and even verbally 
 attacked  staff when they tried to administer medicines. 
 In January 2012, he returned to Santiago seeking care at the same primary care 
clinic he had previously visited, continuing to test positive but now presenting respi-
ratory symptoms. A fi nal attempt at treatment, this time with second-line treatment, 
failed after 2 months due to his irregular attendance at the health care facility and 
failure to take the  medic ation regularly. 
 Pedro acknowledged he understood the consequences of his behavior and the 
possibility of microbial mutations leading to  antibiotic resistance , which would 
change his condition to incurable. Yet, when questioned about the reasons for his 
behavior, he refused to take responsibility, claiming, among other things, that TB 
drugs made him feel sick. 
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 In October 2012, he again visited the primary care medical clinic, this time 
accompanied by his mother and claiming he wanted to “start over.” He was feel-
ing ill, having night sweats, losing weight, and had diminished functional capac-
ity that prevented him from working. Because of his previous history, he was 
now referred to a specialized center, where the physician in charge of the TB 
program evaluated his case and wrote in his medical records, “The patient does 
not seem to understand his situation and the risk he is posing to his family…it 
seems to me that health care personnel are more concerned about patient’s dis-
ease than the patient himself.” The specialist concluded that the chance of the 
patient completing treatment after six failures was unlikely. The specialist 
therefore decided not to renew treatment “since this would cause even more 
microbial resistance. Disciplinary discharge would be more fi tting for this 
patient,” the physician added, “especially in view of the great demand for  hos-
pital  care.” 
 Pedro subsequently revisits the medical center demanding treatment, this time 
claiming he will not withdraw from therapy because he has joined a church and has 
had “an awakening of consciousness to the will of God, which is to serve and love 
your neighbor as yourself, and therefore, not to infect others.” 
 Despite the earlier decision of the physician in charge of the TB program, doctors 
reevaluate the case and decide that he should receive further TB treatment. Doctors 
refer him to a social worker for a  mental health assessment and  th e initiation of men-
tal health treatment if needed as a condition of  restarting  TB treatment. 
4.15.3  Discussion Questions 
 1.  Do you agree with the doctors’ decision to allow further TB treatment for the 
patient? Why or why not? 
 2.  Can denial of treatment to a patient with a potentially curable disease be ethi-
cally justifi ed, considering that this denial could lead to the patient’s death? On 
what ethical basis should the decision to deny or not deny treatment be made? 
 3.  Given that health resources are limited, what role does the principle of distribu-
tive justice play in determining whether patients should be allowed to start treat-
ment after multiple episodes of noncompliance with previous treatment? 
 4.  In view of the risk that the patient could infect his family with TB, should he be 
denied further treatment or should he be given another chance to complete it? 
How would you ethically justify your decision? 
 5.  What role should social factors such as educational level, economic status, or 
family situation play in making such decisions? 
 6.  When a patient could transmit a serious infectious disease, should there be legal 
enforcement of the requirement to get treated? 
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 This case is presented for instructional purposes only. The ideas and opinions expressed 
are the authors ’  own. The case is not meant to refl ect the offi cial position ,  views ,  or 
policies of the editors ,  the editors ’  host institutions ,  or the authors ’  host institutions . 
4.16.1  Background 
 Mass  evacuation involves moving people (and sometimes their property and ani-
mals) to alternative locations to protect them from threats to their health and safety 
(Kemetzhofer and Weinstein  2012 ). Threats to public health can be direct or indirect. 
Direct threats include natural hazards (e.g., hurricanes, fl oods, earthquakes, wild-
fi res) and human-caused hazards (e.g., release of hazardous materials, nuclear inci-
dent, bioterrorist attack). These threats can also negatively affect essential public 
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services (e.g., water, sewage, electricity) or create conditions for the proliferation of 
waterborne and vectorborne diseases. Mass evacuation is an important public health 
response, but it raises practical and moral issues (Settles  2012 ; Kodama  2015 ). 
 The sudden and unpredictable nature of some threats limits opportunities to pro-
vide notice for safe, orderly, and rapid evacuation. Such threats often force large 
numbers of people with different capabilities to travel great distances. Given limited 
time, resources, and personnel, those requiring assistance in evacuating will need to 
be categorized according to method of evacuation (e.g., medevac, ambulance, bus) 
and in what order they should be evacuated. 
 Although evacuation aims to promote or protect the well-being of the population, 
its use also raises considerations of  fairness .  Because  evacuation orders may nega-
tively affect  vulnerable and marginalized populations disproportionately (Morrow 
 1999 ), special attention needs to be paid to these populations (Van Willigen et al. 
 2002 ). Public health offi cials need to consider  socioeconomic disparities that can 
disadvantage community members in ways that impede  compliance with evacuation 
orders. For example, during the 2005 Hurricane Katrina in New Orleans, lack of 
access to transportation or to fi nancial resources prevented many people from evac-
uating. To mitigate such disadvantages and defi ciencies, evacuation policies and 
procedures must be established for vulnerable or  marginalized populations . 
 Mass evacuation can be voluntary or mandatory. Most evacuations will be 
voluntary because most people will comply with the recommendation to evacu-
ate. Nevertheless, implementation seldom occurs without complication, and pre-
dicting evacuation behavior of a population is inherently diffi cult (Baker  1991 ; 
Perry and Lindell  1991 ; Riad et al.  1999 ; Dash and Gladwin  2007 ). Evacuations 
are often ordered by different levels of government and carried out by local 
responders, requiring a high level of  coordination among agencies. Mandatory 
evacuation adds further complications. Requiring people to leave their homes or 
work whether or not they consent raises moral questions, such as justifying  lib-
erty restrictions. 
 Whether evacuation is voluntary or mandatory, a small segment of the commu-
nity will choose not to evacuate, even if they have the ability to do so. In all cases, 
efforts should be made to educate the public about the personal risks and societal 
costs of noncompliance with evacuation orders. Those who do not comply with 
evacuation orders raise the issue of whether they should be forced to evacuate and 
whether fi rst responders have a moral  obligation to go back and rescue them. 
 Enforcement of evacuation orders illustrates how law might be used as a public 
health tool (e.g., a  jurisdiction  may criminalize failure to comply with an evacuation 
order) (Viens et al.  2013 ). 
 Attention also has to be paid to the process of returning evacuated populations to 
their communities. Here, too, both practical and ethical issues arise: the extent to 
which damaged property and infrastructure should be rebuilt, the level of  compen-
sation or restitution that could be paid to evacuees or fi rst responders, and possible 
 sanctions to be levied on  nonevacuators later rescued. 
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4.16.2  Case Description 
 Your community is a large, metropolitan city under a category 5 hurricane warning. 
The hurricane, which has been forecasted to make landfall in 48–72 h, threatens 
massive fl ooding and property damage. A large number of people widely dispersed 
in the city will need to be evacuated. They speak many languages, have varying 
levels of access to transportation, and require various levels of care. Special needs 
and  vulnerable populations (e.g., the disabled, ill and injured, homeless, and the 
incarcerated) will also need help to evacuate. 
 As a result of emergency preparedness incident-training simulations, some agen-
cies have developed evacuation plans. These plans are not always easily accessible 
to all fi rst responders and the lack of  coordination between agencies has led to con-
fusion. Responders are unclear about who should be given priority in evacuation 
assistance, which resources and personnel should be devoted to evacuation efforts, 
and when to halt evacuation and rescue efforts and shift to recovering bodies. Of 
particular concern are the number of high-rise commercial buildings and medical 
facilities in the city. Although these buildings and facilities have individual evacua-
tion plans, most only make evacuation provisions for short-term events, such as 
power outages or fi res. Worse, no central registry or database lists which community 
members will require help to evacuate. 
 In less affl uent neighborhoods, some residents lack access to a car or suffi cient 
money to transport their family outside the hurricane’s path. Some of those unable 
to evacuate will be able to stay with friends or family. However, evacuees who can-
not stay with people they know are quickly overwhelming the capacity of evacua-
tion facilities in nearby towns. Decisions will need to be made about how to 
coordinate and effi ciently use resources and personnel to maximize the number of 
people protected from the hurricane. 
 Offi cials managing the evacuation have realized that mass evacuation raises some 
logistical and ethical issues shared by public health measures involved in the move-
ment or restriction of people (e.g., quarantine, isolation, social distancing). They 
have therefore asked you, an experienced public health offi cial, to provide input on 
which groups of people should be evacuated, how, and in what order of priority. Your 
special concern in planning and coordinating with other agencies will be the health 
of the population, mitigating inequalities and the safety  of  the  fi rst  responders. 
4.16.3  Discussion Questions 
 1.  What are the relevant ethical considerations for deciding who should be evacu-
ated fi rst and whether the evacuation order should be mandatory or voluntary? 
Of those to be evacuated, who should we evacuate fi rst? How should decisions 
be made regarding who to evacuate when not all can be evacuated? 
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 2.  What role should community engagement play in determining the order of prior-
ity of groups to be evacuated? 
 3.  How should authorities deal with those who do not comply with an evacuation 
order? What are the ethical implications of allowing people not to evacuate? Do 
authorities have obligations toward people who refuse to evacuate and later 
need to be rescued? Should people who had the ability to evacuate but failed to 
do so be blamed or punished in some way when they later need to be rescued? 
 4.  What kind of legal protections are needed to protect people who are made more 
vulnerable by virtue of having to evacuate? For example, should there be provi-
sions to prevent price gouging on gasoline or to keep extra police offi cers around 
to prevent looting? 
 5.  Are those who comply with voluntary evacuation orders owed anything? To 
what extent must resources be provided for the evacuated population? How 
much effort should be put into keeping families together? Should compensation 
be paid when people are asked to evacuate with little time for protecting valuable 
items that end up getting lost, damaged, or destroyed? How would your answers 
to these questions change if the evacuation orders were mandatory? 
 6.  In a clinical setting, some patients will be too unstable to be moved or, if mov-
able, will require disproportionate medical care and resources. Would it ever be 
acceptable to abandon some patients? If so, under what conditions? Would it be 
morally required that a clinician or fi rst responder stay within the evacuation area 
with such patients—at greater risk to themselves—to provide constant care until 
rescue can be provided at a  l ater time? 
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 Chapter 5 
 Chronic Disease Prevention and Health 
Promotion 
 Harald  Schmidt 
5.1  Introduction 
 Chronic diseases include conditions such as heart disease, stroke, cancer,  diabetes , 
respiratory conditions, and arthritis. In high-income countries, chronic diseases 
have long been the leading causes of death and disability. Globally, more than 70 % 
of deaths are due to chronic diseases, in the  United States , more than 87 %  (World 
Health Organization [WHO]  2011 ). Almost one in two Americans has at least one 
chronic condition (Wu and Green  2000 ). Aside from the  cost in terms of human 
welfare,  treatment of chronic disease accounts for an estimated three quarters of 
U.S. health care  spending  (Centers for Disease Control and Prevention [CDC] 
 2012 ). Chronic diseases directly affect overall health care budgets, employee pro-
ductivity, and economies. Globally,  noncommunicable diseases account for two-
thirds of the overall  disease burden in middle-income countries and are expected to 
rise to three-quarters by 2030, typically in parallel to  economic development (World 
Bank  2011 ). Of particular concern to many low- and middle- income  countries is 
that threats to  population health occur on two fronts simultaneously: “In the slums 
of today’s megacities, we are seeing  noncommunicable diseases caused by unhealthy 
diets and habits, side by side with undernutrition” (WHO  2002 ). 
 Four modifi able  risk factors are principal contributors to  chronic disease , associ-
ated disability, and premature death: lack of physical activity, poor nutrition,  tobacco 
use, and excessive alcohol  consumption  (CDC  2012 ). One in three adult Americans 
is  overweight , another third is obese, and almost one-fi fth of young people between 
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6 and 19 years of age is obese, even though rates are not increasing at previous lev-
els (Katz  2013 ). Although  smoking has declined considerably over recent decades, 
about 20 % of Americans still  smoke . Rates of smoking are markedly different 
across socioeconomic groups, and much higher among economically disadvantaged 
people (Garrett et al.  2011 ). Globally, deaths from smoking are expected to increase 
dramatically in low-income countries. In the twentieth century, tobacco-use killed 
around 100 million people worldwide. In the twenty-fi rst century, an estimated one 
billion will die prematurely—a tenfold increase. By 2030, more than 80 % of deaths 
attributable to tobacco will be in low-income countries (WHO  2012 ). 
 In  principle , if a  risk factor can be modifi ed, then much illness and suffering 
(morbidity) and early death (mortality) can be avoided or  prevented . Therefore, 
prevention and  health promotion  policies seek ways in which the impact of modifi -
able risk factors can be reduced. How one analyzes the causal pathways that lead to 
the development of risk factors may encourage one to explore a range of different 
interventions. An obvious starting point is to focus on individual behavior or  life-
style , because what an individual does (or fails to do) typically plays a central role 
in  chronic disease . Consider the following line of thought by John H. Knowles, an 
outspoken critic of the American health care system in the 1970s:
 Prevention of disease means forsaking the bad habits which many people enjoy—[but the] 
 cost of sloth, gluttony, alcoholic intemperance, reckless driving, sexual frenzy, and  smoking 
is now a national, and not an individual, responsibility. This is justifi ed as individual  free-
dom —but one man’s freedom is another man’s shackle in taxes and insurance premiums. I 
believe the idea of a ‘right’ to  health should be replaced by the idea of an individual moral 
 obligation to preserve one’s own health—a public  duty if you will. The individual then has 
the ‘right’ to expect help with  information , accessible services of good  quality , and minimal 
 fi nancial  barriers (Knowles  1977 ). 
 Knowles comment is interesting on several counts. First, it underscores that even 
though  population health usually features centrally in  health promotion ,  cost con-
siderations are never far removed and are equally prominent in current debates, 
especially in  political fora. 1 
 Second, in invoking three of the deadly sins (gluttony, sloth, and lust),  Knowles 
illustrates in a frank way that discussions about  health promotion are not confi ned 
to medical or public health concepts. Implicitly or explicitly, these  discussions 
almost always entail moral concepts (such as  personal responsibility or deserving-
ness) that are embedded in deeply held normative frameworks. 
1  For an example of such a political debate, see the 2012 platform of the U.S.’s Republican Party: 
“… approximately 80 % of  health care costs are related to  lifestyle —smoking, obesity,  substance 
abuse —far greater emphasis has to be put upon  personal responsibility for health maintenance …” 
(GOP  2012 ). Reforming Government to Serve the People is available at  https://www.gop.com/
platform/ . This quote also illustrates the inaccurate use of statistics. Although the burden of  chronic 
diseases is indeed roughly 80 %, it is an exaggeration to claim that  personal responsibility alone 
accounts for the total burden. Exact estimates may not be straightforward due to complex interac-
tions of different factors. Consequently, a more realistic estimate attributes 40 % to personal 
behavior, 30 % to genetic predispositions, 15 % to social circumstance, 10 % to inadequate health 
care, and 5 % to environmental causes (Schroeder  2007 ). 
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 And fi nally—although  Knowles acknowledges elsewhere in his essay the role of 
taxes and other measures to improve health and eradicate poverty—he concludes by 
stating “the  costs of individual irresponsibility in health have now become prohibi-
tive. The choice is individual responsibility or social  failure ” (Knowles  1977 ). The 
 policy  interventions he mentions aim for broader recognition of  personal responsi-
bility and therefore focus on education and  information campaigns to empower 
people to behave responsibly. But this analysis is shortsighted. It fails to consider 
the responsibility of those who produce, market, and sell products (e.g., unhealthy 
foods, drinks, or  tobacco ) and of those who regulate markets or set business  stan-
dards (e.g.,  trade groups or national or regional policy makers). His point could best 
be made if all people lived in similar environments and conditions, had suffi cient 
disposable income, had ready access to healthy and affordable food, had equal 
opportunity to exercise, and experienced other health-conducive conditions. But 
this is not the case. People live in vastly different contexts, and many different fac-
tors determine health (Fig.  5.1 ).
 Although Fig.  5.1 provides a useful overview of many factors that affect health, 
the concept of “ lifestyle ,” commonly encountered in the broader debate around 
 chronic diseases is problematic. It can suggest that people choose, for example, 
 smoking or heavy drinking as others might decide between taking up golf or tennis 
as a hobby. The point is that “ lifestyle ” implies degrees of  freedom and the possibil-
ity of genuine opportunity and choice. But assume that you grew up in an inner-city 
 Fig. 5.1  Factors determining  health and  chronic diseases (Originally published in Dahlgren and 
Whitehead ( 1991 ). Reproduced from Acheson ( 1998 ). Reproduced with permission) 
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borough as a child of low-income obese and smoking  parents . Many in your family 
and social environment smoke and are obese. Compared to the national average, 
you are among the most  overweight , and you fail to lose weight as an adolescent. 
You remain obese. Calling your  obesity a matter of lifestyle  makes little sense. Now 
assume you started smoking as a minor (<18 years of age) just as 88 % of U.S. 
adults who  smoke  daily (U.S. Department of Health and Human Services  2012 ). It 
can be cynical to treat this “ lifestyle ” as  voluntary and freely chosen if, for example, 
many of your role models  smoke and if smoking in your social setting and challeng-
ing environment functions as a coping mechanism to relieve stress. The different 
spheres in the diagram therefore need to be understood as highly interdependent. 
Regarding terminology, the concept of  lifestyle factors should be replaced with that 
of  personal behavior . Doing so acknowledges that powerful constraints can severely 
infringe on the development of healthy habits and behavior. In the worst case, these 
constraints may thwart development of healthy habits and behaviors altogether, 
even when individuals have the best of intentions. 
 Focusing on just the individual is therefore overly narrow when identifying  poli-
cies to prevent  chronic diseases . Yet, removing the individual from the equation is 
also unhelpful (Schmidt  2009 ). The central ethical issues surrounding  health pro-
motion and prevention of chronic diseases concern the relative responsibilities of all 
agents whose actions infl uence the health of others. These agents include, in addi-
tion to individuals, health workers,  governments (at different levels), and corporate 
entities. 
5.2  Individuals 
 Except for some genetic conditions and extremely toxic environments (i.e., chemi-
cal exposure), individual behavior typically plays a causal role in bringing about 
bad—as well as good—health. People may or may not eat healthily; they may or 
may not use  tobacco or illegal drugs; they may consume alcohol excessively or in 
moderation; they may exercise too little or too much; and they may regularly brush 
their teeth, go for medically recommended checkups, and take their  medications —
or fail to do so. However, it is important to recognize that implementation of mea-
sures such as praise or blame, or fi nancial rewards, or  penalties —although they 
presuppose a certain degree  of causal responsibility—do not mean that individuals 
also automatically need to be held fully responsible in a moral (or legal) sense. 
Causal responsibility in the present context simply means that a person has behaved 
in ways that contributed to, say, poor health. Therefore, a smoker with lung disease 
arguably has some causal responsibility for the condition. But if it turns out that the 
smoker started becoming addicted as a child, it is clear that the outcome cannot 
simply be treated as the result of an entirely  voluntary choice . Where there is no, or 
limited, opportunity of choice, there is the  risk of “ victim blaming ” (Crawford 
 1977 ) and holding people responsible for factors that are, in fact, beyond their 
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control. Conversely, ignoring the scope of possible behavior change can lead to 
fatalism and resignation (Schmidt  2009 ). 
 For individuals to take causal and other responsibility for their health, they 
require, among other things,  information that they can understand, affordable access 
to health care, and, oftentimes far more important, environments conducive to health 
in which capabilities may be developed so that one can fl ourish in life (e.g., residen-
tial, work, and play settings) (Venkatapuram  2011 ; Ruger  2006 ). According to the 
adage “ought implies can,” we can only hold people responsible for their actions if 
they could have acted otherwise. Of course, it is true in some sense that people who 
 smoke , or overconsume unhealthy food, or fail to exercise, could oftentimes have 
acted otherwise, in  principle : it was not literally impossible for them to act other-
wise. However, the relevant question is not whether it is literally possible to engage 
in healthy behavior, but whether it reasonably feasible for people to engage in 
healthy behavior. Talk of  personal responsibility therefore requires a clear focus on 
the settings in which people live and on their behaviors when presented with differ-
ent choices. Consideration should also be given to the possibility that  policies 
implementing personal responsibility through, for example, rewards and  penalties , 
may impact core  values underlying a health system, such as a sound doctor-patient 
 relationship ,  equity , or risk  sharing , which may affect their overall acceptability in 
positive or negative ways (Schmidt  2008 ). 
5.3  Formal and Informal Health Workers 
 Health  professionals play a central role in chronic disease prevention and  health 
promotion (Dawson and Verweij  2007 ). In  primary prevention , they focus on avert-
ing poor health in the fi rst place and on promoting good health. In  secondary pre-
vention , they offer  information , tests, and  screenings aimed at early detection and 
 treatment  of diseases.  Diabetes , blood pressure, and some cancer screenings can 
have utility, especially when targeting at-risk  populations in a nonstigmatizing way. 
Primary care physicians are often in a good position to decide on the appropriate-
ness of screenings. Their knowledge of patient background and overall situation can 
help them tailor tests on the supply side to the actual needs on the demand side, 
bearing in mind patient preferences and individual risks. 
 Cost effectiveness aside, a physician would be wrong to offer every available test 
to every patient because the clinical benefi t is not always clear. A recent systematic 
review and meta-analysis of  randomized controlled trials concerning general health 
checkups (i.e., comprising  health risk assessments and biometric screening for high 
blood pressure, body mass index, cholesterol, and blood sugar) found no association 
with lower overall mortality or morbidity (Krogsbøll et al.  2012 ). On the basis of 
these fi ndings, the  researchers caution that checkups may needlessly increase diag-
noses and use of drugs. They recommend clinically motivated testing of individuals 
to initiate preventive efforts but discourage  screening at the population-level for 
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lack of evidence. The authors acknowledge limitations in their  research , including 
that most of the trials were relatively old and that changes in interventions and care 
pathways reduce applicability to current practice. All studies entailed  voluntary 
invitations to get  checkups , so selection bias may have overrepresented privileged 
people (in typically better health to start with) and not reached those needing atten-
tion the most (Krogsbøll et al.  2012 ). The focus on all-cause mortality has also been 
criticized as setting too high a threshold (Sox  2013 ). Yet despite the somewhat intui-
tive appeal of using general health checkups in  secondary prevention , there is little 
robust evidence from  randomized controlled trials to show any major impact on 
overall mortality. 
 An ethical problem arises when offering preventive  screenings that do not fol-
low evidence-based  guidelines (U.K. National Screening Committee  2013 ). Such 
screenings may increase the number of “worried well” who oftentimes are con-
fused by complex probabilities of detecting and preventing  diseases . Clinicians 
must therefore do their utmost to understand  risks and benefi ts of screening tests 
and communicate these to patients in ways that are easily comprehensible and not 
misleading (Wegwarth and Gigerenzer  2011 ). For example, a physician might tell 
his 50-year-old patient that she should undergo  breast cancer screening because it 
reduces risk by 14 %. But this  information is incomplete, as relative risk rates 
alone obscure the basic reference point against which the comparison is made. 
Another way of providing the same  information would be to use absolute risk 
rates and to say that if one screens 1000 women for 20 years, four breast cancer 
deaths can be averted, even though eight among all screened women still die from 
breast cancer. In addition, over the 20 years, the 1000 women taking part in 
screening experience 412 false positives, and of 73 women who are diagnosed 
with breast cancer, 19 experience overdetection and are treated for a cancer that 
would not have developed into a lethal tumor, with  treatment typically consisting 
of hormone- radio- or chemo- therapy, and partial or full surgical breast-removal 
(Hersch et al.  2015 ). This way of presenting data (Fig.  5.2 ), especially when com-
bined with other relevant  information about  screening accuracy and rates of over-
diagnoses, provides more adequate  context for considering benefi ts and risks—yet, 
this presentation method is far from being universally adopted (Gigerenzer et al. 
 2010 ).
 Adequate  risk  information in  secondary prevention matters not only from a 
patient-empowerment perspective but also because it can mitigate real or perceived 
 confl icts of interests of physicians. Physicians, anyone who markets or manufac-
tures screening equipment, and those who analyze data typically experience fi nan-
cial gain when more patients undergo  screening . Therefore, a central ethical issue of 
secondary prevention is not only how to avoid premature mortality in the most effi -
cient and cost effective way but also how to eliminate potential confl icts of inter-
ests. Patients can become entangled in competing interests, as illustrated by the 
controversy surrounding prostate-specifi c antigen, or PSA, testing to detect prostate 
cancer. Although physicians and others experienced fi nancial gain, patients experi-
enced no reduced mortality and instead higher morbidity and loss of quality of life 
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due to the entailed procedures (Ablin  2010 ). The question of “what is the magnitude 
of benefi ts and  risks , and to whom?” is therefore an important one to ask in all  sec-
ondary prevention , especially because the net gain for patients is not always 
obvious. 
 For these and other reasons, many in the public health community are skeptical 
about the relative utility of  secondary prevention in a clinical context. Often this is 
paired with a call for shifting  political and fi nancial support to  primary prevention 
and the broader sphere of public health (Sackett  2002 ; Mühlhauser  2007 ). Here, the 
objective is to avoid poor health in the fi rst place by empowering people with differ-
ent ways to lead healthy lives. Too often, only the privileged few in certain  popula-
tions have this capability (WHO  2008 ). 
 Of course, this way of thinking immediately broadens the concept of health  pro-
fessional . Clearly, it is outside the scope of, say, a hospital-based general internist to 
reduce junk-food outlets or to increase exercise opportunities in a low-income part 
of town, even if the internist has good reasons to believe these structural features are 
key contributors toward rising levels of  obesity among patients. But once we recog-
nize how differences among settings in which people live can affect the incidence 
and prevention of chronic diseases, it becomes apparent that public health profes-
sionals outside the clinical context have as much, if not more, of a role to play 
compared to physicians when it comes to chronic disease prevention and health 
promotion. 
 A range of corresponding interventions are relevant to this discussion, including 
literacy, safe sex, hygiene and health awareness campaigns, fi nancial subsidies for 
healthy food or gyms, exercise stations in parks, breastfeeding rooms in workplaces, 
Relative risk data can be misleading or confusing. Absolute risk data can provide more 
appropriate information and minimize possible conflicts of interest. Visual illustrations 
similar to the ones shown below are helpful as part of evidence-based mammography 
screening decision-aids.  
 Fig. 5.2  Communicating benefi ts and  harms of  breast screening (Originally published in Hersch 
et al. ( 2015 ). Used with permission) 
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and fl uoridation of water. The public health fi eld is heterogeneous and comprises 
numerous different actors both in and outside a clinical context. Public health, 
despite its many contexts and support from  government and private sectors, is typi-
cally underfunded. This is especially true for informal grassroots campaigns, which 
often have a considerable competitive advantage over formal program structures. 
Grassroots campaigns evolve from the communities they seek to help. Because 
nearly every intervention that addresses chronic diseases has to do with how one 
lives one’s life, top-down interventions are often experienced as intrusive forms of 
external meddling (Morain and Mello  2013 ). Conversely, initiatives led by a com-
munity member can be perceived more sympathetically than instructions from men 
in white coats who speak in formal and technical terms (unless, of course, that hap-
pens to be the target  population , which, typically, it is not). 
 Health  professionals working on chronic disease prevention and health promo-
tion therefore span a wide fi eld. In a looser sense, many professionals not generally 
seen as concerned with health could be included too, such as teachers, architects, 
town  planners , or spiritual leaders. Each has perspectives that can be highly infl uen-
tial, but each is inherently limited in scope because chronic conditions result from 
complex interplay of different factors. This raises another key ethical issue involv-
ing how to determine the optimal mix of strategic approaches, bearing in mind the 
relative strengths and weaknesses. 
 Further, just as users and payers of health care should have a keen interest in hav-
ing systematic studies and evaluations done to determine which of several drugs 
aimed at reducing, for example, severe headache, is most effi cacious (and cost 
 effective), we should be interested in the evidence base for possible benefi ts and 
 harms of different interventions being implemented by health  professionals con-
cerned with chronic conditions. Yet, in an almost tautologic approach, health profes-
sionals often assume any preventive  method will be good because its aim is 
prevention. But several strategies could be aimed at the same problem. Given that 
budgets are generally limited, it can be useful to determine which intervention is 
most effective and, for example, how its relative  effectiveness and  cost compare 
with its intrusion into peoples’ lives. Such comparisons can help achieve  value for 
money, even if the complex interplay of agents complicate this process. 
5.4  Governments (At Different Levels) 
 Chronic disease prevention and health promotion  policies often face criticism for 
promoting a “ nanny state .” This means that although government may legitimately 
use taxes and other measures to create health-conducive infrastructure that pre-
vents chronic disease such as clean water supplies,  sanitation services, or clean air 
acts, it should otherwise stay out of people’s lives, and, in particular, refrain from 
telling citizens how to live their life (Childress et al.  2002 ; Gostin  2010 ; Dawson 
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and Verweij  2007 ). Many good reasons support this viewpoint. Still, many vari-
ables related to chronic diseases are linked to legitimizing governments in the fi rst 
place. 
 For example, consider the U.S. Declaration of Independence. It declares that 
“all men are created equal; that they are endowed by their Creator with certain 
unalienable Rights; and that among these are Life,  Liberty , and the pursuit of 
Happiness.” Numerous countries express similar sentiments in legal frameworks 
and charge states with providing environments that enable conditions for a good 
life, and prevent  harm . Moreover, building on the United Nations’ (U.N.) 
 International Covenant on Economic ,  Social and Cultural Rights of 1966 and 
clarifying  General Comment 14 by the U.N.’s Committee on Economic, Social 
and Cultural Rights, several countries have incorporated the  right to health in their 
constitutions (WHO  2013 ). Yet, not all people live equally long, nor are they 
equally happy (in a nontrivial sense). For example, life expectancy differs widely, 
not just between countries at different levels of development, but also within 
countries, and sometimes with differences of almost 30 years across just 10 miles 
(see the data on two areas in Glasgow, Scotland, located near one another, 
Fig.  5.3 ). Chronic diseases are a major contributor to this variation.
 Going back to the focus on  personal responsibility , one might argue this variation 
in life expectancy is due to some people  simply not wanting to be healthy or living 
long. But this is clearly myopic. Government planning at different levels has 
immense impact on both the prevalence and prevention of chronic diseases. It is 
sometimes argued that the best  prevention is to instill in people the desire to live 
long and healthily (Rosenbrock  2013 ). For some, this might entail a state- guaranteed 
minimum income (irrespective of whether one works), since economic livelihood is 
 Fig. 5.3  Male life expectancy, between- and within-country inequities, selected countries (Figure 
is adapted from World Health Organization ( 2008 )) 
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of course a major factor in how one views one’s own future. While a positive impact 
of such  policies on the incidence of chronic disease and mortality would certainly 
be plausible, there is a wide  range of less radical and  politically more feasible 
options in the menu of different levels of government action. These include town 
planning, zoning  laws ,  school and university meal plans, and, of paramount impor-
tance,  regulation of industry where markets fail. These and other interventions can 
only be implemented by governments. An important part of chronic disease preven-
tion and  health promotion is to monitor where differences in morbidity and mortal-
ity are such that government action is warranted, and to impress on elected offi cials 
their responsibility in creating appropriate environments. 
 The monolithic notion of “the” government is, of course, an overly simplistic 
one. Key personnel in health departments may well wish to limit the size of, for 
example, soft drinks. Or they may wish to standardize ways in which nutritional 
content is shown on food packaging. Such measures would enable more informed 
 consumer choice, and, more indirectly, incentivize producers to reconsider 
whether food composition can be optimized for health impact, given the second-
ary “showcasing” effect of labeling. 2 But their colleagues in  trade or industry, as 
well as in the treasury, may point out the  risk of tax shortfalls that could result 
from lower  consumption. Or they may worry about pushback from lobbyists in 
the corporate sector who fear losing profi ts for their  clients . Politicians may often 
be more concerned with their short-term re-election prospects than with making 
substantial (or even just incremental) longer-term progress on chronic disease 
prevention. These  confl icting perspectives within government are  inevitable . But 
only government can determine the playing fi eld and ground rules for industries 
producing, selling and marketing food, drink,  tobacco , and other products contrib-
uting to unhealthy behavior. In liberal economies that, typically, pursue a hands-
off approach toward regulating markets, the central ethical challenge then is to 
decide at which points markets are considered to have failed, other options of 
market  regulations are unfeasible, and government action is warranted, despite 
possible drawbacks. 
 A second closely related question is what intervention to pursue once the need 
for action has been identifi ed. Figure  5.4 shows the  Intervention Ladder published 
in a report by the  Nuffi eld Council on Bioethics ( 2007 ) on public health ethics. The 
 model suggests that governments have a range of different options at their disposal 
that become increasingly intrusive or  paternalistic the higher one moves up the lad-
der. At the same time, each rung up the ladder requires more robust justifi cation and 
 evidence , although the report points out the bottom rung, “doing nothing or simply 
monitoring,” also requires justifi cation.
2  For example, it has been shown that large U.S. chain restaurants changed menus in anticipation 
of a legal mandate requiring public calorie posting, resulting in a 12 % reduction in calories (or 
about 56 fewer calories per item, see Bleich et al.  2015 ). 
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5.5  Corporate Entities 
 In the  United States , the Institute of Medicine ( 1988 ) defi nes public health as “what 
we, as a society, do collectively to assure the conditions in which people can be 
healthy.” In the  United Kingdom , the Faculty of Public Health ( 2010 ) of the Royal 
Colleges of Physicians suggests that public health is the “science and art of prevent-
ing  disease , prolonging life, and promoting health through organized efforts of soci-
ety.” These, and other conceptualizations, emphasize the collective nature of public 
health work (Verweij and Dawson  2007 ). Companies that facilitate  consumer access 
to  tobacco or to healthy and unhealthy food and drink are part of society and con-
tribute via goods, services, and employment opportunities. In return, they often 
receive generous tax breaks. Company operations benefi t further from diverse fi nan-
cial arrangements and infrastructures put in place by  governments to ensure stability 
• Eliminate choice: Prohibit substances such as transfats. Remove obese children
from their home.
• Restrict choice: Ban unhealthy foods from shops or restaurants. Add fluoride to water.
• Guide choice through disincentives: Tax cigarettes. Discourage the use of cars 
in inner cities through charging schemes or by limiting parking spaces.
• Guide choice through incentives: Give tax breaks to commuters.
• Guide choice by changing the default policy: In restaurants, instead of
providing fewer health options and including fries as a standard side dish (with 
healthier options available) make healthy options standard menu fare (with fries 
optional). Regulate salt levels of fast food meals because consumers can add salt 
afterwards. 
• Enable choice: Create tax-funded smoking cessation programs, build cycle lanes, 
or provide free fruit in schools.
• Provide information: Implement campaigns to encourage people to walk more 
or to eat certain amounts of fruit and vegetables daily.
• Do nothing or simply monitor the current situation.
In preventing chronic diseases and promoting health, governments have a range of 
policy options differing in justification, evidence requirements, and extent of 
intrusion.
 Fig. 5.4  The  intervention ladder (Adapted from Nuffi eld Council on Bioethics ( 2007 )) 
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of civic and economic life, since both are essential to how markets function. It is 
therefore reasonable to ascribe some responsibilities for public health to companies. 
In many instances, this is achieved through  voluntary corporate social commit-
ments, such as charters or formal partnerships with charitable or community orga-
nizations. Increasingly, companies view their own ethical actions as an attractive 
side of their branding, especially in countries where  consumers’ awareness is high. 
 Although many companies generate profi ts through healthful products, many 
others benefi t from bringing products to market that will likely cause  harm . Product 
demand is rarely a function of basic human needs but, rather, is defi ned by social 
and cultural  norms . These norms are often fueled—if not generated—by aggressive 
marketing to adults and  children . The basic tension regarding the role of companies 
in relation to public health is their  prima facie  obligation to contribute to  population 
health , while also maximizing owners or shareholders’ profi ts. Public health would 
be promoted by measures such as providing honest nutritional  information and 
other content of products; avoiding claims that are misleading (as is sometimes the 
case with vitamins, supplements, or some diagnostic tests); not denying or under-
playing potential  harm (as with so-called alcopops, which are high-alcohol drinks 
made to look like soft drinks); or not exploiting the “pester  power ” of  children , 
particularly by marketing products to them and confusing the boundary between 
giving  information and  advertising . But realizing these aspirations typically curbs 
consumption and therefore reduces market shares and profi ts. 
 Companies therefore prefer as little  regulation as possible and favor information- 
based over price-based interventions or more intrusive options (Fig.  5.4 ). In all 
high-income countries, company and  government offi cials liaise to negotiate  con-
sumer protection  policies , insofar as  political and consumer pressure creates 
demand. These negotiations often reveal  the limitations of  corporate social respon-
sibility , as perhaps illustrated most clearly by the tobacco industry. For decades, the 
industry pursued the strategy that there was no hard evidence that  tobacco was 
harmful to health. When this strategy became too absurd to sustain, and, in particu-
lar, when the evidence of the harmful effects of secondary  smoke became over-
whelming, the industry caved in and agreed to implement a series of  consumer 
protection measures in most developed countries (Brandt  2007 ). However, in many 
instances, this tug-of-war was repeated in other countries, despite a range of robust 
provisions in WHO’s  Framework Convention on Tobacco Control ( 2003 ), the only 
supranational hard  law instrument on a major  risk factor for chronic conditions that 
is legally binding in more than 170 countries. From a narrow business perspective, 
this behavior is entirely rational. But from an ethical viewpoint, it is extremely ques-
tionable. For example, it has been accepted in the  United States and Europe that it 
is not appropriate to glorify tobacco on billboards, to give cigarettes away for free 
in promotions at rock concerts geared towards young people, or to sell them indi-
vidually, then why should these and other practices be commonplace in many low- 
income countries, especially in  Africa (Action on Smoking and Health  2007 )? The 
obscene tenfold global increase in deaths attributable to  tobacco in the twenty-fi rst 
century has already been noted. What makes this prospect all the more appalling is 
the industry’s refusal to take seriously the  standards it agreed to uphold in high- 
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income countries. For if these standards were upheld, history would not repeat itself 
with such horrifi c consequences. 
5.6  Case Studies 
 In the following fi ve cases, the reader is put in the position of a public health prac-
titioner to illustrate how key ethical issues can arise in the prevention of chronic 
diseases and health promotion. The cases highlight several real-world, practical 
 constraints : limited budgets; insuffi cient evidence for how interventions will work 
in structurally different settings; organizational constraints, particularly from spe-
cifi c formats for decision making; and clashes of perspectives and worldviews. 
Three cases concern  children , an especially  vulnerable population (Verweij and 
Dawson  2011 ). The cases ask whether the  parents alone can make sound health 
decisions for their children, and if not, what interventions would be acceptable to 
reach the parents. The interventions range from chemical and behavioral to social 
ones, and central to each are ethical questions around their justifi cation (because of 
competing interests) and oftentimes unclear evidence. Several cases touch on 
whether or not to engage the public in decision making—and if so, how? Public 
engagement is an increasingly popular approach being applied broadly to health 
 policy . Yet, it is not always clear who should be involved in which  decision-making 
processes and on what grounds (Kreis and Schmidt  2013 ). 
 Mah et al. provide an intriguing scenario in which a municipal public health 
department needs to decide whether to accept increased contributions to a  youth 
after-school program from a local fast food-chain in exchange for mentioning the 
chain’s name as part of the (renamed) program. The background section describes 
how food and beverages are marketed to  children and notes that globally,  self- 
regulation models are the most common approach. This case combines real and 
perceived  confl icts of interests for the company and for notoriously cash-strapped 
public health workers. Woven into the case is the media’s role. The discussion ques-
tions invite analyses from the vantage points of different  stakeholders and address 
ways to modify the base scenario, adding layers of complexity. 
 Blacksher’s case focuses on  obesity  prevention ,  media campaigns , and stigma. 
She describes the human and fi nancial toll of obesity worldwide, focusing on chil-
dren as an especially vulnerable group. She also presents a range of different  policy 
options to address childhood obesity before charging the reader, acting as a state 
commissioner for  health , to recommend a statewide obesity policy for a dispropor-
tionately poor and  vulnerable population . The process for reaching consensus on 
this policy recommendation is common. A task force of a dozen members is 
appointed, half the seats are reserved for state legislator appointees, and half 
reserved for public health  professionals and community representatives. Due partly 
to their different background and priorities, the task force disagrees about how 
intrusive the policy should be. Members settle, however, on a statewide  media cam-
paign aimed at changing  social norms . Still, how hard-hitting should the campaign 
5 Chronic Disease Prevention and Health Promotion
150
be? In the discussion questions, readers may consider, among other things, the evi-
dence needed to justify different campaign types and if other stakeholders should 
(or need not) be included in the  decision-making process to confer legitimacy. 
 The case by Goldberg and Novick focuses on an intervention program in which 
task force members grapple with whether the use of stigma might be acceptable 
under certain circumstances. The authors describe empirical  research fi ndings and 
conceptual arguments that suggest stigma is always correlated with negative  health 
outcomes —especially in otherwise disadvantaged  populations , and certainly in the 
case of  obesity . They describe how stigmatizing approaches are based on certain 
conceptions of  personal responsibility that fail to consider the broad underlying 
structural determinants of obesity. Then the case shifts focus to another situation 
often encountered in public health practice: applicability of evidence base in mul-
tiple settings. Here, a program intended to empower residents to take control of their 
weight through meal planning, physical activity, and behavioral modifi cation proves 
effective in controlled studies. The director of the county health department, 
attracted to the program on grounds of potential  cost effectiveness , readily embraces 
the program. Later, however, during a program meeting, one of the department’s 
public health nurses expresses concern about an overly strong focus on  personal 
responsibility , which she feels makes the program unfair. Based on her knowledge 
of the target  population , she also feels the program will be  rejected . Could the 
 program nonetheless be effective? And how might  risks of stigma be minimized? 
These and related issues form part of the questions section. 
 Whereas the fi rst three cases are set in the  United States , the case by Aspradaki 
et al. takes us to  Greece and concerns issues raised by water fl uoridation. The  dis-
ease burden attributable to preventable tooth decay is laid out along with the risks of 
using  fl uoride .  Oral disease is on the rise in low- and middle-income  countries , with 
poorer populations disproportionately affected. The authors describe water fl uorida-
tion in different countries before suggesting that the primary ethical tension sur-
rounding water fl uoridation arises between the concepts of  autonomy and 
 paternalism . The case description puts the reader in the position of  Greece’s central 
oral health director providing a consult to the head of public health programs in the 
health ministry. Negotiations on a national strategy have been held up by  political 
 and organizational digressions and by public skepticism. Still, the health ministry 
wants to go ahead and put in place a countrywide fl uoridation program. Your task is 
to identify which  stakeholders should be involved, how the different elements of 
empirical data and ethical  values should be considered, and what role economic 
pressures might play in the decision making. 
 The case by Aleksandrova-Yankulovsak is about banning  smoking in public 
 places in  Bulgaria . Almost half of the men and a third of the women in Bulgaria are 
smokers. The case provides context to smoking in Europe and nearby regions before 
summarizing the regulatory framework that prompted Bulgaria to consider the ban. 
The  political process, threatened by business interests and strife within  government 
departments, is also addressed. The case then poses the question if you, as director of 
the regional health inspectorate, can guarantee implementation of the new  law . Other 
questions invite discussion on whether the law is the right tool to achieve lower 
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 smoking rates , in  principle , and how the public might view temporary legal provi-
sions that could be repealed if political support dwindles. A further central  point is 
how or whether economic  costs can ever be set against cost in human welfare. 
 The cases illustrate but a fraction of the ethical issues that arise in chronic disease 
prevention and health promotion. Many cases will present differently depending on 
the country and its culture, infrastructure, health care system, and legal and political 
system. Similarly, this introduction is far from exhaustive. Yet, when combined, the 
cases and introduction introduce many central ethical issues that arise in  global 
public health . Analyzing the ethical issues that featured centrally in justifying  poli-
cies (or in the refusal of policy makers or other actors to change existing policies) 
will deepen the reader’s engagement and refl ection and, ideally, contribute to better 
policy and practice in the future. 
 Acknowledgements  I am grateful to Anne Barnhill for helpful comments on an earlier version 
of this introduction. 
 References 
 Ablin, R.J. 2010. The great prostate mistake.  New York Times , March 10, A27. 
 Acheson, D. 1998.  Independent inquiry into inequalities in health . Department of Health: 
U.K. Government.  http://www.archive.offi cial-documents.co.uk/document/doh/ih/contents.
htm . Accessed 20 Oct 2013. 
 Action on Smoking and Health. 2007.  Bat’s African footprint .  http://www.ash.org.uk/fi les/docu-
ments/ASH_685.pdf . Accessed 20 Oct 2013. 
 Bleich, S.N., J.A. Wolfson, and M.P. Jarlenski. 2015. Calorie changes in chain restaurant menu 
items: Implications for obesity and evaluations of menu labeling.  American Journal of 
Preventative Medicine 48(1): 70–75. 
 Brandt, A.M. 2007.  The cigarette century: The rise, fall, and deadly persistence of the product that 
defi ned America . New York: Basic Books. 
 Centers for Disease Control and Prevention (CDC). 2012.  Chronic disease prevention and health 
promotion .  http://www.cdc.gov/chronicdisease/overview/index.htm#ref2 . Accessed 21 Sept 
2013. 
 Childress, J.F., R.R. Faden, R.D. Gaare, et al. 2002. Public health ethics: Mapping the terrain. 
 Journal of Law, Medicine & Ethics 30(2): 170–178. 
 Crawford, R. 1977. You are dangerous to your health: The ideology and politics of victim blaming. 
 International Journal of Health Services 7(4): 663–680. 
 Dahlgren, G., and M. Whitehead. 1991.  Policies and strategies to promote social equity in health . 
Stockholm: Institute for Future Studies. 
 Dawson, A., and M.F. Verweij. 2007. Introduction: Ethics, prevention, and public health. In  Ethics, 
prevention and public health , ed. A. Dawson and M. Verweij, 1–12. New York: Oxford 
University Press. 
 Faculty of Public Health, Royal Colleges of Physicians of the United Kingdom. 2010.  What is 
public health?  http://www.fph.org.uk/what_is_public_health . Accessed 20 Oct 2013. 
 Garrett, B.E., S.R. Dube, A. Trosclair, R.S. Caraballo, and T.F. Pechacek. 2011. Cigarette smok-
ing—United States, 1965–2008.  Morbidity and Mortality Weekly Report. Surveillance 
Summaries 60(suppl): 109–113. 
 Gigerenzer, G., O. Wegwarth, and M. Feufel. 2010. Misleading communication of risk.  British 
Medical Journal 341: c4830. 
5 Chronic Disease Prevention and Health Promotion
152
 GOP. 2012.  Reforming government to serve the people . Available at  https://www.gop.com/plat-
form/ . Accessed 20 Oct 2013. 
 Gostin, L.O. (ed.). 2010.  Public health law and ethics: A reader . Berkeley: University of California 
Press. 
 Hersch, J., A. Barratt, J. Jansen, L. Irwig, et al. 2015. Use of a decision aid including information 
on overdetection to support informed choice about breast cancer screening: A randomised con-
trolled trial.  Lancet 385(9978): 1642–1652. 
 Institute of Medicine. 1988.  The future of public health . Washington, DC: National Academy 
Press. 
 Katz, D.L. 2013. Childhood obesity trends in 2013: Mind, matter, and message.  Childhood Obesity 
9(1): 1–2. 
 Knowles, J.H. 1977. The responsibility of the individual.  Daedalus 106(1): 57–80. 
 Kreis, J., and H. Schmidt. 2013. Public engagement in health technology assessment and coverage 
decisions: A study of experiences in France, Germany, and the United Kingdom.  Journal of 
Health Politics, Policy and Law 38(1): 89–122. 
 Krogsbøll, L.T., K.J. Jørgensen, C. Grønhøj Larsen, and P.C. Gøtzsche. 2012. General health 
checks in adults for reducing morbidity and mortality from disease.  Cochrane Database of 
Systematic Reviews 10: CD009009.  http://onlinelibrary.wiley.com/doi/10.1002/14651858.
CD009009.pub2/abstract . Accessed 22 Oct 2013. 
 Morain, S., and M.M. Mello. 2013. Survey fi nds public support for legal interventions directed at 
health behavior to fi ght noncommunicable disease.  Health Affairs 32(3): 486–496. 
 Mühlhauser, I. 2007. Ist Vorbeugen besser als Heilen?  Zeitschrift für ärztliche Fortbildung und 
Qualität im Gesundheitswesen 101(5): 293–299. (Mühlhauser I. 2007. Is prevention better than 
healing?  German Journal for Evidence and Quality in Health Care 101(5): 293–299.) 
 Nuffi eld Council on Bioethics. 2007.  Public health: Ethical issues . London: Nuffi eld Council on 
Bioethics. 
 Rosenbrock, R. 2013. Die beste Prävention ist die Lust auf die eigene Zukunft.  Der Paritätische , 
Ausgabe 3/2013, Soziales zählt, 16–18. (Rosenbrock R. 2013. The best prevention is the desire 
for their own future.  The Joint , March edition, Social Matters, 16–18.) 
 Ruger, J.P. 2006. Health, capability, and justice: Toward a new paradigm of health ethics, policy 
and law.  Cornell Journal of Law and Public Policy 15(2): 403–482. 
 Sackett, D.L. 2002. The arrogance of preventive medicine.  Canadian Medical Association Journal 
167(4): 363–364. 
 Schmidt, H. 2008. Bonuses as incentives and rewards for health responsibility: A good thing? 
 Journal of Medicine and Philosophy 33(3): 198–220. 
 Schmidt, H. 2009. Personal responsibility in the NHS Constitution and the social determinants of 
health approach: Competitive or complementary?  Health Economics, Policy, and Law 4(2): 
129–138. 
 Schroeder, S.A. 2007. Shattuck lecture. We can do better—Improving the health of the American 
people.  New England Journal of Medicine 357(12): 1221–1228. 
 Sox, H.C. 2013. The health checkup: Was it ever effective? Could it be effective?  Journal of the 
American Medical Association 309(23): 2496–2497. doi: 10.1001/jama.2013.5040 . 
 U.K. National Screening Committee. 2013.  Criteria for appraising the viability, effectiveness and 
appropriateness of a screening programme .  http://www.screening.nhs.uk/criteria . Accessed 22 
Oct 2013. 
 U.S. Department of Health and Human Services. 2012.  Preventing tobacco use among youth and 
young adults: A report of the surgeon general . Atlanta: U.S. Department of Health and Human 
Services, Centers for Disease Control and Prevention, National Center for Chronic Disease 
Prevention and Health Promotion, Offi ce on Smoking and Health. 
 Venkatapuram, S. 2011.  Health justice: An argument from the capabilities approach . Cambridge: 
Polity Press. 
 Verweij, M., and A. Dawson. 2007. The meaning of ‘public’ in ‘public health’. In  Ethics, preven-
tion, and public health , ed. A. Dawson and M. Verweij, 13–29. New York: Oxford University 
Press. 
 Verweij, M., and A. Dawson. 2011. Children’s health, public health.  Public Health Ethics 4(2): 
107–108. 
H. Schmidt
153
 Wegwarth, O., and G. Gigerenzer. 2011. Statistical illiteracy in doctors. In  Better doctors, better 
patients, better decisions: Envisioning health care 2020 , ed. G. Gigerenzer and J.A.M. Gray, 
137–151. Cambridge, MA: MIT Press. 
 World Bank. 2011.  The growing danger of non-communicable diseases: Acting now to reverse 
course . Washington, DC: World Bank Human Development Network. 
 World Health Organization (WHO). 2002.  The World Health Report 2002: Reducing risks, pro-
moting healthy life . Geneva: World Health Organization. 
 World Health Organization (WHO). 2003.  WHO framework convention on tobacco control . 
Geneva: World Health Organization. 
 World Health Organization (WHO). 2008. Commission on social determinants of health—fi nal 
report.  Closing the gap in a generation: Health equity through action on the social determi-
nants of health . Geneva: World Health Organization. Online at  http://www.who.int/social_
determinants/thecommission/fi nalreport/en/index.html . 
 World Health Organization (WHO). 2011.  Noncommunicable diseases country profi les 2011 . 
Geneva: World Health Organization. 
 World Health Organization (WHO). 2012.  WHO report on the global tobacco epidemic, 2008: The 
MPOWER package . Geneva: World Health Organization. 
 World Health Organization (WHO). 2013.  The right to health, fact sheet no. 323 .  http://www.who.
int/mediacentre/factsheets/fs323/en/ . Accessed 8 Dec 2013. 
 Wu, S.Y., and A. Green. 2000.  Projection of chronic illness prevalence and cost infl ation . Santa 
Monica: RAND Health. 
5.7  Case 1: Municipal Action on  Food and Beverage 
Marketing to  Youth 
 Catherine  L.  Mah 
 Faculty of Medicine 
 Memorial University 
 St. John’s ,  NL ,  Canada 
 e-mail: catherine.mah@mun.ca 
 Brian  Cook 
 Toronto Food Strategy, Toronto Public Health 
 Toronto ,  ON ,  Canada 
 Sylvia  Hoang 
 Social and Epidemiological Research Department 
 Centre for Addiction and Mental Health 
 Toronto ,  ON ,  Canada 
 Emily  Taylor 
 Dalla Lana School of Public Health 
 University of Toronto 
 Toronto ,  ON , Canada 
 This case is presented  for  instructional purposes only. The ideas and opinions 
expressed are the authors ’  own. The case is not meant to refl ect the offi cial position , 
5 Chronic Disease Prevention and Health Promotion
154
 views ,  or policies of the editors ,  the editors ’  host institutions ,  or the authors ’  host 
institutions . 
5.7.1  Background 
 Children are exposed to a greater intensity and frequency of marketing than ever 
before. Evidence has demonstrated that marketing of food and beverages to children 
contributes adversely to health, affecting food knowledge, attitudes, dietary habits, 
consumption practices, and health status. Marketing to children has always raised 
concerns. But recently, numerous nongovernmental and international organizations 
and all levels of  government have expressed their concern about food and beverage 
marketing and  advertising to children as a public health issue. 
 Often used interchangeably with “advertising,” the term “marketing,” actually 
encompasses a broader range of issues.  The  World Health Organization (WHO) 
( 2010 ) defi nes marketing as “any form of commercial  communication  or message 
that is designed to, or has the effect of, increasing the recognition, appeal and/or 
consumption of particular products and services. It comprises anything that acts to 
 advertise or otherwise promote a product or service.” 
 Two large-scale global systematic reviews of evidence in the last decade have 
concluded that  food and beverage marketing substantially affects young people and 
is associated with adverse  health outcomes . In 2003, the U.K. Food  Standards 
 Agency commissioned a systematic review of the infl uence of food promotion on 
children’s food-related knowledge, preferences, and behaviors (Hastings et al. 
 2003 ). WHO updated the report in 2007 and 2009 (Hastings et al.  2007 ; Cairns et al. 
 2009 ). In 2006, the  U.S. Institute of Medicine conducted a systematic review of the 
infl uences of food and beverage marketing on the diet and diet-related health of 
 children and youth (McGinnis et al.  2006 ). Key fi ndings from these reports follow:
•  Food and beverages developed for and advertised to young people are predomi-
nantly calorie dense and nutrient poor; 
•  Marketing infl uences children’s  food and beverage preferences , purchase 
requests, and short-term consumption, even among young children (ages 
2–5 years); and 
•  There is strong evidence that child and youth exposure to television  advertising 
is signifi cantly correlated with poor health  status , although suffi cient evidence of 
a causal link with  obesity is not yet available. 
 The authors of the 2009 WHO report suggest that existing  research “almost cer-
tainly underestimates the infl uence of food promotion” and that more research is 
needed, especially for newer forms of media (Cairns et al.  2009 ). 
 As part of its global strategy for the  prevention and control of  noncommunicable 
diseases (WHO  2004 ), WHO subsequently endorsed  policy recommendations for 
 governments to take action on  food and beverage marketing to  children ( 2010 , 
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 2012 ). The recommendations emphasize governments’ key role in developing poli-
cies to protect the public interest, including leadership roles in managing  intersec-
toral processes and negotiating  stakeholder rights and responsibilities. 
 The scope of existing  policy interventions that address food  advertising to  chil-
dren includes statutory  regulation (i.e., general restrictions or outright prohibitions) 
and industry self-regulatory codes. Globally, industry self-regulatory approaches 
tend to be the most common approach. 
 Many organizations promote the adoption of comprehensive public  policy  inter-
ventions , with the scope of these interventions ranging from total ad bans (all com-
mercial advertising) to food ad bans or junk food ad bans (WHO  2012 ). 
 Other organizations suggest stepwise approaches that target particular expo-
sures, products, ages, or specifi c forms of marketing or media. For example, such 
approaches could include limiting marketing in venues such as  schools , restricting 
junk  food , protecting  children younger than a certain age, defi ning certain television 
broadcasts as children’s programs, or restricting promotions in television broadcasts 
before 10 pm, respectively (WHO  2012 ). 
 In recent years, many food and beverage companies, working with industry asso-
ciations, have issued  voluntary pledges to alter marketing practices toward children. 
For example, such pledges typically include criteria for the nutritional quality of 
foods advertised to children, limitations on the use of licensed characters, and mar-
keting in schools. However, critics argue that these types of voluntary changes are 
not suffi cient to reduce the  risks of food marketing to  children in a substantive way. 
 Despite this array of interventions, the absence of widespread agreement on the 
most appropriate form of collective action has led many  policy makers to default to 
inaction. 
5.7.2  Case Description 
 You direct the Healthy Public Policy program for a large municipal public health 
department that recently has come under fi re in a newspaper exposé about contribu-
tions from fast food companies to after-school programs for youth that the city 
 government runs. The exposé highlighted the contributions of Big Boss Burger, a 
local fast food hamburger chain with 12 locations across the city. Big Boss Burger 
donates cooking equipment to the city’s high-priority, after-school cooking program 
for 9- to 11-year-olds. Although the program is well-liked by youth, it is regularly 
threatened by funding cuts. The chain has recently offered to scale-up its annual 
cash donation to cover all food and equipment  costs in exchange for renaming the 
program “The Big Boss Burger Community Kitchen” and for placing the chain’s 
 logo  on all signage and promotional materials. 
 The highly successful Big Boss Burger chain is owned by a beloved, self-made 
restaurateur who has spent his entire career in the local food industry. Considered a 
colorful local personality, he frequently sends Twitter updates that refl ect his over- 
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the- top  advertising style. One tweet, for example, offered a free sample of the 
chain’s “quadruple bypass” burger to anyone who visited one of the chain’s loca-
tions within the hour. 
 Media spokespersons for the mayor, meanwhile, have reiterated the community 
benefi ts of cultivating positive partnerships with local businesses. They note that only 
registered public health nutrition staff run the city’s cooking programs, while insisting 
that Big Boss Burger has no infl uence whatsoever on city  policies or youth curricula. 
 The media furor nevertheless has prompted city offi cials to explore developing a 
 sponsorship policy for municipal child and youth programs. The Medical Health 
Offi cer has asked you to prepare a briefi ng note outlining the key public health con-
siderations that such a sponsorship policy needs to address. 
 You face a  dilemma . On the one hand, several years ago your Healthy Public 
Policy team launched a study of the impact of food and beverage  advertising on 
 children . Last year’s update on the study to the Board of Health included a recom-
mendation that city-operated venues and programs avoid commercial advertising of 
food and beverages targeting children younger than 13 years of age. Thus far, the 
recommendation has not led to any formal  policy changes. Municipal employees 
partly attribute this inaction to the reluctance of local authorities to act when there 
are no state or national policies that govern  sponsorship or marketing restrictions. 
 On the other hand, the fi nancially strapped city relies on engagement with the 
local business community to fund many city-run programs, including health educa-
tion activities. It is also well-known that the owner of Big Boss Burger grew up in a 
local low- income community and frequently volunteers his time at events in his 
former neighborhood. 
5.7.3  Discussion Questions 
 1.  What key points will you emphasize in your briefi ng note? How will scientifi c 
 information from past public health reports and decisions infl uence your 
response? How should ethical considerations infl uence your briefi ng note? 
 2.  What  population groups are you most concerned about with regard to the spon-
sorship  policy ? What if the cooking program sponsored by Big Boss Burger was 
for 14- to 16-year-olds instead of 9- to 11-year-olds? For adults? For  children in 
a high-income neighborhood? 
 3.  Does corporate sponsorship constitute food promotion? What benefi ts to the 
municipality might be derived from Big Boss Burger’s contributions (for exam-
ple, local economic benefi ts or having increased public attention and private- 
sector support of priority neighborhoods)? How should the public health 
department weigh these benefi ts against  population health benefi ts and  harm s? 
Consider your response if Big Boss Burger
(a)  Had offered its support without the naming rights request; 
(b)  Had instead  offered a cash donation to a  parents’ association supporting the 
program; 
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(c)  Was an organic, vegan comfort food restaurant; or 
(d)  Was a large,  multinational fast food corporation. 
 4.  How will public opinion inform your briefi ng note? How will you handle the 
situation given that Big Boss Burger is a highly popular fast food chain and that 
the owner is a local public personality? 
 5.  What are (and should be) the roles and responsibilities for various city depart-
ments in defi ning the sponsorship  policy ? Consider, for example, city depart-
ments responsible for public health, parks and recreation, municipal licensing, 
social services, and  economic development . 
 6.  Let’s imagine that you are a  parent of two girls, ages 6 and 9 years. In an ideal 
world, how much  food and beverage marketing do you think they should be 
exposed to? How does your perspective as a parent  ente r into your  professional 
decisions as director of the Healthy Public  Policy program? How about your 
perspective as a voting citizen or city resident? 
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5.8  Case 2:  Obesity  Prevention in  Children :  Media 
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 This case is presented for instructional purposes only. The ideas and opinions 
expressed are the author ’ s own. The case is not meant to refl ect the offi cial position , 
 views ,  or policies of the editors ,  the editors ’  host institutions ,  or the author ’ s host 
institution . 
5.8.1  Background 
 Worldwide  obesity has doubled since 1980 and kills some 2.8 million adults each 
 year  (World Health Organization [WHO]  2012 ). Childhood obesity also has 
increased at alarming rates with some 42 million children estimated  to be  over-
weight (WHO  2013 ). Among  Organisation for Economic Cooperation and 
Development (OECD) countries, the  United States has the highest rate of obesity 
(OECD  2012 ). More than 35 % of adults and almost 17 % of  children are obese 
(Ogden et al.  2012 ), with especially high rates among poor and minority children 
(Centers for Disease Control and Prevention [CDC]  2012 ). 
 Childhood obesity has serious short- and long-term health consequences. Obese 
children are more likely to have  risk factors for cardiovascular disease, including 
high cholesterol and blood pressure; type 2 diabetes; skeletal problems; sleep apnea; 
and  mental health issues, such as low self-esteem and depression (CDC  2012 ; Reilly 
et al.  2003 ).  Children now account for half of all new cases of type 2 diabetes. 
Obese children are also subject to systematic  discrimination (Strauss  2002 ). More 
than 50 % of  overweight children become obese adults who experience elevated 
health risks for heart disease, stroke, diabetes, osteoporosis, lower-body disability, 
some types of cancer, and premature mortality (Freedman  2011 ;  CDC  2012 ). 
 The burdens of  obesity are also economic. Rising  health care costs are mostly 
driven by obesity-related  costs . Estimates indicate that in 2008 some 10 % of medi-
cal spending in the  United States was related to obesity, amounting to as much as 
$147 billion (Finkelstein et al.  2009 ). Experts estimate obesity-related costs will 
account for 21 % of medical spending by 2018 if  obesity rates continue to rise 
(United Health Foundation  2009 ). 
 As the human and  fi nancial  costs of  obesity have become better recognized,  gov-
ernment offi cials and public health leaders increasingly have called for strong 
action. Comprehensive approaches that act on environmental and  social determi-
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nants of food choice and activity level are widely  recommended (OECD  2012 ). The 
complexity of such an approach is refl ected in the following recommended  policies 
and strategies: taxing unhealthy foods and beverages, such as soda and snack food, 
to make them cost prohibitive; providing agricultural subsidies to lower the cost of 
healthy foods, such as fresh produce and whole grains; setting  standards to lower 
sodium levels and prohibit the use of trans fatty acids in food products; banning 
unhealthy foods from public  schools and child care facilities; restricting or banning 
the  advertising of unhealthy foods to  children ; posting calorie counts on restaurant 
and take-out menus; using “counter-advertising” to show the harmful effects of 
unhealthy foods; redesigning communities and streets to incorporate parks, 
 sidewalks, and bike paths; and reducing sedentary behavior by limiting time view-
ing television and playing computer games (Frieden et al.  2010 ; Butland et al. 
 2007 ). 
 Children’s status as developing agents further complicates childhood  obesity 
 prevention .  Parents have primary responsibility for rearing children and consider-
able discretion over cultural and  lifestyle matters, including many daily decisions 
that directly affect a child’s food and activity-related environments and behaviors 
(Blacksher  2008 ). Some measures would likely confer benefi t regardless of parental 
behavior (e.g., banning food advertising to children or removing trans fats from 
packaged foods). But others will have their intended effect only if parents make 
certain choices, some of which will require that they change their health-related 
habits. 
 Many preventive measures will be controversial because they involve  govern-
ment action and seek to shape personal  choice . Perhaps the least controversial of the 
measures enable healthier choices by providing people with  information and mak-
ing  healthy  options more available and affordable; however, many are more coer-
cive, ranging from those that eliminate and restrict choice to those that guide choice 
through  disincentives and default  policies ( Nuffi eld Council on Bioethics  2007 ). 
Intervening in  voluntary  choices where effects impose no harm to others constitutes 
strong  paternalism and is diffi cult though not impossible to justify (Childress et al. 
 2002 ). However, society may justifi ably intervene to prohibit behaviors that expose 
others to serious  harms , and this “ harm principle ” has been appealed to as the basis 
for removing  children from homes where parental practices are judged to contribute 
to severe childhood  obesity and attendant comorbidities (Murtagh and Ludwig 
 2011 ). Removing a child from the home poses other potential  harms , further com-
plicating the ethical  dilemma (Black and Elliott  2011 ). These ethical considerations 
in combination with the diffi culty of changing health habits makes obesity preven-
tion one of the more challenging public health priorities of the twenty-fi rst 
century. 
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5.8.2  Case Description 
 Your state is the poorest in the nation with high rates of childhood poverty,  obesity , 
and  diabetes . Located in the southeastern part of the  United States in what is known 
as the “stroke belt,” adults disproportionately suffer from stroke and its  risk fac-
tors—hypertension, high cholesterol, diabetes, and obesity. As the state’s new com-
missioner of health, the governor has tasked you with making obesity  prevention a 
public health priority. The governor is concerned about public health and rising 
 health care costs . More than 50 % of the state’s  children and some 20 % of adults 
are enrolled in  Medicaid (a federal-state program that provides health care services 
for low-income Americans), making it the largest item in the state budget. 
 The governor has  requested  that you convene and chair a 12-member task force 
to make recommendations for a statewide  obesity  prevention strategy. Six seats are 
reserved for state legislator appointees because the recommendations will need 
 political support to be implemented. The other seats are reserved for public health, 
health care, and community representatives. For several months, task force mem-
bers debated measures that eliminate or restrict adult choice through government 
 action , such as taxes and bans on unhealthy foods and drinks. Those who favored 
such measures argued they would be the most effective, citing the success of  tobacco 
taxes and  smoking bans in reducing  smoking , and could be justifi ed on grounds that 
obesity-related  costs constitute an economic  harm to others (Pearson and Lieber 
 2009 ). Yet, many task force members, particularly elected representatives, found 
such measures objectionable forms of government intrusion into adult choices. 
 Task force members did, however, agree to tackle obesity  prevention in  children 
on grounds that the state has a role in protecting them. To that end, they endorsed 
measures to improve  school lunches and to remove vending machines that sell soda 
and other sugary beverages from public school grounds. Task force members also 
wanted to invest in a statewide  media campaign about the causes and  harms of 
childhood obesity because they believed it would raise awareness and promote 
 informed choices . They also thought a media campaign would help to change social 
 norms , which they deemed essential to long-term change in their state, where fried 
and fatty foods are part of the cultural heritage. 
 Task force members cannot, however, agree on the orientation of such a cam-
paign. Some favor an approach used by a nearby state that has attracted attention for 
its graphic depiction of obese and unhappy children accompanied by hard-hitting 
 messages , such as “It’s hard to be a little girl if you’re not.” Opponents believe the 
campaign blames the victims and further stigmatizes obese  children . They propose 
instead an approach that highlights environmental barriers to healthy  choices and 
depicts unhealthy food as the culprit, not those who consume it. But proponents of 
the more hard-hitting approach say it is honest about the facts and highlights the 
essential role of  parents in regulating children’s behavior. To support their case, they 
cite the use of similarly graphic  media campaigns in  tobacco cessation efforts and 
note that public health efforts have often relied on stigma as a tool of disease  pre-
vention , despite the controversy (Bayer  2008 ; Burris  2008 ). The task force has for-
mulated a series of questions to take up at the next meeting. 
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5.8.3  Discussion Questions 
 1.  What  harms are associated with childhood  obesity ? 
 2.  Are the harms of obesity and tobacco use analogous? Is the economic  cost of obe-
sity a harm to others in the same way that secondhand  smoke is a harm to others? 
 3.  Do public  media campaigns that depict images of obese  children stigmatize 
them? What is stigma? 
 4.  Is it ever ethically permissible to use stigmatization as a tool of disease  preven-
tion and  health promotion ? If so, in what sort of cases? Should children ever be 
the targets of stigmatization? 
 5.  Do  public  media campaigns that highlight the role of  parents in regulating chil-
dren’s food and activity-related environments and choices blame the victims? 
 6.  Should the task force consider gathering community input, particularly from 
people who are  overweight or obese, about the sorts of messages they would fi nd 
effective in changing their health habits and also fi nd ethically acceptable? If so, 
should  children be included in these focus groups? If so, at what age? 
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Groups 
 Daniel  S.  Goldberg 
 Department of Bioethics and Interdisciplinary Studies, Brody School of Medicine 
 East Carolina University 
 Greenville ,  NC ,  USA 
 e-mail: goldbergd@ecu.edu 
 Lloyd  Novick 
 Brody School of Medicine 
 East Carolina University 
 Greenville ,  NC ,  USA 
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 views ,  or  policies  of the editors ,  the editors ’  host institutions ,  or the authors ’  hos t 
institutions . 
5.9.1  Background 
 For empirical and normative reasons, stigma is an enormous public health problem 
that can have devastating psychosocial impact (Vanable et al.  2006 ; Chapple et al. 
 2004 ). Moreover, there is evidence that even after controlling for confounders, 
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stigma is robustly correlated with adverse  health outcomes (Vardy et al.  2002 ; Puhl 
and Brownell  2003 ). Stigma increases human suffering and diminishes health, both 
of which anchor ethical concerns. However, its ethical defi ciencies are not solely a 
function of its health effects; as Burris notes, “even if [stigma] had no adverse 
effects on health … it may readily be seen as repugnant in a humane society” (Burris 
 2002 ; Courtwright  2013 ). 
 According to Hatzenbuehler et al. ( 2013 ), stigma in a public health context con-
sists of two central components: (1) an in-group marks an out-group as different on 
the basis of some common demographic characteristic, and (2) the in-group assigns 
a negative evaluation to the characteristic. Stigma is therefore intimately connected 
to entrenched social power structures (Link and Phelan  2006 ; Scambler  2006 ). 
Unsurprisingly, while precise estimates are lacking, evidence suggests that the 
 burden of such stigma is unequally distributed along the  social gradient , and that 
already disadvantaged groups are more likely to experience more intense levels of 
stigma (Scambler  2006 ; Shayne and Kaplan  1991 ). The prospect of compound dis-
advantage and  inequalities renders stigma a critical issue for public health ethics, 
one that strongly  implicates concerns of  distributive and social justice (Powers and 
Faden  2006 ; Courtwright  2009 ). 
 Recent data shows that the prevalence of  obesity is 35.7 % in the  United States 
(Ogden et al.  2012 ) and 12.0 % globally (Stevens et al.  2012 ). Tracking these high 
estimates, obesity stigma is one of the common and ethically alarming health stig-
mas (Puhl and Heuer  2009 ; Puhl and Brownell  2003 ). Puhl and Heuer ( 2010 ) 
expressly link the commonality of obesity stigma to the emphasis on  personal 
responsibility in the United States, which is the subject of an active debate (Wikler 
 2002 ). This debate has nineteenth century roots but is ongoing (Leichter  2003 ) and 
infl uences public perceptions on whether collective action in the name of public 
health is warranted. Moreover, such perceptions vary with particular public health 
problems. For example, although many advocate for greater individual responsibil-
ity in wearing seat belts, few contend that such responsibility eliminates the need for 
guardrails and speed limits. The perceived linkages between obesity and  personal 
responsibility suggest that approaches to health promotion emphasizing the latter 
run a signifi cant  risk of intensifying obesity stigma (Puhl and Heuer  2010 ). Goldberg 
( 2012 ) argues that such risk renders these approaches ethically suboptimal. 
 In addition, it is well recognized that background  socioeconomic conditions are 
primary components of obesity-creating environments (McLaren  2007 ; Pickett 
et al.  2005 ). The fact that socioeconomic conditions have an immense impact in 
determining patterns of  obesity among and within  populations suggests reasons for 
doubting that public  health interventions targeted at individual  lifestyle change will 
be particularly effective in  countering  obesity (MacLean et al.  2009 ). Indeed, the 
evidence obtained from analysis of other major  risk factors, such as  smoking , 
strongly suggests a lack of longitudinal effi cacy for such interventions (Jarvis and 
Wardle  2006 ; Ebrahim and Smith  2001 ; Rose  1985 ). 
 There exists signifi cant debate over the  effectiveness of stigmatization in chang-
ing risky health behaviors. Some commentators argue that the  denormalization and 
stigmatization of  smoking has produced positive public health consequences given 
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the overall decline in incidence in the  United States (Bayer  2008 ; Bell et al.  2010 ) 
and in parts of Europe (Ritchie et al.  2010 ). One leading bioethicist even recently 
endorsed a kind of “stigmatization lite” as a tool to reduce  obesity (Callahan  2013 ). 
Although the evidence for effi cacy of stigma as a means to enhancing public health 
in general remains in dispute, the evidence as to obesity overwhelmingly suggests 
that stigma is more likely to exacerbate obesity than to reduce it (Puhl et al.  2013 ; 
Puhl and Heuer  2010 ). 
 Finally, there is excellent evidence that interventions that target individual behav-
ior change have the unfortunate tendency to expand health  inequalities . Capewell 
and Graham ( 2010 ) term such interventions “agentic” because the extent of their 
benefi ts depends on the resources the individual agent can bring to bear. Thus, for 
example, even when the least well-off are targeted, smoking cessation programs 
disproportionately benefi t the affl uent. The result is that effective programs target-
ing  lifestyle change can unintentionally expand health  inequalities , a fact that raises 
signifi cant concerns of  justice . 
 Ultimately, though efforts to counter  obesity are critically needed, it is all too 
easy to implement public  health interventions that intensify obesity stigma, expand 
health  inequalities , and take little account of the role background  social conditions 
play  in structuring patterns of  obesity and limiting health choices. Efforts to address 
 obesity must therefore grapple with signifi cant ethical issues centering primarily on 
 justice and on  health equity . 
5.9.2  Case Description 
 The Brennan County Health Department (BCHD) is considering a new  health pro-
motion program to ameliorate the high and growing rates of adult  obesity in the 
county (prevalence and incidence of 38 and 3.5 %). The program emphasizes the 
need to “Take Control” by (1) assessing weight; (2) losing weight; and (3) prevent-
ing weight  gain  (Centers for Disease Control and Prevention  2012 ). It highlights the 
signifi cance of  personal responsibility in countering obesity and aims to empower 
individuals to implement  lifestyle change. The program consists of twice-weekly 
meetings facilitated by a nutritionist held over 8 weeks, with  screening performed 
by a family nurse practitioner. The regimen consists of modules on meal planning, 
physical activity, behavioral modifi cation, and cooking instruction. The meetings 
would occur at 6:30 pm at Brennan County Memorial Hospital. 
 The hospital is located in the town of Bernsville, which sits in the northwestern 
corner of the county. Brennan County is rural and geographically large, with a small 
 population spread across large distances. Multiple bodies of water traverse the 
county. Road quality is uneven. Educational attainment is low, with only 43 % of 
residents having completed some college. Thirty-eight percent of  children in 
Brennan County live in poverty, and the violent crime rate per 100,000 people is 605 
(the national benchmark is 73). Unemployment is 14.2 %. Farming is a chief eco-
nomic activity, with several migrant labor camps existing in the southeastern part of 
H. Schmidt
165
the county. In terms of demographics, 40 % of Brennan County residents are 
Caucasian, 35 % are  African-American , 14 % are Hispanic/Latino, 10 % are Native 
American, and 1 % is Asian/Asian-American. 
 The BCHD  obesity  program is based on reasonably good evidence. Several con-
trolled studies of  model programs have demonstrated both reduction in body weight 
and  prevention of weight gain. Such effects decreased over time, but statistically 
signifi cant improvements were maintained at 8-month follow-up. Ongoing studies 
are intended to assess effect endurance at 18 and 24 months postintervention. 
 At a recent BCHD meeting, Pauline, a public health nurse employed by the 
health department, expressed concern about the implementation of the program. 
Surprised, several attendees ask Pauline why she is hesitant, and she replies that she 
is concerned that the obesity program’s emphasis on  personal responsibility and 
 lifestyle change might not be received well in a resource-poor county that serves 
multiple vulnerable populations, many of whom have documented levels of medical 
and institutional mistrust. The BCHD director, James, admits that Pauline’s con-
cerns are legitimate, but he also notes the evidence suggesting the intervention’s 
effi cacy. He argues that such results are so important that they justify immediate 
implementation. James also notes that several county commissioners have publicly 
declared an obesity crisis in Brennan County and have privately indicated to him 
that BCHD is expected to lead a transparent and vigorous response. In addition, 
James points out that the county does not have the funds to devote to more upstream 
interventions and they have several staff already trained in  lifestyle change methods, 
so that the  costs could be low. 
 Pauline shakes her head and says that while it is critical to address  obesity in 
Brennan County, the program ignores the environmental and background conditions 
in which the most at-risk communities in Brennan County live, work, and  play . She 
reiterates her concern that the program as it currently stands is unfair. 
5.9.3  Discussion Questions 
 1.  To what extent does the program  risk creating or intensifying  obesity stigma 
against marginalized and vulnerable groups in Brennan County? Why does this 
matter ethically? 
 2.  Why are the social and economic conditions residents of Brennan County expe-
rience relevant to an ethical assessment of the obesity program? 
 3.  How does the rural nature of Brennan County infl uence the ethical analysis of 
the program? 
 4.  What concerns related to  justice and/or  health equity does the program raise? 
 5.  How should obesity interventions be structured to minimize  risks of stigma? 
 6.  To what extent should public  health interventions intended to counter obesity 
target upstream  social determinants of obesity and obesity-related diseases? 
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5.10.1  Background 
 Dental caries is a condition with major public health impact worldwide. In most 
industrialized countries, it affects 60–90 % of  school  children and most adults, 
whereas in several Asian and  Latin American countries, it is the most prevalent  oral 
disease (Petersen and Lennon  2004 ). Dental caries signifi cantly affects individuals 
and communities, leading  to pain and discomfort, impairment of oral and general 
health, and reduced quality of life. It also highly correlates with health systems, 
living conditions, behavioral and environmental factors, and implementation of 
preventive  measures (World Health Organization [WHO]  2005 ,  2007 ; Shariati et al. 
 2013 ). In low- and middle-income  countries , the prevalence of  oral diseases is on the 
rise; and in all countries, the greatest burden of  oral diseases falls on disadvantaged 
and poor  populations (Petersen  2008 ). Although oral disease ranks as the fourth most 
expensive disease to treat (WHO  2007 ), effective  prevention and health promotion 
measures can greatly reduce the  cost of dental  treatment . As a result, the WHO has 
emphasized the importance of developing global oral health  policies , especially the 
implementation of  fl uoride programs to prevent  dental caries (WHO  2012 ). 
 For the past 60 years,  fl uoride use has consistently proven to be one of public 
health’s most successful interventions (Clarkson et al.  2000 ). Used in tablets, 
mouthwash, toothpaste, gels or varnishes, fl uoride also may be added to salt or 
drinking water to protect against  dental caries (WHO  2011 ). High fl uoride levels in 
drinking water (>10 mg l −1 ), are associated with dental fl uorosis, a discoloring or 
mottling of tooth enamel, while levels below 0.1 mg l −1 are associated with higher 
levels of dental decay (Edmunds and Smedley  1996 ). A level of about 1 mg l −1 is 
associated with lower incidence of dental caries, particularly in  children (Fawell 
et al.  2006 ). Water  fl uoridation adjusts the  fl uoride concentration of a public water 
supply to an optimal level to prevent dental caries (WHO  2002 ). Countries such as 
Australia, Malaysia, Ireland,  Spain , the  United Kingdom , and the  United States use 
water fl uoridation, delivering fl uoride to about 300 million persons worldwide 
(Clarkson et al.  2000 ). 
 Despite the demonstrated  effectiveness of  fl uorides in preventing dental carries, 
public discussions about the effectiveness of water fl uoridation continue (Awofeso 
 2012 ; Rugg-Gunn and Do  2012 ). Several publications discuss the benefi ts and 
 harms of water fl uoridation (McDonagh et al.  2000 ; European Commission, 
Directorate General for Health and  Consumers , Scientifi c Committee on Health and 
Environmental Risks  2011 ; Phillips et al.  2011 ; Community Preventive Services 
Task Force  2013 ). However, a lack of good-quality evidence on the potential bene-
fi ts and harms has been reported ( Nuffi eld Council on Bioethics  2007 ). Moreover, 
with the advent of genomic techniques in studying  oral diseases , susceptibility to 
 dental caries has been shown in part to be due to genetic variations (Eng et al.  2012 ), 
increasing in this way the complexity and the multicausality of dental caries. 
 Implementing water fl uoridation programs can be controversial and generate 
tension between competing ethical  principles and  values —primarily  confl icts 
between the principles of  paternalism and  autonomy . While water fl uoridation is 
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considered to be a “test case” in the discussion about the  paternalism of “collective 
decisions” (Dworkin  1988 ), appeals to paternalism point to water fl uoridation’s 
benefi ts for entire communities (e.g., health needs of  children ,  reduction in health 
 risks and health  inequalities ). However, those who  prioritize  autonomy point out 
that water fl uoridation intervenes in an important area of personal life without the 
 consent of those affected, essentially coercing adults to lead healthy  lives  (Nuffi eld 
Council on Bioethics  2007 ). Despite the controversy, water fl uoridation is “the most 
celebrated example” of “collective action/ effi ciency ” to justify public health pro-
grams and  policies (Faden and Shebaya  2010 ). In deliberative democracies,  govern-
ments tend to address the  confl ict between  paternalism and autonomy by focusing 
on elements of  procedural justice —rational explanations, transparency of the  deci-
sion-making process , and involvement of individuals and  stakeholder groups in 
decision  making  (Nuffi eld Council on Bioethics  2007 ). 
 Greece , a coastal Mediterranean country in southeastern Europe, has nearly 11 
million people. Among 12-year-olds, the average number of  dental caries —mea-
sured as the number of decayed, missing, or fi lled teeth—is 2.07 per child (Kravitz 
and Treasure  2009 ). Public institutions such as universities, hospitals, and health 
centers of the National Health System provide limited  oral health care . Most oral 
health care takes place in private clinics, where dental patients pay the entire  cost of 
care. Oral health care constitutes an estimated one-third of the total expenditure on 
private health care in  Greece (Kravitz and Treasure  2009 ). Since 2009, Greece has 
faced a severe fi scal crisis. In providing health care, public health authorities have 
to deal with severe budget limitations. The fi nancial crisis is also straining the abil-
ity of individuals to pay for private sector dental  treatment . 
 The Greek central government regulates many public health programs, including 
 oral disease  prevention and oral health promotion  policies , but implementation is 
local. Although the  government mandated water fl uoridation in 1974, as of 2013 the 
program had not been implemented because of diffuse public resistance to such 
interventions. In 2008, a special commission proposed to the Ministry of Health and 
Social  Solidarity to include water fl uoridation in the national strategy for public 
health (Ministry of Health and Social Solidarity  2008 ). Given the long hiatus in 
implementing the program, reasonable questions could be raised about its justifi ca-
tion,  political legitimization, and social acceptance. A two-part study on these ques-
tions was carried out (Aspradaki  2012 ). It included interviews with key fi gures in 
the dental community from academia, the  professions , and  trade unions. It also 
included a systematic content analysis of all mentions of water fl uoridation by the 
involved actors (e.g., dental professionals,  policy makers ) reported in the  Journal of 
the Hellenic Dental Association for 1983 through 2011. The results showed strong 
skepticism among professionals about the program’s feasibility—refl ecting the 
public’s concerns over this issue. Signifi cant concerns were about a lack of techni-
cal infrastructure and organizational problems in the institutions that would 
 implement water fl uoridation. The vigorousness of the opposing arguments in the 
 autonomy / paternalism debate in terms of  justice ,  procedural justice , and public 
interest added to the skepticism. Concerns were also raised about the overall 
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 importance of oral health for human life, the signifi cance of  prevention in dental 
care, and the concept of  dental caries as an epidemic. 
5.10.2  Case Description 
 You serve as the central oral health  policy director . One morning you receive a call 
from Dr. Papadakis, head of the Public Health Programs and Policies Division at the 
Ministry of Health and Social  Solidarity . Dr. Papadakis is considering implement-
ing mandatory water fl uoridation but is concerned about the many diffi culties he 
may confront (i.e., ethical, legal,  political and social challenges). Dr. Papadakis asks 
you to provide input about what to consider before mandatory water fl uoridation is 
implemented in  Greece . 
5.10.3  Discussion Questions 
 1.  Who are the  stakeholders to consider in deciding if this program should be 
implemented? What are their  values , perspectives, and primary interests? 
 2.  How should the relevant values be considered, in particular, scientifi c evidence, 
ethical concerns, and economic factors? 
 3.  Do public health institutions have special  obligations to protect oral health? 
 4.  When public  health interventions are environmental, should public  participation 
and democratic deliberation be considered in the decision-making processes? 
 5.  How important is transparency about the benefi ts and  risks of these interven-
tions, in the light of the rapid progress and the tremendous achievements in life 
sciences and biotechnologies? 
 6.  How would the rationale for such public health interventions change if the  gov-
ernment and individuals were not facing a severe fi nancial crisis? 
 Acknowledgements  We thank the peer reviewers and editors for their comments. We also thank 
Professor Stavroula Tsinorema, Director  of Studies of the Joint Graduate Programme in  Bioethics , 
University of Crete, Crete, Greece, for her valuable support. 
 References 
 Aspradaki, A.A. 2012.  Autonomy and paternalism in medical care, with special emphasis on den-
tal care. Doctoral dissertation, University of Crete, Crete, Greece.  http://elocus.lib.uoc.gr/
search/?search_type=simple&search_help=&display_mode=overview&wf_step=init&show_
hidden=0&number=10& . Accessed 30 Mar 2013. 
H. Schmidt
171
 Awofeso, N. 2012. Ethics of artifi cial water fl uoridation in Australia.  Public Health Ethics 5(2): 
161–172. 
 Clarkson, J.J., K. Hardwick, D. Barmes, and L.M. Richardson. 2000. International collaborative 
research on fl uoride.  Journal of Dental Research 79(4): 893–904. 
 Community Preventive Services Task Force. 2013. Preventing dental caries: Community water 
fl uoridation. In  The guide to community preventive services: The community guide: What 
works to promote health.  http://www.thecommunityguide.org/oral/fl uoridation.html . Accessed 
13 Aug 2013. 
 Dworkin, G. 1988. Paternalism: Some second thoughts. In  The theory and practice of autonomy , 
121–129. Cambridge: Cambridge University Press. 
 Edmunds, W.M., and P.L. Smedley. 1996. Groundwater geochemistry and health: An overview. 
 Geological Society, London, Special Publications 113(1): 91–105. doi: 10.1144/GSL.
SP.1996.113.01.08 . 
 Eng, G., A. Chen, T. Vess, and G.S. Ginsburg. 2012. Genome technologies and personalized dental 
medicine.  Oral Diseases 18(3): 223–235. 
 European Commission, Directorate General for Health & Consumers, Scientifi c Committee on 
Health and Environmental Risks. 2011.  Critical review of any new evidence on the hazard 
profi le, health effects, and human exposure to fl uoride and the fl uoridating agents of drinking 
water. Brussels: European Union.  http://ec.europa.eu/health/scientifi c_committees/environ-
mental_risks/docs/scher_o_139.pdf . Accessed 10 Nov 2012. 
 Faden, R., and S. Shebaya. 2010. Public health ethics. In  Stanford encyclopedia of philosophy , ed. 
E. N. Zalta.  http://plato.stanford.edu/archives/sum2010/entries/publichealth-ethics/ . Accessed 
10 Mar 2011. 
 Fawell, J., K. Bailey, J. Chilton, E. Dahi, L. Fewtrell, and Y. Magara. 2006.  Fluoride in drinking–
water . London: World Health Organization, IWA Publishing. 
 Kravitz, A.S., and E.T. Treasure. 2009.  Manual of dental practice (version 4.1). See esp. pp. 171–
178 part 11: “Individual Country Sections -Greece” Council of European Dentists: Cardiff. 
 http://abdentist.com/en/assets/fi les/man_dent_prac.pdf . Accessed 15 Nov 2012. 
 McDonagh, M.S., P.F. Whiting, P.M. Wilson, et al. 2000. Systematic review of water fl uoridation. 
 British Medical Journal 321(7265): 855–859. 
 Ministry of Health and Social Solidarity. 2008.  National plan of action on public health. National 
plan of action on oral health 2008–2012.  http://www.moh.gov.gr/articles/health/domes-kaidra-
seis-gia-thn-ygeia-ethnika-sxedia-drashs/95-ethika-sxedia-drashs?fdl=222 . Accessed 3 June 
2015. 
 Nuffi eld Council on Bioethics. 2007.  Public health: Ethical issues.  http://nuffi eldbioethics.org/
project/public-health/ . Accessed 20 Dec 2011. 
 Petersen, P.E. 2008. World Health Organization global policy for improvement of oral health—
World Health Assembly 2007.  International Dental Journal 58(3): 115–121. 
 Petersen, P.E., and M.A. Lennon. 2004. Effective use of fl uorides for the prevention of dental car-
ies in the 21st century: The WHO approach.  Community Dentistry and Oral Epidemiology 
32(5): 319–321. 
 Phillips, C., B. Amphlett, and I.J. Robbé. 2011. The long-term effects of water fl uoridation on the 
human skeleton.  Journal of Dental Research 90(5): 683. 
 Rugg-Gunn, A.J., and L. Do. 2012. Effectiveness of water fl uoridation in caries prevention. 
 Community Dentistry and Oral Epidemiology 40(suppl 2): 55–64. 
 Shariati, B., M.I. MacEntee, and M. Yazdizadeh. 2013. The economics of dentistry: A neglected 
concern.  Community Dentistry and Oral Epidemiology 41(5): 385–394. 
 World Health Organization (WHO). 2002.  World water day 2001: Oral health by R. S. Smith. 
 http://who.int/water_sanitation_health/oralhealth/en/ . Accessed 10 Dec 2012. 
 World Health Organization (WHO). 2005.  The Liverpool declaration: Promoting oral health in the 
21st century. A call for action.  http://www.who.int/oral_health/events/liverpool_declaration/
en/ . Accessed 10 Dec 2012. 
 World Health Organization (WHO). 2007. WHA60.17 Oral health: Action plan for promotion and 
integrated disease prevention. In  Sixtieth world health assembly: Resolutions and decisions, 
5 Chronic Disease Prevention and Health Promotion
172
annexes. Geneva: WHO.  http://apps.who.int/gb/ebwha/pdf_fi les/WHASSA_WHA60-Rec1/E/
cover-intro-60-en.pdf . Accessed 10 Dec 2012. 
 World Health Organization (WHO). 2011.  Guidelines for drinking-water quality , 4th ed. Geneva: 
World Health Organization.  http://www.who.int/water_sanitation_health/publications/2011/
dwq_guidelines/en/ . Accessed 10 Dec 2012. 
 World Health Organization (WHO). 2012.  Oral health , Fact Sheet No. 318. Geneva: World Health 
Organization.  http://www.who.int/mediacentre/factsheets/fs318/en/ . Accessed 30 Mar 2013. 
5.11  Case 5: The Prohibition of  Smoking in Public  Places 
in  Bulgaria 
 Silviya  Aleksandrova-Yankulovska 
 Faculty of Public Health, Department of Public Health Sciences 
 Medical University of Pleven 
 Pleven ,  Bulgaria 
 e-mail: silviya_aleksandrova@hotmail.com 
 This case is presented for instructional purposes only. The ideas and opinions 
expressed are the author ’ s own. The case is not meant to refl ect the offi cial position , 
 views ,  or  policies  of the editors ,  the editors ’  host institutions ,  or the author ’ s host 
institution . 
5.11.1  Background 
 Chronic  noncommunicable diseases , including cardiovascular diseases, malignant 
neoplasms, and noninfectious pulmonary diseases, are a major cause of  the global 
burden of disease in the  European Region 3 (86 % of the 9.6 million deaths and 77 % 
of the 150.3 million  disability-adjusted life years (DALYs) (Vassilevsky et al.  2009 ). 
Commonly associated  risk factors include  smoking , alcohol consumption, unhealthy 
diet, and low physical activity. 
 Tobacco smoking alone produces 12 % of the global  disease burden in the 
 European Region (ranges from 3 to 27 % for the individual countries) and it causes 
2–21 % of all deaths. For Bulgaria, these rates are 13.5 % and 12.4 %, respectively 
(Vassilevsky et al.  2009 ). Annually, more than four billion people die worldwide 
from diseases related to tobacco products. By 2030, this number is expected to 
reach ten million, which will turn tobacco smoking into the biggest single cause of 
 death (World Bank  1999 ). 
 Bulgaria is among the countries with the highest level of morbidity and mortality 
from cardiovascular diseases, especially cerebrovascular disease.  Standardized 
death rates of all  smoking-related causes of death for 2011 were estimated to be 318 
3 As of 2015, the  European Region includes 51 countries (see  http://www.who.int/choice/demogra-
phy/euro_region/en/ ). 
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per 100,000 people, whereas the average for the  European Union (EU) 4 was 195 per 
100,000 people. Standardized death rates of stroke in Bulgaria were about three 
times higher than the average level for the EU. Only Ukraine, Moldova, Kyrgyzstan, 
and Russia had higher  rates  (World Health Organization [WHO]  2012 ). 
 At the same time,  Bulgaria is a leading country in  cigarette use among Central 
and Eastern European countries (Ministry of Health, Bulgaria  2008 ). About 40 % of 
the  population are smokers: 47 % of men and 33 % of women (Vassilevsky et al. 
 2010 ). Cigarettes smoked per person per year in Bulgaria (2793 cigarettes) is sig-
nifi cantly higher than the average for the  European Region (1681 cigarettes) (WHO 
 2012 ).  Smoking among teenagers in Bulgaria is also among the highest in 
Europe—40 % of teenagers smoke (36 % of boys and 44 % of girls) (Tsolova et al. 
 2010 ). A 2011 survey found that Bulgaria was fourth out of 36 countries in teenage 
smokers (Hibell et al.  2012 ). 
 These data are alarming. But additional concern for public health is the effect of 
secondhand smoking. The  risk of death from coronary heart disease increases 30 % 
from exposure to secondhand smoke (American Heart Association  2013 ). 
Secondhand smoke—“passive” smoking—increases a child’s risk of developing 
pneumonia, asthma, and other allergic conditions (Naydenov et al.  2007 ). A survey 
of countrywide integrated noncommunicable disease intervention (CINDI) 
programme- Bulgaria found more than 80 % of teenagers were exposed to passive 
smoking daily (20 % of teenagers were exposed for 1–2 h per day; 50 % were 
exposed for more than 2 h per day). Exposure was higher among girls than boys 
(43.1 % of boys and 56.7 % of girls were exposed to secondhand smoke for more 
than 2 h per day) (Tsolova et al.  2010 ). 
 As a member of the  EU , Bulgaria has had to harmonize its legislation with 
European legislation. The fi rst  smoke free  legislation in Europe was adopted in 
March 2004 in Ireland (Howell  2004 ). Currently, all EU member  countries have 
some form of regulation aimed at limiting exposure to secondhand smoke. However, 
the scope of these  regulations differs widely within the  EU (European Public Health 
Alliance  2012 ). First attempts to prohibit  smoking in public places in Bulgaria date 
back to January 2005. Restaurants and other food and drink places were separated 
into zones for smokers and nonsmokers. The Bulgarian society also split into groups 
of supporters of the changes and opponents of smoking restrictions. 
 On November 7, 2005, Bulgaria ratifi ed the  World Health Organization 
Framework Convention on Tobacco Control . Article 8 of the Convention stipulates 
that “effective legislative, executive, administrative and other measures, providing 
for protection from exposure to  tobacco smoke in indoor workplaces, public trans-
port, indoor public places and, as appropriate, other public places should be taken” 
 (WHO  2003 ). 
 On May 17, 2012, the parliament voted to amend the  Bulgarian Health Act pro-
hibiting smoking in public places (Republic of Bulgaria Council of Ministers  2012 ). 
According to the new  regulation , which took effect June 1, 2012,  smoking was 
4 As of 2013, the  European Union consisted of 28 member countries (see  http://europa.eu/about-eu/
countries/member-countries/ ). 
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prohibited in all indoor public places and workplaces including stadiums,  children 
playgrounds, kindergartens, and other  schools . Still, Bulgarian society remained 
 confl icted about the issue. 
 In November 2012, two independent members of the Bulgarian parliament raised 
the issue of business losses from the  smoking ban . They claimed that 10,000 people 
lost jobs due to fewer patrons of food and drink establishments and pleaded for revi-
sion of the  law (Todorova  2012 ). Offi cial data about business losses were not pro-
vided, and such surveys have not been done. Nevertheless, these claims increased 
public debate about the  smoking  bans . On December 10, 2012, the Bulgarian Hotel 
and Restaurant Association offi cially protested the  law and insisted it be revised. 
The prime minister initially agreed that some revision could be possible but later 
supported the minister of health, who opposed changing the law. The minister of 
health pointed out that pitting business against health was unacceptable and, instead 
of discussing business losses, the  government should be discussing the  cost of treat-
ing oncological and cardiovascular diseases (Dimitrova  2012 ). The minister of 
economy, energy, and tourism favored a more fl exible application of the  law . 
Eventually, decision making was transferred to parliament’s Economic Committee 
with the idea that the ban on  smoking could be abolished through the Law of 
Tourism, particularly if certain amendments were adopted to allow smoking in spe-
cifi c areas of bars and restaurants. On December 18, 2012, the Economic Committee 
rejected any amendment to the law. Thus, despite the controversy and public 
debates, the law prohibiting smoking in public places has survived without change 
as of May 2013. 
5.11.2  Case Description 
 The  law prohibiting  smoking in public places has been enacted. You are aware of 
the public debate and tension surrounding the issue. What would you, as a director 
of the regional health inspectorate, do to guarantee the implementation of the law in 
the region? 
5.11.3  Discussion Questions 
 1.  When is  it acceptable to limit  personal autonomy to benefi t of the health of 
others? 
 2.  How should economic interests be weighed in public health decision making? 
Specifi cally, how should health care expenditures due to smoking-related dis-
eases be weighed against economic losses incurred by the ban on  smoking ? 
 3.  Law is usually regarded as the strongest measure of public control. Is law the 
best approach for infl uencing health behavior in a society where citizens tradi-
tionally feel no responsibility for their own health or the health of others? 
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 4.  What long-term effects could repealing or revising the  smoking ban have on the 
public’s  trust and support? 
 5.  In future years, if a new government decides to revisit the law, what would you, 
as an expert in public health, advise the new minster of health? Who are the 
relevant stakeholders, and which of their values should the minister of health 
consider?  
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 Chapter 6 
 Environmental and Occupational Public 
Health 
 Bruce  Jennings 
6.1  Environment and Workplace: Key Venues 
for Public Health 
 Environmental health and  occupational health and safety have long been established 
subfi elds of  public health research ,  policy , and practice (Frumkin  2010 ). More so 
perhaps than areas such as  infectious disease or  health promotion , environmental and 
occupational health remind us that the health of a society is profoundly affected by 
its  economic system and  economic development . Today, the environmental health 
fi eld is largely concerned with a human-made (anthropogenic) environment brought 
about by urbanization, the extraction of natural resources, industrial manufacture, the 
physical separation of home and workplace, and the transportation systems needed 
to support this mode of economy and pattern of living. Economic development alters 
the natural environment and sometimes  harms  ecosystems in terms of the humanly 
useful services they provide, their  diversity , and their resilience. We are coming to 
understand that all of this has signifi cant consequences for human health. 
 Environmental health has been understood as a public health issue in relation to 
air quality, water quality, and exposure to environmental pollutants that are toxic, 
carcinogenic, or teratogenic or are chemically bioactive in other ways. The rise of 
fossil fuels as the energy base for economic production and transportation, the 
industrial-scale advances in  mining and metallurgy, and the creation and widespread 
presence of synthetic chemical substances have contributed to  environmental health 
risks throughout the past two centuries. Indeed, these changes have redefi ned the 
meaning of environmental health. For the most part, environmental health involves 
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the domain of chronic illness and disease, and it investigates factors that increase 
 population  risk and susceptibility to patterns of physical and mental illness in vari-
ous forms. Epidemiological investigation is key to public health response to envi-
ronmental health hazards. 
 If the public health of entire populations is affected in the background by modern-
ization and industrialization in the form of environmental hazards, the personal health 
of a large number of individuals—especially people who work in industrial settings or 
are otherwise exposed to  workplace hazards —is also affected directly in often injuri-
ous ways (Bayer  1988 ). Despite struggles to protect people in the workplace, the lit-
erature on occupational health is replete with examples of work-related cancers and 
pulmonary disease. Moreover, issues of safety and health go hand in hand in the 
occupational arena. Occupational accidents and injuries are a substantial factor in the 
overall health profi le of society. Some occupational sectors remain particularly dan-
gerous due to inherent features of the work environment, the necessary technology 
and equipment, or the absence of adequate policies and protections for workers. The 
recent emphasis in  public health research and policy on personal injury and  trauma 
may lead to renewed interest in occupational health as a public health issue. 
 More effective  public health policy in regard to environmental and occupational 
health is made diffi cult by the fact that they tend to have distinct regulatory struc-
tures. Each is governed by different authorizing statutes and accumulated bodies of 
administrative rules and is overseen by different agencies of varying  government 
levels (particularly in countries with federal systems). Nonetheless, occupational 
health and  environmental health should be viewed in relation to each other, since 
both ultimately spring from a common root in the recent history of the impact of 
science and technology on society. Moreover, the public health responses to these 
two areas has varied with different understandings of the appropriate role of the 
state and public authority. This is to be expected, given that health matters overall, 
though biologically and biochemically connected, raise  political , economic, and 
social issues. Major disparities in environmental and  occupational  risk, for example, 
stem from race and socioeconomic status (Shrader-Frechette  2005 ), and thus raise 
ethical questions about political and social rights, economic entitlements and wel-
fare safety nets, and the just distribution of risk, wealth, and  power . 
 One additional feature of a contemporary perspective on environmental and 
occupational public health should be noted: Our paradigm for understanding the 
interrelationships of health, the natural environment, and the workplace environ-
ment is  broadenin g. Lang and Rayner ( 2012 ) distinguish among fi ve models for 
public health, each with its own historical origins and core ideas. These models are 
(1) the sanitary-environmental model; (2) the biomedical model, both individual 
and  population focused; (3) the social-behavioral model; (4) the techno-economic 
model; and (5) the ecological model. 
 The fi rst four models take an essentially human-centered approach. In these mod-
els, the term “environment” is understood as a mere backdrop or aggregation of condi-
tions and  risk s for states of human health and illness. By contrast, model fi ve, the 
ecological model, understands the natural environment to be comprised of complex 
 systems , not as an array of separate factors. The environment is the functional and 
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relational context in which human health and behavior emerge, not just a set of back-
ground conditions. The growing infl uence of the ecological model of public health is 
reorienting the study and  regulation of both  environmental health and occupational 
health, and this model has the potential to bring them into closer alignment. 
 There are several reasons for this. First,  research on the  social determinants of 
health indicates that distinguishing the social from the natural aspects of an environ-
ment’s health effects is not straightforward. Even in remote wilderness areas, the 
natural environment is shaped by human activity. Moreover, the social features of 
everyday life include not only psychological effects (happiness and well-being) but 
also physiological effects (cardiovascular, hormonal) on the internal biological 
environment of the human body. 
 Second, the growing discussion around the health effects of global  climate 
change contributes to this reorientation of  environmental health by reminding us 
that  ecosystems are holistic and complex networks of interrelationships and interde-
pendencies. Therefore, hazards to human health take the form of both discrete 
threats and general factors that undermine the integrity or functioning of ecosys-
tems upon which the health and functioning of all life ultimately depend. For exam-
ple, a recent literature review on the public health effects of climate change 
summarizes the situation as follows:
 Impacts of climate change cause widespread harm to human health, with  children often suf-
fering the most. Food shortages, polluted air, contaminated or scarce supplies of water, an 
expanding area of vectors causing  infectious diseases , and more intensely allergenic plants 
are among the harmful impacts. More extreme weather events cause physical and psycho-
logical harm. World health experts have concluded with “very high confi dence” that  climate 
change already contributes to the global burden of disease and premature death. IPCC 
[Intergovernmental Panel on Climate Change] projects the following trends, if global warm-
ing continues to increase, where only trends assigned very high confi dence or high confi -
dence are included: ( 1 ) increased malnutrition and consequent disorders, including those 
related to child growth and development, ( 2 ) increased death, disease and injuries from heat 
waves, fl oods, storms, fi res and droughts, ( 3 ) increased cardiorespiratory morbidity and mor-
tality associated with ground-level ozone. While IPCC also projects fewer deaths from cold, 
this positive effect is far outweighed by the negative ones (Hansen et al.  2013 , 8). 
 Third, the way the  built environment is developed can affect not only greenhouse 
gas emissions but also lifestyle factors that impinge on human health–for example, 
land use and zoning patterns that lead to suburban housing sprawl and automobile 
dependency (Frumkin and McMichael  2008 ). 
 Environmental health hazards can no longer be thought of simply as discrete entities 
(e.g., pathogens, toxic chemicals, carcinogenic substances) within an otherwise health-
neutral fi eld (Kassel and Stephens  2011 ). Previously environmental health hazards 
(even air and water pollution) were viewed on rather narrow local or regional scales and 
in close proximity to effected human populations. Now we must view the health haz-
ards emerging from systemic disruptions or dysfunctions as operating on far broader 
scales and far more remotely than previously suspected. Deforestation in tropical areas 
involves a chain of factors that ultimately affects the quality of life of people with 
asthma in Central Asia; changes in the salinity and temperature of the oceans will affect 
heat emergency events in Europe. A contaminated well is a  localized health risk. 
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Conversely, environmental changes on the Himalayan plateau that alter the hydrology 
of a river spanning miles upon which hundreds of millions depend for fresh water, 
represents a different challenge for public health analysis and response. The problem is 
 global and  institutional , which is to say, fundamentally  political and economic. The 
public health response needs to involve not only specifi c protections and rules or  law s 
aimed at individual decisions and behaviors, such as toxic dumping in a particular site, 
or the point source pollution of a river, but also the institutional and systemic gover-
nance that alters the structure of  power and wealth, and the process by which decisions 
and policies are made. The perennial debate between an approach aimed at individual 
behavior and one aimed at structural change is endemic to both  environmental health 
and  occupational health and safety . 
 Because both environmental and occupational public health raise public issues 
that involve public perception, a couple of the thorniest ethical problems concern 
the concept of  acceptable risk and criteria for  risk management and  risk reduction . 
Environmental risks to the public’s health can be managed (or prevented) in multi-
ple ways. The same can be said of workplace risks, especially when conditions put 
workers in contact with dangerous machinery or industrial processes; expose work-
ers to harmful substances; and, in the case of health care  profession als and  biomedi-
cal researchers , expose them to  infectious diseases . The debate always concerns 
how  risk management should be done and at what  cost . 
6.2  Population  Benefi ts , Individual Rights, and Ethically 
Acceptable Risk 
 The four intriguing cases in this chapter provide examples of  policy , decision mak-
ing, and public health practice under specifi c circumstances. Looming in the back-
ground of each case are fundamental questions about power, equality, and  social 
justice . The cases indicate the need for a more systemic understanding of environ-
mental and occupational health factors, from the small-scale  ecosystem of poten-
tially contagious organisms within the human body to the large-scale natural 
ecosystem’s reaction to the effects of  mining technology and operations. 
 Here are the main themes and issues that the cases in this chapter pose for envi-
ronmental and occupational health, especially from the perspective of an ecological 
model of public health ethics:
•  How should a society democratically set priorities and manage its economic sec-
tors to ensure productivity in the global economy and at the same time protect its 
limited natural resources, its core values, and cultural  diversity of regional and 
ethnic ways of life? Snyder and colleagues address this theme in their case on 
 mining and  health equity . 
•  How should  vulnerable  populations , such as hospitalized patients, be protected 
from serious infection, and to what extent should those measures impinge on 
 individual rights and careers of health  profession als who are subject to screening 
and possible exclusion from clinical practice? This theme is addressed by Rump 
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and colleagues in their case involving the exclusion of physicians who test posi-
tive for  Methicillin-resistant  Staphylococcus aureus (MRSA) from performing 
patient related interventions. 
•  How should  nongovernmental organizations (NGOs) working on development 
projects in resource poor and underserved areas allocate limited resources effec-
tively and equitably? What responsibility does the NGO have when its programs 
inadvertently pose health risks to the community that also may threaten its future 
capacity to provide services? This theme is addressed in Hayward’s case about 
 well construction in areas without access to safe drinking water. Hayward com-
pares the health  risk s and benefi ts to the cost of different construction methods. 
•  What are the ethical responsibilities of organizations whose staff and volunteers 
do public health work in areas lacking public safety and security resources? 
What balance should be struck between outreach to  those  who need services and 
the personal health and safety of the organization’s employees? This case, also 
by Hayward, describes how  Peace Corps volunteers use motorcycles to reach 
otherwise inaccessible areas, which increases their risk of traffi c accidents. 
 As mentioned previously, the forces of economic, scientifi c, and technological 
development brought  environmental health and  occupational health and safety issues to 
the forefront of contemporary public health. Indeed, public health as we know it today 
is an outgrowth of the industrial revolution, which has brought about both great 
advances and signifi cant disparities of wealth and  power . Worldwide, public health 
operates amid highly urbanized social systems stratifi ed by class, race, and ethnicity. In 
its quest for optimal  health outcomes on a  population basis, public health is ethically 
constrained by  individual rights and liberties that may  confl ict with that goal, just as it 
is politically constrained by powerful vested interests. Nonetheless, social inequality is 
an obstacle against which public health pushes. For the most part, certainly in the post-
World War II era, the direction of public health has been toward greater access to the 
resources and conditions necessary for widespread health and well-being, greater 
social and economic equality, and  fairness for the most  vulnerable  and marginalized. 
 Operating within that trend, decision making about environmental and occupa-
tional health draws primarily on two ethical concepts of public health: One is a utili-
tarian ethic of population well-being, and the other is an ethic of human  right s , 
dignity, and  justice . 
 Utilitarianism defi nes the ethical rightness of human acts toward maximizing 
aggregate net social benefi t (happiness, utility, preference satisfaction). Not surpris-
ingly,  utilitarianism is a signifi cant aspect of public health ethics. Its orientation 
toward aggregative outcomes befi ts its concern for  population s rather than individ-
ual health—weighing and  balancing  options rather than delimiting intrinsic value or 
ethical absolutes. 
 Rights- and justice-based ethics focus on intrinsic rightness or wrongness of spe-
cifi c acts and general actions— not on the consequences of those acts. Actions embody 
fundamental values such as  respect , dignity, equality,  autonomy , and inclusiveness 
and therefore have intrinsic rightness. This ethical orientation appeals to cultures with 
a heritage of humanitarian concern and to  political and legal systems that are simulta-
neously democratically egalitarian and protective of  individual liberty . 
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 Utilitarian ethics and rights-based ethics may  confl ict when situations pit aggre-
gate net  population benefi ts (i.e., health and welfare) against  equity and  fairness 
perspectives that reject  discrimination and are unwilling to violate the rights of one, 
or a few, to achieve well-being among many. Such  dilemmas and trade-offs often 
arise in public health practice. 
 For example, one confl ict involving  individual rights arises in the case from 
Rump and colleagues. In this case, a precautionary  policy of exclusion provides 
safety for hospitalized patients who have contact with a medical student who is a 
carrier  of  MRSA. But at the same time, the exclusion policy burdens the medical 
 student who faces personal and  profession al risk to her livelihood. An individual’s 
rights may be violated when health status becomes the basis for discriminatory 
treatment or for the loss of  liberty or opportunity. A physician or other health care 
professional with a condition that poses undue risk to patients illustrates the  confl ict 
between  individual rights or  freedom and protection of patients health collectively, 
or indeed, protection of patient health individually. To resolve such confl ict, one 
must strike a balance among competing values, informed by factual (biomedical) 
knowledge. No individual has the right to intentionally harm an innocent person, 
and no physician has a right to deliberately harm a patient. These confl icts typically 
arise when facts are uncertain and knowledge is imperfect or probabilistic. Thus, the 
question turns not on  absolute right and wrong, but on  reasonably  acceptable risk . 
Is a policy that provides  a  blanket exclusion of health workers who are  MRSA posi-
tive appropriate? Or is this  policy overly inclusive and cautious? Moreover, how do 
we ethically factor in the costs or  harms done by exclusion of risk? Perhaps a gifted 
physician who poses a low risk of infecting patients may greatly benefi t them. If so, 
then considerations of nondiscrimination for the individual (physician) and aggre-
gate  net benefi t for the  population (patients) could coincide. 
 Hayward presents a mirror image in her case on threats to  personal safety . This 
case involves  transportation safety in the developing world, a signifi cant public health 
problem to everyone living and working there. Under discussion is a policy that pro-
hibits staff and volunteers from using dangerous forms of travel, such as motorcycles, 
even when alternative means of accessing remote areas do not exist. This would affect 
many fi eld staff and volunteer health workers who strive to maximize client services 
by minimizing transportation time, even at the risk of a traffi c accident. The rights-
based question in this case has to do with individual  freedom of choice versus  pater-
nalistic protection by institutional authorities, again within the context of ethically 
 acceptable risk . The utilitarian question may be framed as a cost–benefi t comparison 
of population harm done by the death or injury of health workers (to themselves, their 
families, and their clients) and the harm done by suboptimal service delivery (slower, 
but safer modes of transportation). A far-reaching consequence may be the loss of 
public health and  economic development programs that benefi t the community. 
 Risk and harm appear in yet another guise in Hayward’s case on  safe water stan-
dards and  well construction in rural  Africa . An ethical  dilemma arises because a less 
expensive drilling technique (shallow rather than deep-drilled wells) can produce 
more water for more people; however, the risk of contamination and harm to users 
will increase. How can decision makers resolve the trade-off between water quan-
tity and quality to benefi t the aggregate net  population ’s health and welfare? In this 
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instance, an organizational and programmatic risk is also involved. The dilemma 
decision makers face has broad implications for future public health initiatives in 
the region. If too few wells with a high per unit cost are produced, the community 
might perceive that the needs of many are not being considered. Similarly, they 
might perceive their health and safety are being neglected if the wells are inexpen-
sive. Decision makers should strive to preserve community  trust if they are to gain 
cooperation in future public health  initiatives . 
 These three cases illustrate how almost every conceivable approach to  risk man-
agement can pose one or more ethical problems. Risk management interventions 
may protect some while shifting the exposure and burden of risk to others, raising 
serious questions of distributional  equity or  fairness . Or, interventions to mitigate 
risk and protection efforts may supplant or inhibit other programs or public health 
activities since intervention is expensive and may lay claim to scarce  resources . 
 Moreover, the concept of risk is seemingly impossible to defi ne in value-neutral 
terms and is inherently controversial. Even more ethically charged are the questions 
of what level or degree of risk is socially acceptable, who should decide, and how 
exposure to risk should be distributed across the affected population. Routine public 
health practice in environmental and occupational  risk management involves inter-
ventions and policies designed to prevent harm to individuals and to lower health 
risks within the  population . Interventions include various forms of  public health 
surveillance —screening and testing—of different groups, with the attendant untow-
ard effect of  discrimination or social stigma. Policies may involve  regulations with 
substantial fi nancial consequences in the form of job loss in regulated industries and 
hence higher unemployment rates in the overall economy or higher production costs 
and hence higher prices for  consumers . 
 The question of ethically justifi able public health  paternalism versus individual 
 autonomy arises when individuals want to continue engaging in activities that put 
themselves, third parties, or the general public at risk. Among the diffi cult issues 
raised about situational ethics are ( 1 ) identifying the genuine interests and agendas 
of public health authorities who follow seemingly  paternalistic programs to reduce 
risks and  harms ; ( 2 ) identifying when individuals knowingly (and willingly) expose 
themselves to environmental or occupational risks, given the context of  inequalities 
 of  power and wealth involved and the lack of employment or residential options 
available to these individuals and their families; ( 3 ) determining a reasonable level 
of acceptable risk in the face of scientifi c uncertainty; and ( 4 ) gauging how a  policy 
to reduce public health risk  will affect public perception and  trust . 
6.3  Systems and Power: The Ethical Importance 
of Ecological and Social Context 
 We generally know that human health is undermined when the  diversity , services, 
and functioning of  ecosystems are compromised. We also know that various eco-
nomic activities that extract raw materials, manufacture commodities, and provide 
jobs often secure these benefi ts at the expense of the environment. On a local or 
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regional scale, the health burdens are often felt by people in the immediate area, 
whereas the benefi ts and wealth often accrue to people far removed from the local 
environmental disturbances and health risks. When viewed as a manifestation of  eco-
nomic systems ,  environmental health and occupational health are inseparable from 
questions of  global health justice, and these are very diffi cult theoretical and practical 
questions indeed. Moreover, these dimensions of the ethics of environmental public 
health are evolving. Today, given what is known about  climate change , we can rea-
sonably say that economic activity virtually anywhere can be environmentally dam-
aging—from oil drilling in the Artic to land clearing in tropical rain forests—and that 
such damage affects the health and well-being of people everywhere, not just of 
those in the local or regional areas where the environmental damage takes place. 
 If environmental public health cannot be divorced from economics, neither can it 
be understood apart from conditions of governance at international, national, and 
local levels. International policies and interventions, including the  Millennium 
 Development Goals and  climate change response defi ned by international protocols 
beginning with the Kyoto treaty, are forms of global governance in which environ-
mental public health and public health ethics play indispensable roles. 
 Questions are no less complex for public health and for ethics at the national 
level. In the developing world, particularly countries still experiencing widespread 
poverty and lacking fundamental infrastructure and services, economic growth 
remains a priority and benefi t. Nonetheless, there is a trade-off between short-term 
economic gains and long-term national (and global) interest in health, economic 
sustainability, and environmental conservation. For example,  ecosystems like rain-
forests perform a vital function in absorbing atmospheric CO 2 . This global function 
can be undermined by economically driven decisions about land use and other com-
mercial activities that lead to deforestation. Climate change is only one, albeit dra-
matic, illustration. The collective carbon footprint of developing countries is 
growing, often placing the preservation of their ecosystems, biodiversity, and fresh 
water at risk. Putting the economic growth of developing nations on a more 
 sustainable path is not only critical to global control of greenhouse gas emissions, it 
is also key to each nation’s economic future and to  global public health . 
 Economic development is no longer simply an issue for each national government 
to acknowledge in its internal affairs and domestic  policy . In our global market, 
external forces impinge on options and resources of individual countries, even 
wealthy and powerful ones. Yet in the absence of international governance, it is the 
 government of each country that remains ethically responsible for the health and 
welfare of its citizens and should legislate and regulate its social and economic affairs 
accordingly. In a democracy, public  participation , debate, and consensus in view-
point and among plural groups are valued and essential components of governance. 
 The case from Snyder and colleagues provides an opportunity to examine the global 
and systemic dimensions of environmental public health ethics and governance. In 
 Mongolia ’s economy, which is heavily dependent on the  mining industry and mining 
operations, the trade-off between economic growth and environmental protection is 
acute. The country clearly needs investment and job opportunities to combat poverty. 
But issues of  social justice , including  health equity , are made complex by the stratifi ca-
tion of wealth and income and by the uneven development of different regions and 
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sectors of the society. Mining operations can threaten a complex and fragile  ecosystem 
and adversely affect health (e.g., toxic waste, air and water pollution). Mining opera-
tions can also create social dislocations (work  migration ) and change patterns in land 
use, especially in areas with a long cultural and economic tradition of pastoralism. 
 The case by Hayward questions whether to drill expensive deep wells or less 
expensive shallow water wells in  sub-Saharan Africa . Part of the health risk posed 
by the shallow wells requires a change in cultural behavior by preventing livestock 
from contaminating the wells and by controlling surface run-off. Thus, any success-
ful public health effort cannot be assessed apart from the capacity of the local soci-
ety to manage and behave toward both its natural and constructed environment in 
prudent and sustainable ways. Similarly, but on a larger scale,  Mongolia ’s  regula-
tion of economic growth and its mining industry raise questions of cultural rights 
and cultural capacity as well as questions of  social equity and institutional capacity 
to govern in an effective and socially legitimate fashion. 
 In summary, environmental and occupational health policy and practice is an 
ethical minefi eld. Overly cautious approaches when predicted outcomes fail to 
materialize may reduce the general public’s attentiveness and  compliance with pub-
lic health warnings, recommendations, and directives in the future. Insuffi cient, 
cautious responses leading to health consequences that could have been avoided can 
carry a heavy  political price for offi cials involved. 
 As you read and examine the cases in this chapter, pay particular attention to how 
public opinion is formed, ethical decisions are justifi ed, and inclusive and participa-
tory deliberation and consensus are achieved. We need effective and meaningful 
approaches for engaging the public in health decisions. In particular, we need to fi nd 
ways to make a participatory and deliberative form of democracy practical and effec-
tive, especially in the context of environmental and occupational health. Civic educa-
tion about  environmental health and ethical literacy will prepare not only stakeholders 
but all citizens to make wise decisions about economic interests and the use of tech-
nology. What would motivate genuine deliberation and not simply special interest 
 advocacy ? And civic deliberation is not free-standing; it requires special organiza-
tional forums and needs to move from spontaneity to institutionalized practice if it is 
to make a lasting difference. Proper access to  information and the cooperation of 
experts with specialized technical knowledge are examples of the organizational side 
of effective grassroots  participation and discussion of key environmental and occu-
pational health issues. How can public health  profession als facilitate and contribute 
to the formation of civic practice and democratic public judgment in this sense? 
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 This case is presented for instructional purposes only. The ideas and opinions expressed 
are the authors ’  own. The case is not meant to refl ect the offi cial position ,  views ,  or 
policies of the editors ,  the editors ’  host institutions ,  or the authors ’  host institutions . 
6.4.1  Background 
 Mongolia is a landlocked country bordered by Russia to the north and China to the 
south. Although one of the largest countries in Asia in land area (1.56 km 2 ), it has a 
small population (2.74 million in 2010). Nearly two-thirds of the  population is 
urban and reside in provincial capitals and cities. Nomadic pastoralists who tend 
mixed herds of animals across the desert and steppe grasslands primarily make up 
the remaining third of the population (Central Intelligence Agency  2010 ). 
 Beginning in 1990, Mongolia transitioned from a single-party socialist state to a 
multiparty democracy, which led to withdrawal  of  Soviet aid and termination of 
 trade relations with Soviet bloc countries. The loss of state subsidies and price con-
trols and implementation of trade liberalization caused the economy to falter during 
the transition (Stiglitz  2002 ). Not until 2004 did the gross domestic product (GDP) 
return to pre-transition levels (Rossabi  2005 ). Since then, macroeconomic growth 
has been strong, driven by a rapidly expanding mineral sector. 
 Although resource extraction had been a major economic activity in  Mongolia 
for some time, the scale of exploration and investment increased markedly in the 
early 2000s (Central Intelligence Agency  2010 ). As of 2008, general mining explo-
ration licenses covered a quarter of the country. Copper, gold, and coal dominate 
mining activities, with much of the product exported to neighboring China (The 
Economist  2012 ). The mining industry’s proportion of the total GDP tripled from 
11 to 33 % during 2003 through 2007, the sector contributing about one-third of 
 government tax revenues (World Bank  2013 ).  Propell ed by mining and related con-
struction and transportation sectors, in 2011 Mongolia became the world’s fastest 
growing economy, reporting annual economic growth of 17 % (World Bank  2011 ). 
 Mining in Mongolia occurs in a context of a lower middle-income country with 
a GDP of $8.8 billion, rural underdevelopment, and social and economic inequality 
(World Bank  2013 ). Mongolia exhibits signifi cant wealth disparities: more than 
one-third of the population lives in poverty, a proportion that has persisted despite 
rapid economic growth. Although income poverty levels in rural areas exceed those 
in urban areas, both settings have large numbers of  vulnerable  poor. In rural set-
tings, those lacking suffi cient herd animals to sustain livelihoods, especially female- 
headed households, rank among the poorest of the poor. Urban areas are inundated 
with rural migrants  forced into cities by weather disasters and lack of employment. 
There they labor in the informal economy, typically living in squatter or “ger” set-
tlements without access to running water, sewerage, or electricity. 1 
1 A ger settlement, or “yurt,” is a rural parcel of land in  Mongolia comprising several detached and 
portable dwellings (gers) or shanties. Traditional ger settlements were occupied by pastoralists 
(nomadic Mongolian people). Gers typically lack modern conveniences such as water, sewage, and 
electricity. Occupants, although mostly self-suffi cient, rely on some communal services such as wells. 
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 Although mining potentially can provide employment, improve infrastructure, and 
support  government services, it also poses substantial social, environmental, and 
health risks. Adverse environmental impacts noted in  Mongolia include dust pollu-
tion, diminution and degradation of ground and surface water, and loss of traditional 
grazing lands by erosion and pollution. Especially concerning is the infl ux of thou-
sands of mine and construction workers, their families, entrepreneurs, job seekers, and 
artisanal miners into rural mining areas (World Bank  2006 ).  Thi s infl ux, which greatly 
strains infrastructure in some areas, can potentially increase the risk of local epidem-
ics of  infectious disease , including  HIV . As a result, resource development in Mongolia 
has become a hotly contested  political issue, which has subjected the mining sector to 
increased public and regulatory scrutiny (Reeves  2011 ). Mongolians retain a strong 
identity with their pastoralist history and culture, which has manifested itself in strong 
pressure to develop resources that benefi t the nation while protecting  vulnerable 
 herder  population s. Recently, and with international donor support, the  government of 
Mongolia began addressing some of these concerns. In May 2012, the efforts culmi-
nated in landmark environmental legislation that took into its purview the broad social 
 and  health impacts of mining (Mongolian Mining Journal  2012 ). This legislation 
demonstrates Mongolian interest in mitigating the negative health impacts of mining, 
though administering this legislation will be challenging. 
 Expansion of the Mongolian mining sector raises ethical challenges in three areas. 
First, the Mongolian government must assess a proposed mining project’s impact on 
Mongolian stakeholders, taking into account the economic, environmental, social, and 
health impacts. Because projects will affect stakeholders differently, the assessment 
should adopt an  equity lens, with differential impacts noted. A wide- ranging assess-
ment of this kind requires that the government determine how equity will be assessed 
and how competing negative and positive impacts will be measured and compared. 
Second, the Mongolian government must use the assessment to help mitigate potential 
negative social and health impacts. Third, however, the government must consider 
how  regulations could deter mining investments and reduce potential economic ben-
efi ts of this industry. In a country with a growing population and limited economic 
development, the loss of these benefi ts could impact the country’s welfare signifi -
cantly, limiting modernization and expansion of the health care system. 
 Before the equity impacts of mining activities can be assessed, stakeholders must 
fi rst agree to a  standard of equity to prevent misunderstandings. These include equality, 
priority to the least advantaged, and suffi ciency accounts where the aim is to achieve a 
threshold level of well-being for all people. Second, offi cials must determine whether 
any local  population s who are particularly vulnerable to mining’s impact merit special 
consideration. Third, to meet the diverse needs of the Mongolian people, an impact 
assessment must be locally appropriate and assume various forms. For example, differ-
ent remediation requirements may apply to different mine developers, depending on 
circumstances. Fourth, one needs to be clear about when differential impacts of mining 
become problems  of  equity. Finally, offi cials should investigate what requirements for 
mitigating equity impacts should be included in any  policy (Snyder et al.  2012 ). 
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6.4.2  Case Description 
 The  rapid urbanization and social upheaval brought on by the mining industry and 
economic liberalization in Mongolia threaten to destabilize the country and squander 
its resources. To avert these threats, Mongolia has already developed robust 
legislation to assess the environmental and health impacts of mining. Some 
 government offi cials believe that an equity-focused  health impact assessment policy 
represents the logical next step in the country’s management of its rapid  economic 
development . Implementation of an equity-focused health impact assessment for 
new mining projects could ensure that economic benefi ts are distributed equitably. 
Doing so could improve health and social cohesion without disproportionately 
burdening some populations with mining’s adverse consequences (Douglas and 
Scott-Samuel  2001 ). A policy of this kind, while diffi cult to develop and implement, 
is crucial to Mongolia’s future. 
 A panel that includes public health  profession als is being organized to make 
recommendations to the Mongolian government on its equity-focused health impact 
assessment policy for new mining projects. The agenda for discussion includes  the 
following three areas:
•  How to best include stakeholders in the development of the policy? 
•  How should health equity be conceptualized? 
•  How can an equity-focused health impact assessment be applied broadly? 
6.4.3  Discussion Questions 
 1.  Giving a fair hearing to stakeholders in deliberations about issues that affect 
them is central to democratic deliberation.
 (a)  How important or practical is it in Mongolia to give a meaningful voice to all 
stakeholders in the deliberations about whether and how a mining project 
should be allowed to develop? 
 (b) What level of consultation constitutes meaningful participation? 
 (c)  Should stakeholders be given veto power over decisions and an equal voice 
in a democratic process? 
 (d)  Is consultation by the government without a vote in the fi nal decision 
adequate? 
 2.  Equity can be conceptualized differently, leading to various interpretations and 
attendant misunderstandings.
 (a)  Are stakeholders unfamiliar with theories of health equity suffi ciently quali-
fi ed to discuss health equity impacts? 
 (b) If not, how can they prepare for discussions of this kind? 
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 (c)  Should stakeholders undertaking an equity-focused health impact assess-
ment be asked to reach a consensus on a concept of equity? 
 (d) Is it preferable to supply a single conception of equity? 
 (e)  How can cultural and linguistic differences in understanding concepts such 
as equity and fairness be resolved? 
 3.  Some countries are incorporating a health equity assessment component in all 
policies.
 (a)  Is there any unique feature of mining development that sets it apart from 
other developments (e.g. road or housing construction)? 
 (b)  Could equity-focused health impact assessment be used more generally to 
assess the health equity impacts of projects and policies? 
 (c) What are the challenges of doing so, especially in a fl edgling democracy? 
 4.  Should the panel recommend to the Mongolian government that it apply an 
equity-focused health impact assessment policy to new mining projects? 
 Acknowledgements  We thank everyone who participated in a workshop on equity- focused 
health impact assessments in Mongolia in October 2010. This workshop was funded through a 
Health Equity Catalyst Grant from the Canadian Institutes of Health Research. 
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 This case is presented for instructional purposes only. The ideas and opinions expressed 
are the authors ’  own. The case is not meant to refl ect the offi cial position ,  views ,  or 
policies of the editors ,  the editors ’  host institutions ,  or the  authors ’  host institutions . 
6.5.1  Background 
 Antimicrobial resistance (AMR) is an increasingly serious threat to  global public 
health . First described in 1961, methicillin-resistant  Staphylococcus aureus (MRSA) 
is one of the best known antimicrobial resistant (AMR) pathogens. It has become an 
increasingly serious cause of  health care associated infections worldwide (Boyce 
et al.  2005 ). People infected with MRSA, which resists standard beta-lactam  antibi-
otics , can present symptoms or be asymptomatic carriers. 
 In a community setting, most MRSA carriers have few or relatively minor symp-
toms. In hospitals, however, open wounds, invasive devices, and weakened immune 
systems pose a greater risk of infection, making MRSA a serious health problem. 
The presence of Panton-Valentine leukocidin (PVL) cytotoxin in a  Staphylococcus 
aureus has the potential to cause more severe infections, such as pneumonia and 
skin infections, although these are rare events considering the number of asymp-
tomatic carriers (Gorwitz  2008 ). 
 Worldwide, prevalence of MRSA among the general public and in hospitals var-
ies widely, as do the strategies used to control hospital-acquired MRSA (Boyce 
et al.  2005 ). In the  Netherlands and  Scandinavia , for example, MRSA causes less 
than 1 % of all cases of  Staphylococcus aureus bacteraemia. This percentage con-
trasts with percentages of up to 50 % in other European countries (Wertheim et al. 
 2004 ). To maintain this low incidence, hospitals in the Netherlands and Scandinavia 
follow a strict AMR related search and destroy  policy . This policy consists of active 
screening of patients and staff for MRSA, strict  enforcement of contact precautions, 
and judicious use of broad-spectrum  antibiotics (Boyce et al.  2005 ). 
 In the Netherlands, the  Working Party on Infection Prevention (WIP) has incorpo-
rated this search and destroy policy into national MRSA  guideline s. The WIP, funded 
by the Dutch Ministry of Health, was founded 25 years ago by respective  profession al 
societies of physicians, hygienists, and microbiologists. WIP-issued guidelines are pro-
fessional standards most health professionals and institutes follow (Boyce et al.  2005 ). 
 The 2012 WIP guidelines for MRSA  prevention in hospital settings involve three 
principal procedures, which address both symptomatic and asymptomatic patients, 
since carriers can also transmit the infection. First, patients with MRSA are isolated 
in single rooms and treated to eradicate MRSA. Isolation procedures require those 
entering the patient’s room to wear a gown and mask. Second, hospital patients at 
increased risk of being carriers are also placed in isolation until proven MRSA free. 
Patients considered potential carriers include all patients (a) transferred from hospi-
tals abroad to Dutch hospitals, (b) transferred from Dutch hospitals with an existing 
MRSA condition, and (c) placed in the same room as a patient subsequently detected 
unexpectedly with MRSA. Third, hospital staff who care for MRSA patients are 
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screened for MRSA and treated with  antibiotics and mupirocin nasal ointment if 
found positive (Boyce et al.  2005 ). 2 
 Nationally, this search and destroy  policy has proved highly successful and effec-
tive at maintaining a low prevalence of  MRSA  in Dutch hospitals (van der Zee et al. 
 2013 ). However, MRSA screening and treatment of health care staff can seriously 
affect their lives because they cannot return to work unless testing confi rms MRSA- 
negative status. Fortunately, MRSA colonization ( antibiotic-resistant strain of bac-
teria that lives on skin) is usually temporary, but when persistent, eradication 
requires longer-term efforts. Although untreatable colonization is rare, it can neces-
sitate job change (Boyce et al.  2005 ). 
6.5.2  Case Description 
 A Dutch medical  student has the potentially more virulent Panton-Valentine leukoci-
din (PVL) form of MRSA colonization yet shows no signs or symptoms of infection. 
More than a year ago, a routine MRSA screening of health care personnel providing 
care for MRSA-positive patients detected the colonization. Since then, the student 
has been treated intensively but unsuccessfully in an attempt to decolonize her. 
During this decolonization period, the medical student was barred from performing 
patient-related interventions, temporarily interrupting her medical residency. After 
initial treatment with mupirocin nasal ointment and  antibiotics proved ineffective, a 
more stringent hygiene regime was added that included hand, nose, hair, and body 
scrubbing with disinfecting soap. Additional precautions included simultaneous 
treatment of household members and disinfection of the family home. Despite these 
efforts, her MRSA status has remained positive.  WIP  guideline s bar  any  health  care 
worker diagnosed with MRSA from performing patient-related interventions. Unable 
to complete the residency requirement of at least 1 year of patient care, the medical 
 student was advised to pursue a career in another profession. 
 Refusing to accept this verdict, she united with other similarly excluded medical 
students to launch a protest that gained media attention. In a press interview, she 
acknowledged that potential iatrogenic spreading of MRSA could risk institutional 
or community safety. However, she questioned the seriousness of this risk and 
argued that the protesting students were being unfairly targeted. She pointed out that 
medical staff are not routinely screened for MRSA unless they have cared for a 
MRSA-positive patient or have worked in a country with high MRSA prevalence. 
Because MRSA can be acquired in the community, potentially many undiagnosed 
MRSA-colonized medical staff  or  residents currently work in hospitals. She also 
pointed out that other European countries, despite a higher MRSA prevalence, allow 
MRSA carriers to work in health care settings. Despite being persistently MRSA 
positive, these professionals can safely work in medical specialties that do  not 
involve direct patient contact. 
2 An English version of the WIP guidelines is available at  http://www.wip.nl 
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 As a result of this press coverage, the public has pressured  the WIP to reconsider its 
guidelines. Because iatrogenic spreading of disease has public health implications, you, 
as a public health  profession al, have been asked to serve on a WIP committee charged 
with considering whether the guidelines need to be changed to address these and future 
cases.  The chair of the committee wants to discuss the following questions. 
6.5.3  Discussion Questions 
 1.  Who are the main stakeholders in this case, and what are their primary interests? 
 2.  What is the ethical rationale for allowing or not allowing medical students who 
are MRSA carriers to continue their medical education? 
 3.  What would be your ethical justifi cation for either recommending or not recom-
mending universal screening for all medical students and doctors? 
 4.  How would it change your recommendation if
 (a)  The MRSA of this student was not PVL positive? 
 (b)  The overall prevalence of MRSA in the Netherlands was high or rapidly 
increasing? 
 (c)  There was little or no evidence that excluding colonized health care workers 
decreases risks to patients? 
 (d)  The students agreed to pursue medical specialties that do not involve patient care? 
 5.  Although the European Union (EU) is increasingly standardizing its AMR  pol-
icy , some EU countries have less stringent regulations than others. Would it be 
ethical to advise the medical students in question to fi nish their education in a 
European country with a less stringent MRSA policy? 
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expressed are the author ’ s own. The case is not meant to refl ect the offi cial position , 
 views ,  or policies of the editors ,  the editors ’  host institutions ,  or the author ’ s host 
institution . 
6.6.1  Background 
 The lack of access to safe drinking water is a serious public health problem affecting 
many developing countries. More than 780 million people, mostly located in  sub- 
Saharan Africa , lack safe drinking water.  Sub-Saharan Africa only has coverage 
with safe drinking water sources for 61 % of its  population , a stark contrast with 
regions such as  Latin America , northern Africa, and most of Asia, which have all 
achieved greater than 90 % coverage (World Health Organization/United Nations 
Children’s Fund Joint Monitoring Programme for Water Supply and Sanitation 
 2012 ).  T he  Millennium Development Goals (MDGs) have specifi ed that by 2015, 
the proportion of people who lack access to  safe water  and sanitation should be 
halved (United Nations  2013 ). Signifi cant progress has been made towards achiev-
ing this goal; however, vast inequities emerge when comparing populations of rural 
areas to urban ones, and of more impoverished communities to those with a higher 
socioeconomic status. As such, progress toward achieving access to safe water and 
sanitation facilities is not likely to be equitable. As an example, one estimate by the 
United Nations Development Program suggests that the world overall will attain the 
safe water and sanitation MDGs by 2016 and 2022 respectively, but sub-Saharan 
Africa is not projected to attain these goals until 2040 and 2076 (Jimenez and Pérez- 
Foguet  2010 ). 
 In sub-Saharan Africa, 19 % of the rural population resort to using surface water 
collected from streams, rivers, ponds, or other such sources.  Unprotected water 
sources are particularly dangerous because those who fetch  water contaminate the 
water source by reaching their hands into the water and wading into it as they fi ll 
their basins and jerrycans. Open defecation and lack of  sanitation also contribute to 
contamination, as does fecal runoff from livestock wandering through unprotected 
water sources. Water that is not contaminated at the source runs a high risk of 
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becoming contaminated on its way to the drinking cup due to inadequate home  stor-
age and dispensing methods that allow  children or other household members to 
reach into the water while serving it. As a result of this rampant drinking water 
contamination,  diarrheal disease is common in residents of areas without access to 
safe water. Diarrheal disease is deadliest for young children, the elderly, and immu-
nocompromised community members, such as people living with  HIV/AIDS . In 
children younger than 5 years of age, diarrheal disease is the second leading cause 
of death (World Health Organization  2009 ).  Wit h proper access to safe water and 
sanitation,  most of these deaths would be prevented. 
 Access to  safe water  can prevent many other potentially lethal  infectious dis-
eases . These include schistosomiasis, intestinal worms, and malnutrition from 
repeated diarrheal and intestinal worm infections.  Diarrheal disease , however, rep-
resents the bulk of the  disease burden contributed by poor  sanitation , hygiene, and 
drinking water quality (Prüss-Üstün et al.  2008 ). 
 The World Health Organization (WHO) publishes a simple set of recommenda-
tions to help small communities with limited water supplies maintain water safety. 
One key recommendation calls for the creation of, and adherence to, a  Water Safety 
Plan (WSP) , using illustrated pamphlets to convey the need for preventive mainte-
nance of water supplies. Another recommendation calls for innovative monitoring 
strategies such as the use of mobile phones to send data from the fi eld to public 
health inspectors (WHO  2010 ). Water treatment products like chlorine can be added 
either at the well, when the water is collected, or at the point of use in the home to 
reduce the risk of  water contamination (WHO  2011 ). 
 The WHO also has detailed  guideline s for drinking water quality. These guide-
lines promote the use of  health-based targets , which take into account local vari-
ables such as public health status, contribution of drinking water to the transmission 
of  infectious disease , and social and cultural factors. Some international organiza-
tions set infl exible water quality standards for pathogen concentrations used in ana-
lyzing data from water sources and drinking water. The WHO instead suggests that 
such targets be modifi ed to realistic and attainable goals. In order to most appropri-
ately allocate limited resources, the WHO additionally suggests “less stringent tran-
sitional targets supported by sound  risk management systems ” to achieve a “tolerable 
 disease burden ” for waterborne illness, with incremental improvement in a health- 
based transitional target eventually progressing towards tight water quality control, 
as resources allow. Such transitional targets can be developed with the aid of risk 
management theory. Data collection and  advanced  statistical modelling may be 
challenging in countries with limited resources. Estimations of organisms per liter 
in raw water can be combined with  information on risk of diarrheal illness from a 
given infection, and  health outcome targets , to calculate performance targets for 
reducing pathogens through water source control or treatment interventions. 
Modifi able targets should consider the relevant risks and benefi ts in a local area to 
attain the desired reduction in illness occurrence, and thus, health outcomes, as 
measured in  disability-adjusted life years per person per year. These targets should 
be outlined in the  Water Safety Plan (WHO  2011 ). 
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6.6.2  Case Description 
 You are a managing director for a small  nongovernmental organization (NGO) in 
rural  sub-Saharan Africa . Your organization partners with rural villages to construct 
protected shallow wells in areas where residents otherwise need to walk more than 
2 km to reach the nearest safe source. This program was designed to be as cost 
 effective as possible, with village residents volunteering their time and manual labor 
for well construction. 
 Organization members debated whether to use borehole drilling or cheaper, hand-
dug protected shallow wells. Because boreholes draw water from deep underground, 
the likelihood of contamination from surface runoff is far less. In contrast, shallow 
wells risk contamination, particularly if steps are not taken to address the problem, 
such as constructing a fence around the site to keep grazing livestock away. The 
nonprofi t board concluded that boreholes would be about ten times as expensive to 
drill, allowing construction of one-tenth the number of wells for the same funding. 
They therefore decided to focus on shallow well construction to reach the greatest 
number of communities in need. Still, questions remained about the relative health 
risks of an approach prone to contamination. Some members of the organization are 
concerned that the shallow well method was pushed, in part, because it was less 
 expensive and the number of wells constructed would impress donors. 
 The program was designed in  collaboration with the District Water Offi ce for 
sustainability. Although the District Water Offi ce agreed to assume responsibility for 
testing the water quality of wells being built, its ability to conduct the tests has been 
limited by a lack of fi nancial resources. Your organization therefore has undertaken 
its own  water quality testing of roughly 50 wells constructed in the district. Your well 
construction program manager has reported to you the discouraging results of the 
water quality tests. Of the wells tested, 20 % have  coliform bacteria present in levels 
unacceptable to international standard drinking water  guideline s, which the staff use 
as a target for water quality as part of the program’s monitoring and evaluation plan. 
The program manager, who has been in discussions with the District Water Offi ce 
and other nonprofi ts involved in well construction, has several ideas to improve the 
well construction process and strengthen protection against coliform contamination 
in the wells. He also wants to remediate the wells that failed the testing. 
 Before committing to any of these ideas, you hold an organizational meeting to 
help you decide whether or how to convey these results to the community members 
who use the wells, knowing they mistrust both governmental and nongovernmental 
programs. You particularly worry about the damage to your organization’s reputation 
in trying to convey that the water from wells it has built is dangerous to drink. One 
staff member suggests holding community meetings to discuss the issue. Meanwhile, 
all heavily contaminated wells would be marked with signs and red tape to indicate 
the water is unsafe to drink. Another staffer argues that marking the wells in such a 
way might frighten community members and discourage them from drinking from 
the wells even after remediation. He notes that if told not to use these sources, com-
munity members might prefer using nearby but similarly (or worse) contaminated 
open water sources to walking a long distance to fi nd another protected source. 
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Although the educational workshops the organization offers have always empha-
sized the need for boiling water or chemically treating it with a chlorination product 
to ensure its safety, you know that in practice, many community members consider 
water from a protected source to be “safe,” regardless of whether it is boiled or 
treated. As you leave the meeting,  you realize you have four key questions to resolve. 
6.6.3  Discussion Questions 
 1.  What ethical implications are raised by considering whether or not to publicize 
the water quality test results? Which option is more justifi ed, and why? 
 2.  What ethical concerns are raised by the use of shallow well construction, which 
allows more wells to be constructed at lower cost but at higher risk of water 
contamination? 
 3.  If the water quality test results are publicized, what participatory approach might 
best address the problem with water quality? 
 4.  Considering that lower water quality standards could result in more illnesses and 
deaths in the community, is the WHO’s risk-benefi t approach the most appropri-
ate way to determine what is environmentally, economically, and socially pos-
sible? Would it be better to base one’s strategy on an internationally recognized 
standard for acceptable water quality? 
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6.7  Case 4: Implementation of  Global Public Health 
Programs and Threats to Personal Safety 
 Alison  Hayward 
 Department of Emergency Medicine, Yale School of Medicine 
 Yale University 
 New Haven ,  CT ,  USA 
 Uganda Village Project 
 Iganga ,  Uganda 
 e-mail: ahs.hayward@gmail.com 
 This case is presented for instructional purposes only. The ideas and opinions expressed 
are the author ’ s own. The case is not meant to refl ect the offi cial position ,  views ,  or 
policies of the editors ,  the editors ’  host institutions ,  or the author ’ s host institution . 
6.7.1  Background 
 Many global public health agencies and organizations from high-income countries 
conduct programs in locations where the personal safety of workers and volunteers 
cannot be guaranteed. Staff and volunteers of  nonprofi t organizations and  govern-
ment aid agencies face a variety of threats. In 2012, aid workers were harmed in 100 
discrete incidents involving 187 aid workers, 43 of whom were  international aid 
workers (Humanitarian Outcomes  2013 ). These incidents included kidnappings, 
murder, and traumatic injury. The profi le of deaths amongst aid workers and volun-
teers who serve in  confl ict zones signifi cantly differs (Sheik et al.  2000 ). Contrary 
to popular belief, tropical  infectious diseases rarely cause death in aid workers 
(Hargarten et al.  1991 ). A systematic review of  unintentional injury in international 
travelers found that only 2 % of traveler deaths were secondary to infectious dis-
ease, whereas injury represented a major cause of death.  Motor vehicle accidents 
were the leading cause of fatal injury to travelers (McInnes et al.  2002 ). 
 According to the World Health Organization’s  Global Status Report on  Road 
Safety , more than 90 % of the world’s road fatalities occur  in  low and middle- 
income countries. The report further notes that the majority of road fatalities in 
these countries occur among  vulnerable  road users—pedestrians, cyclists, and rid-
ers of motorized two-wheeled vehicles (World Health Organization  2009 ).  Little 
 research has been conducted on health and safety policies and procedures for inter-
national nongovernmental  organizations (O’Sullivan  2010 ). One exception is the 
U.S. Peace Corps. A study done of fatalities in the  Peace Corps between 1962 and 
1983 revealed that  unin tentional injuries caused 70 % of deaths, with motor  vehic le 
crashes the top cause of fatality, and motorcycle collisions responsible for 33 % of 
the deaths related to  motor vehicles (Hargarten and Baker  1985 ). 
 After release of the report, the Peace Corps banned motorcycle use in many 
countries in which their volunteers serve and mandated a motorcycle safety course 
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and helmet usage in countries where the use of motorcycles was still permitted. A 
follow-up study of fatalities through 2003 concluded that injury  prevention mea-
sures instituted as a result of the prior study had signifi cantly decreased the risks 
faced by Peace Corps volunteers (PCVs), although, once again, motor vehicle col-
lisions topped the list of causes of death. In the 20 years prior to institution of the 
 helmet rules , 22 of 105,539 PCVs died in motorcycle collisions. In the following 
20 years, another 71,198 PCVs participated in the program, but only 2 died in 
motorcycle collisions (Nurthen and Jung  2008 ). These studies provide evidence that 
preventive measures can save the lives of aid workers and volunteers even in low- 
income countries with poor  transportation safety and  infrastru cture. 
6.7.2  Case Description 
 In rural  sub-Saharan Africa , you oversee the operations of a  nonprofi t organization 
that provides public health programs to remote communities. Needs assessments 
have shown that these areas have the greatest poverty, as well as lack of access to 
safe water sources and health care facilities. But the roads leading to the villages, 
which become little more than footpaths at some points, pose challenges to travelers 
that include erosion, fl ooding, and large potholes as well as the physical obstacles 
of livestock,  children , other pedestrians, and bicyclists. The optimal strategy for 
reaching the villages is to use a motorcycle. 
 While working on a grant proposal one afternoon at the offi ce, you receive a cell 
phone call from Moses Izimba, a program manager for your nonprofi t. Earlier in the 
day, several staff and volunteers had taken “boda-bodas” (motorcycle taxis) to a 
remote village to offer a  sanitation outreach program. Despite passenger warnings 
to drive slowly due to the road conditions, the taxi drivers were speeding when a car 
that pulled suddenly into their path caused a collision. 
 One victim is a staff member who had left without his motorcycle helmet as the 
group rushed to depart. With a quivering voice, Moses reports that this staff member 
did not survive the collision. Another victim is a volunteer who had purchased a 
helmet at a local shop, which likely was not safety certifi ed by the Ministry of 
Transportation. This helmet now lies shattered near the accident scene, while the 
volunteer, still bleeding from a large scalp laceration, is alive but comatose. 
 The only four-wheeled vehicle on hand for transportation is the car involved in 
the accident, which now has a broken windshield, but the driver has offered to trans-
port the victims to a health care facility. You urge Moses to get the injured staff 
member  to  the district hospital quickly. As you end the phone call, shocked by the 
tragic news, several thoughts come immediately to mind. Could this accident have 
been prevented? How can the organization best deal with a serious  trauma to one of 
its staff members during fi eldwork? 
 You convene a committee to discuss the ramifi cations of the accident. The com-
mittee’s pragmatic charge will be to examine staff insurance benefi ts, including 
evacuation coverage and repatriation of remains; organizational  policy improve-
ments to minimize the likelihood of riding without a helmet; appropriate standards 
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for safety equipment; an alert system to warn of hazardous road or transportation 
conditions; and innovative strategies to optimize  transportation safety under local 
conditions. But the committee has also been asked to consider three areas of ethical 
challenge  the  situation has presented. 
6.7.3  Discussion Questions 
 1.  Under what circumstances should you limit humanitarian aid based on the 
assessment of risk to workers or volunteers? What is an acceptable level of risk, 
and what  harms —to the organization, its staff, and the communities being 
served—could potentially result from limiting or ending aid? 
 2.  What are the obligations of nonprofi ts or humanitarian agencies to protect their 
workers from safety threats, given that they frequently operate in dangerous 
environments where infrastructure is lacking? Do the obligations of nonprofi ts 
differ from the private sector when it comes to protecting the health and safety of 
their staff, and if so, how? 
 3.  How can a nonprofi t or humanitarian agency best deal with a tragic accident 
resulting in the death or serious injury of a volunteer or worker? Consider the 
ethical pros and cons of the potential approaches that could be taken to prepare 
for risks to aid worker health and safety and address such a situation as it unfolds, 
including risk communication. 
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 Chapter 7 
 Vulnerability and Marginalized Populations 
 Anthony  Wrigley and  Angus  Dawson 
7.1  Introduction 
 Public health practitioners attempt to identify and then remove, or at least reduce, 
threats of harm. However, harm does not affect everyone in the same way. Some 
people and communities are resilient, whereas others are more susceptible to poten-
tial harm. Much public health work is carried out by, or on behalf of,  government s. 
Where people or communities are at great risk of harm, government has a clear and 
fi rm responsibility to protect its citizens. One way of describing a potential source 
of such a risk of harm is to focus on the idea of  vulnerability . This introduction 
explores the concept of ‘vulnerability’ and the role that it may play in public health. 
 Vulnerability is a concept often used in public health ethics and more broadly in 
 bioethics —but its exact meaning is unclear. Roughly, it indicates that an individual 
or group is thought to have a particular status that may adversely impact upon their 
well-being, and that this implies an ethical  duty to safeguard that well-being because 
the person or group is unable to do so adequately themselves. This concept, although 
important, consistently eludes precise defi nition. The diffi culty in defi ning the con-
cept arises from disagreement as to how to characterize the idea of “special status” 
and to whom it applies. As a result, more and more categories of individuals and 
groups are being classifi ed as vulnerable in an ever-increasing range of situations. 
This raises the concern that almost everyone can be classifi ed as vulnerable in some 
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tion ,  views ,  or policies of the editors ,  the editors ’  host institutions ,  or the authors ’  host 
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way and, in turn, that almost every activity now requires this additional attention. If 
true, then the concept of ‘vulnerability’ ceases to be useful because if everyone is 
vulnerable, then no one is. 
 There is currently no clear, single, defi nitive account of this concept that is univer-
sally accepted, although numerous different approaches have been adopted by, for 
example, various international bodies in their  guideline s. In this chapter, we shall 
critically examine some leading defi nitions of vulnerability and attempt to explain 
and classify them to make clear the differences in approach. Then we will offer an 
account of vulnerability that seeks to provide a universal basis for the everyday use 
of the concept while avoiding the pitfalls associated with the other defi nitions. Our 
approach aims to reduce the concept to a simple role, not as a basic moral concept in 
its own right, but as a marker, or signal, to public health practitioners that something 
in the situation before them requires ethical attention. The real ethical work is to be 
done by the practitioner, not by vague appeal to the idea of vulnerability, but via the 
application of other concepts and ethical concerns that are already familiar in public 
health and  bioethics .  We shall use case studies to illustrate how this approach works. 
7.2  Different Approaches to the Concept of Vulnerability 
 Before looking at the approaches taken to defi ne vulnerability, a worthwhile starting 
point is to examine the concept that can be derived from the term’s everyday use. 
Vulnerability, in line with the etymological root of the word meaning “to wound,” is 
widely interpreted as
 ( V1 ) Open to harm or under threat of harm. 
 This basic defi nition is perfectly adequate, for a range of uses, with context deter-
mining the nature and kind of harm at stake. However, such a defi nition only captures 
a broad background use as to how the concept should be employed. Though this defi -
nition will be suffi cient for most purposes, further clarity and greater specifi city of the 
concept is needed here. In attempting to refi ne this basic defi nition, several challenges 
arise. First, how we formulate any defi nition will change whether or not we see some-
one as vulnerable. Therefore, in providing a more substantial defi nition, one has to 
avoid the problem of inadvertently excluding those who should be considered genu-
inely vulnerable or including those who are not vulnerable. Second, if we want the 
concept of vulnerability to function as something that generates a  duty or responsibil-
ity to prevent  harms from befalling people, then we must move beyond a basic, factual 
description and include some normative ethical element, something along the lines of 
what Goodin  c haracterizes as “the principle of protecting the vulnerable” ( 1985 , 110). 
 Providing a sound defi nition of  v ulnerability that satisfi es these elements is more 
diffi cult than might be expected.  Hurst ( 2008 ) captured this diffi culty well by liken-
ing it to the attempts of six blind men trying to describe an elephant. As each blind 
man touches a different part of the elephant—the trunk, ear, tusk, tail, etc.—they 
cannot agree on how to describe the animal. This analogy maps directly to the chal-
lenge of defi ning vulnerability. Because different perspectives abound on what con-
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stitutes the grounds of vulnerability, consensus on the defi nition is diffi cult to reach 
(Schroeder and Gefenas  2009 ). 
 Much of the focus on vulnerability in the  bioethics literature has been in  research 
ethics, where many international guidelines recommend or impose some duty to 
provide extra protection for those considered vulnerable. However, these  guideline s 
generally fail to defi ne the concept (although the  Council for International 
Organizations of Medical Sciences [CIOMS] ( 2002 ) does provide a defi nition) and, 
instead, list groups commonly  considered  vulnerable (U.S. Department of Health, 
Education, and Welfare  1979 ; World Medical Association  2013 ; CIOMS  1993 ). 
Although this practice is slowly changing, strategies for analyzing and defi ning the 
concept are usually limited to simply adding or subtracting from a  list  of properties, 
conditions, or categories that typify what it is to be considered vulnerable. 
 The approaches taken to defi ne vulnerability beyond everyday use ( V1 ) can be 
categorized broadly into three basic types:
 ( V2 ) Vulnerability is a universal condition that humanity has in virtue of our physi-
cal or social nature (Fineman  2008 ; Hoffmaster  2006 ; Turner  2006 ; Rogers et al. 
 2012 ; MacIntyre  1999 ; International Bioethics Committee of UNESCO [IBC] 
 2013 ; and to  s ome extent Hart  1961 ). 
or
 ( V3 ) Vulnerability involves one or more specifi c attributes, contexts, or group types 
(Rendtorff  2002 ; and this is perhaps also the approach taken by the International 
Bioethics Committee of UNESCO when it considers what it calls special vulner-
abilities,  2013 , 5–6). 
or
 ( V4 ) Vulnerability involves one (or more) familiar but overarching ethical  conc ept(s) 
(Goodin  1985 ; Wrigley  2010 ). 
 Before we critically examine each approach, it is worth noting that all defi nitions 
are perfectly adequate depending on what we want the concept to do or what role 
we want it to play. One possible explanation for the failure to produce a single, uni-
versally agreed-upon defi nition of this concept is that, put simply, those who use the 
term have different aims and roles in mind. 
7.3  Concerns Surrounding Approach (V2): Universal 
Condition 
 Approaches to the concept along the lines of ( V2 ) use vulnerability to mark every 
human as somehow open to harm—including physical injury, dependency on oth-
ers, loss of power, and so forth—just by virtue of being human (Fineman  2008 ). 
Hence, by that logic, everyone is vulnerable because we all have bodies that can be 
injured, disabled, and fail through illness and old age. On this view, we are also 
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vulnerable because whilst we live in social units that require  interdependence , high 
quality interaction does not always exist. 
 ( V2 ) is a very particular way of thinking about the concept of vulnerability inas-
much as it motivates and drives discussion of the human condition in general. However, 
the major problem with such accounts is that the general truth that we, as humans, are 
open to  harms of various kinds or that we live in social groups, fails to pick out a spe-
cial category because it applies to absolutely everyone. It becomes diffi cult to talk of 
‘ degrees ’ or ‘ types ’  of vulnerability on such accounts. This, in turn, has led to the criti-
cism that such an approach results in the “naturalizing” of the concept, whereby it is 
held to be normal or natural to be vulnerable in one way or another (Luna  2009 ). Of 
course, if the idea behind using the term ‘ vulnerable ’ is ( a ) to articulate a fundamental 
aspect of the human condition, ( b ), to say something substantive about the interdepen-
dence of humans, and, perhaps, ( c ) to thereby affi rm a natural commitment to human 
 solidarity , then much substantive (and controversial) content is built into the concept, 
and our discussion moves far from the everyday meaning of vulnerability. If we are all 
vulnerable, then appealing to this concept as a means to avoid a harm or seek special 
protection becomes problematic, as it is hard to see how particular priorities can be set. 
 This approach makes vulnerability far too broad to serve as anything other than 
an underlying presumption about all human beings, and so it is unable to generate 
ethical  duties beyond what we owe to every human by virtue of being human. As a 
result, this approach does not provide an account of vulnerability that can identify 
cases where people or groups are potentially open to harm in any special way. 
7.4  Concerns Surrounding Approach (V3): Specifi c 
Attributes, Contexts, or Groups 
 In direct contrast to the approach taken in ( V2 ), ( V3 ) characterizes vulnerability by 
identifying it with some specifi c attribute, context, or group membership. This 
approach focuses on vulnerability  in terms of something , such as physical vulnera-
bility, social vulnerability, vulnerability  in terms of lacking capacity, vulnerability  in 
terms of belonging to a certain identifi able group, or vulnerability because of 
belonging to a marginalized population, etc. 
 This approach to defi ning the concept is an excellent way of illustrating the sorts 
of conditions that we might want to pick out as requiring special consideration in 
terms of susceptibility to harm. As such, ( V3 ) serves as a useful heuristic device 
because it gives examples of the sorts of things that are often considered vulnerabili-
ties. However, this check-list approach is to  borrow  David Lewis’s ( 1986 ) phrase, an 
attempt at explanation by “way of example,” whereby we provide some key para-
digmatic examples or illustrations of what constitutes vulnerability and state that 
vulnerabilities are “these sorts of things.” 
 This approach does a poor job of defi ning vulnerability. Listing everything that 
falls under a concept, even if it were possible, does not give us a good defi nition of 
that concept. ( V3 ) neither tells us whether the examples listed are appropriate nor 
guides our decision making on controversial cases where identifying someone as 
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vulnerable is unclear. Further, by using the ( V3 ) approach, attention is directed 
away from the underlying question of what vulnerability  is ; and instead, the focus 
is on whether or not to add a particular group to a continually expanding unstruc-
tured list of examples (Rogers et al.  2012 ). Of course, any such list might prove 
useful as an aide memoir during, for example, an emergency event. Such a prag-
matic role may be useful, but it should not be mistaken for  an  ontological category 
or conceptual boundary. 
 The ( V3 ) approach has therefore met with the criticism that it is both too broad 
and too narrow to satisfactorily defi ne vulnerability (Levine et al.  2004 ; Schroeder 
and Gefenas  2009 ; Luna  2009 ). Concerns about being too broad stem from the list 
of vulnerabilities becoming infl ated to the point where “virtually all potential human 
subjects are included” (Levine et al.  2004 ). As such, the same concern for ( V2 ) 
applies to ( V3 ), since both approaches fail to specify in suffi cient detail those who 
need additional or special protection from  harms . 
 ( V3 ) is also, potentially, too narrow because it focuses all attention onto specifi c 
or group characteristics and therefore fails to address concerns outside the particular 
designated categories (Rogers et al.  2012 ). It will, therefore, potentially miscatego-
rize certain individuals or groups as  not being vulnerable if, for example, they are a 
group that has not been encountered previously or if some trait has not made it onto 
the list of specifi ed characteristics. Moreover, by focusing on specifi c or group char-
acteristics, ( V3 ) can stereotype individuals who fall under category headings (Scully 
 2013 ). If, for example, we assign names to different categories of vulnerability (e.g., 
‘the elderly’, ‘the disabled,’ or ‘women,’ or ‘the poor’ as categories of vulnerabil-
ity), then many people could be classifi ed as vulnerable without them necessarily 
being at any greater risk of harm. 
7.5  Concerns Surrounding Approach (V4): Overarching 
Concepts 
 The ( V4 ) approach explains vulnerability in terms of one or more overarching but 
more familiar ethical concept(s). Perhaps the best example of this kind is  Goodin ’s 
( 1985 ) account of vulnerability, which builds on the everyday use of the term 
( V1 )— open to or under threat of harm— but goes a step further by exploring what 
the relevant harms might be. This leads Goodin to interpret “harm” in terms of a 
person’s “welfare” or “interests” so giving us an initial defi nition of being vulnera-
ble in terms of ‘ being susceptible to harms to one ’ s interests ’( 1985 , 110–114). 
 However, as the concepts of ‘welfare’ and ‘interests’ can in turn be open to a 
great deal of interpretation, including the possibility of focusing on subjective expli-
cations involving the satisfaction of preferences or desires, further clarifi cation is 
needed. To this end, Goodin suggests that a particular sub-group of interests, that 
is—people’s “vital interests” or “needs”—are the universally important welfare 
considerations that we need to be concerned about. On this view, one is vulnerable 
if one’s needs are threatened. And one is most vulnerable if one’s most  vital  needs 
are threatened. 
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 Goodin also adds an explicit normative role to the concept of vulnerability by 
imposing an ethical  duty to safeguard the potentially vulnerable from harm. This 
role is imperative if the concept of vulnerability is to be anything more than a factual 
description of an individual’s or a group’s characteristics. Goodin does this by link-
ing his account of vulnerability to the “principle of protecting the vulnerable,” 
which is, essentially, an  obligation to protect the vital interests of others. Hence 
there is a direct link between the classifi cation of someone as being vulnerable, with 
a requirement on the part of others to protect them from any potential harms. 
 Despite being a highly infl uential account of vulnerability, this approach has 
been criticized. One concern is that it potentially promotes widespread  paternalism 
in an attempt to meet others’ needs (Rogers et al.  2012 ), thereby characterizing all 
vulnerable people as, in some way, being helpless. This criticism misses the mark, 
though, because being vulnerable by Goodin’s account does not mean one is power-
less. More telling, however, are the concerns that this account does nothing more 
than reduce the concept of vulnerability to the well-recognized concept of needs, 
together with a moral theory that demands we aid those in need. In essence, this 
implies that the concept of vulnerability is redundant and could be replaced with the 
concept of being in (serious) need. 
7.6  Simplifying the Concept of Vulnerability (V5): 
The Moral-Marker Approach 
 Rather than continuing this attempt to defi ne vulnerability along the lines of the 
approaches already mentioned ( V2 ,  V3 ,  and V4 ), an account of vulnerability can be 
offered in much simpler terms. Instead of seeking a substantive defi nition that tries 
to establish conditions for vulnerability, another option is to interpret the word “vul-
nerability” as nothing more than an empty marker or signal for potential moral 
concern. This approach can be seen in  Hurst’ s view of vulnerability as a sign of 
“increased likelihood of incurring additional or greater wrong” ( 2008 ). However, 
this view can be taken further. A formal moral-marker approach simplifi es the 
account of vulnerability by avoiding any reliance on moral theory or preconceived 
wrongs as part of the defi nition. On this account,  vulnerability will simply be
 ( V5 ) A marker that additional consideration needs to be given to whatever existing 
ethical issues there may be. 
 It can be seen that what is then in dispute between the different accounts presented 
is what sorts of considerations are the relevant ones. However, if we stop at the point 
where “vulnerability” is recognized as just a warning marker, we don’t need to 
engage with the substantial task of trying to provide a catch-all defi nition that some-
how incorporates all physical, mental, or emotional, etc. cases that might constitute 
vulnerability. Instead, we can focus on substantive ethical concepts such as harm, 
consent, exploitation, etc. and explore how each applies to the particular case before 
us. On the basis of this approach, “vulnerability” says nothing at all about what gen-
erates the need for any special scrutiny because the substantive  ethical weight of the 
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concern (and how to address it) requires us to engage with these substantive moral 
concepts. So, for example, it says little to talk about marginalized populations as 
being vulnerable, but if we recognize the ‘moral marker’ of  vulnerability here, we 
might then explore how exploitation,  inequity , and harm are relevant when deliberating 
about a particular case. One of the priorities for educating public health  profession als 
about ethical issues is to seek to increase their sensitivity to the relevant features of 
each situation, rather than teach them the formulaic application of rules or vague 
concepts such as that of “vulnerability” (Coughlin et al.  2012 ). 
 The ( V5 ) approach offers other advantages as well. For example, it avoids stereo-
typing based merely on belonging to a specifi ed category; it avoids exclusion on the 
grounds of not already being on the list of vulnerable groups; and it avoids the vacu-
ity of identifying “all” as vulnerable, while maintaining the crucial aspect that the 
concept marks out the need for special ethical scrutiny. Trying to provide more 
substantial components to the defi nition  of  vulnerability diverts scrutiny and energy 
from where it matters most—sensitive, rational thought about specifi c problems—
and instead, promotes a formulaic approach to ethical safeguarding. 
 Although other writers on vulnerability, such as Levine et al. ( 2004 ) and Luna 
( 2009 ), criticize this approach claiming generic guidance about paying “special atten-
tion” or giving “special consideration” to something is not useful, the same criticism 
could also apply to an account that identifi es specifi c categories or relies on some over-
riding concept. For example, if we try the specifi c category or context route ( V3 ) so 
that, say, we hold “the elderly” vulnerable, how would that guide our actions without 
reference to established concerns about, for example, physical  harms or exploitation? 
The same holds true of ( V4 ) accounts such as  Goodin ’s focus on vulnerability as being 
open to harms to one’s interests, which then requires further analysis of “vital” needs. 
The best that can be said for such accounts is that each provides something of a heuris-
tic, teaching anyone who wants  to  learn ways in which harms or wrongs might arise. 
 The importance and implications of these issues become apparent as we consider the 
various cases in the rest of this chapter. The implications of ( V2 ), the approach focused 
on vulnerability as arising from the human condition, is that all are vulnerable, includ-
ing the police and  immigration offi cials in Blight’s and McDougall’s cases, the public 
health offi cials with responsibility for launching national programs to reduce  Sudden 
Infant Death Syndrome (SIDS) in the Jonas and Haretuku case, and the prison governor 
in Christopher et al.’s case. This outcome demonstrates the key problem with this view. 
The very concept of vulnerability ceases to have much meaning, although presumably 
there might be a retreat to the thought that some individuals and populations are ‘more’ 
vulnerable than others, although it is unclear how this is to be specifi ed. 
 Many of the cases could more obviously be used to endorse ( V3 ), the approach 
focused on specifi c groups, contexts, or categories. Many of these cases focus on 
marginalized groups within society, such as prison  inmates (Christopher et al.), 
immigrants,  asylum seekers ,  refugees (McDougall; Blight), substance abusers 
(Christopher et al.), minority communities of various kinds (Bernard et al.; Blight; 
Jonas and Haretuku), and the poor (Vergès et al.). This is a traditional, infl uential, 
and powerful way of thinking about vulnerability. However, as stated previously, 
this approach has its problems. Does it necessarily follow that if you belong to one 
of these groups that you are vulnerable? You may well be at increased risk of harm 
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of various kinds if you belong to such groups. However, you might also be at 
increased risk of harm as a recreational drug user, skydiver, or American football 
player, although individuals belonging to such groups are not likely to be seen, 
intuitively, as being necessarily vulnerable. 
 The more specifi c focus on providing a normative explanation for vulnerability pre-
sented in the work of writers such as  Goodin ( V4 ), is more useful, in that we can begin 
to clearly identify subgroups that are at risk of harm to their vital interests (the girl fed 
through a tube and unable to feel pain involved in a forced  deportation case: Blight), 
rather than just being routinely disadvantaged (the surrogate encouraged to take on that 
role because of poverty: Vergès et al.) or at increased risk of harm due to the cultural 
traditions or choices of their  parent s (Jonas and Haretuku). How should we think about 
risk factors and vulnerability? Some will think of  smoking around  children (increasing 
the risk of SIDS) as being an individual’s choice. Others will argue that it is unfair to 
assume that it is always individuals that are responsible for such choices and the 
resultant outcomes, as people may be addicted to nicotine or they may have  become 
 smokers through the infl uence of  norms within their social environment. 
 The advantage of the ‘moral-marker’ approach ( V5 ) is that it allows us to dive 
beneath the surface offered by the label of ‘vulnerability’ and offer more sophisticated 
explanations for the situations described in the cases, as well as providing the oppor-
tunity to develop strong normative reasons to respond. For example, all of these cases 
are about various kinds of injustice, disadvantage, and inequities in society, and their 
impact on individual and  community health . They are appropriate issues for those 
working in public health to be concerned about precisely because they provide refer-
ence to the identifi cation of various  harms at the population-level, and many of the 
solutions to these issues will have to come through collective and public action. 
 As the discussion of the different approaches to defi ning vulnerability consid-
ered above illustrate, most of the approaches to vulnerability do little more than 
encourage us to engage in additional ethical scrutiny using already well recognized 
and well understood moral concepts. The fi nal ‘moral-marker’ approach ( V5 ) sug-
gests that this is exactly what the concept should be used for, and nothing more. 
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 views ,  or policies of the editors ,  the editors ’  host institutions ,  or the authors ’  host 
institutions . 
7.7.1  Background 
 Sudden Infant Death Syndrome (SIDS) involves the death of apparently healthy 
sleeping infants, usually within the fi rst year of life. It is a diagnosis of exclusion, 
that is, it denotes an unknown cause of death (Willinger et al.  1991 ; American 
Academy of Pediatrics  2011 ). It is also known as cot or  crib death and is  classifi ed 
 as a form of Sudden Death in Infancy (SUDI). 
 Unlike many public health issues, SIDS unites clinical and forensic considerations, 
as this fi nding of cause of death can determine attribution of criminal (and moral) 
responsibility. Police collect evidence and coroners assess the circumstances of the 
death and release judgments. This is the method by which a SIDS death is determined. 
Context heightens the ethical signifi cance of SIDS diagnosis, research, and  prevention . 
 In 1991, when the New Zealand Cot Death Study (NZCDS) commenced, New 
Zealand’s rate of SIDS was high by international standards at 4 deaths per 1,000 live 
births (Mitchell et al.  1997 ) compared, for example, to the  Netherlands (1.3/1,000 in 
1989) (de Jonge et al.  1989 ) and Hong Kong (0.3/1,000 in 1986–1987) (Lee et al. 
 1989 ). Within New Zealand, SIDS deaths occurred in the indigenous  Māori popula-
tion at twice the rate of the non-Māori population (Mitchell et al.  1994 ). The reason 
for this signifi cant disparity was not  well understood. 
 The NZCDS was the fi rst national  case-control study designed to identify risk 
factors for SIDS. By comparing  infants whose deaths were attributed to SIDS with 
a representative sample of live births, within a year, the NZCDS had identifi ed a 
number of risk factors. The study confi rmed an association between increased risk 
of SIDS and lower socioeconomic status, along with a range of associated maternal 
factors, including fewer years of education, younger age at fi rst  pregnancy , greater 
number of previous pregnancies, and lower attendance at prenatal classes (Mitchell 
et al.  1991 ). The NZCDS selected three risk factors to address among this range of 
fi ndings: lack of  breast-feeding , maternal  smoking , and placing infants to sleep in a 
prone position (Mitchell et al.  1991 ). 
 The ensuing national  prevention campaign focused on publicizing these risks, 
which  parent s were seen as able to infl uence. These were categorized as ‘ modifi able 
risk factors .’ Many parents changed their practices in response to the campaign (Cowan 
 2010 ). Abandonment of the prone sleeping position was the most readily and widely 
adopted measure and is credited with delivering the largest proportion of the national 
reduction in SIDS rates (Mitchell et al.  1997 ). Factors that were less susceptible to 
parental alteration were classifi ed as ‘ nonmodifi able risk factors .’ Nonmodifi able fac-
tors included the baby’s sex, the mother’s age, and the family’s socioeconomic status. 
 Analysis of the second year’s data revealed another risk factor: bed-sharing 
(Mitchell et al.  1992 ). Bed-sharing was  categorized  as a  modifi able risk factor , and 
 parent s were advised to avoid sleeping on the same surface as their baby or allowing 
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others (for instance, other  children ) to do so. The study’s fi ndings were immediately 
fed into the  prevention campaign. 
 Communicating with parents about this particular risk factor became more prob-
lematic than initially anticipated. The diffi culties partly refl ected a developing under-
standing about the subtle nature of bed-sharing risk. While early messages counselled 
against all bed-sharing, subsequent fi ndings prompted adjustments (Cowan  2010 ). 
Now bed-sharing is not viewed as a signifi cant risk unless coupled with maternal 
 smoking or with the baby’s bedmate being intoxicated or excessively tired. Other 
factors such as the baby’s age, the site, and duration of bed-sharing have also been 
identifi ed as affecting the magnitude of risk. These considerations make it diffi cult to 
summarize the risk in a way that is scientifi cally sound and that parents can easily 
understand. Also, the prevention campaign took place against a backdrop of numer-
ous changes in prevailing thought since the 1950s about the causes of SIDS. These 
changes were associated with changing advice about parental practices, which cre-
ated uncertainty  within families about which advice should be followed. 
 The cultural signifi cance attributed to bed-sharing meant that there were differ-
ent reactions among groups to advice not to bed-share. While bed-sharing is not 
traditional among  New Zealand European (Pākehā) families, it is fi rmly rooted in 
Māori and Polynesian child-rearing practices (Tipene-Leach et al.  2000 ). In these 
communities, bed- s haring is seen as positive and benefi cial, promoting bonding 
between mother and child and enabling mothers to comfort and care for their child 
(Abel et al.  2001 ; Tipene-Leach et al.  2000 ). The message that bed-sharing is risky 
had serious implications, then, for Māori and Polynesian child-rearing practices. 
 The early years of the SIDS  prevention  campaign succeeded in reducing the rate 
of SIDS, but the tenor of the anti-bed-sharing message alienated many, particularly 
indigenous Māori, consequently turning whānau (wider family networks) away 
from SIDS prevention messages altogether (Stewart et al.  1993 ; Tipene-Leach et al. 
2000; Cowan  2010 ). Some interpreted the campaign as blaming Māori for  infant 
deaths. After an infant death, the involvement of police, pathologists, and a coro-
ner’s court compounds overtones of culpability, intensifying the guilt and grief 
associated with the loss of a child (Clarke and McCreanor  2006 ). 
 Several years after the ongoing SIDS prevention campaign was launched, rates 
of SIDS among Māori remained disproportionately high. In 2009, the rate of SIDS 
for Māori was 1.5 per 1,000 live births, compared with 0.6/1,000 for Pacifi c Peoples, 
and 0.3/1,000 for Other, including Pākehā (Ministry of Health  2012 ). 
 Several  modifi able risk factors for SIDS, including maternal  smoking and bed- 
sharing, are more prevalent in the Māori community. Māori  parent s less frequently 
attend prenatal classes than non-Māori parents. Along with the modifi able factors, 
many nonmodifi able factors are more likely to apply to Māori families, including 
lower socioeconomic status, younger age of mother at fi rst  pregnancy , greater num-
ber of pregnancies, and fewer years of education (Mitchell et al.  1993 ). These con-
tributors to rates of SIDS among Māori do not receive the same level of scrutiny in 
the media as modifi able parental practices, and  prevention campaigns continue to 
focus upon  altering  parental practices. 
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 A sense of injustice and a perception that the state lacks a true commitment to 
addressing the societal factors underpinning SIDS prevails in parts of the Māori 
community. The prevention campaign’s focus upon discouraging bed-sharing con-
tributes to the community’s sense that the campaign undermines rather than sup-
ports traditional Māori practices. In particular, the coronial process—the 
investigations into the cause of death, the invasive process of autopsy, and the slow 
return of the body to whānau—cannot easily accommodate the deep-felt need of 
whānau to complete the traditional Tangihanga process, the spiritual rituals and 
burial proceedings following a death (Clarke and McCreanor  2006 ; McCreanor 
et al.  2004 ). Nor is the high profi le of the bed-sharing risk matched by a  commitment 
to tackle other risk factors, which may require more resources. Some have therefore 
called for examination of the process by which risk factors are categorized as modi-
fi able or nonmodifi able (Tipene-Leach  2010 ; McManus et al.  2010 ). 
 The  government has committed substantial resources to culturally appropriate 
SIDS prevention for Māori and Polynesian families and is conducting trials of 
appropriate supports for families  to  bed-share safely (Tipene-Leach  2010 ). 
Meanwhile, criminal proceedings against Māori  parent s relating to the deaths of 
their  infants while co-sleeping continue to receive media attention (R v Tukiwaho 
2012; APNZ  2013 ). No wonder, then, that the strong sense of parental responsibility 
for SIDS deaths, where bed-sharing is a factor,  remains. Although inequities under-
write the high exposure of Māori families to both modifi able and nonmodifi able risk 
factors, both government-funded  health promotion and media coverage of SIDS 
remain focused on parental practice. 
7.7.2  Case Description 
 Following high-profi le media coverage of the greater burden of SIDS among Māori, 
new funding is available for a SIDS prevention campaign to reduce SIDS in Māori 
and Polynesian families. Part of this funding is reserved for the generation of new 
 guideline s acceptable to Māori. There is also an opportunity to brief the Minister of 
Health and the Minister of Social Development about measures that can reduce 
rates of SIDS deaths among  Māori  infants. 
7.7.3  Discussion Questions 
 1.  Evidence suggests that several factors affect the magnitude of risk and that bed- 
sharing in the absence of these factors does not signifi cantly increase the risk of 
SIDS. But the interplay of risks can be complex and diffi cult to communicate 
effectively in a national campaign.  Can a defi nitive “no bed-sharing” message be 
defended, on ethical grounds, if it causes less confusion but overstates the risk to 
some groups? What are the most important ethical considerations here? 
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 2.  What weight should be attributed to the cultural signifi cance of bed-sharing 
when generating  guideline s, and why? Should risks that relate to culturally sig-
nifi cant parental practices, such as bed-sharing, be treated differently from risks 
relating to practices that are not held to be culturally signifi cant? 
 3.  Māori and Polynesian families value bed-sharing because of the health and 
social benefi ts they attribute to it. These benefi ts are not captured in studies 
investigating SIDS risk. Should the health and social benefi ts attributed to 
bed-sharing by families who practice it be accorded weight when formulating 
guidelines? If so, how much weight? If not, why not? 
 4.  Colonization has imposed and continues to impose an assault upon Māori cul-
ture. Anti-bed-sharing advice might be seen to extend that assault, privileging a 
narrow range of health concerns. The inherent beliefs and practices that led 
Māori to value bed-sharing, such as bonding between mother and child that pro-
motes strong social bonds, seems particularly worth preserving. How can respect 
for Māori social practices and ways of viewing the world inform SIDS-related 
health promotion? How much difference does the magnitude of the relevant 
health risk make? If the risk is less serious, would you favor a different approach? 
 5.  Consider how risk factors might be categorized as modifi able or nonmodifi able. 
What role should fairness play in this process? 
 6.  Consider the role guidelines might play in coroners’ investigations to identify 
contributing factors to an infant death. Should this possibility be kept in mind 
when guidelines are being drafted?  Why? Why not? 
 7.  Does parental responsibility require compliance with child health guidance? 
How should parents evaluate confl icting or changing advice about risk? 
 8.  Parents can control some risk factors for SIDS, but others involve broader soci-
etal issues, such as socioeconomic status. Does social  justice require that  preven-
tion campaigns targeting parental practices be coupled with efforts to tackle 
social and economic disparities and inequities? Who should be responsible for 
ensuring that this is the case? What should researchers do when they identify a 
parental  pract ice as risky if resourcing for broader action is not forthcoming? 
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 This case is presented for instructional purposes only. The ideas and opinions 
expressed are the authors ’  own. The case is not meant to refl ect the offi cial position , 
 views ,  or policies of the editors ,  the editors ’  host institutions ,  or the authors ’  host 
institutions . 
7.8.1  Background 
 Advances in  biotechnology regularly generate novel ethical challenges that fall 
between the cracks of safeguards designed for conventional cases. Innovations—
especially  in  reproductive technologies—can even create new classes of vulnerable 
people. Such novel cases often force us to thoroughly reexamine ethical safeguards 
and reveal the legal and ethical gaps. 
 Panama , like most Latin American countries, divides its health care system into 
public and private systems. Public insurance covers roughly 81 % of the population 
(Contraloria de la Republica de Panamá  2012 ). Families lacking permanent work 
and unable to afford insurance can fi nd public assistance for health services through 
the Ministry of Health (MoH). The MoH by  law regulates most health research and 
health services, including  regulation and supervision of hospitals and public and 
private clinics (Asamblea Nacional de Panamá  1947 ). The private system, although 
legally supervised by the Ministry of Commerce, exists mostly free of external con-
trol and relies heavily on self-regulation. Medical doctors, after initial MoH certifi -
cation, are no  longer  monitored (Decreto de Gabinete  1970 ). 
 Like the certifi cation process, the ethical guidance that applies to doctors is not 
overseen. Although a Panamanian Medical College code of ethics has applied to 
doctors since 2009, its ethics committee meets only to consider malpractice charges 
brought against doctors (Colegio Médico  2012 ). Independent associations for medi-
cal specialties exist, but they focus on academic and social matters, not on public 
health issues. Only recently have some associations begun to discuss the ethical, 
legal, and social implications of their specialty-related health topics such as trans-
plantation, blood banks,  storage of biological tissues, sale of organs for transplant, 
and rights and  obligations of organ donors and recipients. 
 In response to a growing burden of  maternal mortality , sexually transmitted dis-
eases, and adolescent pregnancy, the World Health Organization in 2000 began a 
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sexual and reproductive health program (World Health Organization  2000 ). This 
initiative prompted the Panamanian  government to begin covering infertility prob-
lems and permitting the public health care system to treat married couples (Ministerio 
de Salud  2000 ).  Alt hough the MoH did not include  in-vitro fertilization (IVF) and 
 surrogate pregnancy in this program, a public institution, the Gorgas Institute for 
Health Research, announced in 2011 that it would launch an IVF program in 2013 
for couples with limited resources (Soto  2012 ). The government, however, was 
silent about IVF, so the  regulations governing IVF remain unclear. However, a  law 
governing organ transplantation, which permits donation of living cells, comes clos-
est to offering legal guidance for IVF. This law requires the donor and recipient to 
give written  consent but does not permit the donor to receive  compensation . Nor 
does it protect the health and confi dentiality of the donor and recipient or offer treat-
ment of medical complications (Asamblea Nacional de Panamá  2010 ). Nowhere, 
does this law or any other address surrogacy. 
 Medical tourism is a new and growing industry in  Central America , where a 
quarter of the world’s medical tourism occurs (Martinez  2011 ). At 16 %, Costa Rica 
commands the largest industry share in Central America; but according to estimates 
of its National Science and Technology secretary,  Panama will achieve a 12 % share 
in 2015 through services offered by its four private hospitals. At these hospitals, 
medical tourism may represent nearly 20 % of the patients being treated. The 
patients, who come mainly from Canada and the  United States , usually seek surgery 
for orthopedic problems, infertility, and cardiac disease. Although private advertise-
ments for medical tourism have been appearing since 2007 (Sbwire  2013 ), lawmak-
ers have not yet created a national legal framework to address the issue. 
 Couples  from neighboring countries or the  United States come to Panama seek-
ing infertility treatment because it is inexpensive, is largely unregulated, and per-
formed by Panamanian doctors noted for technical ability. Moreover, anyone who 
travels to Panama for treatment is entitled to receive it. IVF using fertilized eggs 
from anonymous donors has become standard practice, but surrogacy is not offi -
cially offered. No medical or legal problems  with  IVF surfaced until 2011 when the 
Panamanian MoH was asked to weigh in on a high-profi le case of an abandoned 
child born with severe birth defects to a Panamanian woman acting as a  surrogat e 
for a foreign couple. 
7.8.2  Case Description 
 A Panamanian woman, who was married with two  children , had a primary  school 
education. She worked in her own home but was experiencing economic diffi culties 
because her husband could not fi nd permanent employment. Why she agreed to sur-
rogacy is unknown, but presumably economic considerations played a major role. 
Because her fi rst two pregnancies had presented no problems, she signed a surro-
gacy contract to carry the fertilized egg of a married couple who had traveled to 
 Panama seeking surrogacy services. Little is known about how the foreign couple 
and the Panamanian woman came to know each other, because no lawyer 
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participated in this transaction. Nor did the surrogate’s husband learn of the transac-
tion until after she had signed the contract. Why no one thought to include the hus-
band is a mystery. After signing the  informed consent form, the surrogate was 
inseminated in a private clinic in Panama. Doctors involved in the case state that 
they followed medical recommendations and obtained the informed  consent of the 
surrogate and the egg donor. Neither the procedure nor the pregnancy presented any 
problems, but the surrogate unexpectedly died after severe complications developed 
during delivery. These complications, which also caused hypoxia and convulsions 
in the  newborn , left him with severe cerebral paralysis. As a result of his birth 
defects, he will never walk or speak and will require care for the remainder of his 
life. 
 The couple rejected the child, arguing that the contract specifi ed “a healthy 
child.” The husband of the Panamanian surrogate also rejected the child claim-
ing it was neither his wife’s, nor his, especially as he had not participated in the 
contract. He also pleaded that he now had to cope with his wife’s death and 
raising two motherless children. Appealing to the MoH, the clinic sought state 
custody of the child. The MoH offered medical assistance, but it declined to 
accept long-term responsibility for the child. Instead, the MoH charged a ethics 
panel to  examine  the case and, pending its outcome, sent the child to a religious 
orphanage. 
 The  ethics panel has been charged not only with making a ruling on this case, but 
in recommending measures to regulate  surrogacy  in the future, particularly cases 
involving medical tourism. 
7.8.3  Discussion Questions 
 1.  In the context of surrogacy and medical tourism, who is responsible for raising 
this child, and who should pay for his care and upbringing? What role should 
 government and  profession al associations play in these cases? What is the 
responsibility of doctors involved in  such  practices? 
 2.  What measures should the  ethics panel recommend to protect vulnerable women 
in the future who have agreed to surrogacy? 
 3.  What ethical basis could justify compensation for surrogates or their families in 
the case of death or injury to the surrogate? 
 4.  What measures should the ethics panel recommend for protecting medically 
compromised and abandoned infants when surrogacy-involved pregnancy or 
delivery goes radically wrong? How should informed consent forms be modifi ed 
to anticipate such outcomes? 
 5.  Do cases of medical tourism require international regulation of medical tech-
nologies? If not, why not? If so, how should the panel’s ethical arguments be 
incorporated into legal agreements between countries to guarantee the protection 
of vulnerable populations? 
 Acknowledgments  To Sandra Lopez Vergès and Elizabeth King for their English edits. 
7 Vulnerability and Marginalized Populations
220
 References 
 Asamblea Nacional de Panamá. 1947.  Por la Cual se Aprueba el Código Sanitario. Ley 66 de 10 
de noviembre de 1947. Gaceta Ofi cial, 10467.  https://www.panamaemprende.gob.pa/descar-
gas/Ley%2066%20de%201947%20-%20Codigo%20Sanitario.pdf . Accessed 13 Aug 2013. 
 Asamblea Nacional de Panamá. 2010.  General de Transplantes de Componentes Anatómicos. Ley 
3 de 2 agosto 2010. Gaceta Ofi cial, 26468-B.  http://www.gacetaofi cial.gob.pa/
pdfTemp/26468_B/25676.pdf . Accessed 13 Aug 2013. 
 Colegio Médico. 2012.  Código de Ética Panama 2003–2011.  http://www.hn.sld.pa/sites/default/
fi les/upload/CÓDIGO%20DE%20ÉTICA%20COLEGIO%202011.pdf . Accessed 13 Aug 
2013. 
 Contraloria de la Republica de Panamá. 2012.  Cuadro 421–02. Población Protegida por la Caja 
de Seguro Social Asegurados y Dependientes, Según Provincia y Comarca Indígena: Año 2011. 
 h t t p : / / w w w. c o n t r a l o r i a . g o b. p a / i n e c / P u b l i c a c i o n e s / P u b l i c a c i o n e s . a s p x ? I D _
SUBCATEGORIA=1&ID_PUBLICACION=503&ID_IDIOMA=1&ID_CATEGORIA=1 . 
Accessed 13 Aug 2013. 
 Decreto de Gabinete. 1970.  Por el Cual se Establecen los Requisitos para Obtener la Idoneidad y 
el Libre Ejercicio de la Medicina y Otras Profesiones Afi  nes. 196 del 24-06-1970. Gaceta 
Ofi cial 16639.  http://docs.panama.justia.com/federales/decretos-de-gabinete/decreto-degabi-
nete-196-de-1970-jul-3-1970.pdf . Accessed 13 Aug 2013. 
 Martinez, J.C. 2011.  El Turismo Médico en Panama.  http://www.panamaqmagazine.com/2011_
May/Medical_tourism_QT_2011_pg1_spanish.html . Accessed 13 Aug 2013. 
 Ministerio de Salud. 2000.  Programa de Salud Sexual y Reproductiva.  http://www.minsa.gob.pa/
programa/programa-salud-sexual-y-reproductiva . Accessed 13 Aug 2013. 
 Sbwire. 2013.  PlanetHospital announced today that it has started offering surrogacy in Mexico 
forstraight and gay clients.  http://www.sbwire.com/press-releases/planethospital-announced-
today-that-it-has-started-offering-surrogacy-in-mexico-for-straight-and-gay-clients-219420.
htm . Accessed 13 Aug 2013. 
 Soto, G. 2012.  Instituto Gorgas aplaza proyecto de fertilidad. Panama America  http://www.pana-
maamerica.com.pa/content/instituto-gorgas-aplaza-proyecto-de-fertilidad . Accessed 4 June 
2015. 
 World Health Organization (WHO). 2000.  Programa de Salud Sexual y Reproductiva.  http://www.
who.int/reproductivehealth/es/ . Accessed 13 Aug 2013. 
7.9  Case 3: Compulsory Treatment for  Injection Drug Use 
after Incarceration 
 Paul  Christopher 
 Department of Psychiatry and Human Behavior, Warren Alpert Medical School 
 Brown University 
 Providence ,  RI ,  USA 
 e-mail: paul_christopher@brown.edu 
 Dora  M.  Dumont 
 Division of Community, Family Health and Equity 
 Rhode Island Department of Health 
 Providence ,  RI ,  USA 
A. Wrigley and A. Dawson
221
 Josiah  D.  Rich 
 Department of Medicine, Warren Alpert Medical School 
 Brown University 
 Providence ,  RI ,  USA 
 This case is presented for instructional purposes only. The ideas and opinions 
expressed are the authors ’  own. The case is not meant to refl ect the offi cial position , 
 views ,  or policies of the editors ,  the editors ’  host institutions ,  or the authors ’  host 
institutions . 
7.9.1  Background 
 Inject ion drug use is a major public health problem, with an estimated 3.5 million 
users in the United States (Armstrong  2007 ) and 15.9 million users worldwide 
(Mathers et al.  2008 ). Between 24 and 36 % of U.S. adults addicted to heroin pass 
through the criminal justice system each year (Rich et al.  2005 ). Compared with the 
general population, injection drug users have higher rates of  HIV ,  tuberculosis ,  hep-
atitis B and C, and sexually transmitted diseases (Baussano et al.  2010 ; Nelson et al. 
 2011 ; Weinbaum et al.  2005 ). Injection drug use contributes to correctional and 
community-level transmission of these conditions and threatens public  safety 
because users frequently engage in criminal behaviors to support their drug use. 
 In the  United States , more than two million people are incarcerated (Glaze and 
Parks  2012 ), and an estimated 70–80 % of U.S.  inmates have at least one  substance 
abuse problem (Karberg and James  2005 ; National Center on Addiction and 
Substance Abuse at Columbia University  1998 ). At least 40 % of state and federal 
inmates injected drugs in the month before their arrest (National Center on Addiction 
and Substance Abuse at Columbia University  1998 ). Moreover, 95 % of drug users 
return to drug use within 3 years of release from prison (Marlowe  2006 ). Compared 
with the general population,  prisoners are nearly 13 times more likely to die of any 
cause in the 2 weeks after their release and 129 times more likely to die from an 
overdose (Binswanger et al.  2007 ). 
 Rates of incarceration are also  substantial ly higher among minority groups, with 
 African American males being more than 6 times as likely, and Hispanics males more 
than 2.5 times as likely, to be incarcerated than white males (Carson and Sabol  2012 ). 
African Americans and Hispanics also experience higher rates of conviction for drug-
related offenses than whites (Carson and Sabol  2012 ) despite comparable rates of 
injection drug use between whites and Hispanics and lower rates among  African 
 Americans (Substance Abuse and Mental Health Services Administration  2007 ). 
 Although  inmates make up only 0.8 % of the U.S. population, about 22–31 % of 
Americans with  HIV , 40 % with  tuberculosis , and 29–43 % with chronic  hepatitis C 
pass through the correctional system each year (Hammett et al.  2002 ; Weinbaum 
et al.  2005 ). In the general community and prison population, minority groups bear a 
disproportionately high burden of new  HIV infections and  hepatitis , particularly 
 amon g injection drug users (Blankenship et al.  2005 ; Centers for Disease Control and 
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Prevention  2013 ; Estrada  2002 ).  Successful strategies to limit the spread of  infectious 
disease , therefore, need to include interventions  with  effective substance abuse treat-
ment that target minority groups,  particularly  anyone with a criminal background. 
 Correctional programs that link  prisoners to treatment for  substance abuse and 
related illnesses upon reentry to the community may reduce risky behaviors that 
contribute to high post-release mortality rates, bring much-needed care to a vulner-
able and medically and socially disenfranchised population, and interrupt transmis-
sion of infectious diseases to the broader community. However, despite the lack of 
widespread access to such services during and after incarceration, perhaps the great-
est obstacle to effectively treating drug users is poor motivation. In the  United 
States , 95 % of people with untreated substance abuse fail to recognize the need for 
treatment (Substance Abuse and Mental Health Services Administration  2012 ). 
When people with substance abuse do present for care, it is often because of exter-
nal, coercive pressure (Fagan  1999 ). Indeed, coercive strategies have long been used 
for treating individuals with substance abuse who do not otherwise seek help (Nace 
et al.  2007 ; Sullivan et al.  2008 ). One common argument in favor of coerced treat-
ment is that it restores  autonomy to people who have lost their ability to control their 
addiction (Caplan  2006 ). Another reason coercion may be necessary, in at least the 
initiation phase of treatment, is because permanent cognitive defi cits can result from 
extended drug use (Sullivan et al.  2008 ). 
 The World Health Organization has concluded that legally coerced treatment is 
justifi ed if due process and effective and humane treatment are assured (United 
Nations  2010 ). Still, although compulsory substance abuse treatment is frequently 
used for  pretrial offenders, studies fi nd little evidence that it reduces subsequent drug 
use (Perry et al.  2009 ). Indeed, fi ndings are largely mixed about whether legally 
coerced substance abuse treatment—irrespective of a person’s criminal  justice 
involvement—works in different settings (Klag et al.  2005 ). Similarly, there are 
inconsistent fi ndings on the  effectiveness of coerced drug treatment in the U.S. crimi-
nal justice setting and concerns about a lack of experimental controls in those studies 
that suggest relative  effi ciency (Hough  2002 ; Marlowe  2006 ; Zhang et al.  2013 ). 
 Several  reviews conclude that coerced treatment is certainly more effective than 
no treatment (Hough  2002 ; Kelly et al.  2005 ; Marlowe  2006 ).  Eme rging data sug-
gest that coercive  substance abuse treatment for  parolees reduces rates of reincar-
ceration; however, data are lacking on whether other clinical outcomes are improved 
(Zhang et al.  2013 ). 
7.9.2  Case Description 
 You serve as the director of Substance Abuse Services (SAS) in a  western state in 
the  United States . Rates of substance abuse, particularly injection drug use, are 
higher than the national average. Several large cities in your state have among the 
highest rates in the country. SAS shares data and conducts collaborative  research 
with the Department of Correction (DOC) and other state agencies within the 
Department of Health (DOH), of which SAS is a branch. Your research efforts have 
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identifi ed  needle sharing among former  prisoners , most of whom are members of 
minority groups, as the source of most new community cases of  HIV and  hepatitis 
B and C. You also found that more than half of these infected prisoners do not con-
tinue treatment when released and have high rates of reincarceration. 
 Following aggressive implementation of a statewide prison-based screening and 
treatment program for  infectious diseases , your state has experienced a marked drop 
in prevalence of these diseases among prisoners. However, for three straight years 
rates have increased steadily and disproportionately among injection drug users, 
with rates rising faster among minorities. 
 To confront this problem, you have successfully worked with representatives from 
the DOC to offer methadone maintenance programs to opioid-dependent prisoners 
and have hired reentry specialists to help parolees get treatment for  substance abuse 
and infectious diseases upon release. Unfortunately, to date, only 10–15 % of recently 
released prisoners who are eligible for these voluntary services have used them. 
 The governor has issued a directive to think creatively and foster better interagency 
 collaboration so programs can be developed to reach the other 85–90 % of recently 
released  prisoners who inject drugs or have infectious illnesses. You have been 
appointed to a task force along with other high-level representatives of state agencies, 
including the DOH, DOC, Department of Parole, and Department of Mental Health, 
to identify and implement other potential solutions. One suggested policy option is to 
establish compulsory post-release substance abuse  treatment  as a condition of parole 
that would be linked with  v oluntary infectious  disease screening and treatment. Your 
own interagency  research  suggests a high rate  of  transmission of HIV and  hepatitis 
B and C from  needle sharing with  former  prisoners who have been incarcerated multiple 
times and have not been treated successfully. Accordingly, the target population would 
be recently released prisoners who have two or more incarcerations and at least one 
drug-related conviction, a  history  of injection drug use, and either HIV or hepatitis. 
7.9.3  Discussion Questions 
 1.  Given your research fi ndings that most new community cases of HIV and hepatitis B 
and C result from needle sharing with former prisoners, most of whom are minorities, 
how would you defend or object to this policy proposal given it will disproportion-
ately subject minority groups to compulsory treatment as a condition of their parole. 
 2.  If such compulsory drug treatment for prison releases is shown to have little 
impact on community rates of infectious disease, what effect would the program 
need to have on recently released prisoners for you to support its use? Given a 
parolee’s vulnerable status in society, would you support the program if it 
reduced criminal recidivism alone? If not, what other outcomes are important to 
you and why? Would outcomes have to be clinical, or could outcomes refl ect a 
parolee’s well-being or functioning in society? 
 3.  What are the ethical implications of implementing (and funding) compulsory treat-
ment for released prisoners in a community where availability of (or funding for) 
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voluntary treatment is currently inadequate? To what extent does lack of access to 
voluntary services (and other social determinants of health such as income and 
education) contribute to the need for compulsory treatment, particularly among 
people who are vulnerable to substance use, incarceration, and infectious disease? 
 4.  Public resources and facilities are already in place to provide involuntary treat-
ment for certain health conditions (e.g., tuberculosis and mental illness). Suppose 
that some mental health advocates object to the proposal to introduce compul-
sory drug treatment by arguing that it would divert funds from treating people 
with serious mental illness, including those with criminal histories. People  with 
 serious mental illness, they contend, constitute a far more vulnerable prison 
group, many of whom have co-occurring substance abuse problems. If true, how 
will your thinking about the case be infl uenced? Why? 
 5.  Suppose someone argues that the compulsory treatment program under consid-
eration is another example of society’s punitive approach to managing substance 
abuse. To what extent do you agree or disagree with this argument? Why? 
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7.10.1  Background 
 Infl uenza is  a  common respiratory pathogen that affects the nose, throat, bronchi 
and lungs. The virus is spread through droplets and small particles when people 
cough or sneeze. Though infl uenza regularly affects people worldwide, the emer-
gence of novel infl uenza virus subtypes has the potential to cause a  pandemic (World 
Health Organization [WHO]  2008 ). In such a case, the population’s low immunity 
can lead the virus to spread rapidly with high rates of sickness and death. Although 
no one can predict when a pandemic will strike, attack rates of 25–45 % have been 
suggested with mortality rates varying greatly depending on the virulence of the 
strain (WHO  2010 ). 
 With a virulent strain of pandemic infl uenza, many patients will become extremely 
ill, and their need for specialized treatment and intensive care may exceed resources. 
In addition, front-line  health care workers will face great risk of becoming ill, dwin-
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dling human resources further and straining the health care system (WHO  2008 ; 
University of Toronto Joint Center for Bioethics  2005 ). In anticipation of these 
human and physical  resource shortages , hospitals, public health agencies, and states 
have created plans to prepare for an infl uenza pandemic. Such plans typically include 
health services, public health measures,  priority setting , and  resource allocation and 
usually direct  surveillance , preparedness, and response (WHO  2010 ). 
 Pan demic plans typically aim to minimize serious illness and overall deaths, but 
more comprehensive plans also refer to special needs of vulnerable groups. The 
term “vulnerable,” however, often is left undefi ned, and, if specifi ed (e.g., the 
elderly), it usually refers to increased biological or medical risk of succumbing to or 
transmitting pandemic infl uenza (Uscher-Pines et al.  2007 ). Few plans refer to vul-
nerability in social or economic terms (Uscher-Pines et al.  2007 ). This lack of speci-
fi city raises questions about whether (and how) special consideration ought to differ 
for vulnerable conditions, such as being homeless, being immunocompromised, or 
living in a remote community. Even when plans do mention such vulnerabilities, 
have decision makers or practitioners consulted the people in these categories about 
their needs in such situations? (Uscher-Pines et al.  2007 ) More importantly, has 
anyone reconciled the aim of minimizing sickness and death with the oft competing 
aim of meeting the needs of the vulnerable? 
 Meeting the needs of the most vulnerable while being mindful of  health equity 
and  social justice has been a long-standing tradition of public health (Beauchamp 
 1976 ; Krieger and Birn  1998 ). In particular, public  health interventions targeting 
the  social determinants of health have been heralded as an effective way to combat 
systemic inequities that lead to disparities in  health outcomes (Wilson  2009 ). 
However, some challenge the notion of vulnerability as a static condition that can 
be predefi ned. Broadly defi ned categories of vulnerability can exclude people not 
traditionally seen as vulnerable (such as  health care workers ), while including peo-
ple thought to be vulnerable who, with the right supports, can actually participate 
in the  emergency response (e.g., retired older adults) (Mastroianni  2009 ). 
Considering and doing something about the context-specifi c needs of those who 
might be most vulnerable during a  pandemic , can easily become a complex, ethi-
cally fraught task. 
 A further complication is that the interventions taken in response to a pandemic 
can unintentionally render some people more vulnerable (Mastroianni  2009 ). Most 
pandemic infl uenza plans, for example, seem to focus on hospitals, directing atten-
tion to managing intensive care unit (ICU) bed and equipment shortages and distrib-
uting resources in high-acuity settings. Such plans often call for redeploying workers 
from community settings to hospital settings. Because many of these workers 
already work part-time in the community and hospital sectors, this option is appeal-
ing. But if workers are shifted from  community health care settings to hospitals, 
people in the community who depend on these workers may become vulnerable 
from the  intervention . 
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7.10.2  Case Description 
 It has been 1 week since the World Health Organization offi cially declared the pres-
ence of an  infl uenza pandemic. Person-to-person spread has been confi rmed in sev-
eral Canadian cities, and emergency rooms in your large metropolitan city overfl ow 
with infl uenza patients. Because routine cases usually fi ll the medical fl oors and 
intensive care units to capacity, there is concern that the surge of infl uenza admis-
sions will overwhelm resources. To set priorities and possibly reallocate resources 
within the health care system, the regional health authority has called a meeting in 
anticipation of the surge in admissions. As the lead of the local health emergency 
management program, you are asked to attend. 
 A  couple  of hours before the meeting, you listen to a call on your answering 
machine from Julia, a friend and the director of the local community care access 
center (home care agency). This is the largest center in the region, employing 600 
and subcontracting 20,000 health and community service workers through other 
agencies.  Profession al services that are subcontracted include in-home nursing, 
occupational therapy, physiotherapy, social work, speech and language therapy, and 
nutritionists; nonprofessional services include personal support workers and health 
care aids and attendants who assist with activities of daily living. 
 Having become aware of the upcoming meeting with the regional health 
authority, Julia wonders why no one from the community-based organizations 
that care for people in home settings has been asked to attend. She appreciates the 
media focus on the available ventilators and ICU beds in local hospitals, but she 
is concerned with the lack of attention on  vulnerable populations in the community. 
She has heard rumors of plans to reallocate some nursing and personal  support 
workers from community settings to acute care hospitals and asks if offi cials have 
considered that such a move may require some people, who normally manage 
their illness at home, to be hospitalized. Convinced that someone representing the 
community should attend  priority-setting discussions, she urges you to advocate 
for such a presence. 
 Thinking on various levels about how you would respond to the message even 
as you plan for the meeting, you are particularly struck by how such decisions 
could adversely affect Julia herself.  Her multiple sclerosis is serious enough to 
require the  daily assistance of a personal support worker to help her get from 
home  to  her offi ce. 
7.10.3  Discussion Questions 
 1.  In what ways does this case challenge conventional notions of who might be 
considered vulnerable during a pandemic? 
 2.  What does Julia’s exclusion from the meeting say about the attitude towards 
vulnerable populations at the administrative level? 
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 3.  How might a decision to shift fi nancial and personnel resources from the com-
munity to the hospital setting deepen the health and social inequities that many 
vulnerable populations already face? 
 4.  Would it be fair for Julia to ask her community workers to work more hours 
because the needs of the community have increased? What if the workers feel 
safer working away from the gravely ill at the hospital and prefer to increase 
community work at the expense of hospital work? 
 5.  If the workers remain in their communities with their patients, it could mean they 
are able to help fewer members of the population than if they attended their shifts 
at the hospital. What is more important, treating more people or giving priority 
to the vulnerable or less privileged? 
 6.  Do those who develop pandemic plans have a responsibility to identify people 
whose vulnerability might increase during a pandemic? If so, how should plan-
ners identify these people? 
 7.  The document you received before the meeting indicated that one of the discus-
sion topics will be priority setting, particularly the scarce resource of ventilators. 
The document proposes that a physical disability should disqualify a person 
from having access to a ventilator. How do you balance the need for rationing 
scarce acute care resources, like ventilators, with social justice values that advo-
cate for the respect and consideration of those who are vulnerable due to system-
atic social disadvantage? How will you discuss this matter with Julia? 
 8.  In light of Julia’s message, how would you begin to identify systemic barriers 
that limit the inclusion of vulnerable populations in planning for a pandemic? 
How would you involve these populations in determining if barriers exist that 
may signifi cantly limit their access to essential health services available to other 
populations during a pandemic? 
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7.11.1  Background 
 Migration is a challenge managed against the backdrop of international accords and 
the social and historic circumstances peculiar to each country. The 1948  U niversal 
Declaration of Human Rights (UDHR) states “everyone has the right to seek and to 
enjoy in other countries asylum from persecution” (United Nations  1948 , Article 
14). In 1951, the newly established International Organization for Migration (IOM) 
began promoting “humane and orderly  migration for the benefi t of all,” affi rming 
that all migration can be managed (IOM  2013 ). The  United Nations (U.N.) estimated 
221 million migrants worldwide in 2010 (U.N.  2013 ). EUROSTAT estimated 1.7 
million immigrants, including forced migrants, in the  European Union (EU) in 2011 
(EUROSTAT  2014 ). 
 Sweden , a Nordic country that joined the EU in 1995, has a long tradition of moni-
toring the health of its residents. For example, its National Institute of Public Health, 
the National Board of Health and Welfare, and Statistics  Sweden monitor public 
health trends, and a national center monitors suicide and mental illness (the National 
Centre for Suicide Research and Prevention of Mental Ill-Health). “Health on equal 
terms” is a  political priority in Sweden that aligns with the country’s strongly egalitar-
ian and multicultural traditions dating back more than 300 years (Linell et al.  2013 ; 
Westin  2000 ,  2006 ). However, social contingencies throughout Sweden’s history have 
put pressure on these values and traditions. For example, poor harvests and famine in 
the mid- to late-1800s triggered extensive  emigration , virtually closing borders when 
A. Wrigley and A. Dawson
231
emigration ended in the 1930s. In the 1940s, the borders reopened fi rst for  refugees 
from neighboring countries, then, in the 1950s–1960s, for labor immigrants from 
European countries. From the 1970s onward, the focus shifted to family reunifi cation 
of migrants and refugees from outside the EU. According to Statistic Sweden’s fi gures 
from 2012, of its 9.6 million population, about 15 % are foreign born (Statistics 
Sweden  2013 ). The  S wedish Migration Board (SMB) suggests that 16 % of residen-
cies granted in 2012 were on refugee, protection, humanitarian, or similar grounds 
(including temporary grounds) (SMB  2014 ). 
 The term  migration management (MM) was coined in the 1990s, although the 
MM fi eld originated in the 1950s (Widgren  1994 ). The rise of MM coincided with 
a time when several factors, including the mechanisms of colonialism and the  Cold 
War , worked to control and minimize global  migration . But other factors also infl u-
enced MM, such as resettlements after World War II; efforts to safeguard rights of 
 refugees and migrant workers rights led by international organizations (e.g., the 
International Labour Organization, the United  Nations High Commissioner for 
Refugees and the International Organization for  Migration ); and regional initiatives 
that removed immigration barriers to improve national economies (e.g., the 
 Organis ation for Economic Co-operation and Development and the Treaty of 
Rome). In the mid-1970s to mid-1980s,  Western countries jointly attempted to har-
monize entry controls, efforts that the third pillar of the EU’s 1993  Maastricht 
Treaty later incorporated (Maastricht Treaty  1992 ). 
 Policies enacted since this treaty have focused on deterring unwanted migrants, 
arguably to the detriment of  human rights and  refugee protections (Fekete  2001 ). By 
2002, experts suggested that reducing unwanted and unauthorized  immigration could 
increase public support for integration assistance for foreign residents in Western 
countries (Martin and Widgren  2002 ). But this focus on reduction had the side effect 
of criminalizing “unwanted” migrants. By implying that unwanted migrants could 
pose a national security threat, policy instruments such as the 2006 Schengen Borders 
Code may have fed xenophobic tendencies (Schengen Borders Code  2010 ). Article 
5 in the code includes, for example, a statement about entry conditions for short- stay, 
third-country nationals, that they are not “… considered to be a threat to public pol-
icy, internal security, public health, or the international relations of any of the Member 
States.” At any rate, such increased  deterrence  and control measures do restrict 
access to work, housing, health care, and independent legal advice, and even sepa-
rates families (Johansson Blight et al.  2009 ). Not surprisingly,  detention policies 
harm health with disproportionately high rates of poor  mental health , suicide, and 
self-harm amongst detainees (Silove et al.  2000 ; Cohen  2008 ). Moreover, evidence 
suggests that such controls have resulted in the rejection of asylum claims of torture 
survivors and people with severe health problems (Steel et al.  2006 ; Migration Court 
of Appeal  2007 ; Johansson Blight  2015 ). The evidence also suggests that controls 
led to  children suffering due to exacerbated vulnerability in detention and to unac-
counted deaths of forced migrants at  Western country borders (Grewcock  2009 ; Steel 
et al.  2011 ). These injustices prompted repeated appeals to national  law , the UDHR, 
and the Convention on the Rights of the Child and calls for change to relevant World 
Medical Association (WMA) documents such as the Geneva and Lisbon declarations 
(Hunt  2007 ; Bodegård  2014 ; Johansson Blight  2014 ; Johansson Blight et al.  2014 ). 
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 An especially poignant example of the health challenges found among  asylum 
seekers , especially children, is the condition known as  pervasive arousal withdrawal 
syndrome (PAWS) (Bodegård  2014 ). This condition presents as pervasive loss of 
functioning and profound social withdrawal and  apathy (Söndergaard et al.  2012 ; 
Envall  2013 ; Bodegård  2014 ; Johansson Blight  2014 ; Johansson Blight et al.  2014 ). 
Few children show signs of severe PAWS upon arrival in  Sweden ; however, routine 
data on incidence and prevalence are lacking (Envall  2013 ). Surveys conducted in 
the past 10 years have identifi ed anywhere from 30 to 424 children with this condi-
tion (Envall  2013 ). Common predictors include exposure to severe persecution, 
 human rights abuses or other traumatic experiences in the country of origin, and the 
prospect of  deportation to countries with poor  human rights records. Other signs of 
distress include suicide attempts (Johansson Blight  2014 ). PAWS commonly affects 
health and functioning gradually, over time rendering a child unresponsive and 
unable to eat or drink without support, which makes the condition life-threatening. 
Unfortunately, the required health assessment of  asylum seekers is insuffi cient for 
detecting PAWS in its early stages (Johansson Blight  2014 ). Typically, static mea-
sures of health (such as the use of yes/no check boxes) are used, and life events such 
as  discrimination , traumatizing episodes, or prolonged stress carry little weight in 
the health evaluation process requested by the  migration authorities. From a health 
perspective, broader and more culturally appropriate assessments are recommended 
instead, such as illness narratives, family medical history taking, and recording of 
past and present social contexts (Bhugra et al.  2010 ). If adopted, more cases of 
 P AWS could be identifi ed, prevented, and treated. No cases of  children dying with 
PAWS have been reported in  Sweden , but there has been no systematic follow-up of 
children deported from Sweden (Envall  2013 ). 
7.11.2  Case Description 
 The Swedish Migration Board (SMB), the ultimate authority on  deportation of  asy-
lum seekers , announced it no longer deports children with PAWS. After this 
announcement, however, the media reported on a rejected asylum seeker, a 14-year- 
old Roma girl 1 with the condition, deported with her family to their country of ori-
gin (Edquist  2013 ; Myhrén  2013 ). During deportation, the girl who had lost all 
ability to function, was being fed through a feeding tube, and was unresponsive to 
pain. Upon arrival at their home country, the family was refused entry due to the 
girl’s advanced illness and was eventually forced to return to Sweden. 
 A family friend in  Sweden said that widespread persecution of  Roma people in 
the family’s home country had restricted the 14-year-old girl’s life. For example, the 
girl had never attended  school because her  parent s feared she would be ostracized, 
teased, ridiculed, or even physically hurt. The friend explained that the symptoms of 
1  The  Roma people are an ethnic group who trace their origin to the Indian subcontinent, some-
times referred to as gypsies. 
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severe PAWS began the previous month after Swedish police visited the family’s 
home in  Swed en. 
 According to the SMB, the police who enforced the  deportation reported that when 
they fi rst visited the family, the girl was attending  school , and although said to be some-
what shy and withdrawn, she appeared relatively healthy. A routine health assessment 
of  asylum seekers to assess barriers to enforcing deportation found no medical or other 
reason to impede deportation. This claim confl icted with the statement of a therapist 
working for a  human rights organization, who said he had informed the SMB about the 
girl’s history of  discrimination ,  trauma , and her state of complete function loss, which 
included her inability to communicate and engage in social interaction. In their defense, 
police say they followed standard procedures and stand by the initial assessment 
regarding deportation, which prompted no grounds for halting deportation. 
 Upon returning to  Sweden , the family was detained in an  immigration facility, 
where the father at fi rst was separated from the family. At the time of the media 
reports, the family had been reunited and was awaiting a new SMB decision on 
whether they should again be deported. 
 You are a member of a commission established to decide the outcome of this case 
and come up with ways to improve the asylum and deportation system. Other mem-
bers of the commission include medical offi cers, public health offi cials, lawyers, 
 and former immigration offi cials. 
7.11.3  Discussion Questions 
 1.  Who are the main  stakeholder s and organizations in this case? What are their 
primary interests and obligations? 
 2.  What bearing does vulnerability or increased risk of harm have on public health’s 
obligation to prevent or mitigate harm to an individual? What impact should 
legal status have on that obligation? 
 3.  What are the goals of the asylum and deportation process, and what are the val-
ues that drive these goals? How should these values be prioritized? 
 4.  What decision would you make in this case? 
 5.  Based on your prioritization of values, what recommendations would you make 
to improve the asylum and deportation system? 
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7.12.1  Background 
 Tuberculosis (TB), an airborne transmissible bacterial infection that most commonly 
affects the lungs, has been dubbed “the greatest killer in history” and one of “human-
kind’s worst enemies” (Selgelid  2008 ). TB is typically contracted after prolonged 
close exposure to the coughing and sneezing of people with active infections. 
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Although only 5–10 % of people who are infected (but who are not  HIV positive) 
become sick or infectious at some point during their lives, untreated TB kills about 
two-thirds of those it does infect, despite the availability of effective medicines since 
the 1950s (World Health Organization [WHO]  2012 ). Since 1995, the WHO stan-
dard for treatment has been  directly observed therapy, short-course (DOTS) , which 
involves people watching patients swallowing their pills. Treatments delivered 
through DOTS are inexpensive and 95 % effective, although 6–9 months may be 
required to cure ordinary  acti ve or latent strains of the infection (Minion et al.  2013 ). 
 Inconsistent or partial treatment—when patients do not take their medicines 
regularly for the required period because they start to feel better, because doctors 
and health workers prescribe the wrong treatment regimens, or because  drug supply 
is unavailable due to  cost or unreliable due to lack of  regulation —has led to TB 
strains that resist one or more fi rst-line drugs (i.e., those most effective and least 
likely to cause adverse side effects). Drug-resistant TB has been documented in 
every country surveyed (WHO  2012 ). A particularly dangerous form of drug- 
resistant TB is  multidrug-resistant TB (MDR-TB) , defi ned as the disease caused by 
TB bacilli resistant to at least isoniazid and rifampicin, the two standard anti-TB 
drugs. Curing MDR strains of the bacteria is much less  effective (with a 30–40 % 
failure rate in Canada, slightly better than the global average of 52 %, according to 
Minion et al.  2013 ), costs much more, produces reactions that diminish  compliance , 
and may take as long as 20–24 months (Public Health Agency of Canada.  2014 ). 
MDR-TB accounts for 1.2 % of all TB cases in Canada, for example, and typically 
 cost s fi ve times as much ($250,000 vs $47,290 per patient) (Public Health Agency 
of Canada  2014 ; Menzies et al.  2008 ). 
 TB has retained dramatically high levels of incidence, prevalence, and morbidity 
and mortality worldwide, especially in developing countries, because social,  politi-
cal , and economic factors (rather than simply biological ones) play key roles in  infec-
tious disease patterns. Recent global estimates put the numbers at 15 million active, 
and perhaps 2 billion latent (asymptomatic) infections, with 9 million new infections 
yearly, and 1.5 to 2 million deaths per year (95 % of which occur in  sub- Saharan 
Africa and Asia) (WHO  2012 ). TB is the world’s leading cause of preventable death 
among young adults, and the leading cause of death among those who are  HIV posi-
tive, since the infection tends to affect and progress quickly in those whose immune 
systems are compromised by other conditions, particularly HIV but also  measles , 
malaria, or alcoholism. TB is thus often referred to as a “classic social disease” and 
a “disease of poverty” because of its association with overcrowding, malnutrition, 
stress, destitution, and rapid social change. TB has also been dubbed the forgotten 
plague because it rarely affects the wealthy, who are largely insulated from exposure 
(Kim et al.  2005 ; Ryan  1993 ). Thus, although TB was extremely common in eigh-
teenth- and nineteenth-century England throughout the industrial revolution, infec-
tion rates declined substantially when housing,  sanitation , nutrition, and labor 
conditions improved and endemic infections all but disappeared in developed coun-
tries well before effective drugs were widely available (Selgelid  2008 ). 
 TB, though relatively uncommon in Canada today with around 1,600 cases 
reported annually, is costly ($58 million in direct costs, and $74 million total related 
expenditure, in Canada in 2004) (Menzies et al.  2008 ), frequently results in hospital 
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admission, and retains an 11 % mortality rate (Greenaway et al.  2011 ).  Fore ign-born 
 persons  account for 65 % of active TB, although they make up only 20 % of the 
population. Up to half of recent immigrants and  refugees to Canada are estimated to 
harbor latent TB and are thus at risk of progressing  to  active infection, and TB in 
refugee populations is about double that in other classes of immigrant populations 
(Greenaway et al.  2011 ). Those most at risk domestically are the urban homeless 
and aboriginal communities, followed by residents of long-term care and correc-
tional facilities, and then the staff who work in such institutions (Public Health 
Agency of Canada  2014 ). 
 The cornerstone of TB ethics, according to the WHO, is the protection of indi-
viduals and communities through the proper treatment of infected individuals 
( active  and latent) and the  prevention of new infections. These goals are said to 
rely on the promotion of key values including  social justice and  equity ,  solidarity , 
the common good,  autonomy , reciprocity,  effectiveness , subsidiarity,  participa-
tion , and transparency and accountability (WHO  2010 ). The WHO also stresses, 
in cases where involuntary isolation or detention measures are implemented, the 
importance of using the least restrictive means necessary to achieve public health 
goals, as set forth in the  Siracusa Principles . These principles require states to 
ensure that such interventions are proportional to the risk of public harm, neces-
sary and relevant to protecting the public good, and applied without  discrimina-
tion (WHO  2010 ). 
7.12.2  Case Description 
 On a chilly gray autumn morning, Canadian Coast Guard offi cials take into cus-
tody 77 people (66 men, and 11 boys between 8 and 16 years of age) after their 
vessel, suspected to have been abandoned by human smugglers, is found adrift off 
the northwest Pacifi c coast. All immediately claim  refugee status and are trans-
ferred to a provincial prison, the nearest facility judged suffi ciently secure to detain 
them, review their claims, and physically examine them per  immigration proce-
dures. Overcrowding at the criminal correction center, already an issue, becomes 
severe with the addition of these individuals, many of whom are housed four or fi ve 
to cells designed for only two people, and often in portable trailers parked in the 
prison yard. The asylum seekers are subject to the same institutional rules as crimi-
nal detainees: they must wear prison uniforms and are signifi cantly restricted in 
making or receiving telephone calls (Nakache  2011 ). The federal Refugee 
Protection Division and provincial health authorities jointly appoint you as a mem-
ber of an ad hoc local public health unit task force  responding to the situation. 
 Canadian  immigration  law requires asylum seekers in the country to undergo a 
medical examination, including screening to assess potential burden of illness, 
linked to ongoing  surveillance or clinical actions only for TB,  syphilis , and  HIV 
(Gushulak et al.  2011 ; Gardam et al.  2014 ). Within 48 h, medical examinations and 
chest X-ray results suggest active TB in four of the new detainees: two adults and 
two brothers ages 6 and 11. Based on their overall health conditions and patient 
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histories (to the extent that these can be verifi ably ascertained under the circum-
stances) and TB epidemiology in the region of origin, the medical team strongly 
suspects all four to be infected with MDR-TB, and cultures are thus ordered. The 
tests will take 2 weeks before results can confi rm the presence of drug-resistant 
strains (6 weeks are needed to confi rm negative cultures). 
 The  Canadian Immigration and Refugee Protection Act (IRPA) (Government of 
Canada  2001 ) and accompanying  regulations (Government of Canada  2013 ) stipu-
late that people likely to be a danger to public health or a “public charge” (defi ned 
as likely to make excessive demands on health or social services but likely unable 
or unwilling to support themselves) may be deemed inadmissible for refugee sta-
tus. However, considerable discretionary power, particularly for  children and oth-
ers in need of protection, is built into the law and related regulations, and initial 
decisions by immigration offi cers are generally subject to appeal (Bailey et al. 
 2005 ; Greenaway et al.  2011 ). Section 249 of the IRPA regulations, moreover, sets 
out special requirements for minor refugee claimants, including the  duty to con-
sider the availability of local childcare arrangements, of segregated spaces in 
detention centers, and of education, counseling, and  recreational  ser vices 
(Government of Canada  2013 ). 
7.12.3  Discussion Questions 
 1.  Although all 77 refugee claimants have been screened for TB, they have not been 
tested for TB. Given the journey and conditions just endured by this group on 
board the cramped vessel, should the task force advise local public health author-
ities to test all claimants for active or latent TB? Why or why not? 
 2.  What recommendations should the task force make concerning ongoing detain-
ment conditions? What information should be provided to the current residents 
and staff of the regional corrections center? 
 3.  Given the clinicians’ conclusions, should second-line TB treatment be immedi-
ately offered to the four affected refugees? If they refuse treatment, should treat-
ment be compelled? How and why? 
 4.  When news breaks locally of the TB status of the two young brothers, commu-
nity leaders of the same ethnic background offer to shelter the boys and oversee 
their treatment. Discuss the relevance of the principle of “least restrictive means” 
to such a scenario, and indicate when or whether local public health authorities 
should consider community care and support approaches to MDR-TB 
treatment. 
 5.  Three months into their detainment, the claims of several refugees are rejected. 
Hunger strikes and violence among the detainees ensue. How should the task 
force respond? 
 6.  Consider a scenario in which the status of one of the two adults suspected of being 
infected by MDR-TB is subsequently confi rmed and the patient is denied refugee 
status as well. What are the  cost s and risks of the repatriation of MDR- TB cases 
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compared with standard TB cases? Do the task force, public health  auth orities, 
and provincial or federal authorities have any obligations under such a scenario? 
 7.  How should the goals of public health and those of immigration policy be 
balanced? 
 Open Access  This chapter is distributed under the terms of the Creative Commons Attribution-
NonCommercial 2.5 License ( http://creativecommons.org/licenses/by-nc/2.5/ ), which permits 
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 Chapter 8 
 International Collaboration for Global Public 
Health 
 Eric  M.  Meslin and  Ibrahim  Garba 
8.1  Introduction 
 There is a long tradition of global  collaboration in biomedicine and public health. 
Examples range from medical outposts in rural communities run by foreign mis-
sionaries (Good  1991 ) to the early  infectious disease programs of the  Rockefeller 
Foundation (Fosdick  1989 ) and from medical services and training programs for 
indigenous  populations set up by colonial authorities (Marks  1997 ) to the  Pan 
American Health Organization (PAHO) established by a collective of sovereign 
 governments (Cueto  2007 ). 
 Two complementary sets of factors provide context for understanding collabora-
tion in  global public health : fi rst, the factors that inform  globalization generally and 
 global  health specifi cally; second, the factors that shape ethical  standards for global 
health programs generally and global health  research  specifi cally. Good examples 
of both factors are refl ected in this chapter’s case studies. 
 The opinions, fi ndings, and conclusions of the authors do not necessarily refl ect the offi cial 
position, views, or policies of the editors, the editors’ host institutions, or the authors’ host 
institutions. 
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8.2  The Rise of  Globalization and  Global Health 
 Collaboration in global health, as we know it today, began taking shape after World 
War II when new  laws and institutions were established to govern relations among 
countries. The war’s end was marked by efforts to establish a body that would 
facilitate peaceful relations among member countries. In 1945, the  United Nations 
(U.N.) was established “to save succeeding generations from the scourge of war” 
and to “promote social progress and better  standards  of life” (U.N.  1945 ). Various 
U.N. agencies were set up to realize these goals—most prominently the  World 
Health Organization (WHO) , founded in 1948 “to act as the directing and 
coordinating authority on international health work” (WHO  1948 ). 1 Yet even as 
these institutions were being established, their ability to encourage  international 
collaboration was hampered in two ways.
 First , most  low- and middle-income countries (LMICs) , which bear the bulk of 
today’s global  disease burden , were under  colonial rule for the fi rst decade of the 
U.N.’s existence. Hence, these countries were unrepresented in the new organiza-
tion. In later years, the  principle of  self-determination (i.e., the right of “peoples” to 
govern themselves and choose their developmental priorities) and the efforts of 
nationalist movements secured  political independence and membership in the inter-
national community. In effect, the  governments of these countries were authorized 
under international  law to represent their  populations in relations with other govern-
ments, thereby enabling equitable partnerships, even in matters of health. 
 Second, the escalation of the  Cold War in the founding years of the U.N. intro-
duced ideological rivalries into its workings. These rivalries often impeded coordi-
nated actions involving health. For example, the 1950s and 1960s were marked by 
the superpowers’ competitive attempts to eradicate specifi c (often communicable) 
diseases (e.g., the  United States targeted malaria while the Soviet Union focused on 
smallpox) (WHO  2008b ). This selective, disease-specifi c vertical approach  con-
fl icted with the realization in the 1970s that primary health care was a vital compo-
nent of a national health system. The latter approach defi ned “health” broadly, 
recognizing it as a right and acknowledging the impact of socioeconomic factors on 
wellness (WHO  1978 ). The emphasis on primary health care became critical for 
 governments of newly independent countries faced with the task of expanding 
health systems that under  colonial rule had catered to a narrow, privileged segment 
of the  population (WHO  2008a ). However, ideological disputes over government’s 
role in society and the  policies of the  International Monetary Fund (IMF) , which 
favored privatization of certain public services (Stuckler and Basu  2009 ), neglected 
the primary health care approach (WHO  2008b ). The  Cold War also infl uenced pat-
terns of  global health  collaboration , particularly among members of feuding coali-
tions that continued to support ideologic allies (Feldbaum et al.  2010 ). 
1  Other U.N.-affi liated agencies not directly related to health but infl uencing collaboration in public 
health include the International Monetary Fund ,  World Bank , and World Trade Organization. 
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 The  fall of the Berlin Wall in 1989 and the collapse of the Soviet Union shortly 
thereafter marked the end of the  Cold War . These events led more countries to adopt 
liberal and capitalist  principles . Other developments—advances in communications 
(most notably, the Internet) and greater  trade and travel across borders—intensifi ed 
exchanges among national communities. Collectively referred to as  the process of 
 globalization , 2 these changes altered the global context for public health 
 collaboration . 
 On the one hand, the absence of a drawn-out ideological battle led to constructive 
deliberation and global action in public health. For example, in 2000, all members 
of the U.N. General Assembly declared their commitment to achieving eight objec-
tives (the Millennium Development Goals) by 2015—half of which pertained to 
health. Also signifi cant were widespread efforts to address the  HIV/AIDS epidemic 
through such mechanisms as the Joint United Nations Programme on HIV/AIDS 
(UNAIDS) 3 and the more recently established  Global Fund to Fight AIDS, 
Tuberculosis and Malaria. 4 
 On the other  hand , the growing infl uence of liberal and capitalist  principles in the 
global environment of the 1990s affected the extent to which  governments (espe-
cially those of  LMICs ) were involved and able to collaborate in public health. These 
changes included
 … an increasing reliance upon the free market; a signifi cant growth in the infl uence of 
international fi nancial markets and institutions in determining national  policies ; cutbacks in 
public sector spending; the privatization of functions previously considered to be the exclu-
sive domain of the state; and the deregulation of a range of activities with a view to facilitat-
ing investment and rewarding entrepreneurial initiative. These trends serve to reduce the 
role of the state in economic affairs, and at the same time increase the role and responsibili-
ties of private (non-state) actors, especially those in corporate business, but also those in 
civil society…. (WHO  2002 ) 
 Generally associated with neoliberal  principles , the changes discussed above 
have reduced  governments ’ public policy role. These developments notwithstand-
ing, there remain compelling arguments for deliberate and sustained engagement by 
governments in the interest of  global public health . Three are discussed below. 
8.2.1  Collective Health 
 The fi rst argument is that even with their reduced profi le in national health systems, 
 governments continue to bear primary responsibility for  population health . 
Individual citizens can take responsibility for personal health, but certain health 
2  Defi nitions of  globalization vary by disciplinary focus. Richard Labonté ( 2004 ) describes global-
ization as “a process by which nations, businesses, and people are becoming more connected and 
interdependent across the globe through increased economic integration and communication 
exchange, cultural diffusion (especially of  Western culture), and travel.” 
3  See  http://www.unaids.org/en/ 
4  See  http://www.theglobalfund.org/en/ 
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 benefi ts (e.g., clean air, safe roads, potable water) can be secured only through orga-
nized, collective efforts generally involving the exercise of public authority. As 
such, in the interest of global  health , a country’s public health institutions should be 
robust—equipped to protect  population health , reduce disease, and administer pro-
grams that save money and lives (Frieden and Koplan  2010 ). This case needs to be 
made for  LMICs especially; otherwise, neoliberal  principles guiding  globalization 
may further weaken emergent, poorly governed, or underfunded health systems. 
 Indeed, the exercise (or failure) of public authority infl uence all ethical issues 
presented by the cases in this chapter. In Jensen and Gaie’s case, an  LMIC  govern-
ment has neither passed legislation nor provided support that would effectively pre-
vent  discrimination against citizens seeking  HIV services. In Zinner’s case, an 
 international aid worker must make diffi cult decisions about who gets preventive 
 HIV/AIDS  treatment in an African community characterized by a neglected, poorly 
funded health system. In Timms’ case, a physician encounters an ethical challenge 
brought about by the underdeveloped health infrastructure in  India , the govern-
ment’s lax  enforcement of research  regulations , and the substantial infl uence of 
large foreign  pharmaceutical companies on national  policy . In List and Boyd’s case, 
a foreign researcher must decide whether there is an ethical  obligation to expose an 
African government’s avoidable failure to prevent a TB medication  stock-out . 
Under question in Millum’s case is the degree to which both the U.N. (as a collec-
tive body of  governments carrying out a humanitarian intervention) and the Haitian 
government (as the provider of health infrastructure for its citizens) can be held 
morally or legally liable for a cholera outbreak. In Al-Faisal, Hussain, and Sen’s 
case, a public health expert testifying before a U.N. Commission must weigh in on 
the extent to which (1) foreign governments are obliged to minimize  harm to the 
health of Syrians and Iraqis when applying  sanctions and (2) Syrian and Iraqi gov-
ernments are obliged to conduct a foreign  policy that does not jeopardize the health 
of their citizens. A U.S.-based researcher grapples in Lee, Kleinfeld, and Glassford’s 
case with the question of whether she can ethically justify publishing a paper based 
on data obtained from two African countries whose governments have neither insti-
tutional review  boards nor national research  guidelines . 
8.2.2  Coordination 
 The second argument favoring  active  engagement of  governments in national health 
systems is their longstanding ability to enter binding legal agreements with each 
other and other  stakeholders . A government’s continued involvement is indispens-
able to shaping broad-based and sustainable solutions to the challenges of  global 
public health . The broad scope of a government’s responsibilities (and authority 
associated with performing these responsibilities) enables it to coordinate public 
health efforts involving public, private, and civic institutions. The importance of 
governmental involvement was crystallized in the words of former WHO Director 
General, Gro Harlem Brundtland, as the 2003 WHO  Framework Convention on 
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Tobacco Control was being drafted: “Tobacco control cannot succeed solely through 
the efforts of individual  governments , national NGOs (nongovernmental organiza-
tions) ,  and media advocates. We need an international response to an international 
problem” (Bodansky  1999 ). Tackling one of the world’s leading causes of prevent-
able death (i.e.,  smoking ), the Framework Convention adopts a comprehensive 
strategy that has been signed by the governments of 168 countries. 5 
 With completion of the human genome and development of various technologies 
to use it, interest in DNA repositories has surged (Kaye et al.  2009 ). The develop-
ment and increasing use of biorepositories of DNA, tissues, and other biological 
materials in institutions worldwide present far-reaching ethical challenges. Some 
challenges, such as those resulting from the collection and use of dried blood spots 
(Hendrix et al.  2013 ) or from regular  surveillance like the U.S.  Centers for Disease 
Control and Prevention (CDC)  HIV surveillance projects, are recurrent and famil-
iar. 6 When specimens must be shared in the context of  collaborative public health 
emergency  response and planning, the challenges can take on greater urgency. Such 
emergency collaborative sharing has occurred with virus strains for  pandemic infl u-
enza planning 7 and with the sequencing of the SARS coronavirus jointly undertaken 
by researchers from Canada, Hong Kong, Taipei, the  United States , and Vietnam 
during the global outbreak (Tong et al.  2004 ). Similarly, the sharing of data and 
health  information has long been a source of ethical and legal commentary and is 
widely viewed as desirable ethical behavior with demonstrable scientifi c benefi t 
(Committee on National Statistics  1985 ; Benkler and Nissenbaum  2006 ). 
8.2.3  Accountability 
 The third  argument supporting  government engagement in  global public health is 
based on democratic theory. Put simply, a country’s citizens can hold their govern-
ments accountable for failure to meet health commitments. In contrast to govern-
ments that are accountable to their entire  populations , NGO  stakeholders in  global 
health answer to narrower constituencies (i.e., corporations to their stockholders, 
NGOs to their funders, and foreign health organizations to their home govern-
ments). Because public health is of general concern, a level of accountability is 
essential for the entire health system to function properly. The involvement of gov-
ernments is, therefore, critical both to ensure the widest  participation possible in 
formulating health  policies and to sustain such policies despite shifting interests or 
diminishing profi ts of partners. 
 Setting aside the issue of relative advantages or demerits, the diminished role of 
 governments in  global public health —especially governments of  LMICs —creates 
5  See  http://www.who.int/fctc/signatories_parties/en/index.html 
6  See  http://www.cdph.ca.gov/programs/aids/Pages/TOASurv.aspx 
7  See  http://www.ip-watch.org/2013/05/27/world-health-assembly-pandemic-fl u-framework-
clears-committee/ 
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room for others to enter the fi eld. Entrants include public institutions (e.g., interna-
tional intergovernmental  bodies , governments of emerging economies); NGOs 
(e.g., development and relief agencies, academic health partnerships, faith-based 
initiatives); private entities (e.g., corporations, philanthropies, individuals); and 
hybrid entities that pool resources and expertise from public, nongovernmental, and 
private  stakeholders (e.g., The  Global Fund to Fight AIDS, Tuberculosis and 
Malaria). Each entrant to the  global health environment plays a unique role. Some 
take direct action by providing care, some facilitate and leverage the work of others, 
and some effect change in  policies to cultivate better and closer  collaboration . All 
undertake some form of partnership activity. 
 Essentially, rather than being merely an instrument of foreign policy and diplo-
macy or a means to technical aid between governments, collaboration in health has 
grown into a global endeavor involving many actors and  stakeholders (Elmendorf 
 2010 ). The declining role of governments in public policy presents special chal-
lenges for  global public health , and the proliferation of stakeholders makes the for-
mation of partnerships more demanding and critical. As  such , effective ethical 
frameworks that can serve as guides for planning and also as arbiters between com-
peting  values are indispensable. 
8.3  Ethics Frameworks for Global Health 
 Complementing this  political history has been an equally comprehensive set of 
approaches, each of which provides a moral foundation for defending actions,  poli-
cies , and decisions in global health. Foremost among these are principle-based 
approaches,  human-rights frameworks, and  social determinants of health (SDH) , 
although other approaches have been suggested (Ruger  2009 ). 
8.3.1  Principles and Benchmarks 
 The debate arising from the 1997 AIDS Clinical Trial Group Study 076 (ACTG- 
076) to reduce maternal–fetal transmission of  HIV served many purposes. Among 
the most useful was the attention focused on how ethical arguments are applied to 
substantive problems in global health (Lurie and Wolfe  1997 ; Varmus and Satcher 
 1997 ). Until then, most bioethical refl ection had concentrated on domestic topics, 
aside from revisions to the  Declaration of Helsinki and other documents. ACTG-
076,  however , energized discussion about, among other things, the nature of ethical 
 obligations and commitments to groups, countries, and regions—whether of 
researchers to research  participants , of science to society, or sponsors to host coun-
tries (Shapiro and Meslin  2001 ).  Accusations  of parachute research and double 
 standards abounded, leading many to rethink the applicability of accepted ethical 
principles and practices and to consider new contexts. They also questioned whether 
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researchers, sponsors, or  governments owed any continuing  obligation of care to 
research participants at the end of a  study . The  bioethics principles developed over 
three decades by Beauchamp and Childress ( 2009 ) provided a formidable founda-
tion upon which debates about research and health care could be played out—even 
in the face of critiques about their adequacy and suffi ciency as moral theory (Clauser 
and Gert  1990 ). Other principles have been recommended by scholars (Lavery et al. 
 2007 ) and  organizations (United Nations Educational, Scientifi c and Cultural 
Organization [UNESCO]  2005 ), but even proponents of principle-based approaches 
recognized that more was needed to meet challenges in emerging areas of science 
(e.g., public health genomics and transborder studies) (Lavery et al.  2007 ; Emanuel 
et al.  2008 ; Macklin  2008 ). 
 Indeed, early in the tenure of the  National Bioethics Advisory Commission 
(NBAC) that later reported on the ethics of  clinical trials (NBAC  2001 ), Ezekiel 
 Emanuel  proposed that the Commission review the  Belmont Report principles. He 
urged the Commission to adopt a new principle to its canon of  bioethics , namely a 
principle of c ommunity to accommodate ethical issues arising from the recruitment 
of groups. Although the Commission did not adopt this principle, Emanuel’s pro-
posal has since emerged as one of several benchmarks for assessing ethical accept-
ability of clinical  research in developing countries (Emanuel et al.  2004 ). More 
relevantly, the concept of community engagement and  participation has taken on a 
greater role in discussions about the importance of partnerships. 
 The cases by Timms and by Lee, Kleinfeld, and Glassford illustrate the utility of 
using ethical principles to frame the unique challenges of  global  collaboration in 
 biomedical research . Timms raises a critical issue about whether a  multinational 
pharmaceutical  company conducting  clinical trials in an  LMIC is responsible for 
 harms sustained by research participants during its investigations. The ACTG-076 
debate has broadened the question of  accountability , recognizing that impoverished 
and poorly educated  populations living with underdeveloped regulatory, health, and 
social service infrastructures must prompt reassessment of a  multinational trial 
sponsor’s ethical  obligations . Such reassessment has focused, naturally, on mea-
sures that prevent exploitation of vulnerable and desperate individuals in  LMICs 
(e.g., appropriate  informed consent , vigilant recruitment practices). But it has also 
raised the question of whether foreign sponsors and researchers have an ethical 
 obligation to the host community or country supplying the large and diverse recruit-
ment pool at comparatively lower  cost . 
 In the case  described  by Lee, Kleinfeld, and Glassford, a researcher must deter-
mine, apart from questions of scientifi c validity and potential health utility, whether 
proper  informed consent was obtained in the acquisition of data and tissue samples 
being used for  research on which she has been invited to  collaborate . These data and 
specimens were gathered using various  consent methods from six African countries, 
none of which had ethics review boards or national research  guidelines . Her collabo-
rator assures her that the consent modalities applied, though varying widely, were 
appropriate to the settings in which they were used. In deciding whether to coauthor 
an article based on acquired data, the researcher must consider how (or whether) the 
requirements of  informed consent , a foundational principle of ethical research, can 
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be met in different global settings, particularly those characterized by cultural or 
linguistic differences, low health literacy, and absence of regulatory infrastructure. 
8.3.2  Human Rights 
 Human rights constitute a compelling ethical framework for global collaboration. 
Based on an ethical vision discernable in early Greco-Roman writings, these  prin-
ciples matured in the work of such social contract  theorists as Thomas  Hobbes , 
Jean-Jacques  Rousseau , and John  Locke . The modern view of human rights presup-
poses that all persons, simply for being human, have inherent dignity. This dignity 
constitutes the normative foundation for people having certain inalienable rights. 
The terms  inherent  and  inalienable mean such dignity and rights belong to people 
naturally and are, certainly,  not bestowed by a  political authority . According to 
 human rights theory, a political authority has no ethical basis for arbitrarily depriv-
ing individuals of these rights (not having granted such rights in the fi rst place). But 
because some needs are common and not all goals can be met individually, people 
choose to surrender certain rights to a public authority established to ensure these 
ends are realized. Hence, a  government 
 … exists to ensure the well-being of the individuals who give up certain rights in exchange 
for certain protections and benefi ts […]. The same applies to the community they jointly 
establish. From this analysis, the traditional roles of  government include such things as col-
lective security, the administration of  justice , the protection of property and […] the  promo-
tion of the public’s health…. (Meslin and Garba  2011 ) 
 This theoretical sketch provides a backdrop to the 1948  U.N.  Universal 
Declaration of Human Rights (UDHR) , the ethical cornerstone of the  human rights 
system since the end of World War II. Using  human dignity as its starting point, the 
UDHR codifi es a unifi ed ethical vision for preserving a peaceful and just interna-
tional order while also emphasizing “social progress and better  standards of life” 
(U.N.  1948 ). Correspondingly, the UDHR contains rights that are broadly  political 
(e.g., fair trial, free speech,  freedom of religion) and others that focus on economic 
and  social conditions (e.g., housing, education, health). 
 As discussed previously, however, the  Cold War introduced ideological rivalries 
into the U.N., rifts that split the unifi ed ethical vision of the UDHR into two treaties: 
the  International Covenant on Civil and Political Rights (ICCPR) (U.N.  1966a ) and 
the  International Covenant on Economic, Social and Cultural Rights (ICESCR) 
(U.N.  1966b ). 8 The two treaties refl ected the priorities of the  opposing  sides—the 
 ICCPR advocated by the U.S.-led capitalist alliance and the  ICESCR championed 
by the U.S.S.R.-led communist bloc. Having two treaties hindered the deployment 
of  human rights as an effective ethical framework for health  collaboration during 
the latter half of the twentieth century. 
8 Article 12 of the  ICESCR codifi es the right to health. 
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 As the  Cold War abated, the global community adopted a more holistic approach 
to  human rights , including the  right to health . This was captured in the 1993 
 U.N. Vienna Declaration and Programme of Action , a document that reaffi rmed 
human rights as “universal, indivisible, and interdependent and interrelated” (U.N. 
 1993 ). The Vienna Declaration laid the foundation for the creation of the  Offi ce the 
United Nations High Commissioner for Human Rights (OHCHR) , an agency that 
oversees the promotion and protection of  human rights throughout the U.N.  system . 
Moreover, the  U.N. Human Rights Council (HRC) , 9 through its special procedures, 
appoints independent experts (or “special rapporteurs”) 10 to report on areas of con-
cern, including such health-related themes as food, physical and  mental health , 
adequate housing and extreme poverty, and healthy and sustainable environments. 11 
As noted previously, this holistic approach was also refl ected in the adoption of the 
Millennium Development  Goals (most of which are related to health) and exempli-
fi ed in the coordinated approach to tackling  HIV/AIDS . The health and  human 
rights  movement , which gained traction during the global discussion on sexual and 
reproductive health, fi rmly took root once health  professionals responded to the 
peculiar challenges of treating HIV-positive people facing  discrimination (Gruskin 
et al.  2007 ; Mann  1997 ). 
 Quite apart from the scarcity of fi scal resources that often plague  LMIC  govern-
ments , other challenges preclude adopting an integrated approach to the  right to 
health . For example, a long-standing argument is that the right to health as codifi ed 
in the International Covenant on Economic, Social and Cultural  Rights attaches to 
individuals and is, hence, unsuited for effectively achieving public health objec-
tives, goals that by defi nition focus on  population health (Meier  2006 ). In addition, 
the proliferation of non-state actors in  global health mentioned earlier (e.g., relief 
agencies, academic health partnerships, corporations, philanthropies) make  coordi-
nation and  accountability about the right to health more demanding. By and large, 
governments are the sole entities authorized to sign health-related  human rights 
treaties such as the  ICESCR . International treaties typically have mechanisms for 
ensuring that signatories fulfi ll legal commitments. But as discussed earlier, the 
diminishing role of governments in national  policy and the increasing privatization 
of public services under  globalization (WHO  2002 ) mean that treaty  law will likely 
play a correspondingly smaller role in  global health  collaboration . Although the 
infl ux of new non-state actors allows  stakeholders to partner in innovative ways to 
address challenges in global health, the stability and accountability of international 
 human rights law remains a valuable asset in a constantly evolving fi eld. 
 Most  cases in this chapter feature ethical issues that are illuminated but some-
times complicated by the  human rights framework. In Jensen and Gaie’s case, 
human rights potentially impede a public health strategy for controlling the spread 
of  HIV/AIDS . The case calls for a public health offi cial to balance the human rights 
9  Until 2006, the U.N. Commission on Human Rights. 
10  The Human Rights Council also uses working groups. 
11  For special procedures of the Human Rights Council, see  http://www.ohchr.org/EN/HRBodies/
SP/Pages/Welcomepage.aspx 
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of individuals (possibly suffering  discrimination and stigma-related violence under 
routine or mandatory testing  policies ) against the health of the community, which, 
arguably, is better served by precisely such testing regimes. 
 A distinguishing mark of  globalization is the increased infl uence of transnational 
businesses on the policies of  LMIC  governments . Timms’ case illustrates the impact 
of this  development . Given the economic and  political clout of transnational busi-
nesses, there are continuing discussions on the extent of their  human rights  obliga-
tions (Weissbrodt and Kruger  2003 ; Ratner  2001 ). In this case, even if the 
pharmaceutical  company conducting  research in  India is not directly bound by a 
 human rights treaty, is it obliged to comply with human rights  norms on some other 
basis (e.g., national  laws , industry  standards , corporate codes of conduct)? 
 In 2011, the  U.N. Human Rights Council endorsed the  Guiding Principles on 
Business and Human Rights , a document outlining what has come to be known as 
the U.N. “Protect, Respect and Remedy” framework.  Guiding Principles recognizes 
governments’  duty to  protect human rights, acknowledges corporate responsibility 
to  respect  human rights , and requires  governments to ensure that people  harmed 
within their jurisdiction have access to effective judicial and nonjudicial  remedies . 
 List and Boyd’s case questions how one’s  freedom of expression (Article 19, 
 ICCPR ) affects public health. Should one be allowed to use the free press to advo-
cate on behalf of fellow citizens? Does the free press furnish a forum for an informed 
and representative discussion on  public health policy ? Are expatriate workers less 
likely than nationals to face offi cial retaliation when they use media outlets to criti-
cize  government ? 
 Confl ict in the Balkans and killings in Rwanda in the early 1990s revived lively 
debate on the international community’s  obligation to intervene in internal affairs of 
member countries to defend  human rights (Kardaş  2010 ; Chopra and Weiss  1992 ). 
Organizing international action to address human rights  violations remains a peren-
nial challenge—exemplifi ed by the intractable situation in  Syria following major 
pro-democracy protests in 2011. But ideological alliances and rivalries during the 
 Cold War made consensus building around such interventions arduous (Eisner 
 1993 ). The Balkan and Rwandan  confl icts and a growing atmosphere of  cooperation 
 in the face of global challenges (e.g., environmental degradation,  climate change ) 
contributed to an increase in peacekeeping and humanitarian operations organized 
by the international community. These operations, though designed to further 
 human rights , sometimes undermined the target  population’s  right to health . 
 Millum’s case and that of Al-Faisal, Hussain, and Sen raise issues that result, 
paradoxically, from increasing adoption of the  human rights framework as an inter-
national  norm . Millum’s case questions responsibility during a major cholera out-
break originating in a camp occupied by Nepali soldiers on a U.N. peacekeeping 
mission in the Caribbean. The Al-Faisal, Hussain, and Sen case considers how the 
health of vulnerable groups in  Iraq and  Syria is affected by economic  sanctions 
imposed on the two countries’  governments and shows how interventions intended 
to protect  human rights can still have adverse health consequences. 
 Increasingly, human rights are being used to frame responses to  global public health 
challenges (Adorno  2009 ; Mann  1997 ).  Human rights are a pervasive transcultural and 
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normative discourse. Issues once relegated to  bioethics are now cast as human rights 
concerns (Adorno  2009 ; Faunce  2005 ). For example, UNESCO adopted three declara-
tions that use human rights to frame health challenges: the  Universal Declaration on 
the Human Genome and Human Rights ( 1997 ), the  International Declaration on 
Human Genetic Data ( 2003 ), and the  Universal Declaration on Bioethics and Human 
Rights ( 2005 ). Each declaration codifi es the  principle of  informed consent —a princi-
ple at stake in the case cited by Lee, Kleinfeld, and Glassford and, to a lesser degree, 
the case by Timms. The cross- fertilization of concepts and concerns between bioethics 
and  human rights is a salutary consequence of public health partnerships forged in an 
increasingly interconnected and complex world. 
8.3.3  Social Determinants of Health 
 The social determinants of health (SDH) framework is based on  social justice (Lee 
 2004 ). The guiding  principle of SDH is  equity. As with public health, SDH empha-
sizes  population  health  and  prevention . However, SDH goes beyond traditional pub-
lic health approaches because, in addition to deploying interventions aimed at 
reducing population mortality and morbidity, SDH targets “the social context and 
conditions in which people live” (Blas et al.  2011 ). These contextual factors and 
conditions that affect  health outcomes in a given  population are called  social deter-
minants of health . 12 These include such factors as housing, education, transporta-
tion, employment, insurance coverage, and access to health care (Brennan Ramirez 
et al.  2008 ). 
 The SDH framework stands on 40 years of  research demonstrating that clinical 
care alone cannot improve  health outcomes unless social factors are addressed 
(WHO  2007 ). Statistical associations between social disadvantage and poor health 
became increasingly clear, impelling the inference that closing the gap in health 
status between populations required corresponding improvements in the social con-
texts of disadvantaged populations. 
 The ethical  norm underlying efforts to eliminate these preventable health differ-
ences is the  principle of  equity .  Health  in equities are differences “socially produced; 
systematic in their distribution across the  population ; and unfair” (WHO  2007 ). On 
the other hand,  health  equity is “the absence of unfair and avoidable or remediable 
differences in health among population groups defi ned socially, economically, 
demographically, or geographically” (WHO  2007 ). These defi nitions highlight two 
aspects of SDH. First, the differences in health are not merely descriptive but pre-
scriptive as well, implying an ethical  obligation in favor of their elimination. Second, 
the focus on social context and conditions means that  policy and action must be 
 intersectoral , involving actors and spheres outside the health fi eld (WHO  2007 ). 
12  The social determinants of health have also been characterized as “the conditions in which peo-
ple live and work that affect their opportunities to lead healthy lives” (Labonté and Schrecker 
 2007 ). 
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 Health  disparities among  populations in different parts of the world motivate 
public  health interventions and assist the development of useful analytical tools for 
global health.  A case in point would be the gaps in  infant mortality rates and life 
 expectancy between countries with strong economies and  LMICs . These gaps pro-
vide moral stimulus for elimination and benchmarks for setting goals and assessing 
progress (e.g., the health-related  Millennium Development Goals ). 
 The SDH framework faces several challenges and limitations. Most people do 
not realize the impact of social and contextual factors on  health outcomes .  Political 
orientations and worldviews further impede the acceptance of SDH as a viable  pol-
icy alternative (Gollust et al.  2009 ). Some argue that variations of SDH oversimplify 
the link between wealth and health, thereby failing to consider other causes of  health 
disparities (Poland et al.  1998 ). Even though statistical links have been made 
between social context and ill health, scientifi c questions remain on the mechanisms 
that account for these associations. This is especially critical in the fi eld of  mental 
health , where attempts have been made to clarify associations between SDH and 
psychological well-being (Marmot et al.  1997 ; Bovier et al.  2004 ; Fisher and Baum 
 2010 ; Paananen et al.  2013 ). 
 Aside from the availability of  HIV/AIDS health services and  medication , the 
Jensen and Gaie case and Zinner case demonstrate how social factors affect health. 
In Jensen and Gaie, advocates of client-initiated  voluntary testing (vigilant, rights- 
based) offer compelling reasons to minimize the potential for  discrimination and 
stigma-related violence against people living with  HIV . As the case points out, the 
 risk of violence or discrimination is particularly high in  LMIC societies where 
social, cultural, and legal protections are nonexistent or being developed. 
 Although HIV-positive status can have adverse social consequences, Zinner illus-
trates how social factors increase the risk of infection in the fi rst place. In this case, an 
international anti-AIDS program administering pre-exposure prophylactic  medica-
tion is deciding whether to budget small sums of money to educate young girls in the 
community. Investing in education should reduce their likelihood of getting infected 
in unequal liaisons with  older men (sugar-daddy relationships) while creating open-
ings in the program for other at-risk groups to participate. In effect, the program is 
considering medical intervention (i.e., a pre-exposure prophylactic drug) and social 
determinants of health (i.e., girl–child education) in making its  allocation decisions. 
 Both Timms’ and Lee, Kleinfeld, and Glassford’s cases show how  social deter-
minants (e.g., gender, caste, economic status, literacy) infl uence the  effectiveness of 
 informed consent for vulnerable  LMIC  populations participating in drug  research . 
Less direct but equally critical, these cases also show how geographic disparities in 
 social conditions establish context for  global health research. The challenge of 
ensuring that drug research is conducted ethically in LMICs derives from such con-
textual factors as greater  disease burdens in these regions due to underdeveloped 
health systems, lax  regulation of  biomedical research due to ineffective governance 
structures, and economic and social  vulnerability of most potential research partici-
pants (Barlett and Steele  2011 ). 
 In the context of SDH,  empowerment “is inseparably linked to marginalized and 
dominated communities gaining effective control over the  political and economic 
processes that affect their well-being” (WHO  2007 ). List and Boyd’s case demon-
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strates how citizens of  LMICs can use mass media to infl uence their  governments 
on public health topics. A physician-national in an East African country fears retali-
ation if she talks to the media about a TB medication  stock-out potentially due to 
government corruption and misuse of public funds. Her fears underscore the  risks 
and responsibilities associated with the role of health workers as advocates for the 
socially and politically marginalized in their communities (Pérez and Martinez 
 2008 ; Farmer  2004 ; Geiger and Cook-Deegan  1993 ). Also pertinent from a global 
SDH perspective is the  likelihood that an expatriate whistleblower, especially a citi-
zen from a higher-income country, would not face as serious a risk. 
8.4  Summary 
 The approaches and methods for collaborating in  global public health are diverse—
just like the cases in this chapter. These cases refl ect the rich and multifaceted con-
text for global public health while also emphasizing the role that different ethical 
 standards (and the foundations for those standards) play. In so doing, the cases offer 
a fresh and innovative perspective on the ethics of public health. 
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 Kipton  E.  Jensen 
 Department of Philosophy and Religion 
 Morehouse College 
 Atlanta ,  GA ,  USA 
 e-mail: kipton.jensen@morehouse.edu 
 Joseph  B. R.  Gaie 
 Department of Theology and Religious Studies 
 University of Botswana 
 Gaborone ,  Botswana 
 This case is presented for instructional purposes only. The ideas and opinions 
expressed are the authors’ own. The case is not meant to refl ect the offi cial position, 
views, or policies of the editors, the editors’ host institutions, or the authors’ host 
institutions. 
8.5.1  Background 
 The  global public health community has signifi cantly advanced our understanding 
of the biology of the human immunodefi ciency virus ( HIV ) and developed reliable 
diagnostic tests and effective antiretroviral  treatments . Despite these advancements, 
the rate of prevalence and transmission, especially in low- and middle-income  coun-
tries , remains alarmingly high.  HIV prevention , often considered better than a cure, 
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remains the mainstay of our collective response to the epidemic. By all accounts, 
 HIV testing plays a pivotal role in treatment and  prevention , yet in low- or middle- 
income countries, only 10 % of those who have been exposed to HIV infection may 
have access to  counseling and testing (UNAIDS/WHO  2004 ; Centers for Disease 
Control and Prevention  2012 ) . In general, HIV testing policies range from  voluntary 
or client-initiated counseling and testing to provider-initiated approaches (e.g., rou-
tine testing, mandatory HIV  screening ). Most  policy makers and health workers 
have promoted voluntary HIV testing, although routine HIV counseling and testing 
increasingly is being adopted. Notably, however, the  global health community has 
adamantly discouraged mandatory  HIV testing (UNAIDS/WHO  2004 ). 
 Resource-poor countries may be unable or unwilling to ensure social and medical 
infrastructures adequate for safeguarding the  human rights of people seeking ser-
vices. As a result,  global health offi cials have encouraged countries to adopt  volun-
tary or client-initiated  counseling and testing policies opposed to routine or 
provider-initiated policies. Even in settings in which voluntary counseling and testing 
is readily available, few people take advantage of these services. Stigmatization per-
sists as an obstacle to  HIV counseling and testing, which, by all accounts, is vital to 
effectively treat people living with HIV and  AIDS and to reduce further infection. 
 Many public health ethicists recommend that  policy makers and health workers 
carefully consider the ethical consequences of routine testing policies, especially 
for people in locales that lack protections against  discrimination and stigma-related 
violence (Rennie and Behets  2006 ). To protect individuals against HIV-related dis-
crimination and threat of violence, advocates of the human-rights approach vigi-
lantly oppose the application of  standard methods of disease control, which include 
mandatory testing and partner notifi cation. But this vigilant rights-based approach 
to  HIV prevention , an approach that Bayer ( 1991 ) labelled  AIDS exceptionalism , 
can undermine society’s ability and indeed responsibility to control the epidemic. 
And although public health offi cials are a minority, some argue for mandatory  HIV 
testing (Schuklenk and Kleinsmidt  2007 ), seeing it as the only way to control the 
 HIV epidemic. Failure to apply standard methods of disease control, some argue, 
devalues public health and  social justice (Frieden et al.  2005 ; De Cock et al.  2002 ). 
By treating  HIV/AIDS differently than other  infectious diseases , AIDS exceptional-
ism may inadvertently increase stigmatization rather than reduce it (De Cock et al. 
 2002 ). Proponents of testing point to its potential to reduce stigma by raising aware-
ness, preventing transmission, expanding  treatment , and empowering individuals 
(Crepaz et al.  2004 ). 
 HIV testing policy recommendations from the global international public health 
community can also challenge if not undermine the authority of the indigenous 
knowledge system or indigenous ethical codes (Chilisa  2005 ; Dube  2006 ; Jensen 
and Gaie  2010 ). These recommendations  typically stipulate ethical preconditions 
within  voluntary HIV testing  policies , such as strict confi dentiality,  informed con-
sent , and competent pre- and post-test counseling. Some argue that preconditions 
constitute a  Western approach that blocks local efforts to control the epidemic. 
Although many believe that the context of provider-initiated  HIV testing preserves 
“suffi cient voluntariness,” others have criticized this approach. Critics maintain 
that opting-out from provider-initiated HIV testing differs signifi cantly from 
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 client- initiated or voluntary HIV  counseling and testing (Kenyon  2005 ). In either 
case, all agree, medical practitioners and  policy makers cannot guarantee ideal or 
even adequate social and institutional support services (Weiser et al.  2006 ). 
 These disputes are by no means merely theoretical. In Botswana, for example, 
policy has shifted within the past 5 years from a client-initiated to a provider- 
initiated or routine  HIV diagnostic counseling and testing strategy (Botswana 
Ministry of Health  2012 ). More recently, in response to a parliamentary-approved 
public health bill presently being contested as unconstitutional (Botswana Network 
on Ethics, Law and HIV/AIDS  2012 ), the debate has shifted to whether certain 
conditions render mandatory testing ethically permissible. 
8.5.2  Case Description 
 The Minister of Health of a sub-Saharan nation has asked you, a public health offi cial 
and physician from a  Western country, to recommend an effective  HIV testing policy . 
The sub-Saharan nation is among the hardest hit by the  HIV epidemic (e.g., the HIV 
prevalence rate among pregnant women aged 15–49 is >25 %). In this resource-poor 
nation, people with HIV and  AIDS are commonly stigmatized despite national cam-
paigns to reduce stigma. Even if the nation were to adopt a  policy of  voluntary HIV 
counseling and  testing , more than 50 % of people living with HIV and  AIDS are unaware 
of their serostatus. Although  HIV  treatment is currently unavailable, international donors 
have promised to provide free or inexpensive  antiretroviral therapies (ART) . 
 You have sought the input of your colleagues in  global public health only to dis-
cover they are contentiously divided. Some vigorously oppose enhanced HIV test-
ing  policies that would move from voluntary to routine  HIV testing to protect the 
community against  discrimination or stigma-related violence. They also oppose in 
 principle Western-based interventions, which, they say, undermine traditional loci 
of authority and indigenous systems of medical knowledge. Other colleagues insist 
that human rights-based approaches undermine public health’s ability, as well as 
responsibility, to control the  HIV epidemic. They are for moving beyond client- 
initiated approaches and vigorously support mandatory  HIV testing . These 
 colleagues feel that the only way to control the HIV epidemic is to apply the  stan-
dard methods of disease control. 
 Given these divergent views, you hope to be able to recommend a  HIV  policy 
that strikes a balance between the Hippocratic ideal of doing no harm and the 
equally compelling mandate to protect if not improve public health. 
8.5.3  Discussion Questions 
 1.  How might an emphasis on protecting  human rights in  HIV prevention reduce 
the importance of public health and social justice? 
 2.  Is opting in, or not opting out, as part of the routine testing strategy, ethically 
equivalent to acquiring  consent within a  voluntary testing site? What are the 
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necessary and suffi cient conditions, ethical or otherwise, for “adequate  informa-
tion ” or “suffi cient voluntariness” in cases of  HIV testing ? 
 3.  Is there an ethical  confl ict between one’s duty, whether as a physician or a public 
health offi cial, whether as the minister of health or simply as a person, to adopt 
what are considered to be effective methods of controlling disease, e.g.,  HIV , and 
the  obligation to  respect indigenous knowledge systems and approaches to pub-
lic health? If there is a confl ict, which duty should take  precedent ? 
 4.  What  policy would you recommend under these circumstances? And what ethi-
cal  principles guided your recommendation? 
 5.  How would your recommendation provide, if at all, protections against discrimi-
nation and stigma-related violence? 
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8.6  Case 2: Just  Allocation of Pre-exposure Prophylaxis 
Drugs in  Sub-Saharan Africa 
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 This case is presented for instructional purposes only. The ideas and opinions 
expressed are the author’s own. The case is not meant to refl ect the offi cial position, 
views, or  policies  of the editors, the editors’ host institutions, or the author’s host 
institutions . 
8.6.1  Background 
 During the summer of 2012, the  U.S. Food and Drug Administration (FDA) 
announced the approval of  Truvada (emtricitabine/tenofovir disoproxil fumerate) 
for use in  pre-exposure prophylaxis programs (PrEP) for people at high  risk of  HIV 
infection (FDA  2012 ). After successful use of  antiretroviral therapy (ART) drugs to 
treat HIV/AIDS-infected  populations , researchers found that daily prophylactic use 
of these drugs in uninfected individuals who engaged in high-risk activities was also 
effective in reducing their risk of  HIV/AIDS . The U.S.  Centers for Disease Control 
and Prevention (CDC) noted that PrEP could reduce  HIV rates for men having sex 
with men if those at high risk of  HIV infection were targeted and if PrEP was used 
as part of a comprehensive set of preventive services, including regular monitoring 
of HIV status, adherence, and risk behaviors (CDC  2011 ). Candidates for Truvada 
should fi rst be tested for HIV to ensure that they are in fact HIV negative before 
beginning the  PrEP program. 
 This innovative prophylactic approach to reducing the likelihood of contracting 
 HIV holds great promise. One study found that Truvada reduced the  risk of  HIV 
infection 42 % compared with men taking placebos and having sex with other men 
(Grant et al.  2010 ), whereas a second study found that risk fell by up to 75 % com-
pared with  serodiscordant couples taking placebos (Baeten et al.  2012 ). However, 
Truvada is associated with some side effects, including nausea and  vomiting  (CDC 
 2011 ) and possible decreases in bone mineral density (Grigsby et al.  2010 ). 
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Furthermore,  Truvada is contraindicated for anyone with decreased kidney  function. 
Regular testing of kidney function is recommended for those people taking this 
 medication (CDC  2011 ). 
 Truvada has been tested only in  serodiscordant couples —not in women. Its effi -
cacy in the general  population of women, in sex workers, and in young girls in 
sugar-daddy relationships (i.e., young girls in unequal relationships with older 
males) is unknown. 
 Sub-Saharan Africa has been hit especially hard by HIV/ AIDS . An estimated 
two-thirds of people affected by  HIV worldwide are concentrated in this area, 
although signifi cant variations exist in different parts of the continent (Kalipeni 
et al.  2004 ). Unfortunately, the distribution and availability of  ART drugs have 
exposed the inadequacies of some African national health systems, such as the neg-
ative effects of a long-neglected health sector, economic challenges, declining pub-
lic expenditures, and decentralized funding (Schneider et al.  2006 ). 
 Many international aid groups help fund public health programs, including pro-
grams to reduce the spread of  HIV/AIDS . Programs such as PEPFAR (The  United 
States President’s Emergency Plan for AIDS Relief) , the  Global Fund , the  World 
Bank , the United  Nations , and the  Gates Foundation have all contributed large sums 
of money for this purpose. 
 African groups at high  risk of contracting new infections (and thus good poten-
tial candidates for  PrEP ) include sex workers, men having sex with men,  serodiscor-
dant couples , and girls in sexual sugar-daddy relationships. The latter group poses 
specifi c ethical issues. These girls, typically teenagers, may be coerced into sexual 
relationships with men old enough to be their fathers or even grandfathers through 
the offering of gifts or money. These sugar daddies generally engage in multiple 
sexual relationships, possibly with a spouse and several young women, while put-
ting the girls at risk of  HIV . Every averted case of HIV increases economic produc-
tivity, lowers the risk of social unrest, strengthens the labor force, and improves the 
investment climate (Over  2011 ). 
8.6.2  Case Description 
 You are the head of an international anti-AIDS effort currently stationed in a com-
munity of 40,000 in sub-Saharan Africa, where the  HIV prevalence rate is 21 %. You 
have received funding from different world organizations, including some based in the 
 United States . Your organization is piloting the use of  Truvada in  populations that are 
at high  risk of  HIV . The organizations funding this project will allow you and the two 
health workers assigned to assist you to make all  allocation decisions. 
 The  cost of Truvada for one patient is about $500 per year. Those living in this 
community are poor, and none could afford this drug without the existence of your 
program. Many populations in the community are at high risk of  HIV infection , 
including homosexual and bisexual men who routinely engage in sex with other 
men, girls in sugar-daddy relationships, sex workers, and  serodiscordant couples . 
You have been given enough  Truvada to treat and monitor 100 patients for a year. 
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The funding organizations have indicated that they are likely to provide more 
Truvada if you fi nd its use results in no or few new infections during the year among 
the 100 selected patients. The community of 40,000 people include the following:
•  80 men who have sex with other  men ; 
•  80 girls in sugar-daddy relationships; 
•  40 sex workers; and 
•  30  serodiscordant couples (60 people; noninfected partner receives  Truvada 
while the infected partner is not medically eligible for  ART ). 
 One challenge you face is that many feminist organizations and  child health advo-
cates are pressuring you to include all girls in the group because ample  research shows 
that girls in sugar-daddy relationships are relatively powerless and cannot ask their 
partners to wear a condom, virtually ensuring that these girls will become infected. 
There is some evidence, however, that simply paying girls a small amount of money 
to attend  school (and thus dramatically reducing the possibility of these relationships) 
is cost effective. If you adopt this approach, you could use the  Truvada for the other 
groups. You may need to consider whether to request more money from the funding 
organizations if you adopt this approach. One of your organization’s goals is to  respect 
cultural  norms and beliefs if the health of those at  risk of  HIV/AIDS is not jeopar-
dized. You have been asked to allocate the  PrEP drugs in your community. 
8.6.3  Discussion Questions 
 1.  What role should the community play as you make your  allocation decisions? 
How do you remain culturally sensitive when implementing this program? 
 2.  Create a rubric to help you consider each group for  inclusion in the PrEP pro-
gram. What factors will you weigh in making  allocation decisions? If you do not 
pick an entire group, what criteria do you use to select individuals in that group? 
How would your criteria differ if you were distributing  ART drugs to infected 
individuals (and not to those who are at risk but not infected)? 
 3.  What role should the likelihood of patient adherence play in your  allocation 
decision? Keep in mind that patients are expected to take their  medication daily 
on a strict time schedule. 
 4.  How will you determine if your program is successful? How will you determine 
whether your  allocation decisions are just and fair? 
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expressed are the author’s own. The case is not meant to refl ect the offi cial position, 
views, or  policies  of the editors, the editors’ host institutions, or the author’s host 
institutions . 
8.7.1  Background 
 Clinical trials outsourced to  India offer, in addition to business opportunities for 
clinical  research management, the prospect of health infrastructure development 
and collaborative  research . Since 2005, drug trials in India have increased as foreign 
drug companies eagerly take advantage of the favorable research environment 
(British Broadcasting Corporation [BBC] News  2006 ; Russia Today  2010 ; Overdorf 
 2011 ; John  2012 ). These advantages include highly qualifi ed English-speaking 
doctors, a large and diverse  population , and lower  costs and relative  freedom from 
burdensome  regulations for privately funded research  trials  (World Health 
Organization  2008 ). As a result, clinical research organizations working on behalf 
of  pharmaceutical companies frequently approach doctors in private or  government 
practice to recruit patients for drug trials, often offering attractive payouts per recruit 
and promising coauthorship and publication credits as incentives. 
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 For vast sections of its demographic,  India grapples with inadequate access to 
health services and high rates of  infant mortality and communicable diseases 
(Government of India Planning Commission  2011 ). Only a small slice of the  popu-
lation can afford the high-end private and corporate hospital care in urban pockets 
of the nation. Though extremely deferent to physicians, the Indian population is 
insuffi ciently informed about the  risks and benefi ts of  clinical trials . Illiterate, 
impoverished, and unaware of the implications of  participation , many drug trial 
recruits are vulnerable to exploitation (Srinivasan and Nikarge  2009 ). With limited 
health care options, some gladly enroll in a drug trial, considering themselves fortu-
nate to receive medical attention, food, and  compensation for local travel. Such 
circumstances compromise the intent behind freely giving  informed consent . 
 The media has drawn attention to several high-profi le cases. These involved poor 
people from lower castes who enrolled in drug trials without adequate  consent , 
resulting in severe adverse effects, including death (Lloyd-Roberts  2012 ). Citing 
data for 2005–2012, the BBC reported that 2,000 clinical trials took place in  India . 
The death count among people enrolled in these  clinical trials was 288 in 2008, 
637 in 2009, 668 in 2010, and 438 in 2011 (Lloyd-Roberts  2012 ). The media also 
raised concerns about inadequate  regulation of private trials, inconsistent applica-
tion of  informed consent requirements, and irregularities in ethics reviews (The 
Hindu  2011 ; The Indian Express  2012 ). 
 Although offi cials have been responsive to these concerns, their efforts still leave 
the vulnerable unprotected. In 2000, the Ministry of Health and Family Welfare 
established legal  guidelines regulating the conduct of  research in  India that align 
with international guidelines on  research ethics including the  International 
Conference on Harmonisation of Good Clinical Practice (ICH-GCP) ( 1996 ), the 
 Declaration of Helsinki (World Medical Association  2008 ) and  Council for 
International Organizations of Medical Sciences (CIOMS) guidelines ( 2002 ). The 
 Indian Council of Medical Research also developed guidelines specifi cally for  clini-
cal trials ( 2006 ). Further, the Drugs and Cosmetics Rules were amended to require 
review and registration of trials and to compensate trial participants or their families 
in the event of an  adverse event (Government of India  2005 ) . Unfortunately, adverse 
events go grossly underreported. Few recruits receive compensation, and hardly any 
investigations result in convictions for unethical  research practices . 
8.7.2  Case Description 
 Sharada, a 45-year-old woman of  a  low social caste in an impoverished town in  India , 
lives on less than 2 U.S. dollars a day. She has access only to the  government hospi-
tal system that provides free health care to underserved citizens. Complaining of 
chest pains, she is taken to the nearest government hospital and diagnosed with heart 
and renal failure. Pharmakon, a  multinational pharmaceutical  company , happens to 
be conducting a trial for a drug that has renal-protective effects in cardiac failure. 
From a colleague serving as a site investigator for this trial, Sharada’s cardiologist 
hears that pilot testing of the drug has shown promising results. But he also learns that 
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his colleague’s  compensation is tied to the number of subjects he enrolls in the study. 
Worse, Pharmakon has a history of enrolling patients without ensuring they fully 
understand they will be participating in a  research project . Despite misgivings about 
this history and his colleague’s fi nancial incentive to enroll patients, Sharada’s cardi-
ologist recommends that she enroll in the drug trial. He emphasizes that enrollment 
offers the only way to obtain an expensive drug necessary to save her life that would 
otherwise be unaffordable. Given the family’s lack of education, he is uncertain how 
much they understood, yet they seem grateful for the prospect of immediate care and 
 treatment . While on this  medication , Sharada develops cardiac arrhythmias, is taken 
off the drug, and is discharged from the hospital in a few days. Almost a month later, 
she succumbs to cardiac arrest at home. Soon thereafter, the high number of serious 
drug-related complications forces discontinuation of the drug trial. 
8.7.3  Discussion Questions 
 1.  Who are the  stakeholders in this case, what is at stake for each of them, and what 
 values does each bring to the situation? 
 2.  What are the  risks and benefi ts of enrolling impoverished, uneducated patients 
living in developing countries in clinical drug trials? What are the barriers to 
obtaining true  informed consent from these patients, and what can be done to 
overcome these barriers? 
 3.  What are  the ethical implications of tying a researcher’s  compensation to the 
number of subjects enrolled? Should this practice be permitted? 
 4.  Are  multinational  pharmaceutical companies that benefi t from cost-effective 
drug trials in developing countries obligated to improve the lives of people living 
in those countries? 
 5.  Who should be held responsible for  adverse events due to a drug trial conducted 
by a  multinational company in a country where there is limited health insurance, 
no social security, and poor enforcement of  regulations ? What international or 
grassroots efforts might help ensure  accountability for adverse events? 
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 This case is presented for instructional purposes only. The ideas and opinions 
expressed are the authors’ own. The case is not meant to refl ect the offi cial position, 
views, or  policies  of the editors, the editors’ host institutions, or the authors’ host 
institutions . 
8.8.1  Background 
 The  World Health Organization (WHO) maintains  a  list, updated every 2 years, of 
medications it considers essential—medications that a given country should have on 
hand to distribute to its citizens (WHO  2015 ). In functioning health systems, the 
intent is to have essential medicines of assured quality available at all times in ade-
quate amounts, in appropriate dosage forms, and at an affordable price (WHO 
 2015 ). Among those medications are treatments for tuberculosis (TB), a ubiquitous, 
slow-growing bacteria that kills 1.4 million people annually (WHO  2012 ). 
 Control of TB requires the availability of medication for months of  treatment . 
Procurement of  TB medication requires an intact and predictable supply chain. 
Ideally, ministries of health in low-income countries forecast accurately the number 
and types of medications needed to treat the local burdens of disease. Then  govern-
ments typically purchase medications to store in a central facility for regional distri-
bution. Ineffi ciencies in  drug supply forecasting; stocking practices;  storage 
capabilities; transportation capacity; and timely funding, procurement, and delivery 
can lead to a breakdown in a supply chain. 
 One barrier to TB control in low-resource countries, as well as in the  United 
States , is intermittent unavailability of  TB medication , an occurrence known as a 
stock- out  (Centers for Disease Control and Prevention  2013 ). Medication stock- 
outs often result in delayed  treatment , an increased  risk of  drug resistance in incom-
pletely treated people, and the potential for untreated or incompletely treated people 
to infect others. Stock-outs occur for different reasons, including budget constraints, 
poor drug procurement  policies and distribution networks, and  political corruption 
slowing drug availability (Stop Stock-outs Campaign  2010 ). 
 Although 80 % of national  ministrie s of health reporting to WHO have an unin-
terrupted supply of fi rst-line TB medications, 45 % of the 20 highest-burden coun-
tries report stock-outs (WHO  2009 ). More recently, 14 countries experienced 
anti-TB drug stock-outs in 2011 (Stop TB Partnership  2011 ). To contend with 
 recurrent stock-outs, the Stop TB Partnership provides technical support and drug 
procurement avenues to resource-poor nations through its Global Drug Facility 
(GDF) and Green Light Committee (GLC) (Stop TB Partnership  2011 ). Although 
GDF and GLC are essential players in ensuring at-risk nations have adequate  drug 
supplies , both are limited in how quickly they can respond to stock-outs. 
 Advocacy groups and nongovernmental  organizations can generate widespread 
public attention in hope of quicker resolution of stock-outs. A paucity of literature 
covers the ethical roles of expatriate health workers in stock-outs. The  model of 
“ethics of engaged presence” in health practice for expatriate health workers in low- 
income countries may offer a framework of  solidarity with local people (Hunt et al. 
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 2012 ). This nondirective framework broadly centers on the moral dimensions of 
expatriate involvement in humanitarian health work undertaken with local individu-
als. Still, limited ethical  guidelines exist for expatriates who seek to enter foreign 
 political and social forays to affect change—leaving the problem of essential  TB 
medication stocks-outs unresolved. 
8.8.2  Case Description 
 You are a visiting researcher in an East African country investigating TB case- fi nding 
detection strategies in an urban area. This country has one of the highest TB burdens 
in the world. Its  government funds the national medical stores to stock anti- TB drugs 
per WHO’s essential  medication list. On occasion, you work in the TB clinic at the 
local hospital treating TB patients, some of whom have multidrug- resistant  TB . You 
know that your research  participants are guaranteed TB drugs through your study’s 
funding. Potential participants who do not qualify for the study but have active TB 
infection are referred to a local clinic. 
 After months living and working  i n this country, you learn that many of the urban 
and rural clinics carry an inadequate supply of anti-TB medications. You speak with 
local doctors about the anti-TB drug shortage. They are frustrated and speculate as 
to why there have been stock-outs. Some suspect corruption and misuse of funds by 
the ministries of fi nance and health are to blame. Others blame drug manufacturers 
for unreliable supplies. 
 You search for drug stock-outs in this country using Internet search engines and 
come across stock-outs for other drugs but fi nd no mention of anti-TB drug stock- 
outs. You return to a weekly clinic meeting and note that the news has not covered 
the stock-outs your colleagues are experiencing at their clinics. You ask if any of 
them will push the ministry of health to fi x the shortage. One physician says he 
heard that the ministry will “provide the TB drugs again shortly.” You suggest that 
one of the physicians contact someone from a media outlet to raise attention. After 
a period of silence, a physician says she fears that the  government will somehow 
retaliate if this issue is raised. 
 After further conversations with colleagues, you decide to attract media attention 
to this issue. Your local colleagues support you, even saying they will provide you 
with data about the stock-out. Contacts in your U.S.-based sponsoring organization 
feel ambivalent about your working with the media to raise attention but will not 
prohibit it so long as you do not mention your affi liation. 
 You decide to contact an international health and  human rights organization about 
the stock-out, and its staff puts you in touch with a local partner organization. The 
local partner wants you to speak, along with local human rights advocates, at a stock-
out conference and interview with newspaper reporters. Despite your wanting to help 
those dependent on the national  drug supply for their TB  treatment , you are  confl icted 
about your  participation and its possible repercussions. Before committing, you tell 
the local partner that you need to think the matter through thoroughly. 
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8.8.3  Discussion Questions 
 1.  What are some  risks and benefi ts of your involvement with the stock-out confer-
ence and contact with the media?  What ethical concepts should inform your 
decision? Would your decision change if your colleagues or sponsoring organi-
zation urged you to say nothing? 
 2.  How does your limited understanding of local institutional hierarchy and gover-
nance inform your ethical analysis of whether or not to engage in  advocacy 
around stock-outs? If you conclude you should engage, are there ways to do so 
besides public testimony? 
 3.  Does it matter ethically if the stock-out pertained to antimalarial medications; that 
is, a  medication outside your  research area ( TB medication )? Why or why not? 
 4.  In terms of perceptions and consequences from the media and  government min-
istries, how might your public reporting of the stock-out differ from a local offi -
cial reporting it? What different types of impact might result from each? How 
might your ability to work with local health  professionals in the future be affected 
if you report the alleged stock-out? 
 5.  Knowing that you have ready access to anti-TB medication for research partici-
pants, should you broaden the  inclusion criteria to allow more patients to receive 
guaranteed  treatment ? Why or why not? 
 6.  Should you attempt to bring the stock-out to the attention of the  global health 
international community by inviting members of the international media to the 
stock-out conference? If not, why not? If so, what approaches might interna-
tional and local nongovernmental  organizations , World Health  Organization 
departments, and patient advocacy groups employ to effectively publicize and 
resolve stock-outs? If not, why not? 
 7.  Do you have an ethical  duty  to report the stock-out if local health offi cers will not 
do so? 
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8.9.1  Background 
 Cholera is caused by infection with  Vibrio cholerae bacteria, which colonize the 
small intestine and produce cholera toxin. The disease is characterized by sudden 
onset of severe, watery diarrhea and vomiting. Left untreated, cholera rapidly leads 
to dehydration and shock. Severe cholera can be fatal in more than 50 % of cases. 
Prompt  treatment  reduce s the case fatality rate to less than 1 % (Boore et al.  2008 ). 
Treatment primarily addresses the loss of fl uids: patients should be aggressively 
treated with oral rehydration solution or, if severely dehydrated, through intrave-
nous fl uids. Treatment with  antibiotics shortens the course of the disease. 
 Cholera is transmitted through contaminated food or water. In developing coun-
tries, where most infections and deaths occur, inadequate  sanitation is frequently the 
cause of the spread of  V. cholerae , as untreated fecal matter from cholera sufferers 
leaks into the water supply. Each year, 3–5 million cases of cholera occur, leading 
to about 120,000 deaths (Harris et al.  2012 ). 
 Cholera is endemic in more than 50 countries. In many places, cholera outbreaks 
are seasonal—fl aring up during the rainy season and dying down again during dry 
periods. Outbreaks can be prevented or contained by properly treating sewage, pro-
moting rigorous hygiene practices, and sterilizing drinking water. Two oral cholera 
 vaccines are commercially available but not included in most cholera control 
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 programs, although the  World Health Organization (WHO) recommends them for 
use in outbreaks and for high-risk populations (WHO  2010 ). Before 2010,  Haiti had 
not experienced cholera for at least a century. 
 Haiti , a country of ten million people, occupies the  western portion of the island 
of Hispaniola in the Caribbean. Although its per capita gross domestic product 
(GDP) is about $1,200 (Central Intelligence Agency  2012 ), 13 a tiny elite controls 
most of the country’s wealth. With 80 % of the  population living below the poverty 
line, Haiti is the lowest-ranked country in the Americas on the  United Nations 
(U.N.) Human Development Index (UNDP  2011 ) . The economy depends heavily 
on remittances from Haitians  working abroad and on foreign aid. 
 Life expectancy in  Haiti is 62 years, while  infant mortality is 52 per 1,000 live 
births (UNDP  2011 ). Sixty-four percent of Haitians have access to an improved 
water source (i.e., one that is protected from outside contamination), but just 26 % 
have access to improved  sanitation (i.e., a facility that separates human excreta from 
human contact) (WHO/UNICEF  2013 ). Communicable diseases, including  HIV/
AIDS , tuberculosis,  diarrheal diseases , and malaria remain substantial causes of 
disability and death. There are severe shortages of physicians, nurses, hospital beds, 
and essential medicines. About 6 % of GDP is spent on health, of which three- 
quarters is private expenditure. Out-of-pocket spending on health care is extremely 
high (UNDP  2011 ). 
 Haiti has a long history of  political instability, characterized by multiple coups, for-
eign interference and occupation, and extended periods of dictatorship, notably under 
François Duvalier (Papa Doc) and his son Jean-Claude Duvalier (Baby Doc) between 
1957 and 1986. Following a coup in 2004, the U.N. stationed peacekeepers in Haiti. The 
U.N. Stabilization Mission in Haiti (MINUSTAH) has been in Haiti ever since. 
 In January 2010, a magnitude 7.0 earthquake struck  Haiti . Hundreds of thousands 
of people died and up to a million were left homeless. International aid agencies, 
donor  governments , and  nongovernmental organizations (NGOs) mobilized rapidly 
in response, and substantial amounts of money and aid were promised to assist in 
rebuilding. 
8.9.2  Case Description 
 In mid-October 2010, upstream of the Artibonite River, a sudden rush of people 
began presenting at the local hospital with acute diarrhea, signaling the fi rst cholera 
cases. People living nearby use the river extensively for washing, bathing, and 
drinking water; farmers downstream use it for irrigation. Within days, the spread of 
cholera to the Artibonite River Delta and settlements on the coast had overwhelmed 
local clinics and hospitals. The facilities lacked cholera cots that allow patients to 
defecate hygienically from their beds, while insuffi cient space for all patients pre-
vented isolation of cholera victims. For the thousands of sufferers, the supply of 
13  Purchasing power parity in 2011 U.S. dollars. 
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doctors, nurses, and rehydration packs proved inadequate. The epidemic exploded 
across  Haiti . Since cholera was not endemic, the  population lacked immunity. 
Within months, thousands of people had died and hundreds of thousands had been 
sickened. 
 NGOs and some international donor  agencies , including from the U.N., who 
were already in  Haiti dealing with the aftermath of the earthquake, diverted resources 
to combat cholera. They distributed medical supplies, organized educational cam-
paigns on cholera  prevention , trucked clean drinking water and water purifi cation 
tablets across the country, and worked with local hospitals to institute rigorous 
infection control measures. 
 The Haitian and international response to the cholera outbreak rapidly brought 
the case fatality rate from around 9 % to less than 1 %. Although the outbreak died 
down, the aid efforts failed to rectify the dire state of  Haiti’s water and  sanitation 
infrastructure. During the rainy season, cases would spike again, exposing the dif-
fi culty of improving the Haitian health care system so that it could respond to new 
outbreaks without external assistance. 
 Haiti had been cholera-free for more than a century—so how had cholera got 
there? Almost as soon as the outbreak started, rumors circulated blaming U.N. 
peacekeepers. A contingent of soldiers from Nepal, where cholera is endemic, had 
arrived in October 2010. They were stationed at a camp on a tributary of the 
Artibonite River near where the outbreak began. Waste management at the base was 
rumored to be inadequate and had allowed sewage to fl ow into the river. 
 Initially, U.N. offi cials denied responsibility for bringing cholera to  Haiti . But 
rumors and public protest persisted, fueled by independent investigations suggest-
ing the camp as the source (Piarroux et al.  2011 ). Finally, the U.N. Secretary General 
convened an independent panel of experts charged with determining the source of 
the cholera outbreak. The panel completed its report in May 2011. It argued that the 
evidence from the Artibonite River’s tributary system, the epidemiological timeline, 
and genetic analyses of Haitian  V. cholerae bacteria indicated that the outbreak 
resulted from contamination of the river with feces carrying a strain of the current 
South Asian bacterium. Moreover, the report noted that the “haphazard” plumbing 
construction in the main toilet and showering area offered signifi cant potential for 
cross-contamination, and that heavy rains could cause the open septic pit into which 
black water was deposited to overfl ow into the tributary (Cravioto et al.  2011 ). 
 The report offered a series of recommendations to prevent similar occurrences 
and concluded
 The introduction of this  choler a strain as a result of environmental contamination with feces 
could not have been the source of such an outbreak without simultaneous water and  sanita-
tion and health care system defi ciencies. These defi ciencies, coupled with conducive envi-
ronmental and epidemiological conditions, allowed the spread of the  Vibrio cholerae 
organism in the environment, from which a large number of people became infected. 
 The independent panel concludes that the  Haiti cholera outbreak was caused by the 
confl uence of circumstances as described above and was not the fault of, or deliberate 
action of, a group or individual (Cravioto et al.  2011 ). 
 Since the initial outbreak, more than 7,500 Haitians have died from cholera and 
more than 600,000 have been sickened. Subsequent independent genetic analysis 
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confi rmed that the Haitian strain was almost identical with the strain currently cir-
culating in South Asia (Hendriksen et al.  2011 ). 
 Many commentators believe that the systemic defi ciencies that enabled the out-
break are partly the fault of the Haitian government. It failed to take appropriate 
measures to protect its  population from disease, such as improving drinking water 
and  sanitation , investing in health care infrastructure, and so forth. The Independent 
Panel concluded that the introduction of cholera by the U.N. mission was therefore 
not the fault of the U.N. An alternative view is that multiple actors were at fault for 
this tragedy, including the Haitian government, the U.N., and foreign  governments 
whose  policies affect  Haiti . 
 A distinct issue is whether and how the victims of the outbreak should be compen-
sated. One option is to make  compensation the responsibility of those at fault, although 
the diffi culties in assigning fault may make this option challenging. An alternative is 
to establish a no-fault scheme that would compensate anyone affected, but determin-
ing who must pay is also problematic. Donors working on earthquake relief in  Haiti , 
for example, arguably should not have to divert funds to remedy a problem they did 
not create. In November 2011, a legal suit was brought against the U.N.  seeking  com-
pensation for the victims of the cholera outbreak (Sontag  2012 ). In February 2013, the 
U.N. invoked legal immunity against such suits and refused to provide 
compensation. 
8.9.3  Discussion Questions 
 1.  Which parties’ interests are affected by the cholera outbreak? Which parties 
might have some responsibility to respond to the outbreak? 
 2.  The U.N.’s Independent Panel of Experts concluded that “the  Haiti cholera out-
break was caused by the confl uence of circumstances … and was not the fault of, 
or deliberate action of, a group or individual.” Assume that they are correct about 
the facts. Does it follow that no one is morally at fault? Explain why or why not. 
 3.  Imagine that you are providing recommendations for compensating the victims 
of  infectious disease outbreaks, like Haiti’s. Should individual actors be held 
accountable, or should a no-fault compensation scheme be put in place? If the 
latter, who should provide  compensation ? Explain the reasons for your responses. 
(Douglas  2009 discusses “no-fault” compensation in another context.) 
 4.  If the Haitian government has neglected its responsibilities to its citizens, does 
this make any difference to the help that international aid agencies should pro-
vide to Haiti? Explain why or why not. 
 5.  One possible concern with seeking compensation for the people who contracted 
cholera is that it may have a “chilling effect” on international assistance. For 
example, if aid agencies believe they are at  risk of being sued for unintentionally 
transmitting disease, they may be deterred from working in a country in the fi rst 
 place . Should the Haitian government or the lawyers representing the victims 
take this concern into account? Why or why not? 
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8.10.1  Background 
 During the last century, public health practices have greatly improved the health of 
individuals and societies in the  Middle East and North Africa (MENA) region 
through successful interventional programs like expanded immunization for  chil-
dren and universal salt iodization programs. The major challenge for public health 
in the twenty-fi rst century is to simultaneously maintain and upgrade the infrastruc-
ture created to improve peoples’ lives. 
 Currently, the MENA  region faces multiple challenges to its public health achieve-
ments, one of which is the impact of sanctions being used against MENA countries to 
infl uence  political behavior. Sanctions—defi ned as mostly economic but also political 
and military  penalties introduced to alter political/military threats and behavior—are 
employed by the  United States and other countries to discourage the proliferation of 
weapons of mass destruction and ballistic missiles, bolster  human rights , end  terror-
ism , thwart drug traffi cking, discourage armed aggression, promote market access, 
protect the environment, and replace  governments (Haass  1998 ). Sanctions often 
involve  economic measures , such as restricting or eliminating  foreign assistance , 
freezing countries’ assets, imposing export and import limitations, and revoking most-
favored-nation  trade  status (World Health Organization  2003 ). 
 Empirical evidence indicates that sanctions have profound long- and short-term 
public health impact on the health of citizens in the affected countries, with the great-
est  harm affecting the elderly, women, and  children (Garfi eld  1999 ; Ali and Shah 
 2000 ). This impact goes far beyond problems with medical supplies or other health-
specifi c resources.  Public health services depend on a safe water supply, a functioning 
 sanitation system, and a reliable  power infrastructure; on availability of equipment 
such as  ambulances , X-ray machines, and refrigerators for storing  vaccines ; on the 
public having resources to access health care (e.g., transportation, fi nancial resources); 
and on human resources, the trained staff who use the equipment. 
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 Two examples of the use of sanctions were those imposed by the  United Nations 
(U.N.) against  Iraq in the 1990s and against  Syria beginning in 2011. 
8.10.2  The Case of  Iraq 
 To assess the health impact of the Iraq sanctions, the U.N. Children’s Fund 
(UNICEF), in  collaboration with the World Health  Organization and local health 
authorities surveyed  child health in Iraq during February through May 1999 
(UNICEF  1999a ,  b ). Between 1984 and 1989,  infant mortality in Iraq was 47 per 
1,000 live births (Ali and Shah  2000 ). In southern and central Iraq, the infant mor-
tality rate almost tripled, rising to 108 per 1,000 live births during 1994 through 
1999. The under-5 child mortality rate also drastically increased (more than dou-
bled) from 56 to 131 per 1,000 live births for the same period (Ali and Shah  2000 ). 
Yet in the autonomous northern region of Iraq,  infant mortality declined from 64 to 
59 per 1,000 live births and under-5 mortality fell from 80 to 72 per 1,000 live births 
for the same period. These differences were attributed to better food and  resource 
allocation due to  Western support for an autonomous region and the nonapplication 
of universal sanctions (UNICEF  2002 ). 
 Other studies of the health impact of sanctions on  Iraq have similar negative fi nd-
ings (Armijo-Hussein et al.  1991 ; Hurwitz and David  1992 ; Central Statistical 
Organization, Iraq  1996 ,  1997 ). Table  8.1 summarizes data from these studies and 
shows the change in health indicators once sanctions were imposed in 1990.
8.10.3  The Case of  Syria 
 Since May 2011, economic sanctions against Syria signifi cantly affected the 
exchange rate, devaluing its Syrian Lira (SL). The exchange rate of 45 SL for every 
U.S. dollar increased to more than 200 SL and had serious economic ramifi cations. 
The  cos t of living essentials such as gas, eggs, milk, bread, and cooking oil more 
than tripled over the past 2 years. At the same time, the purchasing  power of 
 Table 8.1  Health status indicators before and after the 1990 sanctions against  Iraq 
 Indicator  1985  1991  1996 
 Infant mortality rate  52  42  97 
 Under-5 mortality rate  64  42  126 
 Chronic malnutrition (%)  18  18  32 
 Stunting (%)  12  29  26 
 Maternal mortality per 100,000 
births 
 –  121  294 
 Diarrhea episodes per child per year  –  3.8  14.4 
 Births below 2.5 Kg (%)  5–9  4.5  12 
 Note. A dash indicates that reliable data are not available 
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salaries was halved. Families, nearing starvation, were forced out of work, and 
more than 20 % of the working  population was unable to purchase living essentials 
(Zarzar  2013 ; Food and Agriculture Organization of the United Nations  2013 ). The 
collapse of the exchange rate increased the cost of health services and of medicines. 
Despite the emphasis of sanctions on  economic measures , they prevented entry of 
essential medical supplies into the country, including those for chronic diseases 
such as cancer,  diabetes , and heart disease, which are not produced locally. Local 
drug production, an area in which Syria had been 90 % self-suffi cient before the 
sanctions and  confl ict , largely collapsed. This opened channels for counterfeit 
drugs and corruption among those who smuggled supplies through the country’s 
porous borders. The high  cost of heating and electricity during 2 years of  confl ict 
compounded the adverse effects of Syria’s extreme winter and summer tempera-
tures. Most notably, the cold chain of  vaccines were destroyed, contributing to the 
virtual collapse of the once successful  vaccination programme (Al Faisal et al. 
 2012a ,  b ). The combination of price increases, job losses, and lower salaries devas-
tated families, especially those with  children or members who were pregnant or 
elderly (United Nations Offi ce for the Coordination of Humanitarian Affairs  2013 ). 
Millions of small businesses collapsed in Syria. Many were small-scale and home-
based, run by women providing invaluable income to cope with price infl ation and 
to purchase food,  school books and uniforms for children, and essential medicines 
and emergency medical care. 
8.10.4  Ethical Considerations 
 Before World War I, economic sanctions were considered acts of warfare that, like 
military sieges, infl icted suffering on entire  populations . Viewed this way, economic 
sanctions appear ethically suspect from a number of perspectives. Sanctions violate 
the just war ban on targeting noncombatants, the Kant’s philosophy not to use peo-
ple as means to an end, and the  negative right of populations not to be deprived of 
their means of subsistence (Gordon  1999 ; United Nations  2005 ). However, after 
World War I when the League of Nations was created, economic sanctions came to 
be viewed as a peaceful, diplomatic alternative to war  t hat could prevent military 
intervention (Gordon  1999 ). This viewpoint holds that to justify sanctions, the ben-
efi ts of avoiding the presumably far greater  harms caused by war, civil war, or long- 
term  political oppression must outweigh the harms sanctions impose on a populace. 
But this grim utilitarian calculus must also consider the probability of the success of 
sanctions, which generally is low. Pape ( 1997 ), for example, estimates that sanc-
tions lead to political  compliance less than 5 % of the time. More optimistically, 
Hufbauer et al. ( 2009 ) judge sanctions effective in 34 % of situations used. However, 
they stress that the success of sanctions depends on many factors including the pur-
pose; the relative economic instability of the country receiving sanctions; whether 
the country receiving sanctions is part of a broad array of diplomatic, economic, 
military, and covert measures; and whether the sanctions are being imposed in the 
context of a broader international coalition (Hufbauer et al.  2009 ). 
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8.10.5  Case Description 
 You are a public health offi cial from a country in the Middle East researching the 
impact of economic sanctions on the health of  populations . You have seen fi rst-hand 
the impact sanctions have had on  vulnerable populations . You also have expertise in 
public health ethics and have written extensively about ethics in the use of economic 
sanctions. You have been invited by a United Nations  commission to testify on the 
health impact of sanctions. The commission  values your opinion on whether sanc-
tions are ever ethical and justifi ed. 
8.10.6  Discussion Questions 
 1.  What are the range of ethical considerations for and against the use of economic 
sanctions? Are there ways of imposing economic sanctions that can avoid forms 
of collective punishment and minimize subsequent adverse health impact on 
individuals and populations? 
 2.  In extreme situations where many human lives are at stake, such as emergency 
disaster relief, doctors and public health offi cials often revert to simple utilitarian 
calculations of lives lost or saved (e.g.,  triage decisions). To what extent is the 
ethical logic surrounding economic sanctions similar or dissimilar  to the ethical 
logic of emergency disaster relief? 
 3.  Can economic sanctions be ethically justifi ed
 (a)  as an alternative to long-standing  political oppression and human rights 
violations? 
 (b)  to prevent civil war? 
 (c)  to avert war? 
 (d)  to effect regime change? 
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views, or  policies  of the editors, the editors’ host institutions, or the authors’ host 
institutions . 
8.11.1  Background 
 In the  United States ,  regulations for informed consent largely came about during the 
1950s through 1970s not only in response to unethical human experiments carried 
out in Nazi Germany, but also to those within U.S. borders (Beecher  1966 ). 
Experiments like the  U.S. Public Health Service Tuskegee  Syphilis Study (Jones 
 1981 ) prompted Congress to enact human research  regulations , initially through the 
1974 National Research Act. Subsequently, other research  guidelines have been 
developed and revised (World Health Organization  2000 ;  Council for International 
Organizations of Medical Sciences  2002 ; The International Conference on 
Harmonisation of Technical Requirements for Registration of Pharmaceuticals for 
Human Use  1996 ; World Medical Association  2008 ), fostering expansion of ethics 
commissions and review boards and making informed consent an integral compo-
nent of health research (Meslin and Johnson  2008 ). Yet, half a century later, many 
countries still lack adequate  human research regulations or regulatory authorities. 
These regulatory gaps leave research participants, their families, and communities at 
 risk for great  harm through sociocultural  discrimination , research-related illness, dis-
ability, and death and post-experimental medical abandonment. In Nigeria, Pfi zer 
tested an unapproved drug on  infants and  children (Abdullahi v. Pfi zer Inc.  2002 ); in 
 India , Johns Hopkins tested cancer drugs on patients without proper  consent (Sharma 
 2001 ); and other such incidents have been reported (LaFraniere et al.  2000 ). Even the 
U.S. National Institutes of Health failed to produce consent forms for experiments on 
HIV-positive women in developing countries (Public Citizen  1998 ). 
 On a practical and ethical level, debate continues over human  research and 
 informed consent (Tri-Council  2010 ; Marshall  2008 ; Nuffi eld Council on Bioethics 
 2002 ) . While some argue for a single ethical  standard for human research (Lurie 
and Wolfe  1997 ; Angell  1997 ), others believe that imposing a global ethical stan-
dard irrespective of cultural differences would amount to ethical imperialism 
(Resnik  1998 ).  The New England Journal of Medicine “has taken the position that 
it will not publish reports of unethical research regardless of their scientifi c merit” 
(Angell  1997 ). But like other scientifi c journals, it has found diffi culty in determin-
ing what is unethical versus what is culturally appropriate  research in different 
settings. 
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 There are many challenges to obtaining  informed consent . Some involve illiter-
acy; noncomprehension of  information ; language and communication barriers; or 
unfamiliarity with certain scientifi c, medical, or ethical concepts. Other challenges 
are attributable to complex sociocultural, psychological, or structural elements, 
such as shared decision making by community members, rather than by an indi-
vidual (Marshall  2000 ,  2008 ). Some studies, however, take the stance that such 
challenges do not preclude an individual’s ability to understand or voluntarily par-
ticipate in research studies (Pace et al.  2003 ). Consequently, in order to ensure that 
 research  participation is  voluntary , it is important to safeguard a participant’s right 
to refuse or withdraw from a study at any time. 
 One practical solution to obtaining appropriate  consent is by implementing cul-
turally acceptable methods such as oral consent, video  d ocumentation, or commu-
nity  meetings (Tri-Council  2010 ; Nuffi eld Council on Bioethics  2002 ; Dawson and 
Kass  2005 ). Another is to require foreign researchers to receive dual approval 
through a local review board and their own institutional review board (IRB) (World 
Health Organization  2000 ;  Council for International Organizations of Medical 
Sciences  2002 ; Tri-Council  2010 ). Nevertheless,  multinational  collaborations in 
 research , especially those originating in regions that lack adequate research  regula-
tions , can be problematic because research “approval” may not provide adequate 
protections. 
 De-identifi ed data and  information 14 pose an additional complication for obtain-
ing proper  informed consent . These can include “x-rays, endoscopic images, images 
of organs or tissues taken during an autopsy, still or video recordings of surgical 
procedures, and microscopic images” (Tranberg et al.  2003 ). As long as these remain 
de-identifi ed, researchers need not obtain informed  consent (European Union  1995 ; 
U.S. Department of Health and Human Services  2009 ; National Institutes of Health 
 2007 ). However, in countries lacking adequate  research ethics infrastructures, waiv-
ing  informed consent is problematic at several levels. First, verifying if appropriate 
 consent was obtained becomes virtually impossible. Second, the lack of consent can 
be medically dangerous for research participants and have legal repercussions for 
researchers (Flory et al.  2008 ). Finally, it can complicate the  research process by 
compromising the utility of research samples and data (Wendler  2008 ). 
 Continued  globalization , international development and increased accessibility 
to data through electronic medical records and online databases will increase multi-
national human research. As  multinational research becomes more common, the 
need to fi nd appropriate ethical  standards and  informed consent  policies will become 
more urgent. Ultimately, the goal of such standards and policies should be to ensure 
that research participants and their  information are safeguarded at the origin and 
throughout every step of the research process. 
14  De-identifi cation involves stripping data and  information of personal identifi ers (e.g. names, 
addresses, birth dates, photos, or any unique identifi ers), such that an individual’s identity remains 
anonymous and cannot be retraced. 
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8.11.2  Case Description 
 You are an  infectious disease specialist working at a university in a high-income 
country and are interested in researching cervical cancer in immunocompromised 
patients. Because you  collaborate regularly with colleagues worldwide, other 
researchers commonly seek your input. An African colleague e-mails you for advice 
on a multinational cervical cancer study she is conducting with several other research-
ers in seven different African countries. This study began 3 years ago to address the 
local  population’s health needs and has been funded by local hospitals and organiza-
tions. This colleague, a public health  professional , has compiled the  research data in 
an online database. The  information she sends you includes an electronic copy of the 
preliminary report,  de-identifi ed data set , and pathology slides of cervical specimens. 
After reviewing her preliminary fi ndings, you agree that her  research could posi-
tively impact the  health outcomes of individuals in her community. 
 Excited by this initial review, your colleague invites you to coauthor an upcom-
ing manuscript on the study. You carefully review the methods section of the pre-
liminary report, focusing on how  consent was obtained. In one research country, 
consent was provided via video documentation; in two others, it was obtained 
through a standardized consent form; and in a fourth, through verbal consent of 
male community leaders  before seeking consent from individual participants, a 
practice in line with local cultural  norms . For the remaining three countries, no 
consent documentation exists. 
 You follow-up with your colleague about the various consent methods. She indi-
cates that none of the countries involved in the project have  IRBs or national 
research  guidelines , but that  consent methods were typical for research projects in 
these countries. Regarding the three countries lacking consent documentation, she 
believes that some form of consent was obtained from the research participants, 
although she lacks supporting evidence. 
 Although the  information you received was de-identifi ed, you wonder about the 
lack of uniformity in the consent process but attribute it to  respect for differing cul-
tural  norms . Based on all  information provided, you believe the  research has scien-
tifi c merit and the data collected is scientifi cally valid. You also believe the study 
should be published, as it could signifi cantly improve the health of the region and 
advance future research. 
8.11.3  Discussion Questions 
 1.  Who would you turn to in your institution for guidance regarding your involve-
ment in the  research , coauthorship of the manuscript, and other contributions to 
this research study? 
 2.  What are some appropriate ways to obtain  informed consent when conducting 
 research in areas with culture or language different from yours? Name some pros 
and cons to each approach. 
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 3.  Does the use of multiple methods to obtain  consent raise questions about the 
reliability of the data or validity of the research project? Without confi rmation of 
 informed consent , would you consider the publication of this research study to 
be scientifi c misconduct? 
 4.  What are some appropriate ways to obtain  informed consent for research con-
ducted in countries with different consent  standards and requirements? Are there 
instances when one set of requirements should take priority over another? 
 5.  Given  th e multiple methods used to obtain  consent , are you willing to coauthor 
your colleague’s paper? Why or why not? 
 Open Access  This chapter is distributed under the terms of the Creative Commons Attribution-
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 Chapter 9 
 Public Health Research 
 Drue  H.  Barrett ,  Leonard  W.  Ortmann ,  Natalie  Brown , 
 Barbara  R.  DeCausey ,  Carla  Saenz , and  Angus  Dawson 
9.1  Introduction 
 Having a scientifi c basis for the practice of public health is critical. Research leads 
to insight and innovations that solve health problems and is therefore central to 
public health worldwide. For example, in the United States research is one of the ten 
 essential public health services (Public Health Functions Steering Committee  1994 ). 
The  Principle s of the Ethical Practice of Public  Health , developed by the  Public 
Health Leadership Society ( 2002 ), emphasizes the value of having a scientifi c basis 
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for action. Principle fi ve specifi cally calls on public health to seek the  information 
needed to carry out effective policies and programs that protect and promote health. 
 This chapter  pres ents ethical issues that can arise when conducting public health 
research. Although the literature about research ethics is complex and rich, it has at 
least two important limitations when applied to public health research. The fi rst is that 
much of research ethics has focused on clinical or  biomedical research in which the 
primary interaction is between individuals (i.e., patient-physician or research partici-
pant-researcher). Since  bioethics tends to focus on the individual, the fi eld of research 
ethics often neglects broader issues pertaining to communities and  population s, 
including ethical issues raised by some public health research methods (e.g., the use 
of  cluster randomized trials to measure population, not just individual, effects). 
However, if our discussion of public health research ethics begins by examining pub-
lic health activities, it becomes apparent that the process of gaining  consent involves 
more than individuals. We must consider that communities bear risks and reap bene-
fi ts; that not only individuals but also populations may be vulnerable; and that the 
social,  political , and economic context in which research takes place poses ethical 
challenges. Public health research, with its focus on intervention at community and 
population levels, has brought these broader ethical considerations to researchers’ 
attention, demonstrating how ethics guidance based on biomedical research may 
limit, if not distort, the ethical perspective required to protect human subjects. 
 The second limitation has to do with how  guideline s and  regulations are con-
ceived and used. As described in Chaps.  1 and  2 of this casebook, research ethics has 
mostly evolved out of concern for research abuses. Consequently, the intent of many 
guidelines and regulations is to strengthen the ethical practice of research with 
human subjects. These ethical guidance documents include the  Nuremberg Code 
( 1947 );  the  Universal Declaration of Human Rights (United Nations  1948 ); the 
 Declaration of Helsinki (World Medical Association  1964 , last revised in 2013); and 
two documents developed by the Council for International Organizations of Medical 
Sciences (CIOMS) in  collaboration with the  World Health Organization (WHO) : 
 International Ethical Guidelines for Biomedical Research Involving Human Subjects 
( CIOMS  2002 ) and the  International Ethical Guidelines for  Epidemiological Studies 
(CIOMS  2009 ). In the United States, the primary ethical guidance for protecting 
human subjects is  Title 45, Part 46, of the Code of Federal Regulations 
(U.S. Department of Health and Human Services  2009 ). The  e thical principles of 
 respect for persons ,  benefi cence , and  justice have  oft en framed the discussion on 
 ethical conduct of research with human subjects . These  principle s were fi rst articu-
lated by the U.S. National Commission for the Protection of Human Subjects of 
Biomedical and Behavioral Research ( 1979 )  in the  Belmont Report and expanded 
upon by Beauchamp and Childress ( 1979 ) in  Principles of Biomedical Ethics . 
 Such guidelines and  regulations often represent a consensus on landmark issues and 
show ways to consider ethical issues. However, consensus documents can pose obsta-
cles if used uncritically with overgeneralized rules applied blindly. For example, such 
documents seem to assume that the  randomized controlled trial is the gold standard of 
research methodology, obscuring the fact that all research methods may raise ethical 
issues. In addition, it is debatable whether these  guideline s adequately capture commu-
nity- and population-oriented values and issues central to public health (Verweij and 
Dawson  2009 ). A general concern is that overreliance on guidance documents encour-
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ages a legalistic or  compliance approach to ethics, rather than encouraging refl ection 
and analysis (Coughlin et al.  2012 ). Coughlin and colleagues argue that to be success-
ful,  research oversight needs to focus on moral judgment and refl ection, not on strict 
rule-like adherence to  regulations documented on a checklist. Though formal training in 
ethics is desirable, moral judgment and discernment are developed by making ethical 
judgments. This highlights a problem inherent in research oversight. Review of research 
protocols requires scientifi c and ethical expertise. However, members of  ethics review 
committees are often unpaid and uncompensated for service time and are frequently 
asked to perform review  duties in addition to their normal work. This lack of regard for 
their service often results in considerable turnover among committee members and does 
not allow suffi cient time for new members to develop moral discernment. Review of 
research protocols for human subjects should include consideration of the wider ethical 
implications of the research and not just focus on compliance with ethics  regulations . 
When inappropriate, guidance should be adapted or even set aside. 
 Chapter  1 of this casebook provides an account of public health ethics that builds 
upon the disciplines of both ethics and public health. Following a similar approach, this 
chapter advances a view of public health research ethics that builds upon  concepts  of 
research ethics and public health research. As a result, many ethical issues discussed 
apply to all health research, including public health research. However, once we exam-
ine public health examples, we see that something beyond the traditional resources of 
current research  regulations is needed. We will discuss these ethical issues by refl ecting 
upon traditional research tenets and studying their limitations in a public health context. 
We will conclude by illustrating via the case studies included in this chapter how ethical 
challenges arise in public health research. It is impossible to closely analyze all possible 
ethical issues that may arise either in health research or public health research; thus our 
intent is to highlight some of the major ethical challenges and considerations. 
9.2  What Is Different About Public Health Research? 
 The community and  population perspective of public health, especially when address-
ing health issues in resource-poor contexts or in  marginalized populations , frequently 
brings ethical challenges into focus. In public health, research typically occurs out-
side of the controlled environment that is characteristic of  biomedical research . 
Instead, in public health, research often occurs in real world settings in a particular 
social,  political , and economic context. It may involve interventions with whole com-
munities or populations impacted by catastrophic  public health emergencies . 
9.2.1  Can Public Health Research Be Clearly Distinguished 
from Public Health Practice? 
 Distinguishing between public health  practice and public health  research is chal-
lenging. Many of the tools and methods are similar. Both involve systematic collec-
tion and analysis of data that may lead to  generalizable knowledge . Public health 
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research can take forms ranging from descriptive approaches (e.g., correlational 
studies and cross-sectional surveys) to analytic epidemiologic approaches (e.g., 
case control studies and cohort studies, including  clinical trials ). These same 
approaches can characterize methods for collecting  information as part of public 
health practice. 
 A common way to defi ne research is on the basis of its goal to develop gener-
alizable knowledge. For example,  the  International Ethical  Guidelines  for 
 Biomedical Research  Involving Human Subjects (CIOMS  2002 )  defi nes  research 
as “… a class of activity designed to develop or contribute to generalizable knowl-
edge.  Generalizable knowledge consists of theories,  principle s or relationships, or 
the accumulation of  information on which they are based, that can be corroborated 
by accepted scientifi c methods of observation and inference.” Similarly, in the 
United States, research is defi ned as “…a systematic investigation, including 
research development, testing and evaluation, designed to develop or contribute  to 
 generalizable knowledge ” (U.S. Department of Health and Human Services 
 2009 ). 
 In jurisdictions with legal requirements governing research activities, such as 
the United States, determining what is and is not research becomes critical. 
Sometimes, however, the line between research and practice-related activities is 
blurry. One way to identify if an activity is research is to look at intent. The primary 
intent of public health research is to yield generalizable knowledge. Key character-
istics of public health research include (1) benefi ts beyond the needs of the study 
participants, (2) collection of data exceeding what is needed to care for study par-
ticipants, and (3) generation of knowledge with relevance outside the  population 
from which data were collected. In contrast, the primary intent of activities that 
constitute public health practice are to “… prevent or control disease or injury and 
improve health, or to improve a public health program or service …” (Centers for 
Disease Control and Prevention [CDC]  1999 ,  2010 ). Key characteristics of public 
health practice include (1) benefi ts that focus on activity participants, (2) collection 
of data needed to improve the activity or the health of the participants, and (3) 
generation of knowledge that does not go beyond the scope of the activity (CDC 
 1999 ,  2010 ). 
 Some researchers suggest that the diffi culty in distinguishing public health 
research from public health practice emerges from a deeper conceptual issue relat-
ing to the impossibility of satisfactorily defi ning “research” and related categories 
(Fairchild and Bayer  2004 ). For example,  public health surveillance might involve 
identical interventions and risks for public health research as for practice. This has 
led many public health  professional s to call for reorienting  ethical review around an 
 activity’s  level of risk, which applies to activities in both public health research and 
practice (Willison et al.  2014 ). Jurisdictions that do not yet have legal structures or 
have more fl exibility to govern research activities than the United States might have 
an advantage. Whereas other jurisdictions might need to modify their approach to 
correlate ethical review with risk instead of on whether something falls under a slip-
pery concept such as research. 
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9.3  Ethical Considerations for Protecting the Public 
during Health Research 
 This section outlines core aspects of research ethics and not only explains their 
relevance to public health, but also delves into why research ethics principles might 
need to be applied differently to public health research than to  biomedical research . 
9.3.1  Informed Consent 
 Informed consent is often treated as the primary means of protecting research par-
ticipants. Although informed consent can be defi ned in different ways, it is foremost 
an active agreement made by someone with the capacity to understand, on the basis 
of relevant  information , and in the absence of pressure or coercion. The common 
ethical justifi cation for seeking informed consent is an appeal to the notion of  auton-
omy , which holds that individuals have values and preferences and thus should vol-
untarily decide whether to participate in research. However, gaining  consent can 
result from a more direct appeal to  benefi cence or to general welfare. Many  research 
ethics  guideline s and  regulations require an interactive process between the investi-
gator and research participant to best provide  information and ensure 
 comprehens ion. 
 Some potential research participants will always lack capacity to look after their 
own interests (e.g.,  children , people with dementia, the unconscious) and thus cannot 
provide consent. To protect people with diminished  autonomy , informed consent is 
usually obtained from a  parent , guardian, or legal representative. While it is clear that 
research participants with diminished capacity need extra protection, empirical evi-
dence shows that even research participants with full cognitive capacity may not 
understand  information presented as part of the consent process (Dawson  2009 ). For 
this reason, informed consent cannot be the only mechanism for protecting research 
participants. For instance, a research ethics committee can protect participants by 
assessing risks and benefi ts. Requiring approval by a research ethics  com mittee 
might be considered a  paternalistic judgment, but not an obviously wrong one 
(Garrard and Dawson  2005 ; Miller and Wertheimer  2007 ). Research ethics commit-
tees routinely consider waiving informed consent. This is true in public health 
research where the risk can be less than in  biomedical research . Reliance on the judg-
ments of research ethics committees presupposes that members have a high level of 
 profession al trustworthiness and have the skills for ethical deliberation and analysis. 
 Cultural or social infl uences can challenge the ideal model of informed consent 
when conducting public health research. Marshall ( 2007 ) provides an excellent 
overview of challenges with obtaining informed consent, especially in resource- 
poor settings. These challenges include cultural and social factors that affect com-
prehension, communication of risks, and decisional authority for consent to do 
research. Language barriers and low literacy, mistaken beliefs about the benefi ts of 
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 participation , especially when access to health care is limited, and the need to com-
municate complex scientifi c  information may reduce comprehension of study pro-
cedures, benefi ts, and risks. Marshall ( 2007 ) emphasizes the importance of engaging 
community leaders and soliciting and considering the opinions of community resi-
dents when identifying project goals and procedures and establishing consent pro-
cesses. She notes that in many communities, relying solely on individual consent 
may not be culturally appropriate. In these situations, adding family or community 
consent is fi tting. 
 Some research cannot be conducted if the standards of autonomous informed 
consent are always applied. A good example is emergency research when uncon-
scious victims of head  trauma may be randomized to different promising treatments, 
but the relative  effectiveness of each treatment option is unknown. Some countries 
allow such research via  waivers of informed consent if relevant conditions are met 
(e.g.,  minimal risk , and the research could not otherwise be carried out) 
(U.S. Department of Health and Human Services  2009 ).  A  public health research 
method for which it sometimes may be appropriate not to seek informed consent is 
the  cluster randomized trial . By design, a cluster randomized trial compares inter-
ventions that target a group (i.e., social entity such as village or town, or a popula-
tion). Various characteristics of these clusters are matched to ensure a robust 
comparison of interventions (including no intervention). In some cluster trials, 
obtaining individual informed consent can seem prohibitively expensive, damaging 
to  a chieving study goals, or even impossible to attain (Sim and Dawson  2012 ; 
McRae et al.  2011b ). Where consent is impossible to attain, is it right to require it at 
the expense of not doing the research? Attempts have been made to justify research 
without fi rst attaining individual consent by appealing to an ethics committee for 
review, soliciting viewpoints from the community about whether the research is 
acceptable, or even seeking some form of community consent. 
 Dickert and Sugarman ( 2005 )  make a distinction between community consent 
and community consultation. Consent means seeking  approval , whereas consulta-
tion means seeking  ideas and opinions . They note, however, that this distinction 
gets blurred in practice, and that community consultation should not be approached 
as a box to check off without scrutinizing the input. They identify four ethical goals 
for any community consultation: enhanced protection, enhanced benefi ts, legiti-
macy, and shared responsibility. Adherence to these goals may ensure that risks are 
identifi ed and protections put into place; that the research benefi ts not only the 
researchers, but also the participants and communities being studied; and that the 
legitimacy of the fi ndings is increased. However, this does not constitute a direct 
parallel to the individual model of informed consent described previously. 
Community consent involves meeting with legitimate community representatives 
empowered to permit researchers to conduct studies involving community members 
(Weijer and Emanuel  2000 ; Dickert and Sugarman  2005 ). The involvement of com-
munity representatives in public health research is most clearly seen in  community- 
based participatory research (CBPR) . In CBPR, authorities are involved at all levels 
of research—from initiation of ideas and projects through data collection, analysis 
and interpretation,  and use of research fi ndings to prompt community change 
(Flicker et al.  2007 ). 
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9.3.2  Risk/Benefi t Analysis 
 A  central concern for research ethics is the weighing of expected benefi ts against 
possible harms. The commonly employed criteria for assessing risk to human sub-
jects who participate in health research are that risks are minimized and reasonable 
in relation to the anticipated benefi ts. For example, one can argue that procedures 
used in research are justifi able when already being used for diagnosis or treatment 
and the risks are proportional to the importance of the knowledge reasonably 
expected to result from the research. However, one problem in such a determination 
is the uncertainty of all judgments about risks and benefi ts. Such determinations 
have to be made carefully and fairly and on the basis of the best possible evidence. 
 Research participants may encounter several types of risks. One obvious risk is 
physical harm, which may include discomfort, pain, or injury from interventions 
such as drug regimens or medical procedures. Another risk is psychological harm. 
Research participants may experience stress,  anxiety , embarrassment, depression, 
or other  negative  emotions. These emotions, which can occur during or after  partici-
pation in the research, are common in research involving sensitive topics such as 
sexual preferences or behavior. Social and economic harms are another type of risk. 
Participants in research that focuses on mental illness, illegal activities, and even 
certain diseases such as  HIV may risk being labeled or stigmatized if precautions 
are not taken to provide adequate  privacy and confi dentially. A person’s economic 
status may be affected if  cost s are incurred for participating (e.g., transportation 
expenses to and from the study site) or by loss of employment (present or future) if 
a breach of confi dentiality occurs (e.g., an employer discovers an employee is being 
treated for  substance abuse ). 
 One common problem—about which ethics guidelines are typically silent—is how 
we should conceptualize study participants (McRae et al.  2011a ). Consider, for exam-
ple, that cluster randomized designs and cohort studies commonly compare a group 
receiving active intervention with a parallel group receiving no intervention. Does the 
term “participant” apply to those receiving no intervention? This question has far-
reaching consequences. If people who do not receive intervention count as participants, 
researchers may have  obligations to them that otherwise would not exist. Another way 
to think about this is to identify who might be at increased risk, rather than who is a 
participant. For example, the U.S.  National Bioethics Advisory Commission (NBAC) 
recommends that whenever researchers anticipate that risks will extend beyond study 
participants, researchers should try to minimize risks to  nonpartic ipants (NBAC  2001 ). 
 The benefi ts of health research are any favorable or positive outcome received as 
a direct result of the research. Put simply, without the research, the outcome would 
not exist. Sometimes the benefi ts of health research extend beyond study partici-
pants to society; other times, however, research participants do not benefi t. And in 
other instances, only a few participants might benefi t. Researchers should thor-
oughly consider what to do in all these scenarios and how benefi ts could be pro-
vided to those in need. Sometimes research involves reimbursement, incentives, or 
other tangible goods. Although such items may be provided when someone agrees 
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to participate in research, these items should not be considered benefi ts arising from 
the research procedures. In some contexts, such as prisons, offering anything in 
return for  participation in  research may be viewed as pressure to participate and 
therefore should be carefully considered. 
 The risks of research must be reasonable when compared to the anticipated ben-
efi ts. This can be diffi cult to assess because risks will vary depending on the study 
 population . For example, research procedures considered safe for healthy adults 
may be risky for adults with compromised health or for  vulnerable populations such 
as  children , pregnant woman, or seniors. Even if the potential benefi ts are the same, 
if the risks differ, the risk/benefi t balance is affected. Another consideration for 
evaluating risks and benefi ts is the expected result of the research. A  higher  level of 
 risk may be acceptable if the research can reasonably be expected to benefi t the 
participants. If there is no expectation that the research participants will benefi t, the 
same level of risk may be unacceptable. 
 Foreseeing the benefi ts and harms in a study can be challenging. Striking a bal-
ance between the two can be diffi cult and, at times, controversial. A good example 
of this is the discussion generated by a series of studies conducted in Baltimore that 
assessed different methods for reducing the exposure of  children to lead paint in 
older rented properties (Mastroianni and Kahn  2002 ). In this case, the fact was 
already known that exposure of children to lead is dangerous. However, due to the 
high  cost of removing lead-based paint (the known, best solution), the researchers 
assessed the  effectiveness of cheaper, partial methods of abatement for reducing or 
even removing the risk of exposure. If found to be effective, these alternative meth-
ods would allow treatment of more homes at the same cost, potentially benefi ting 
more children. Monitoring during the study found that some children in the alterna-
tive abatement options had elevated blood lead levels. Some health offi cials believe 
that the research should not have gone ahead because of this likelihood. Others 
think that the research was justifi ed because the children were not exposed to any 
greater level of lead, and in most cases, signifi cantly less than if the research had not 
been conducted. In other words, no child was put at greater risk through  participa-
tion , and all children  be nefi ted from blood monitoring. This study demonstrates the 
complexities of evaluating  risks  and  benefi ts in public health research. 
9.3.3  Protection of Vulnerable Populations 
 Altho ugh all segments of society should have the opportunity to participate in 
research, vulnerable populations may need additional protections to prevent coercion 
or exploitation. The defi nition of what it is to be vulnerable is contested (Chap.  7 ). 
However, NBAC ( 2001 ) defi nes vulnerability in the context of research as a condition, 
either intrinsic (e.g., mental illness) or situational (e.g.,  incarceration ), that increases 
some participants’ risk of being harmed. Regardless of how we defi ne vulnerability, 
it is often interpreted to require special protections for the safety and well-being of 
 population s such as children, prisoners, pregnant women, mentally disabled people, 
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and economically or educationally disadvantaged people.  The  CIOMS ( 2002 ) 
international  guideline s suggest that special justifi cation is required for inviting 
vulnerable people to serve as  research subjects and, if they are selected, the means of 
protecting their rights and welfare must be strictly applied. The history of research is 
replete with examples of unethical treatment of vulnerable populations (Chap.  2 ). 
 Despite such worries about protecting vulnerable populations, a strong  equity - 
based argument can be made for ensuring that they are appropriately represented in 
health research, unless the rationale for not including them is clear and compelling 
(CDC  1996 ).  To exclude vulnerable populations violates the spirit of the  principle 
of  justice , which requires fair distribution of risks and benefi ts of research.  Inclusion 
of vulnerable populations may require accommodations to address the specifi c 
nature of the vulnerability; however, once these accommodations are in place, vul-
nerable people with the cognitive capacity to provide  informed consent  should exer-
cise autonomous choice about their  participation . For example, it seems arbitrary to 
exclude pregnant women from research as a matter of course rather than making a 
decision based on an assessment of risk levels, the ability to control  risks , and the 
likelihood of direct benefi t to the  participant . 
9.3.4  Returning Research Results 
 Public health research tends  to  focus on population-level research questions.  In 
 some cases, for example where data have been anonymized, even when an issue 
relevant to the clinical care of one or more individuals in the data set is discovered, 
there is nothing that can be done about it. However, in other cases, public health data 
sets or  surveillance data might hold  information that could be crucial to the care of 
individuals. 
 When and how should individual-level data, including  incidental and secondary 
fi ndings , be communicated to research participants? The primary argument for an 
ethical imperative to offer participants research fi ndings, both summary and indi-
vidual results, rests on the principle of  respect for persons ; however, the principles 
of benefi cence and justice are also  frequently  cited (Presidential Commission for 
the Study of Bioethical Issues  2013 ; Miller et al.  2008 ; Fernandez et al.  2003 ). The 
word “offer” is important because giving people the right to decline results is also 
an expression of respect for persons. The ethical justifi cation for a “ duty to disclose 
research results,” especially individual-level data, has been challenged due to the 
potential harms of disclosure (Miller et al.  2008 ). Miller and colleagues argue that 
the lack of consistent  policy guidance for disclosures and the ambiguity about what 
to disclose undermines any generalized ethical duty to disclose. Clearly, before 
making a decision to return results, especially individual-level data, the potential 
benefi ts and harms from disclosure must be carefully assessed. 
 The research consent process should describe plans for returning results or pro-
vide an option for not receiving results. The consent process should explain the 
potential harms and benefi ts associated with receiving research results, the possible 
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strengths and limitations of the results, and the options for follow-up and support if 
unanticipated consequences occur. If a decision is made to return results, careful 
considerations must be given to how the results will be returned (e.g., in person, 
over the telephone, through a letter), whether  opt-in or opt-out procedures will be 
used, and when the results should be returned. Fernandez and colleagues ( 2003 ) 
argue that “research results should, in general, be delayed until the results are pub-
lished or until they have undergone peer review and been accepted for publication.” 
This recommendation is based on the need to ensure the integrity of the interpreta-
tion of the data and to prevent disclosure of inaccurate  information . 
 To illustrate the  diversity of opinion about sharing research data, some research-
ers have taken the  obligation for disclosure further by advocating that research par-
ticipants be granted access to their raw data via a data repository before these data 
are analyzed (Lunshof et al.  2014 ). Lunshof and colleagues suggest that access to 
raw personal data would increase transparency,  personal choice, and reciprocity. 
Further, such access could equalize the relationship between those who donate data 
and those who use data for research. However, this rather utopian view raises issues 
with potential breaches of confi dentiality, so more discussion is needed. More dis-
cussion is also needed about participants increasingly sharing  information about 
 research studies through social media, which can result in breaches of confi dential-
ity and further challenge the integrity  of  research (Lipset  2014 ). 
9.3.5  Confl icts of Interest 
 The potential for  confl icts of interest occurs when an individual or group has mul-
tiple interests, one of which can compromise the integrity or impartiality of the 
other. Research involving human subjects often creates this potential when research-
ers are also involved with participants in the role of health care providers or through 
engagement with communities in the context of public health research. In resource- 
poor contexts, the economic impact of the research enterprise can be of such mag-
nitude that it has sociopolitical ramifi cations  o r complexities with potential to spur 
confl icts of interest. Discussion about confl icts of interest raises issues about integ-
rity in public health and even the very concept of public health as an activity 
(Coughlin et al.  2012 ). 
 Shrinking budgets for public health activities have led many health departments, 
even those in resource-rich countries, to explore alternative approaches to fi nancing 
public health research, leading to questions about what constitutes an appropriate 
partnership and to concerns about real or perceived confl icts of interest. For exam-
ple, should  government s collaborate with vaccine manufacturers to research poten-
tial adverse effects of a vaccine? Should researchers collaborate with soda 
manufactures to study the association between sugar-sweetened beverages and obe-
sity? The  U.S. Institute of Medicine (IOM) Committee on Confl icts of Interest in 
Medical Research, Education, and Practice defi nes  confl ict of interest as “a relation-
ship that may place primary interests (e.g., public well-being or research integrity) 
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at risk of being improperly infl uenced by the secondary, personal interests of the 
relationship (e.g., fi nancial, professional, or intellectual gains)” (IOM  2009 ). When 
Bes-Rastrollo and colleagues ( 2013 ) studied systematic reviews of the association 
between sugar-sweetened beverages and weight gain, they found instances where 
confl icts of interest infl uenced scientifi c fi ndings. The systematic reviews that iden-
tifi ed  sponsorship or confl icts of interest with food or beverage companies were fi ve 
times more likely to report “no positive association” between consumption of sugar- 
sweetened beverages and weight gain or obesity than the reviews that reported hav-
ing no industry sponsorship or confl icts of interest. These fi ndings point to the need 
for guidance on how to identify and avoid confl icts of interest with potential to 
infl uence outcomes of public health research,  especially when the  research shapes 
public policy (IOM  2014 ). 
9.3.6  Conducting Research during Public Health Emergencies 
 Sometimes the  t raditional elements of research ethics are inappropriate frameworks 
for decision making. Let’s consider, for example, a decision being contemplated to 
conduct research during a public health emergency. The research is deemed vitally 
important to analyze what happened during the emergency, to plan for future sce-
narios, and to prevent death and illness during disasters. However, such research 
raises concerns, including the appearance that health offi cials are more interested in 
expanding knowledge than in responding to the disaster and that researchers are 
insensitive to more urgent needs of affected individuals. Still, the case can be made 
for a strong, ethical imperative that obligates public health offi cials to conduct 
research that could yield data useful in preventing future death and illness during 
disasters (London  2016 ). The chief ethical task for conducting research during a 
disaster is to secure future benefi ts for people without sacrifi cing the rights or inter-
ests of research subjects (Jennings and Arras  2008 ; WHO  2015 ). So to justify 
research during a disaster, public health offi cials must fi rst demonstrate a real need 
for the research, which includes its social and scientifi c value (anticipated results). 
Generally speaking, research that can be conducted in a nonemergency setting 
should not be  conducted  during an  emergency response . 
 If the decision is made to conduct research during a public health emergency, 
some unique ethical concerns must be considered: the research should not detract 
resources and personnel from emergency response activities; research activities 
should be prioritized by highest social and scientifi c value; and, as people in an 
emergency are often affected physically and psychologically, and sometimes trau-
matized, they should be considered a  vulnerable population (Jennings and Arras 
 2008 ; WHO  2015 ). At the very least during an emergency, keep in mind that some 
people may not be able to make reasoned, informed decisions to participate in the 
research. Consequently, adequate means of protection for participants must be in 
place. The procedures for an ethics committee review may need to be modifi ed for 
disaster research projects (Lurie et al.  2013 ). Possible approaches for ensuring 
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appropriate review include developing just-in- case protocols and establishing cen-
tralized or specialized  ethics review committees that can approve disaster research 
 protocols  quickly (Médecins Sans Frontières  2013 ). 
9.4  How Ethical Challenges Can Arise in Public Health 
Research: Lessons Learned from Cases 
 The cases presented in this chapter illustrate some of the ethical challenges raised 
by public health research. These challenges range from  compliance with research 
ethics  guideline s to the need to address the economic and  political implications 
from the wider societal context in which public health research occurs. Social, eco-
nomic, and political factors can directly lead to ethical challenges or may affect a 
researcher’s ability to comply with ethical guidelines. 
 The case by Boulanger and Hunt illustrates how well-intentioned international 
efforts to improve access to health care in resource-poor countries can have unin-
tended consequences that present ethical complications. The case raises various 
interconnected issues that have to do with researchers’ responsibilities and  obliga-
tions and with confl icts between individual and public goods. Within a collaborative 
international public health research project, such confl icts can easily arise when 
local investigators fi nd themselves serving multiple roles that create potential  con-
fl icts of interest . Boulanger and Hunt provide an excellent summary of the  respon-
sibilitie s and  obligations of researchers, including to
•  Protect participants from harm and ensure they benefi t from the research when-
ever possible; 
•  Support and protect research staff, especially  students ; 
•  Support and respect research collaborators, building local capacity when possi-
ble; and 
•  Support the research enterprise, which includes building public  trust , maximiz-
ing the relevance and usefulness of the research, and disseminating fi ndings. 
 Central to this case is a local researcher’s uncovering of how informal fees for 
obstetric care are being diverted to senior hospital administrators. The local 
researcher has a  dilemma . If he reveals this ethically dubious informal fee structure, 
he will not only jeopardize his standing at the hospital, but he could also undermine 
the availability of obstetric care to women in his community. The director of the 
research program must ethically weigh the research goal of improving access to 
health care services with supporting the interests of the research staff while also 
maintaining good relations with local health agencies. In many contexts, this case 
would be a clear-cut whistleblower issue demanding revelation. However, where 
informal fees are standard practice, part of the  political culture, or the health infra-
structure is already fragile or minimal, the issue becomes complicated, forcing one 
to  prioritize competing values and moral considerations. 
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 The case by Makhoul and colleagues involves research on  mental health con-
cerns among  youth in a  Palestinian refugee camp . The case highlights cultural and 
social factors that may infl uence the consent process, especially the  power dynam-
ics within communities. Beyond addressing central bioethical and medical princi-
ples of  trust and  respect for persons , the case points to the need for considering 
broad public health concepts such as respect for community values,  empowerment , 
and  advocacy . This case also illustrates how researchers are almost always drawn 
into a community’s  political dynamics by the economic infl uence of research in 
resource-poor settings. Efforts by community members to avoid alienating groups 
that contribute resources to the community may act as a subtle form of pressure to 
participate in the research. 
 The case by Kasule and colleagues illustrates the diffi cult practical choices that 
resource-poor countries face in processing the increasingly complex volume of 
research to be ethically reviewed. In these countries, public health offi cials struggle 
to complete basic administrative and regulatory aspects of research review and 
oversight, let alone provide conditions for careful, conscientious ethical analysis. 
This scenario questions the adequacy of training for members of  ethics review com-
mittees . Failure to adequately train committee members and fund  research oversight 
will result in lost opportunities and revenues, setting back a resource-poor country’s 
research or health infrastructure for years. But funding an organization to  develop 
 research oversight may divert funds from other more urgent public health needs. 
Trading short-term public health solutions for long-term research funding presents 
a classic case of  resource allocation and prioritization. Kasule and colleagues con-
sider the pros and cons of reliance upon outside ethics review committees, which 
might save money at the expense of having less control of oversight. 
 The case by Kanekar describes the use of an Internet-delivered safe sex  health 
promotion intervention for young black men who have sex  w ith men. This case 
raises a number of practical and ethical considerations and questions that arise in 
public health research. How does one differentiate research from public health prac-
tice? What approaches are required to serve  vulnerable populations ? How can one 
use innovative techniques to target hard-to-reach populations? What are the best 
ways to protect the  privacy of participants and ensure confi dentiality of data? How 
can one reconcile or accommodate confl ict among research partners who perceive 
their primary role or function in radically different ways (e.g., medical provider 
 versus epidemiologist)? 
9.5  Conclusions 
 Many ethical issues can arise in public health research. The social, economic, and 
 political context within which the research enterprise functions further complicates 
the ethical landscape. Traditional approaches for considering research ethics issues 
emerged from  biomedical research and initially emphasized ethical considerations 
at an individual level. However, research in public health demonstrates why this 
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traditional approach to ethics should be expanded. A public health approach to 
research ethics is apt because it considers community values, the  interdependence 
of citizens, social or  population benefi t , and  social justice . However, as explained in 
Chap. 1, there is more to ensuring ethical conduct and scientifi c integrity in public 
health research than having an  ethical review committee apply  rule-based guide-
lines . Researchers need to be familiar with the ethical considerations unique to pub-
lic health and have suffi cient training and experience to exercise moral judgment in 
all phases of research. 
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expressed are the authors ’  own. The case is not meant to refl ect the offi cial position , 
 views ,  or policies of the editors ,  the editors ’  host institutions ,  or the authors ’  host 
institutions . 
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9.6.1  Background 
 In 1987, African health ministers met in Mali to address access to quality primary 
health care, particularly in rural areas (Anonymous  1988 ). The resulting  Bamako 
Initiative promoted  universal  accessibility, though it drew some early criticism for 
its support of  user fees (McPake et al.  1993 ). For the next decade, user fees were 
implemented in many African countries to fi nance health care services. The  World 
Bank supported the measure as part of its Structural Adjustments Programs, which 
also included austerity measures,  trade liberalization, and privatization (McIntyre 
et al.  2006 ). However, user fees have since been shown to create access barriers that 
tend to affect the poor disproportionately (Macha et al.  2012 ),  suggestin g that many 
vulnerable individuals have been prevented from accessing needed health care ser-
vices. Against this backdrop, mounting international pressure led to the reform of 
many user-fees programs, particularly in the last decade. One primary strategy for 
increasing  health care access has been  the  introduction of selective exemptions of 
user fees for specifi c groups (Ben Ameur et al.  2012 ; Meessen et al.  2011 ; Ridde 
et al.  2012 ). Although this strategy was originally planned in the  Bamako Initiative , 
it was not uniformly implemented. Given the scale of the changes that  user fees 
removal implies for health care systems, there is ongoing research to evaluate their 
impact (Lagarde and Palmer  2011 ). Health system investigations such as these may 
raise ethical questions (Hyder et al.  2014 ), especially since they involve the study of 
a public  health intervention , often focus on individuals in extreme poverty, and tend 
to be international and collaborative in nature. 
 Collaborative international public health research offers the opportunity to build 
local capacity (Mayhew et al.  2008 ). However, such research raises a number of issues 
about  researchers’ obligations and responsibilities . First is the responsibility to protect 
research participants from harm, an  obligation recognized by all research ethics 
guidelines. This  duty of protection is heightened when the research participants are 
from  vulnerable populations (Hurst  2008 ),  especially when they are recruited from 
extremely impoverished populations. Researchers’ responsibilities toward research 
participants also include ensuring that they benefi t from the results of the research 
whenever possible. For example, the  International Ethical  Guidelines  for  Biomedical 
Research  Involving Human Subjects directs that “any intervention or product devel-
oped, or knowledge generated, will be made reasonably available for the benefi t of 
that population or community” (Council for International Organizations of Medical 
Sciences  2002 , guideline 10). A second researcher responsibility is to support  students 
and staff hired as part of the research project and to protect them from harm (Wilson 
 1992 ). This responsibility can be thought of both as the duty of an employer and the 
fi duciary duty of an academic supervisor and must extend to situations of whistle-
blowing. Third, researchers involved in collaborative research have a responsibility to 
colleagues and collaborators, especially given that research may play a crucial role in 
capacity building (Garcia and Curioso  2008 ). Although partnerships with local 
researchers have been touted as highly valuable (Costello and Zumla  2000 ), these ties 
may  also  result in unexpected ethical dilemmas for local researchers if  confl icts arise 
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between their research activities and their established local  obligations and responsi-
bilities (Richman et al.  2012 ). A fourth responsibility of researchers is dedication to 
the research enterprise. The conduct of public health research can have signifi cant 
implications for the well-being of large segments of the population, but it requires the 
 trust of the public and of relevant authorities. Endangering the relationship of trust in 
the context of one specifi c public health study may jeopardize or ruin other research 
initiatives (Corbie-Smith et al.  1999 ). Finally, a fi fth responsibility of publicly funded 
researchers is their  duty to the public in whose name they conduct research. Good 
stewardship requires that researchers strive to maximize the relevance and usefulness 
of their efforts and that they disseminate their fi ndings (Arzberger et al.  2004 ). 
Researchers conducting collaborative international public health research may 
encounter ethically challenging confl icts among these fi ve lines of  responsibilit ies. 
9.6.2  Case Description 
 Dr. Milena A. is the principal investigator of a large research program that is exam-
ining approaches for decreasing inequities in access to health care services in a 
low-resource setting. She works for an American university, and her research is 
funded by a U.S. agency. One member of her research team, Dr. Timothy N., is a 
local physician studying toward a public health degree at Milena’s institution. He is 
back in his country after fi nishing his coursework and is ready to conduct fi eldwork 
research. Timothy has taken leave from his position at a local hospital to pursue his 
studies and, although he wants to continue his clinical work at the hospital, he also 
wants to expand his focus to include population-level health issues and, eventually, 
work with his country’s ministry of health. His studies are co-funded by Milena’s 
research grant and by the ministry of health. 
 Timothy’s research consists of an examination of the impact of his country’s 
recent abolishment of health care  user fees for  children younger than 5 years. User 
fees had been implemented uniformly in the 1990s without special consideration for 
poorer families with young children. Initial indicators suggest that health care ser-
vices continue to be underused in some districts, especially by poor children, despite 
the recent removal of user fees. Despite the limited uptake, the ministry of health 
touts the  polic y abolishing user fees for children younger than 5 years as an impor-
tant success. Timothy is conducting his study at several urban health centers, includ-
ing the hospital from which he is currently on leave. The research project has received 
ethics approval from Milena’s institution and from the relevant local review boards. 
 Recently, Timothy  r equested a meeting with Milena saying that he needed 
advice. He reports that he has identifi ed a system of informal fees that undermines 
the ministry of health’s offi cial policy by making health care once again too expen-
sive for many families with young children. From what Timothy understands, the 
fees are levied primarily to fund better obstetric care locally, but some indicators 
point toward senior administrators keeping a small share for themselves. Timothy 
worries that making his fi ndings public is too risky for him, especially since his 
involvement in this fi eldwork is well-known. He does not think it possible to share 
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his fi ndings without identifying himself as the source of the  information . His hos-
pital is one of the sites where he has identifi ed the system of informal payments. He 
also has good reasons to believe that some members of the ministry of health are 
already aware of the situation but have not taken action to address it. Disseminating 
his results will jeopardize his employment at the hospital, his  relationships with 
 government offi cials, and, potentially, the plans to improve obstetric care. 
 Milena is also confl icted. She recognizes that she has multiple roles, responsi-
bilities, and interests, and that individual and communal goods are at stake. 
Identifying and seeking to address informal payment structures could improve 
accessibility of health care services for children, which is the primary goal of her 
research program. However, the team has responsibilities to Timothy as their  stu-
dent and colleague. Demanding that he upend his career, either for their benefi t or 
for the improvement of  health care accessibility , might fail to respect him as an 
individual. In addition, bringing the situation to light could embarrass the ministry 
of health. Because the research program depends on the ministry of health’s autho-
rization, tensions in relationships could lead to premature termination of the 
research. Such an event would have unpredictable outcomes on the careers of every-
one on the research team and on the  future  of health care  acces sibility locally. 
9.6.3  Discussion Questions 
 1.  How should Milena and Timothy prioritize their responsibilities, and what 
should they ultimately do? 
 2.  What preemptive actions could the research team have taken to limit the likeli-
hood that the situation described above would happen? 
 3.  How should the fact that, aside from Timothy, the research team members are not 
citizens in the country where they are conducting research be considered in the 
assessment of their obligations? 
 4.  Is this a case where developing partnerships with local researchers might be 
counterproductive? Or, could a more robust partnership with local researchers 
have positioned the team to better address this issue? 
 5.  How would the ethical analysis differ if, instead of identifying unequal access 
due to informal fees, Timothy had observed that those exempted from the fees 
were being offered a lower standard of care than patients whose fees were not 
waived? 
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9.7  Case 2: Ethical Challenges in Impoverished 
Communities: Seeking  Informed Consent 
in a Palestinian Refugee Camp in Lebanon 
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 Department of Health Promotion and Community Health, 
Faculty of Health Sciences 
 American University of Beirut 
 Beirut ,  Lebanon 
 e-mail: ra15@aub.edu.lb 
 This case is presented for instructional purposes only. The ideas and opinions 
expressed are the authors ’  own. The case is not meant to refl ect the offi cial position , 
 views ,  or policies of the editors ,  the editors ’  host institutions ,  or the authors ’  host 
institutions . 
9.7.1  Background 
 Begi nning in 1948, the  United Nations Relief and Works Agency (UNRWA) 
established camps in Lebanon to house  refugees from  Palestine . As of 2013, 12 
camps remained (UNRWA  2013 ). The typical UNRWA camp houses three 
generations of refugees, most of whom are unemployed and face economic hardships 
from state-imposed legal and  political restrictions (Chaaban et al.  2010 ). Camp 
housing is substandard, usually lacking adequate health care and educational 
infrastructures. A household survey of camp residents older than 15 years found 
that the mean length of school attendance is 6–7.5 years, the mean yearly household 
income is below $3,000, and more than half the respondents consider themselves 
poor (Makhoul  2003 ; Khawaja et al.  2006 ). 
 Family structures in the camp vary, ranging from matriarchal families, extended 
families, and traditional patriarchal families to even modern families where  parent s 
jointly make decisions. These family structures also include complex formations 
where, for example, a remarried father lives with his new wife and stepchildren. In 
such complex families,  children often have several guardians or authority fi gures. 
Sociocultural conceptions shared by parents and social workers stress the reliance 
of children on parental decisions—parents know what is best for children, while 
 children know they must obey parental decisions. 
 In resource-poor settings like the camps, many  nongovernmental organizations 
(NGOs) supplement UNRWA services, thereby gaining infl uence. The  perceived 
 power that the local Palestinian NGOs hold in the community derives from years of 
providing supplemental economic and social services to residents. Not surprisingly, 
if an NGO is politicized, it also will hold political power. In this context, if an NGO 
agrees to participate in a project, residents may agree to participate without paying 
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close attention to the details or the scope of work. They participate either because 
they  trust the NGO to decide on their behalf or because they want to avoid being 
perceived as opposing an organization that provides them with needed services. 
Similarly, international NGOs hold perceived power by providing essential services 
and distributing needed supplies, especially during emergencies. Universities can 
acquire such power, even unintentionally, not only from the prestige and status that 
educational institutions generally enjoy, but also from the potential benefi ts that 
research projects bring to the camps. Intentional or not, exercising such power can 
raise unanticipated problems for the research enterprise. 
 To  p rotect research participants, some national and international commissions 
have published guidance documents about equitable distribution of benefi ts and 
respect for  autonomy ,  benefi cence , and  social justice . These documents include the 
 Nuremberg Code ( 1947 ), the  Declaration of Helsinki (World Medical Association 
 1964 ), The  Belmont Report (National Commission for the Protection of Human 
Subjects of Biomedical and Behavioral Research  1979 ),  and the  International 
Ethical Guidelines for  Biomedical Research  Involving Human Subjects ( Council for 
International Organizations of Medical Science  2002 ). Even though these interna-
tional guidelines acknowledge the need to consider culture and community, they 
lack adequate guidance for community-based public health research (Racher  2007 ; 
Bledsoe and Hopson  2009 ). In addition, these guidelines are diffi cult to apply in 
 nonbiomedical research contexts in community settings. This diffi culty could be 
attributed to applying  guideline s without fi rst considering local contexts (Dawson 
and Kass  2005 ; Benatar  2002 ; Chilisa  2009 ). Many community-oriented practitio-
ners fi nd the  principle s too limiting to guide public health research ethics in com-
munity settings and recommend incorporating broader conceptions of respect,  trust , 
 inclusion ,  diversity ,  participation ,  empowerment , and  advocacy (Racher  2007 ; 
Bledsoe and Hopson  2009 ). 
 Biomedical guidelines often clash with community interactions, especially in the 
nonindustrialized world (Bledsoe and Hopson  2009 ; Matsumoto and Jones  2009 ; 
Chilisa  2009 ). One such clash occurs between individual-oriented societies and 
more collectivist societies that view personhood and individual decision making 
through the lens of a person’s relation to society (Marshall and Baten  2003 ). Another 
clash occurs between the artifi cially impersonal character of research environments 
and the centrality of relationships and partnerships in communities. Randomized 
clinical trials (RCTs), for example, require control of  all  possible confounders, a 
nearly impossible standard to achieve in close-knit and dense community settings 
(Makhoul et al.  2013 ). Implementing ethical guidelines in the context of power 
dynamics (Marshall and Baten  2004 ), like the pronounced power that males wield 
over females in  patriarchal societies , can instigate numerous clashes. In communi-
ties like  refugee camps that  offer  few economic or career opportunities, the  per-
ceived  power that  NGO s and, even more so, academic institutions wield is a force 
that must be taken into account. In such restricted settings, the power dynamics 
between researchers and research subjects can take on a subtle coercive character. 
 These same tensions, challenges, and dynamics will emerge in any efforts to 
obtain informed consent to participate in research. The emergence may stem from 
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failure to appreciate the unique complexity of local familial, cultural, and  political 
structures, or it may represent limitations in the principles being applied. 
9.7.2  Case Description 
 A community coalition, initiated by researchers from a nearby university, has been 
meeting for more than a year to  prioritize health concerns for  youth in a  Palestinian 
 refugee camp near Beirut,  Lebanon . The camp is a typical UNRWA camp and 
includes six elementary schools. The coalition comprises camp residents including 
youth (17–25 years), UNRWA representatives, camp NGO workers, and members 
of the university research team. The coalition has decided to focus on the  mental 
health of younger  ado lescents (11–13 years) in this  Palestinian refugee camp and to 
develop a research intervention on this issue. Cross-sectional studies and evaluation 
of interventions that link social and life skills to mental  health outcomes strongly 
support the view that these skills enhance the mental health of youth; however, most 
of the evidence comes from industrialized settings. 
 The goal of the intervention is to enhance positive mental health by increasing 
the social and life skills of young adolescents, who will be recruited through the 
schools. The six elementary schools have comparable resources and student pro-
fi les. Each school has been randomly assigned either to the intervention or to the 
control arm of the study, and only fi fth and sixth graders will participate. Participating 
 students in the intervention group will receive 45 extracurricular sessions of 1½ h 
each over 9 months and gain skills in solving problems, making decisions, building 
self-esteem, and enhancing relationships with peers,  parent s,  and  teachers. Parents 
of the students in the intervention group will receive 15 1-h group sessions, and 
teachers in the intervention schools will be offered six workshops addressing the 
same topics. Students randomized to the control group will receive 10 sessions over 
 the  course of 9 months, but their parents will not participate in the program. 
However, because teachers often work in more than one camp school, some teachers 
at the control schools may participate in the intervention workshops. All partici-
pants in either the intervention or control condition must complete pre- and post- 
assessment questionnaires that measure  mental health and social and life skills 
before and after the intervention and at 6 months follow-up. 
 Recruitment into the research project will unfold in phases. Toward the end of 
the school year preceding the intervention, parents will be invited to an informa-
tional session about the project that will take place in one of the camp schools. After 
the informational session, meetings will take place with individual families in their 
homes to recruit  students entering grades 5 and 6. Some  youth (ages 17–23 years) 
who live in the camp will receive training to become part of the recruitment team. 
These youth will visit the homes of all potential intervention and control partici-
pants to explain the study and to obtain  parental consent . If the parents consent, 
 students will be invited to the school for further discussion (to ensure confi dentiality 
and  autonomy of decision making). Once the study has been explained to them, 
they’ll be asked individually to give their  assent . 
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 You are a member of the university research team leading the effort to obtain 
informed consent. You would like to obtain consent and assent in accordance with 
standard international procedures, but you realize their application may need to be 
adjusted to the context of the camp. In particular, you have considered what role 
 principle s such as  trust ,  inclusion ,  diversity , and broad  community participation 
should play in the research project. That is why you chose to have older  youth from 
the camp obtain both  parental consent and student’s assent, but you are concerned 
about potential problems that this approach may encounter. Also, given  the  power 
dynamics and conditions in the camp, you would like the research team to consider 
how this project can be used to spearhead a discussion with the  community  coalition 
about larger issues of  empowerment and  advocacy . With this in mind, you plan to 
address the  followin g questions with your research team. 
9.7.3  Discussion Questions 
 1.  How could the history of Palestinian refugee camps potentially impact the 
informed consent process and the success of this intervention? 
 2.  Who are the  stakeholder s in this case, and what stake, for or against, do they have 
in the research project? How would you deal with those who believe the project 
is not in their or the community’s interests? 
 3.  What are the advantages and potential disadvantages of using older youth to 
obtain parental consent and student’s assent? What other steps could be taken to 
enhance the informed consent seeking process in such social contexts? 
 4.  What incentives, if any, should be given for participation? To whom should these 
incentives be given? Given the limited opportunities for the inhabitants of the 
refugee camps and the perceived power of NGOs, at what point would incentives 
become compulsive to encourage participation? 
 5.  How do relationships of power infl uence the application of informed consent 
procedures specifi cally, in this context? What steps can be taken to minimize the 
effects of power? 
 6.  What bearing, positive or negative, does the background of the researchers have 
on the researcher-participant interaction, especially for researchers who have 
never lived in such camp settings and would be considered outsiders to the camp 
community? 
 7.  Beyond the informed consent process, are the researchers simply teaching the 
adolescents how to adjust to an oppressive arrangement instead of exploring, 
providing and validating strategies to transform the  si tuation? If so, what are 
some alternative intervention strategies that could foster the latter? 
 8.  By almost any measure, the camp environment is abnormal for a developing ado-
lescent. Given that social determinants severely challenge the health of all members 
of the camp community, how should the researchers take into account the unusual 
and extreme circumstances of the adolescents as they implement and evaluate inter-
ventions that aim to change individual-level circumstances and attributes? 
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 This case is presented for instructional purposes only. The ideas and opinions 
expressed are the authors ’  own. The case is not meant to refl ect the offi cial position , 
 views ,  or policies of the editors ,  the editors ’  host institutions ,  or the authors ’  host 
institutions . 
9.8.1  Background 
 Many low-  to middle-income countries in Africa face a tremendous burden of  infec-
tious diseases .  Tuberculosis (TB) causes particular concern, with incidence rising 
and the greatest prevalence in  children . Compounding this concern is the lack of an 
easy-to-use and accurate diagnostic test (World Health Organization  2012 ). To 
address these challenges, the World Health Organization’s (WHO) 2011 global plan 
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to stop TB by 2050 urgently calls for more research to develop diagnostics, drugs, 
and vaccines. WHO’s call reinforces the 2008 Global Ministerial Forum on Research 
for Health held in Mali, which recommended that each country allocate 2 % of 
health ministry funds to health care research (Yazdizadeh et al.  2010 ). All research 
involving human subjects will require review by  institutional review boards (IRBs) 
or, as they are generally known in Africa,  research ethics committees (RECs) . But 
to expedite the process of high-quality  ethical reviews necessary to keep pace with 
these new research initiatives, a corresponding investment in REC funding and 
training should be made. 
 In TB-endemic areas of Africa, the volume and complexity of research have 
increased without a corresponding strengthening in the capacity of local RECs 
(WHO  2011 ). At least 190 RECs operate throughout Africa, but the quality and 
capacity of each vary widely (IJssemuiden et al.  2012 ). Although some RECs still 
 lac k adequate research regulatory frameworks, the major challenge to strengthening 
capacity is lack of funding (Kass et al.  2007 ). This means, for example, that few, if 
any, African RECs have tools like electronic  information management systems to 
coordinate submissions effi ciently. It also means that few have trained REC admin-
istrators, a gap rightly identifi ed as the missing link to improved quality and through-
put of ethical review (IJsselmuiden et al.  2012 ). These factors can delay ethical 
reviews and create problems with quality and consistency (Milford et al.  2006 ; Kass 
et al.  2007 ).  Whenever signifi cant  research funds are wasted on managing ineffi -
cient RECs, fewer funds are available to study ways to improve public health care 
services (Tully et al.  2000 ). This waste of resources on ineffi cient ethical review 
affects the timeliness of health services, which, in turn, affects subsequent health 
care  polic y and decision making. Ironically, such wastefulness poses an unethical 
barrier to potentially benefi cial public health research activities. Worse, these inef-
fi ciencies can  cost research institutions a chance to compete for grants that require 
prior  ethical review of research proposals by the country’s internal REC. 
 In Africa, external grants are often used to fund health research activities, whereas 
REC funding typically is either nonexistent or constrained by more pressing health 
care needs. Attempting to  prioritize and allocate resources for activities with out-
comes linked to funding puts policy makers in a  dilemma . On the one hand, diverting 
funds from the immediate treatment of life-threatening diseases to a weak, ineffi cient 
REC can waste critical resources. On the other hand, not allocating funds to 
strengthen RECs can lead to the loss of external research funding, the very research 
that could reduce the burden of disease in the long run. Moreover, external funding, 
though fi lling a critical gap, often heightens the tensions at play in prioritizing 
between immediate needs  for  health care and long term needs for research and RECs. 
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9.8.2  Case Description 
 A  multinational pharmaceutical  c ompany put out a call for proposals to research 
institutions in  sub-Saharan Africa to apply for a research grant. The 3-year grant, 
which provides 500,000 U.S. dollars per year to develop an effective paediatric TB 
diagnostic tool, would involve conducting  clinical trials in fi ve African TB-endemic 
countries. Successful award of the grant is contingent upon timely review of the 
proposal by the applicant’s national REC. 
 In one country eligible for the grant, the ministry of health (MoH) encouraged its 
National Tuberculosis Research Centre to apply. The grant funding would have 
boosted the country’s long-term efforts to strengthen the capacity of its public health 
research by restructuring its TB treatment protocol. The Research Centre promptly 
submitted  a proposal to the national REC, which levies 10 % of the grant as over-
head to sustain the REC. 
 Despite the overhead funding, the country’s national REC  l acks an administrator 
formally trained in research ethics and a robust ethics review structure. Although 
the REC receives more than 100 applications annually, it only meets every 3 months, 
often missing deadlines, because it cannot afford essential tools to coordinate sub-
missions effi ciently. To have a proposal reviewed; applicants have to submit 20 hard 
copies of the research application form and 10 copies of all other study materials. 
The review procedure typically forces the principal investigator of a clinical trial to 
submit nearly 20 kg of paper copies, a considerable sum in supplies and manpower. 
Despite its high profi le, the TB Research Centre’s grant application does not prove 
to be an exception to the notoriously slow review process. 
 Professor Y, a highly capable public health specialist, directs the public health 
department in the local MoH. She also lectures at a local medical school, serves as 
Principal Investigator (PI) of an ongoing TB clinical trial in the country, and has 
extensive experience at all levels of REC activity and oversight. Unfortunately, 
Professor Y has never had formal training in research ethics, which is critical for 
anyone involved in managing REC activities. Because of her background, Professor 
Y became aware of the delays in reviewing the TB Research Centre’s application. 
Recognizing its importance to the country, Professor Y offered to serve as the pri-
mary reviewer for the proposal. Professor Y called an ad hoc REC meeting. At this 
meeting, the other members, who had only received copies of the grant application 
form to prepare for their review, unanimously agreed to outsource review of the pro-
tocol because they lacked the expertise to evaluate the application. Amid these delays, 
institutions in other countries competing for the same grant, having already received 
ethical clearance from their RECs, were awarded the grant. Not only did the delays 
 cost the country a funding opportunity to enhance its public health research capacity, 
but preparing the application also wasted precious time and  scarce resources. 
 In response to this bungled opportunity, the MoH set up a task force to analyse 
the situation and offer recommendations. In its report, the task force recommended 
allocating more resources to RECs to strengthen capacity. Due to budget constraints, 
the MoH had to divert the money allocated to RECs from the antiretroviral program. 
Meanwhile, the MoH recommended temporarily outsourcing all REC services to a 
U.S. based clinical research organization. 
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9.8.3  Discussion Questions 
 1.  What ethical tension or challenges could result from the insuffi ciencies in REC 
capacity that forced the MoH’s decision to divert funds from the antiretroviral 
program to strengthen REC capacity? 
 2.  How should a country prioritize between the need to foster research, which can 
have signifi cant long-term impact and immediate health care needs? 
 3.  Funding for the research grant and temporary outsourcing of ethical reviews will 
come from multinational or U.S. based partners. What are the advantages and 
disadvantages for developing countries to accept such funding? What impact 
does accepting such funding have on a country’s ability to determine its own 
health priorities? 
 4.  Professor Y has public health credentials, TB expertise, and extensive experi-
ence as an REC administrator. The case suggests that had she followed the pro-
cedures for the review process, the grant application might have been successful, 
even though she apparently lacks formal ethics training.
 (a)  According to international research ethics regulations, what procedures 
should Professor Y have followed when distributing the proposal for review, 
allocating reviewers, and setting up the REC meeting? 
 (b)  How critical is formal ethics training to serving on an REC or to overseeing 
the development of REC capacity nationwide? 
 (c)  Is it a good use of time for someone like Professor Y to be serving adminis-
tratively on an REC? 
 (d)  Would you recommend that the MoH create a permanent position for a 
trained research ethics administrator solely responsible for REC administra-
tion issues instead of allowing volunteers like Professor Y, who have multiple 
roles and  respon sibilities, to oversee the activity? 
 5.  Given the cultural and economic differences between developed Western nations that 
sponsor research and African host countries, should formal ethics training to prepare 
for serving on an REC be modelled on Western training or on some other model? 
 6.  Keeping the interests and values of all  stakeholder s in mind, consider the best 
ways to address the strengthening of REC capacity in African low- to middle- 
income countries at the local and global levels. 
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9.9.1  Background 
 Since surfacing more than 30 years ago, the HIV/AIDS  pandemic has devastated 
populations worldwide. Various factors have contributed to this epidemic, such as 
lack of awareness of  HIV status, stigma, homophobia, negative perceptions about 
 HIV testing , socioeconomic factors, behavioral risk factors, and high prevalence of 
sexually transmitted diseases ( Centers for Disease Control and Prevention  2015 ). In 
the United States, one goal of the national HIV/AIDS strategy is to  re duce HIV- 
related  hea lth disparities. Any reduction in the collective risk of acquiring HIV will 
require behavior change interventions in communities with the highest HIV preva-
lence. However, extending the reach of HIV/ AIDS preventive interventions in 
remote areas with limited access to  HIV testing and  prev ention services has proved 
diffi cult (Offi ce of National AIDS Policy  2012 ). 
 The challenge of reaching some populations has led many practitioners to con-
sider innovative intervention methods that rely on technologies such as the Internet 
and mobile telephones. Public health  profession als are using these technologies to 
deliver health education to vulnerable populations in big cities, small towns, and 
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hard-to-reach rural areas. In particular, the past decade has seen more  health com-
munication efforts using the Internet to prevent  HIV and sexually transmitted dis-
eases (Bull et al.  2007 ,  2009 ; Rietmeijer and McFarlane  2009 ). Studies of 
interventions that use Internet chat rooms, online modules, and  health intervention 
websites show promising results that bode well for the future of these  technolo gies 
(Chiasson et al.  2009 ; Moskowitz et al.  2009 ). 
 Studies conducted with marginalized and vulnerable populations such as black 
 men who have sex with men (MSM) can pose diffi culties. On the technology front, 
many diffi culties refl ect the Internet’s relative novelty for conducting studies and 
the consequent lack of clarity in dealing with the rules, language, and  norms of a 
virtual community culture compared with a traditional community culture (Loue 
and Pike  2010 ). On the  allocation front, having limited resources usually implies 
that tailoring interventions to a specifi c group will mean forgoing benefi ts to another 
group. Still, in promoting the health of populations, public health professionals 
must strive to distribute resources fairly while responding to the specifi c needs of 
racial, ethnic, and cultural groups. These concurrent goals require maintaining a 
delicate balance between targeted and population interventions. On the ethics front, 
because some projects straddle the line between research and practice, public health 
 profession als can become unsure about  whether  the ethical  guideline s of  research or 
of community work should govern their actions. They must bear in mind that  trust , 
which is essential for conducting  community-based participatory research , becomes 
more crucial when working with vulnerable populations, which tend to show a high 
degree of mistrust (Loue and Pike  2010 ). Those who study vulnerable populations 
need to negotiate community entry either by developing trust or by working closely 
with local practitioners and building upon established trust. 
 In the  United States , the HIV/ AIDS  epidemic has hit the African-American pop-
ulation hardest, with black men accounting for 70 % of new  HIV infections . 
Between 2006 and 2009, new HIV infections increased 48 % among black 13- to 
24-year-old MSM (Centers for Disease Control and Prevention  2015 ); by 2009, 
37 % of new HIV cases among black men were  from  black MSM. Given this high 
prevalence, before the end of 2015, the U.S. national  HIV/AIDS strategy calls for a 
20 % increase in the proportion of African Americans diagnosed with  HIV who 
have an undetectable viral load (Offi ce of National AIDS Policy  2012 ). Already, 
information about HIV issues affecting young MSM (Mustanski et al.  2011 ) is 
widely available on the Internet, including messages about how to reduce risk 
(Hightow-Weidman et al.  2011 ) and interventions to prevent HIV  risk behaviors 
among MSM (Rhodes et al.  2010 ) and blacks who inject drugs (Washington and 
Thomas  2010 ). Studies show that online delivery of HIV counseling and behavioral 
interventions for MSM at high risk for HIV are successful, suggesting that the 
future holds great promise for  Internet-delivered interventions for this vulnerable 
population (Chiasson et al.  2009 ; Moskowitz et al.  2009 ). 
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9.9.2  Case Description 
 Dr. Albert,  a social scientist, and Dr. Baines, a community worker, are employed by 
a public health agency in a medium-size U.S. town. The agency has asked them to 
determine whether a skill-based,  Internet-delivered intervention to promote safer 
sex among young  Black  MSM will increase  HIV knowledge and increase the fre-
quency of using safer-sex practices. 
 Project participants will be recruited via the Internet in gay chat rooms and be 
verifi ed electronically by using Internet Protocol and Microsoft Access usernames 
and passwords (Bull  2011 ). Participants will be surveyed before they begin the 
training modules and again at 1- and 6-week intervals after completing the modules. 
Participants will be randomly assigned to control and experimental arms. Those in 
the control arm will receive 6 h of online  training  about health and well-being (e.g., 
nutrition, physical activity, stress reduction). The experimental arm will receive a 
6-h online program including two 1-h modules on each of the following topics: (a) 
HIV/AIDS-related knowledge; (b) development and improvement of safe sex skills, 
such as partner communication and monogamous sexual relationships; and (c) self- 
effi cacy in using condoms. The modules will include automated reminders for  HIV 
testing . The study will measure improved knowledge on  HIV/AIDS , partner com-
munication about safer sex, and condom usage self-effi cacy. Data will be analyzed 
using statistical software. 
 Dr. Albert thinks the results could be generalized not only to black MSM in the 
community but also to black MSM overall. He plans to write an article describing 
the results for publication in a scientifi c journal. Although Dr. Baines knows the 
impact of education on health, especially in underprivileged communities, she 
wants to educate only a subset of the community they will reach. Besides, since 
their work is for a public health agency, she believes the intervention ought to reach 
as many community members possible. She claims the project’s goal is to provide a 
vulnerable and disadvantaged population with much needed education on health 
matters and health-promoting behavior and doubts their project constitutes research. 
 Dr. Albert worries that, because his colleague lacks academic rigor and underap-
preciates the role of evidence, she fails to appreciate the project’s rationale and 
design and, as a result, is indifferent to the challenges the Internet poses (e.g., 
technology- induced bias, protection of confi dentiality). Conversely, Dr. Baines 
believes Dr. Albert has missed the boat and is wasting resources, spuriously intro-
ducing statistical analysis of experimental and control arms into what  the  agency 
clearly had intended as an education intervention. 
9.9.3  Discussion Questions 
 1.  Is this a research project? Should approval from an ethics review committee be 
obtained? Or should the project be considered nonresearch because it will 
improve the health of the population? How should you decide? 
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 2.  Does the fact that the project is funded by a public health agency play a role in 
this discussion? Should public health agencies conduct studies to generate evi-
dence about HIV education and prevention interventions? Should agencies focus 
on the delivery of interventions based on the existing evidence? 
 3.  How is this black MSM population vulnerable, and how should this vulnerability 
be addressed in research and nonresearch interventions? 
 4.  Do Dr. Albert and Dr. Baines have ethical obligations to other community popu-
lations? On what basis is the public health agency justifi ed in advancing inter-
ventions that target only a subgroup of the community? 
 5.  How should research studies on Internet-based interventions be conducted to 
ensure scientifi c validity, given the diffi culties of knowing, for example, whether 
the participant meets the study’s inclusion criteria? Which measures should be 
taken to protect the privacy and confi dentiality of participants? 
 6.  How should you decide what level and type of evidence you need to back a pub-
lic health educational intervention? Should public health professionals always 
use science to validate educational interventions? 
 Open Access  This chapter is distributed under the terms of the Creative Commons Attribution-
NonCommercial 2.5 License ( http://creativecommons.org/licenses/by-nc/2.5/ ), which permits 
any noncommercial use, duplication, adaptation, distribution, and reproduction in any medium 
or format, as long as you give appropriate credit to the original author(s) and the source, a link 
is provided to the Creative Commons license, and any changes made are indicated.
The images or other third party material in this chapter are included in the work’s Creative 
Commons license, unless indicated otherwise in the credit line; if such material is not included 
in the work’s Creative Commons license and the respective action is not permitted by statutory 
regulation, users will need to obtain permission from the license holder to duplicate, adapt, or 
reproduce the material. 
 References 
 Bull, S. 2011.  Technology-based health promotion . Thousand Oaks: Sage Publications. 
 Bull, S.S., S. Phibbs, S. Watson, and M. McFarlane. 2007. What do young adults expect when they 
go online? Lessons for development of an STD/HIV and pregnancy prevention website. 
 Journal of Medical Systems 31(2): 149–158. 
 Bull, S., K. Pratte, N. Whitesell, C. Rietmeijer, and M. McFarlane. 2009. Effects of an Internet 
based intervention for HIV prevention: The Youthnet trials.  AIDS and Behavior 13(3): 474–
487. doi: 10.1007/s10461-008-9487-9 . 
 Centers for Disease Control and Prevention. 2015.  HIV Among African Americans.  http://www.
cdc.gov/HIV/risk/racialethnic/aa/index.html . Accessed 2 June 2015. 
 Chiasson, M.A., F.S. Shaw, M. Humberstone, S. Hirshfi eld, and D. Hartel. 2009. Increased HIV 
disclosure three months after an online video intervention for men who have sex with men 
(MSM).  AIDS Care 21(9): 1081–1089. doi: 10.1080/09540120902730013 . 
 Hightow-Weidman, L.B., B. Fowler, J. Kibe, et al. 2011. HealthMpowerment.org: Development of 
a theory-based HIV/STI website for young black MSM.  AIDS Education and Prevention 23(1): 
1–12. doi: 10.1521/aeap.2011.23.1.1 . 
 Loue, S., and E.C. Pike. 2010.  Case studies in ethics and HIV research . New York: Springer. 
9 Public Health Research
318
 Moskowitz, D.A., D. Melton, and J. Owczarzak. 2009. PowerON: The use of instant message 
counseling and the Internet to facilitate HIV/STD education and prevention.  Patient Education 
and Counseling 77(1): 20–26. doi: 10.1016/j.pec.2009.01.002 . 
 Mustanski, B., T. Lyons, and S.C. Garcia. 2011. Internet use and sexual health of young men who 
have sex with men: A mixed-methods study.  Archives of Sexual Behavior 40(2): 289–300. 
doi: 10.1007/s10508-009-9596-1 . 
 Offi ce of National AIDS Policy. 2012.  National HIV/AIDS strategy: Update of 2011–2012 federal 
efforts to implement the national HIV/AIDS strategy .  http://www.aids.gov/federal-resources/
national-hiv-aids-strategy/implementation-update-2012.pdf . Accessed 2 June 2015. 
 Rhodes, S.D., K.C. Hergenrather, J. Duncan, et al. 2010. A pilot intervention utilizing Internet chat 
rooms to prevent HIV risk behaviors among men who have sex with men.  Public Health 
Reports 125(suppl 1): 29–37. 
 Rietmeijer, C.A., and M. McFarlane. 2009. Web 2.0 and beyond: Risks for sexually transmitted 
infections and opportunities for prevention.  Current Opinion in Infectious Diseases 22(1): 
67–71. doi: 10.1097/QCO.0b013e328320a871 . 
 Washington, T.A., and C. Thomas. 2010. Exploring the use of Web-based HIV prevention for injec-
tion-drug-using black men who have sex with both men and women: A feasibility study.  Journal 
of Gay & Lesbian Social Services 22(4): 432–445. doi: 10.1080/10538720.2010.491747 . 
D.H. Barrett et al.
319
 A 
 ACA . See  Patient Protection and Affordable 
Care Act (ACA) 
 Acceptable risk ,  180–183 
 Access to care ,  95 ,  99–100 
 Accountability ,  15 ,  245–247 ,  249 ,  265 
 Accountability for reasonableness ,  28 
 A1C Registry ,  39 ,  50–54 
 Adolescent mental health ,  307 
 Adverse events ,  41 ,  264 ,  265 
 Advertising ,  53 ,  148 ,  154–156 ,  159 
 Advocacy ,  185 ,  267 ,  269 ,  297 ,  306 ,  308 
 Africa ,  121 ,  148 ,  182 ,  310–313 
 African-Americans ,  45 ,  165 ,  221 
 Aggregate population health ,  65 . See also 
 Population health 
 AIDS ,  314 
 AIDS exceptionalism ,  257 
 Alabama ,  38 ,  44–50 ,  53 ,  54 
 Allocation ,  62–70 ,  72 ,  73 ,  101 ,  227 ,  252 , 
 260–262 ,  276 ,  315 
 AMR . See  Antimicrobial resistance (AMR) 
 Anthrax attack ,  126 
 Anthrax disease ,  126 . See also  Inhalation 
anthrax 
 Anthrax vaccine ,  101 ,  125–128 
 Anthrax vaccine adsorbed (AVA) ,  126 
 Antibiotic resistance ,  130 ,  193 
 Antibiotics ,  126 ,  127 ,  192 ,  193 ,  270 
 Antimicrobial resistance (AMR) ,  192 
 Antiretroviral therapy (ART) ,  109 ,  258 , 
 260–262 
 Anti-vaccination movement ,  104 
 Anxiety ,  112 ,  291 
 Apathy ,  232 
 Aristotle ,  14 ,  15 
 ART . See  Antiretroviral therapy (ART) 
 Assent ,  22 ,  307 
 Asylum seekers ,  209 ,  232 ,  233 ,  235–239 
 Autism ,  104 ,  106 
 Autonomy ,  13 ,  16 ,  17 ,  19–21 ,  23–26 ,  37–39 , 
 53 ,  95–97 ,  100 ,  116 ,  150 ,  168 ,  169 , 
 181 ,  183 ,  222 ,  237 ,  289 ,  306 ,  307 
 AVA . See  Anthrax Vaccine Adsorbed (AVA) 
 B 
 Bacillus anthracis ,  126 
 Bamako Initiative ,  301 
 Behavioral health . See  Behavioral health 
treatment 
 Behavioral health treatment ,  75 ,  77 ,  78 
 Belmont report ,  21 ,  22 ,  49 ,  247 ,  286 ,  306 
 Benefi cence ,  19 ,  22 ,  23 ,  49 ,  286 ,  289 ,  306 
 Bioethics ,  4 ,  19–23 ,  28 ,  37 ,  47 ,  48 ,  81 ,  170 , 
 203–205 ,  219 ,  247 ,  251 ,  286 
 Biomedical research ,  20 ,  25 ,  180 ,  247 ,  252 , 
 286–289 ,  297 ,  301 ,  306 
 Biotechnology (ethical challenges 
of) ,  21 ,  217 
 Bioterrorism ,  101 ,  133 
 Bloodspot screening ,  97 ,  111–114 
 Bloomberg, M. ,  53 
 Breast cancer ,  142 
 Breast-feeding ,  212 
 Breast screening ,  143 
 Buck v. Bell ,  43 ,  44 
 Built environment ,  179 
 Bulgaria ,  150 ,  172–175 
 Bulgarian Health Act ,  173 
 Index 
© The Author(s) 2016
D.H. Barrett et al. (eds.), Public Health Ethics: Cases Spanning the Globe, 
Public Health Ethics Analysis 3, DOI 10.1007/978-3-319-23847-0
320
 C 
 Canadian Immigration and Refugee Protection 
Act (IRPA) ,  238 
 Case-control study ,  212 
 Casuistry ,  38 ,  39 
 Cataract ,  66 
 CBPR . See  Community-based participatory 
research (CBPR) 
 CDC . See  Centers for Disease Control and 
Prevention (CDC) 
 CEA . See  Cost-effectiveness analysis (CEA) 
 CEDAW . See  Convention on the Elimination 
of All Forms of Discrimination against 
Women (CEDAW) 
 Centers for Disease Control and Prevention 
(CDC) ,  4 ,  31 ,  38 ,  39 ,  44 ,  45 ,  50 ,  109 , 
 120 ,  121 ,  126 ,  137 ,  158 ,  164 ,  222 ,  245 , 
 257 ,  260 ,  267 ,  288 ,  293 ,  314 ,  315 
 Central America ,  218 
 CER . See  Comparative effectiveness research 
(CER) 
 Childbirth ,  100 ,  116 ,  117 
 Child health ,  262 ,  276 
 Childhood obesity ,  149 ,  158–161 
 Childhood vaccination ,  97 ,  105 
 Children ,  10 ,  29 ,  31 ,  40 ,  41 ,  43 ,  48 ,  73 ,  75–78 , 
 96 ,  97 ,  101 ,  148 ,  149 ,  154–156 , 
 158–161 ,  164 ,  168 ,  169 ,  174 ,  179 ,  196 , 
 200 ,  210 ,  213 ,  218 ,  231 ,  232 ,  238 ,  275 , 
 277 ,  280 ,  289 ,  292 ,  302 ,  305 ,  310 
 Chile ,  129 
 Choice 
 healthy ,  160 
 personal ,  23 ,  25 ,  26 ,  111–114 ,  294 
 voluntary ,  140 ,  158 
 Cholera and outbreak ,  244 ,  250 ,  270 ,  272 
 Cholera vaccines ,  270 
 Chronic disease prevention ,  137 ,  138 , 
 140–151 ,  153–165 ,  167–170 ,  172–175 
 Chronic diseases ,  38 ,  137–140 . See also 
 Noncommunicable diseases 
 Cigarette use ,  173 
 CIOMS . See  Council for International 
Organizations of Medical Sciences 
(CIOMS) 
 Climate change ,  179 ,  184 ,  250 
 Clinical ethics ,  4 ,  19–24 ,  37–39 
 Clinical guidelines ,  72 ,  88 
 Clinical trials ,  40 ,  247 ,  263 ,  264 ,  288 ,  312 
 Cluster randomized trials ,  286 ,  290 
 Cold War ,  231 ,  242 ,  243 ,  248–250 
 Coliform bacteria ,  197 
 Collaboration(s) ,  7 ,  20 ,  23 ,  24 ,  32 ,  81 ,  82 ,  123 , 
 197 ,  223 ,  241–243 ,  245–249 ,  263 ,  276 , 
 281 ,  282 ,  286 
 Collective health ,  32 ,  243–244 
 Colom, A. ,  49 
 Colombia ,  66 ,  72 ,  73 
 Colonial rule ,  242 
 Commercial sex work ,  46 ,  47 ,  121 ,  123 . See 
also  Prostitution 
 Common morality ,  13 
 Common rule ,  20 ,  21 
 Commonwealth v. Henning Jacobson ,  41 
 Communicable disease ,  129 
 Communitarian values ,  71 
 Community-based participatory research 
(CBPR) ,  290 ,  315 
 Community health ,  4 ,  6 ,  10 ,  26 ,  39 , 
 210 ,  227 
 Community participation ,  71 ,  308 
 Comparative effectiveness research 
(CER) ,  63 ,  64 
 Compensation ,  102 ,  133 ,  218 ,  264 ,  265 ,  273 
 Compliance ,  15 ,  18 ,  19 ,  72 ,  100 ,  102 ,  133 , 
 185 ,  236 ,  277 ,  287 ,  296 . See also 
 Noncompliance 
 Compulsory treatment program ,  224 
 Conditional cash incentive scheme ,  116–118 
 Confl ict ,  12 ,  13 ,  18 ,  21 ,  27 ,  31 ,  40 ,  66–68 ,  73 , 
 85 ,  93 ,  96 ,  146 ,  168 ,  169 ,  174 ,  181 , 
 182 ,  199 ,  242 ,  250 ,  259 ,  268 ,  277 ,  294 . 
See also  War and warfare 
 Confl icts of interests ,  21 ,  142 ,  149 ,  294–296 
 Consent ,  20 ,  22 ,  23 ,  25 ,  30 ,  31 ,  48 ,  169 ,  218 , 
 219 ,  247 ,  258 ,  264 ,  280–283 ,  286 ,  289 . 
See also  Informed consent 
 Consumers ,  71 ,  146–148 ,  168 ,  183 
 Convention on the Elimination of All Forms of 
Discrimination against Women 
(CEDAW) ,  122 
 Coordination ,  133 ,  134 ,  244–245 ,  249 
 Corporate social responsibility ,  148 
 Cost(s) ,  11 ,  15 ,  17 ,  29 ,  45 ,  61 ,  63 ,  65 ,  68 ,  71 , 
 72 ,  75 ,  76 ,  78 ,  86 ,  137–139 ,  144 ,  151 , 
 155 ,  158 ,  160 ,  161 ,  165 ,  168 ,  169 ,  174 , 
 180 ,  236 ,  238 ,  247 ,  261 ,  263 ,  276 ,  277 , 
 291 ,  292 ,  311 ,  312 . See also  
Cost benefi t; Cost  effective; 
Cost saving 
 Cost benefi t ,  17 ,  182 
 Cost effective ,  66 ,  67 ,  86 ,  88 ,  142 ,  144 ,  196 , 
 261 ,  265 
 Cost effectiveness ,  11 ,  15 ,  64 ,  66 ,  68 ,  72 , 
 141 ,  150 
 Cost-effectiveness analysis (CEA) ,  63 
 Cost savings ,  17 
 Council for International Organizations of 
Medical Sciences (CIOMS) ,  20 ,  205 , 
 264 ,  280 ,  281 ,  293 ,  301 ,  306 
Index
321
 Counseling and testing ,  257 ,  258 
 Crib death ,  212 
 Criminalization of infectious disease 
transmission ,  98 
 Criminal laws ,  120 ,  121 
 Culturally appropriate research ,  280 
 Cutler, J.C. ,  47 
 D 
 DALY . See  Disability-adjusted life year 
(DALY) 
 Decision-making process ,  11 ,  67 ,  69–70 ,  72 , 
 73 ,  149 ,  150 ,  169 
 Declaration of Helsinki ,  20 ,  44 ,  246 ,  264 , 
 286 ,  306 
 De-identifi ed data ,  281 ,  282 
 Denormalization ,  163 
 Dental caries ,  168–170 
 Deportation ,  210 ,  232 ,  233 
 Detention policies ,  231 
 Diabetes ,  39 ,  50–54 ,  137 ,  141 ,  160 ,  277 
 Diarrheal diseases ,  40 ,  196 ,  271 
 Dilemmas ,  13 ,  72 ,  99 ,  100 ,  121 ,  156 ,
 159 ,  182 ,  274–278 ,  296 , 
 300–303 ,  311 
 Directly observed therapy, short-course 
(DOTS) ,  236 
 Disability-adjusted life years (DALYs) , 
 64 ,  172 ,  196 
 Discrimination ,  8 ,  9 ,  98 ,  100 ,  109 ,  158 ,  182 , 
 183 ,  232 ,  233 ,  237 ,  244 ,  249 ,  250 ,  252 , 
 257 ,  258 ,  280 
 Disease burdens ,  8 ,  10 ,  68 ,  137 ,  150 ,  172 ,  196 , 
 242 ,  252 
 Disease prevention and control ,  5 ,  96–102 , 
 104–107 ,  109–114 ,  116–118 ,  120–123 , 
 125–135 
 Disease screening ,  95 ,  97–98 ,  223 
 Disincentives ,  98 ,  159 
 Disparities, black-white ,  67 
 Disparities, health ,  8 ,  67 ,  252 ,  314 
 Distributive and social justice ,  163 
 Distributive justice ,  29 
 Diversity ,  14 ,  105 ,  106 ,  177 ,  180 ,  183 ,  294 , 
 306 ,  308 
 Division of Venereal Disease ,  45 
 DOTS . See  Directly observed therapy, 
short-course (DOTS) 
 Drinking water quality ,  196 
 Drug resistance ,  97 ,  100 ,  267 
 Drug supply ,  236 ,  267 ,  268 
 Drug trials ,  20 ,  263–265 
 Duties ,  15–18 ,  23 ,  53 ,  54 ,  97 ,  98 ,  102 ,  138 , 
 203 ,  204 ,  206 ,  208 ,  238 ,  250 ,  287 ,  293 , 
 301 ,  302 
 E 
 Economic analysis ,  63 
 Economic development ,  137 ,  157 ,  177 ,  182 , 
 184 ,  189 
 Economic measures ,  275 ,  277 
 Economic systems ,  177 ,  184 
 Ecosystems ,  177 ,  179 ,  180 ,  183–185 
 Effectiveness ,  6 ,  10 ,  26 ,  29 ,  40 ,  45–47 ,  53 ,  63 , 
 64 ,  67 ,  144 ,  163 ,  168 ,  222 ,  237 ,  252 , 
 290 ,  292 . See also  Cost effectiveness 
 Effi ciency ,  6 ,  62–66 ,  68 ,  72 ,  169 ,  222 , 
 310–313 
 Effi ciency frontiers ,  63 
 Emanuel, E. ,  247 
 Emergency model ,  112 
 Emergency response ,  95 ,  101–102 ,  227 , 
 245 ,  295 
 Emergency Use Authorization (EUA) ,  126 
 Emigration ,  230 
 Empowerment ,  99 ,  252 ,  297 ,  306 ,  308 
 Enforcement ,  18 ,  41 ,  70 ,  98 ,  133 ,  192 ,  244 
 Environmental hazards ,  178 
 Environmental health ,  38 ,  177–181 ,  184 ,  185 
 Environmental health risks ,  177 . See also 
 Environmental hazards 
 Equity ,  4 ,  8–9 ,  22 ,  23 ,  27–29 ,  53 ,  66 ,  67 ,  71 , 
 73 ,  86 ,  91 ,  141 ,  182 ,  183 ,  188 ,  209 , 
 237 ,  251 
 Essential public health services ,  6 ,  44 ,  54 ,  285 
 Ethical conduct of research with human 
subjects ,  286 
 Ethical reviews ,  20 ,  48 ,  288 ,  298 ,  311 
 Ethical standards ,  13 ,  15 ,  241 ,  253 ,  279–283 
 Ethics (difference from morality) ,  4 ,  10 ,  13 ,  14 
 Ethics frameworks ,  4 ,  26 ,  38 ,  52 ,  53 ,  96 , 
 246–253 
 Ethics review ,  20 
 Ethics review committees ,  20 ,  287 ,  296 ,  297 
 EUA . See  Emergency Use Authorization 
(EUA) 
 European Region ,  104 ,  172 ,  173 
 European Union (EU) ,  173 ,  230 ,  281 
 Evacuation ,  102 ,  132–135 ,  200 
 F 
 Fair chances ,  62–65 
 Fair distribution ,  9 ,  293 
Index
322
 Fairness ,  28 ,  44 ,  47 ,  64 ,  65 ,  70 ,  91 ,  133 , 
 181–183 . See also  Fair chances; Fair 
distribution; Fair outcomes 
 Fair outcomes ,  71 
 Fluorides ,  150 ,  168 . See also  Water 
fl uoridation 
 Food and beverage marketing ,  153–157 . See 
also  Food promotion 
 Food promotion ,  154 ,  156 
 Food and beverage preferences ,  154 
 Foreign assistance ,  275 
 Framework convention on tobacco control , 
 148 ,  244–245 
 Free choice ,  16 ,  17 ,  23 ,  25 ,  70 
 Freedom ,  22 ,  30 ,  41 ,  42 ,  76 ,  101 ,  102 ,  107 , 
 138 ,  139 ,  182 ,  248 ,  250 ,  263 . See also 
 Free choice; Free will 
 Free will ,  16 
 G 
 Gates Foundation ,  261 
 Gender inequality ,  121 
 Generalizable knowledge ,  287 ,  288 
 Global collaboration ,  241 ,  247 ,  248 
 Global Fund ,  243 ,  246 ,  261 
 Global health ,  99 ,  184 ,  241–253 ,  257 ,  269 
 Globalization ,  241–246 ,  249 ,  250 ,  281 
 Global public health ,  32 ,  109 ,  151 ,  184 ,  192 , 
 199–201 ,  241–253 ,  256–265 ,  267–273 , 
 275–278 ,  280–283 
 Goodin, R.E. ,  204 ,  205 ,  207–210 
 Government(s) ,  7 ,  9 ,  10 ,  25 ,  32 ,  40 ,  43–47 ,  49 , 
 50 ,  52 ,  53 ,  76 ,  78 ,  81 ,  140 ,  144–148 , 
 150 ,  154 ,  155 ,  158–160 ,  169 ,  170 ,  174 , 
 178 ,  184 ,  187–189 ,  199 ,  203 ,  214 ,  218 , 
 219 ,  241–245 ,  247–250 ,  253 ,  263 ,  264 , 
 267–269 ,  271 ,  273 ,  275 ,  294 ,  303 
 Greece ,  150 ,  167–170 
 Guatemala STD studies ,  38 ,  44–50 
 Guideline(s) ,  5 ,  13 ,  18 ,  20 ,  44 ,  48 ,  88 ,  142 , 
 192 ,  193 ,  196 ,  197 ,  204 ,  205 ,  214 ,  215 , 
 244 ,  247 ,  264 ,  268 ,  280 ,  282 ,  286 ,  289 , 
 293 ,  296 ,  306 ,  315 
 Guiding Principles on Business and Human 
Rights ,  250 
 H 
 Haiti ,  270–273 
 Harm principle ,  25 ,  26 ,  159 
 Harms ,  39 ,  43 ,  47 ,  48 ,  53 ,  143–145 ,  148 ,  156 , 
 159–161 ,  168 ,  177 ,  182 ,  183 ,  201 ,  204 , 
 206 ,  207 ,  209 ,  210 ,  244 ,  247 ,  250 ,  275 , 
 277 ,  280 
 Health-adjusted life-year measures ,  64 
 Health-based targets ,  196 
 Health care access ,  122 ,  301 ,  303 
 Health care associated infections ,  192 
 Health care costs ,  138 ,  158 ,  160 
 Health care personnel ,  131 ,  193 
 Health care staff ,  193 
 Health care worker(s) ,  130 ,  193 ,  226 ,  227 . 
See also  Health care personnel; Health 
care staff 
 Health communication ,  315 
 Health disparities ,  8 ,  67 ,  252 ,  314 
 Health equity ,  4 ,  8–9 ,  22 ,  23 ,  29 ,  53 ,  164 ,  165 , 
 180 ,  184 ,  186–190 ,  227 ,  251 
 Health impact assessment ,  189 
 Health inequities ,  8 ,  9 ,  22 ,  251 
 Health interventions ,  7 ,  10 ,  17 ,  23 ,  24 ,  27 ,  39 , 
 43 ,  50 ,  53 ,  63 ,  66 ,  163–165 ,  170 ,  227 , 
 252 ,  301 ,  315 
 Health maximization ,  65 ,  67 ,  68 
 Health outcomes ,  9 ,  63 ,  64 ,  66 ,  72 ,  116 ,  150 , 
 154 ,  163 ,  181 ,  196 ,  227 ,  251 ,  252 , 
 282 ,  307 
 Health priorities and resource allocation , 
 61 ,  63–73 ,  75–78 ,  80–82 ,  84 , 
 85 ,  87–92 
 Health promotion ,  9 ,  66 ,  71 ,  73 ,  137 ,  138 , 
 140–151 ,  153–165 ,  167–170 ,  172–175 , 
 177 ,  214 ,  297 
 Health promotion incentives ,  95 ,  100–101 
 Health reform ,  71 
 Health risk assessments ,  141 
 Health status indicators ,  276 
 Helmet rules ,  200 
 Hepatitis ,  221 ,  223 
 HIV/AIDS ,  20 ,  64 ,  121 ,  196 ,  243 ,  244 ,  249 , 
 252 ,  257 ,  258 ,  260–262 ,  271 ,  315 ,  316 
 among African-American men ,  315 
 education ,  314–317 
 Hobbes, T. ,  248 
 Human dignity ,  248 
 Human immunodefi ciency virus (HIV) ,  31 ,  49 , 
 98 ,  99 ,  109 ,  120–122 ,  188 ,  221 ,  223 , 
 236 ,  237 ,  244–246 ,  252 ,  256–261 ,  291 , 
 314–316 
 criminalization ,  98 ,  120–124 
 infections ,  109 ,  121 ,  122 ,  221 ,  260 , 
 261 ,  315 
 prevention ,  109 ,  122 ,  256–258 ,  314 
 surveillance ,  122 
 testing ,  97 ,  98 ,  109 ,  121–123 ,  257–259 , 
 314 ,  316 
 testing policy ,  256–259 
 transmission ,  98 ,  99 ,  108–110 ,  121 ,  223 
 Human research regulations ,  280 
Index
323
 Human-rights ,  9 ,  29 ,  99 ,  101 ,  121 ,  122 ,  181 , 
 231–233 ,  246 ,  248–251 ,  257 ,  258 ,  268 , 
 275 . See also  Human rights 
frameworks; Human rights theory 
 Human rights abuses ,  232 
 Human rights frameworks ,  246 ,  249 ,  250 
 Human rights theory ,  248 
 Hurst, S.A. ,  204 ,  208 ,  301 
 I 
 ICER . See  Incremental cost-effectiveness 
ratio (ICER) 
 Immigration ,  30 ,  97 ,  209 ,  231 ,  233 ,  237 
 Incarceration ,  220–224 ,  292 
 Incidental and secondary fi ndings ,  293 
 Inclusion ,  68 ,  262 ,  269 ,  293 ,  306 ,  308 
 Incremental cost-effectiveness ratio 
(ICER) ,  64 
 India ,  100 ,  116–118 ,  244 ,  250 ,  263 ,  264 ,  280 
 Indian Council of Medical Research ,  264 
 Individual behavior ,  138 ,  140 ,  164 ,  180 
 Individualism ,  22 ,  24 ,  42 ,  43 ,  49 ,  54 
 Individual liberty ,  27 ,  31 ,  42 ,  43 ,  50 ,  96 ,  181 
 Individual rights ,  26 ,  37 ,  43 ,  101 ,  180–183 
 Inequalities ,  67 ,  116 ,  163 ,  164 ,  169 ,  183 
 Infant mortality ,  67 ,  252 ,  264 ,  271 ,  276 
 Infants ,  109 ,  112 ,  212–214 ,  280 
 Infection (active and latent) ,  236 ,  237 
 Infectious diseases ,  30 ,  38 ,  39 ,  41 ,  45 ,  50 ,  96 , 
 98 ,  99 ,  177 ,  179 ,  180 ,  188 ,  196 ,  199 , 
 222 ,  223 ,  236 ,  241 ,  257 ,  273 ,  282 ,  310 
 Infl uenza ,  226 ,  228 
 Information ,  4 ,  29 ,  31 ,  32 ,  37 ,  53 ,  102 ,  105 , 
 112–114 ,  127 ,  138 ,  139 ,  141 ,  142 ,  148 , 
 156 ,  159 ,  185 ,  196 ,  245 ,  259 ,  281 ,  282 , 
 286 ,  288–290 ,  293 ,  294 ,  303 ,  311 
 Informed choices ,  112 ,  160 
 Informed consent ,  20–23 ,  46–49 ,  95 ,  97 ,  98 , 
 101 ,  120 ,  126 ,  127 ,  219 ,  247 ,  251 ,  252 , 
 257 ,  264 ,  265 ,  279–283 ,  289 ,  290 ,  293 , 
 305–308 . See also  Consent 
 Informed consent (in STD experiments) , 
 47 ,  49 
 Inhalation anthrax ,  126 
 Injection drug use ,  220–224 
 Injustice ,  8 ,  210 ,  214 ,  231 
 Inmates ,  209 ,  221 
 Institutional review board 
(establishment of) ,  48 
 Institutional review boards (IRBs) ,  20 ,  49 , 
 244 ,  281 ,  282 ,  311 
 Interdependence ,  7 ,  24 ,  25 ,  27 ,  206 ,  298 
 International aid workers ,  199 ,  244 
 International Bioethics Committee of 
UNESCO [IBC] ,  205 
 International collaboration ,  8 ,  241–253 , 
 257–265 ,  267–273 ,  275–278 ,  280–283 . 
See also  Global collaboration 
 International Conference on Harmonisation 
of Good Clinical Practice 
(ICH-GCP) ,  264 
 International Covenant on Civil and Political 
Rights (ICCPR) ,  248 ,  250 
 International Covenant on Economic, Social 
and Cultural Rights (ICESCR) , 
 145 ,  248 ,  249 
 International Declaration on Human Genetic 
Data ,  251 
 International Ethical Guidelines for 
Biomedical Research Involving 
Human Subjects (CIOMS) ,  20 ,  286 , 
 288 ,  301 
 International Ethical Guidelines for 
Epidemiological Studies ,  286 
 International Monetary Fund (IMF) ,  242 
 Internet-delivered interventions ,  315 ,  316 
 Intersectoral ,  7 ,  24 ,  155 ,  251 
 Intervention ladder ,  146 ,  147 
 Investigational new drug (IND) ,  126 
 In-vitro fertilization (IVF) ,  218 
 IOM . See  U.S. Institute of Medicine (IOM) 
 Iraq ,  250 ,  276 
 IRPA . See  Canadian Immigration and Refugee 
Protection Act (IRPA) 
 IVF . See  In-vitro fertilization (IVF) 
 J 
 Jacobson, H. ,  38 ,  41–44 ,  50 ,  53 ,  54 
 Jacobson v Massachusetts ,  38–44 
 Janani Suraksha Yojana (JSY) ,  116–118 
 Jenner, E. ,  40 
 Jew Ho  v . Williamson ,  43 
 Justice ,  7 ,  8 ,  13 ,  20 ,  22 ,  23 ,  29 ,  44 ,  47 ,  49 ,  53 , 
 86 ,  164 ,  165 ,  169 ,  181 ,  215 ,  222 ,  248 , 
 286 ,  293 . See also  Injustice 
 K 
 Kant, I. ,  15 ,  16 
 Knowles, John H. ,  138 ,  139 
 L 
 Lang and Rayner models for public health 
 biomedical model ,  178 
 ecological model ,  178 
 sanitary-environmental model ,  178 
 social-behavioral model ,  178 
 techno-economic model ,  178 
 Latin America ,  71 ,  116 ,  168 ,  195 
Index
324
 Law ,  4 ,  6 ,  10 ,  12 ,  16–18 ,  23 ,  28 ,  31 ,  38 , 
 41–43 ,  76 ,  77 ,  87 ,  88 ,  146 ,  148 ,  150 , 
 174 ,  180 ,  217 ,  218 ,  231 ,  237 ,  242 , 
 249 ,  250 
 Least infringement ,  26 ,  29 ,  53 
 Lebanon ,  305–308 
 Lewis, David ,  113 ,  206 
 Liberty ,  17 ,  22 ,  25 ,  26 ,  28 ,  41 ,  43 ,  54 ,  96 ,  101 , 
 133 ,  145 ,  182 
 Lifestyles ,  50 ,  73 ,  138–140 ,  159 , 
 163–165 ,  179 
 LMICs . See  Low- and middle-income 
countries (LMICs) 
 Locke, J. ,  248 
 Low- and middle-income countries (LMICs) , 
 137 ,  150 ,  168 ,  199 ,  242–245 ,  247 ,  249 , 
 250 ,  252 ,  253 ,  256 ,  310 
 M 
 Maastricht Treaty ,  231 
 Managed competition ,  71 
 Mandatory notifi cation ,  129 
 Mandatory treatment ,  95–97 ,  100 
 Mandatory vaccination ,  40 ,  43 ,  95–97 , 
 102–107 . See also  Childhood 
vaccination 
 Māori, bed-sharing ,  213 ,  214 
 Māori population ,  212 
 Marginalized populations ,  133 ,  204–215 , 
 217–219 ,  221–224 ,  226–233 , 
 236–239 ,  287 
 Market(s) (and regulations) ,  146 
 Massachusetts, Board of Health ,  41 
 Mass evacuation ,  102 ,  132–135 . See also 
 Evacuation 
 Maternal-child health ,  67 
 Maternal mortality ,  116 ,  217 ,  276 
 Maximizing strategy ,  65 . See also  Health 
maximization 
 MDGs . See  Millennium Development Goals 
(MDGs) 
 Measles ,  96 ,  102–107 ,  236 
 Media campaigns ,  149 ,  158–161 
 Medicaid ,  51 ,  68 ,  160 
 Medical tourism ,  216–219 
 Medication(s) ,  30 ,  100 ,  130 ,  140 ,  244 ,  252 , 
 253 ,  261 ,  262 ,  265–269 . See also 
 Medicines 
 Medicines ,  21 ,  22 ,  25 ,  37 ,  61 ,  127 ,  236 ,  265 , 
 271 ,  277 
 Mental health ,  68 ,  131 ,  158 ,  231 ,  249 ,  252 , 
 297 ,  307 . See also  Mental illness 
 Mental illness ,  68 ,  73 ,  75 ,  76 ,  178 ,  224 ,  230 , 
 291 ,  292 
 Men who have sex with men (MSM) ,  262 , 
 297 ,  314–317 
 Methicillin-resistant  Staphylococcus aureus 
(MRSA) ,  181 ,  182 ,  191–194 
 Middle East and North Africa (MENA) region , 
 275 . See also  Middle East 
 Migration ,  185 ,  230–232 
 Migration management (MM) ,  231 
 Millennium development goals (MDGs) ,  184 , 
 195 ,  243 ,  249 ,  252 
 Mill, J.S. ,  15 ,  25 
 Minimal/least infringement principle ,  26 ,  53 
 Minimal risk ,  290 
 Mining ,  177 ,  180 ,  184 ,  186–190 
 Mining health and social impacts ,  139 
 Modifi able risk factors ,  212 ,  213 
 Mongolia ,  184–190 
 Morality ,  10 ,  13 ,  14 . See also  Common 
morality 
 Moral marker of vulnerability ,  209 
 Mother-to-child HIV transmission (MTCT) , 
 108–110 
 Motorcycles ,  181 ,  182 ,  199 ,  200 
 Motor vehicles ,  199 . See also  Motorcycles 
 MRSA . See  Methicillin-resistant 
 Staphylococcus aureus (MRSA) 
 MSM . See  Men who have sex with men 
(MSM) 
 Multidrug-resistant TB (MDR-TB) ,  29 ,  130 , 
 236 ,  268 
 Multinational ,  157 ,  247 ,  264 ,  265 ,  281 ,  312 
 Multinational research ,  279–283 
 Multiple sclerosis (MS) ,  66 ,  228 
 N 
 Nanny state ,  53 ,  144 
 National Bioethics Advisory Commission 
(NBAC) ,  247 ,  291 
 National Commission for the Protection of 
Human Subjects of Biomedical and 
Behavioral Research (National 
Commission) ,  21 ,  48 ,  49 ,  286 ,  306 
 National Institute of Clinical and Health 
Excellence (NICE) ,  65 
 NBAC . See  National Bioethics Advisory 
Commission (NBAC) 
 Needle sharing ,  223 
 Negative right of populations ,  277 
 Neoliberal concerns ,  73 . See also  Neoliberal 
values 
Index
325
 Neoliberal values ,  71 
 Net benefi ts ,  17 ,  22 ,  182 
 Netherlands ,  113 ,  192 ,  212 
 Newborn bloodspot screening (NBS) , 
 97 ,  111–114 . See also  Bloodspots 
screening; Residual bloodspots 
 Newborns ,  30 ,  31 ,  219 
 New York City Department of Health and 
Mental Hygiene (NYC DOHMH) ,  51 
 New Zealand ,  213 
 New Zealand Cot Death Study (NZCDS) , 
 211–215 
 NICE . See  National Institute of Clinical and 
Health Excellence (NICE) 
 Nonbiomedical research ,  306 
 Noncommunicable diseases ,  39 ,  50 ,  52 ,  54 , 
 68 ,  137 ,  154 ,  172 
 Noncompliance ,  18 ,  100 ,  131 ,  133 
 Nongovernmental organizations (NGOs) ,  32 , 
 181 ,  197 ,  199 ,  245 ,  267 ,  269 ,  271 , 
 305 ,  306 
 Nonmalefi cence ,  19 ,  22 ,  23 
 Nonmodifi able risk factors ,  212 
 Non-paternity ,  112 
 Nonprofi t organizations ,  199 ,  200 
 Norms ,  19 ,  25–29 ,  31 ,  32 ,  38 ,  148 ,  160 ,  210 , 
 250 ,  251 ,  262 ,  282 ,  315 
 Nuffi eld Council on Bioethics ,  146 ,  159 ,  168 , 
 169 ,  280 ,  281 
 Nuremberg Code ,  20 ,  44 ,  286 ,  305 
 O 
 Obesity ,  26 ,  68 ,  82 ,  140 ,  143 ,  149 ,  150 ,  154 , 
 158–165 . See also  Childhood obesity; 
Obesity costs; Obesity prevention 
 Obesity costs ,  159 
 Obesity prevention ,  149 ,  157 ,  159–161 
 Obligations ,  8 ,  11 ,  15–18 ,  21 ,  22 ,  26 ,  32 ,  38 , 
 52 ,  62 ,  63 ,  98 ,  123 ,  133 ,  138 ,  148 ,  170 , 
 208 ,  217 ,  244 ,  246 ,  247 ,  250 ,  251 ,  259 , 
 291 ,  294 ,  296 ,  301 ,  302 
 Occupational health and safety ,  177 ,  180 ,  181 
 OECD . See  Organisation for Economic 
Co-operation and Development 
(OECD) 
 Offi ce the United Nations High 
Commissioner for Human Rights 
(OHCHR) ,  249 
 Opt out/opt in ,  30 ,  52 ,  53 ,  112 , 
 113 ,  294 
 Oral diseases ,  150 ,  168 ,  169 
 Oral health care ,  169 
 Oral health policies ,  168 
 Organisation for Economic Cooperation and 
Development (OECD) ,  158 ,  159 ,  231 
 Overweight ,  137 ,  140 ,  158 ,  161 
 P 
 PAHO . See  Pan American Health Organization 
(PAHO) 
 Palestine ,  305 
 Palestinian ,  307 
 Palestinian refugee camp ,  297 ,  305–308 
 Panama ,  217 ,  218 
 Pan American Health Organization (PAHO) , 
 104 ,  129 ,  130 ,  241 
 Pandemic(s) ,  20 ,  27 ,  28 ,  67 ,  68 ,  226 ,  227 ,  314 
 Pandemic infl uenza ,  62 ,  101 ,  245 
 Pandemic planning ,  226–229 
 Parental consent ,  30 ,  31 ,  114 ,  307 ,  308 
 Parents ,  4 ,  10 ,  15 ,  30 ,  31 ,  76 ,  77 ,  140 ,  149 , 
 156 ,  157 ,  159–161 ,  210 ,  212–214 ,  232 , 
 289 ,  305 ,  307 
 Parity between mental and physical health 
coverage ,  76 
 Parran, T. ,  47 
 Participant ,  293 
 Participation ,  5 ,  7 ,  29 ,  44 ,  46 ,  49 ,  62 ,  71 ,  121 , 
 170 ,  184 ,  185 ,  237 ,  245 ,  247 ,  264 ,  268 , 
 281 ,  290–293 ,  306 
 Paternalism ,  21 ,  25 ,  95 ,  96 ,  150 ,  159 ,  168 , 
 169 ,  183 ,  208 
 Paternalistic ,  21 ,  26 ,  100 ,  146 ,  182 ,  183 ,  289 
 Paternity ,  112 . See also  Non-paternity 
 Patient Protection and Affordable Care Act 
(ACA) ,  63 ,  68 ,  76 ,  77 
 Patriarchal societies ,  306 
 PAWS . See  Pervasive arousal withdrawal 
syndrome (PAWS) 
 PCSBI . See  Presidential Commission for the 
Study of Bioethical Issues (PCSBI) 
 Peace Corps ,  181 ,  199, 200 
 Penalties ,  72 ,  98 ,  122 ,  140 ,  141 ,  275 
 PEPFAR (The United States President’s 
Emergency Plan for AIDS Relief) ,  261 
 Personal autonomy ,  21 ,  22 ,  25–26 ,  47 ,  174 
 Personal responsibility ,  138 ,  139 ,  141 ,  145 , 
 150 ,  163–165 . See also  Individual 
behavior 
 Personal safety ,  182 ,  199–201 
 Pervasive arousal withdrawal syndrome 
(PAWS) ,  232 
 Pharmaceutical companies ,  244 ,  247 ,  250 , 
 263–265 ,  312 
 PHS ,  6 ,  21 ,  38 ,  44–50 ,  53 ,  54 ,  65 ,  112 ,  275 , 
 280 ,  285 
Index
326
 Points of dispensing (PODs) ,  127 
 Policy ,  10 ,  12 ,  13 ,  15 ,  21 ,  30 ,  39 ,  43 ,  48 ,  49 , 
 51 ,  53 ,  54 ,  62–64 ,  66–68 ,  78 ,  84 ,  85 , 
 90 ,  91 ,  138–141 ,  144 ,  146 ,  148 ,  149 , 
 151 ,  154–157 ,  159 ,  162 ,  167–170 ,  172 , 
 177 ,  180 ,  182–184 ,  188 ,  191–194 ,  200 , 
 242–246 ,  249–252 ,  257–260 ,  263 ,  267 , 
 270 ,  273 ,  275 ,  281 ,  293 ,  302 ,  311 
 Policy interventions ,  139 ,  155 
 Political ,  8 ,  10 ,  11 ,  18 ,  19 ,  22 ,  24–27 ,  29 ,  31 , 
 32 ,  37–39 ,  42 ,  44 ,  54 ,  68 ,  76 ,  78 ,  81 , 
 138 ,  143 ,  146 ,  148 ,  150 ,  160 ,  169 ,  170 , 
 178 ,  180 ,  181 ,  185 ,  188 ,  230 ,  236 ,  242 , 
 246 ,  248 ,  250 ,  252 ,  267 ,  268 ,  271 ,  275 , 
 277 ,  278 ,  286 ,  287 ,  296 ,  297 ,  305 ,  307 
 Population ,  4–10 ,  23 ,  26 ,  31 ,  37–39 ,  44 ,  47 , 
 49–54 ,  62 ,  65–69 ,  73 ,  80 ,  82 ,  85 ,  89 , 
 141 ,  143 ,  144 ,  150 ,  156 ,  163 ,  164 ,  168 , 
 173 ,  178 ,  180–183 ,  187 ,  188 ,  195 , 
 241–243 ,  245 ,  247 ,  249–252 ,  260 ,  261 , 
 263 ,  264 ,  271–273 ,  277 ,  278 ,  282 , 
 286–288 ,  292 
 benefi ts ,  23 ,  180–183 ,  298 
 health ,  6 ,  27 ,  50 ,  61 ,  62 ,  66–69 ,  96 ,  137 , 
 138 ,  148 ,  156 ,  243 ,  244 ,  249 ,  251 
 health interventions ,  38 
 Population health ,  6 ,  27 ,  50 ,  61 ,  62 ,  66–69 ,  96 , 
 137 ,  138 ,  148 ,  156 ,  243 ,  244 ,  249 ,  251 
 Poverty-reduction ,  116 
 Power ,  25 ,  26 ,  41 ,  43–45 ,  54 ,  148 ,  178 ,  180 , 
 181 ,  183 ,  275 ,  276 
 perceived power ,  306 ,  308 
 political power ,  305 
 power dynamics ,  297 ,  306 ,  307 
 Perilous path to peace ,  274–278 
 Practical ethics ,  3 ,  19 
 Precedents ,  9 ,  29 ,  50 ,  54 ,  259 
 Pre-exposure prophylaxis programs 
(PrEP) ,  260 
 Pregnancy ,  19 ,  109 ,  116 ,  212 ,  213 ,  216–219 
 PrEP ,  260–262 
 Presidential Commission for the Study of 
Bioethical Issues (PCSBI) ,  45–47 , 
 126 ,  293 
 Presumptive norm ,  25 ,  26 ,  28 ,  29 ,  31 
 Presumptive values ,  25–27 ,  31 
 Prevention ,  5 ,  7 ,  38 ,  39 ,  45 ,  50 ,  71 ,  73 ,  78 ,  80 , 
 81 ,  84 ,  87 ,  138 ,  142 ,  144 ,  145 ,  147 , 
 149 ,  154 ,  158–161 ,  165 ,  168–170 ,  192 , 
 200 ,  212 ,  213 ,  215 ,  222 ,  237 ,  251 ,  272 , 
 314–317 
 Prevention  vs . treatment ,  257 
 Primary prevention ,  38 ,  141 ,  143 
 Principles ,  4 ,  7 ,  10 ,  11 ,  13–24 ,  26 ,  27 ,  32 ,  37 , 
 38 ,  42 ,  43 ,  49 ,  53 ,  54 ,  65 ,  68 ,  78 ,  80 , 
 81 ,  86 ,  138 ,  141 ,  151 ,  168 ,  242–244 , 
 246–248 ,  251 ,  258 ,  259 ,  285 ,  286 ,  288 , 
 293 ,  306 ,  308 
 Principles of Biomedical Ethics ,  286 
 Principles of the Ethical Practice of Public 
Health ,  285 
 Principlism ,  20–23 
 Prioritizes ,  4 ,  7 ,  12 ,  18 ,  21 ,  37 ,  73 ,  169 ,  296 , 
 307 ,  311 
 Priority setting ,  62–73 ,  227 ,  228 
 Priority setting in health care ,  87–89 . See also 
 Health priorities and resource 
allocation 
 Prisoners ,  46 ,  47 ,  221–223 
 Privacy ,  29 ,  30 ,  39 ,  52–54 ,  97–99 ,  113 ,  114 , 
 291 ,  297 
 Procedural justice ,  29 ,  169 
 PROCET . See  Program for Control a
nd Eradication of Tuberculosis 
(PROCET) 
 Profession(al) ,  13 ,  15 ,  19 ,  21 ,  22 ,  24 ,  27 ,  32 , 
 38 ,  47 ,  50 ,  54 ,  72 ,  81 ,  141 ,  143 ,  144 , 
 149 ,  157 ,  169 ,  180 ,  182 ,  185 ,  189 ,  192 , 
 194 ,  209 ,  219 ,  228 ,  249 ,  269 ,  282 ,  288 , 
 289 ,  314 ,  315 
 Program for Control and Eradication of 
Tuberculosis (PROCET) ,  129 
 Proportionality ,  29 ,  96 
 Prostitution ,  98 ,  120 ,  121 ,  123 
 Public health (defi nition of) ,  5 ,  37 
 Public health emergencies ,  106 ,  245 ,  287 , 
 295 ,  296 
 Public Health leadership Society ,  7 ,  15 ,  285 
 Public health policies ,  23 ,  53 ,  69 ,  95 ,  97 ,  98 , 
 100 ,  101 ,  113 ,  178 ,  250 
 Public health research ,  38 ,  44–46 ,  48 ,  49 ,  177 , 
 178 ,  286–297 ,  301–303 ,  305–308 , 
 310–316 
 Public health research  vs public health 
practice ,  38 
 Public health service model ,  112 
 Public health services ,  23 ,  65 ,  275 
 Public health surveillance ,  39 ,  40 ,  51 ,  183 ,  288 
 Public hospitals ,  71–73 
 Public-private partnership(s) ,  68 
 Q 
 QALY . See  Quality-adjusted life year (QALY) 
 Quality-adjusted life year (QALY) ,  17 ,  64–66 
 Quality assurance ,  112 
Index
327
 R 
 Racism ,  46 ,  49 
 Randomized controlled trials ,  141 ,  142 ,  286 
 Refugees ,  209 ,  231 ,  237 ,  305–307 
 Regulations ,  6 ,  18 ,  20 ,  21 ,  23 ,  28 ,  38 ,  40 ,  42 , 
 43 ,  49 ,  66 ,  70 ,  113 ,  121 ,  129 ,  146 ,  148 , 
 155 ,  173 ,  179 ,  183 ,  185 ,  188 ,  217 ,  218 , 
 236 ,  238 ,  244 ,  252 ,  263–265 ,  280 ,  281 , 
 286 ,  287 ,  289 
 Reproductive technology ,  217 
 Research ,  5 ,  7 ,  12 ,  18 ,  20–22 ,  25 ,  38–40 ,  44 , 
 45 ,  47–49 ,  51 ,  53 ,  54 ,  72 ,  88 ,  141 ,  142 , 
 150 ,  154 ,  205 ,  222 ,  223 ,  241 ,  244 ,  246 , 
 247 ,  250–252 ,  262–265 ,  268 ,  269 , 
 279–283 ,  288 ,  289 ,  292–295 ,  311 ,  315 . 
See also  Research funding 
 Researchers’ obligations and 
responsibilities ,  301 
 Research ethics ,  4 ,  18–23 ,  37–39 ,  47 ,  264 ,  281 
 Research ethics committees (RECs) , 
 289 ,  310–313 
 Research funding ,  312 
 Research oversight ,  287 ,  297 
 Residual bloodspots ,  114 
 Resource allocation ,  227 ,  276 ,  297 
 Resource allocation decisions ,  61–63 ,  70 
 Resource allocation (in public health versus 
medicine) ,  61 ,  63–68 ,  70–73 ,  75–78 , 
 80–82 ,  84 ,  85 ,  87–92 
 Resource shortages ,  227 
 Respect ,  7 ,  9 ,  12 ,  13 ,  16 ,  19 ,  22–25 ,  29 ,  30 , 
 48 ,  181 ,  250 ,  259 ,  262 ,  282 
 Respect for persons ,  19 ,  22–24 ,  48 ,  49 ,  286 , 
 293 ,  297 
 Returning research results ,  293 ,  294 
 Revisability condition ,  69 
 Right to health ,  4 ,  8 ,  16 ,  99 ,  100 ,  122 ,  138 , 
 145 ,  249 ,  250 
 Risk(s) ,  8 ,  11 ,  12 ,  17 ,  20 ,  22 ,  28 ,  30 ,  31 , 
 47–52 ,  54 ,  61 ,  67 ,  72 ,  78 ,  137 ,  138 , 
 140–143 ,  146 ,  148 ,  150 ,  155 ,  158 ,  160 , 
 163 ,  165 ,  169 ,  170 ,  172 ,  173 ,  178 ,  181 , 
 252 ,  253 ,  260–262 ,  264 ,  265 ,  267 ,  269 , 
 273 ,  280 ,  292 ,  293 ,  315 
 benefi t analysis ,  
291 ,  292 
 management ,  180 ,  183 ,  196 
 reduction ,  180 
 Road safety ,  199 
 Rockefeller Foundation ,  241 
 Roma people ,  232 
 Rousseau, J.-J. ,  248 
 Rule-based guidelines ,  298 
 Ryan White Care Act ,  120 
 S 
 Safe deliveries ,  116 
 Safe drinking water ,  181 ,  195 
 Safety ,  5 ,  6 ,  11 ,  12 ,  21 ,  41–43 ,  221 
 Safe water ,  182 ,  195–198 . See also  Safe 
drinking water; Drinking water quality 
 Sanctions ,  133 ,  244 ,  250 ,  274–278 
 Sanitation ,  5 ,  39 ,  45 ,  50 ,  144 ,  195 ,  196 ,  200 , 
 236 ,  270–273 ,  275 
 Scandinavia ,  192 
 Schools ,  37 ,  43 ,  82 ,  146 ,  155 ,  159 ,  160 ,  168 , 
 174 ,  218 ,  232 ,  233 ,  262 ,  277 
 Screening ,  29–31 ,  76 ,  141 ,  142 ,  164 ,  257 
 Secondary prevention ,  39 ,  50 ,  141–143 
 Secondhand smoke ,  161 ,  173 
 Self-determination ,  29 ,  52 ,  242 
 Self-regulation models ,  149 
 Self-regulatory approaches ,  155 
 Self-regulatory codes ,  155 . See also  Self- 
regulatory approaches 
 Sequential Organ Failure Assessment (SOFA) 
scores ,  91 
 Serodiscordant couples ,  260–262 
 Sexually transmitted infections (STI) , 
 121 ,  122 
 SIDS . See  Sudden Infant Death Syndrome 
(SIDS) 
 Siracusa principles ,  237 
 Smoke free legislation ,  173 
 Smoking ,  138–141 ,  148 ,  150 ,  151 ,  160 ,  161 , 
 163 ,  172–175 ,  210 ,  212 ,  213 ,  245 
 bans ,  160 ,  174 
 in public places ,  150 ,  172–175 
 Smoking-related causes of death ,  172 
 Social-compact theory ,  42 
 Social conditions ,  9 ,  164 ,  248 ,  252 
 Social consensus ,  11 ,  23 ,  27 
 Social contract theory ,  24 ,  248 . See also 
 Social-compact theory 
 Social determinants ,  8 ,  158–159 ,  165 ,  252 
 Social determinants of health (SDH) ,  8–9 , 
 123 ,  179 ,  227 ,  246 ,  251–253 
 Social equity ,  185 
 Social gradient ,  163 
 Social justice ,  4 ,  8–9 ,  21–23 ,  53 ,  180 ,  184 , 
 227 ,  237 ,  251 ,  257 ,  298 ,  306 
 Social norms ,  19 ,  27 ,  149 ,  160 
 Social welfare ,  117 
 Socioeconomic conditions ,  163 
 Socioeconomic disparities ,  133 
 Solidarity ,  7 ,  8 ,  24 ,  26–29 ,  31 ,  71 ,  169 ,  170 , 
 206 ,  237 ,  267 
 Spain ,  68 ,  96 ,  102 ,  105 ,  106 ,  168 
 Sponsorship ,  156 ,  295 
Index
328
 Stakeholder(s) ,  4 ,  10–13 ,  19 ,  26 ,  28–32 ,  37 , 
 62 ,  67 ,  69 ,  73 ,  78 ,  82 ,  149 ,  150 ,  155 , 
 169 ,  170 ,  175 ,  233 ,  244–246 ,  249 ,  265 , 
 308 ,  313 
 Standards ,  4 ,  6 ,  9–13 ,  15 ,  18 ,  27 ,  30 ,  42 ,  43 , 
 51 ,  65 ,  66 ,  68 ,  76 ,  86 ,  88 ,  139 ,  148 , 
 154 ,  159 ,  172 ,  241 ,  242 ,  246 ,  248 ,  250 , 
 253 ,  257 ,  258 ,  279–283 
 Standards of care ,  98 
 STD Prevention ,  120–124 
 Stigma ,  68 ,  75 . See also  Stigmatization and 
obesity stigma 
 Stigmatization and obesity stigma ,  98 ,  99 , 
 162–165 ,  257 
 Stock-outs ,  244 ,  253 ,  266–269 
 Storage ,  111–114 ,  196 ,  217 ,  267 
 Structural intervention ,  120 
 Structural reform ,  72 
 Students ,  105 ,  182 ,  193 ,  296 ,  301 ,  303 ,  307 
 Sub-Saharan Africa ,  110 ,  121 ,  185 ,  195 ,  197 , 
 200 ,  236 ,  260–262 ,  312 
 Substance abuse ,  123 ,  138 ,  221–223 ,  291 
 Sudden infant death syndrome (SIDS) ,  209 , 
 211–215 
 Surrogacy and egg donor ,  219 
 Surrogate pregnancy ,  218 . See also  Surrogacy 
and egg donor 
 Surveillance ,  5 ,  7 ,  95 ,  97–98 ,  106 ,  121 ,  227 , 
 237 ,  245 ,  293 
 Sweden ,  41 ,  230–233 
 Syphilis ,  21 ,  31 ,  44–49 ,  237 ,  280 
 Syria ,  250 ,  276–277 
 T 
 TB incidence and prevalence ,  29 ,  97 ,  129 , 
 130 ,  310 
 TB medication ,  244 ,  253 ,  267–269 
 TB treatment ,  96 ,  130 ,  131 ,  237 ,  268 ,  311 
 Terrorism ,  101 ,  126 ,  275 . See also 
 Bioterrorism 
 Title 45, Part 46, of the Code of Federal 
Regulations ,  286 
 Tobacco ,  137 ,  139 ,  140 ,  146–148 ,  160 , 
 172 ,  173 
 Trades ,  65 ,  139 ,  146 ,  169 ,  187 ,  243 ,  275 ,  301 
 Transparency ,  15 ,  28 ,  29 ,  62 ,  90 ,  168 ,  170 , 
 237 ,  294 
 Transparent ,  91 . See also  Transparency 
 Transportation safety ,  182 ,  200 ,  201 
 Trauma ,  178 ,  200 ,  233 ,  290 
 Treatment ,  23 ,  29 ,  30 ,  45–49 ,  63 ,  64 ,  66 ,  68 , 
 75–77 ,  81 ,  87 ,  88 ,  90 ,  92 ,  137 ,  141 , 
 142 ,  168 ,  169 ,  244 ,  256–258 ,  265 , 
 267–270 
 Triage ,  67 ,  68 ,  278 
 Trust ,  7 ,  21 ,  32 ,  40 ,  47 ,  49 ,  98 ,  175 ,  183 ,  296 , 
 297 ,  302 ,  306 ,  308 ,  315 
 Truvada ,  260–262 
 Tuberculosis (TB) ,  29 ,  40 ,  51 ,  81 ,  96 , 
 129–131 ,  221 ,  310 . See also  TB 
incidence and prevalence; TB 
medication; TB treatment 
 screening ,  29 ,  235–239 
 testing ,  235–239 
 treatment ,  235–239 
 Tuskegee syphilis study ,  46 ,  49 . See also  U.S. 
Public Health Service Syphilis Study at 
Tuskegee 
 U 
 U.K. Food Standards Agency ,  154 
 U.N. Human Development Index ,  271 
 U.N. Human Rights Council (HRC) , 
 249 ,  250 
 Unintentional injury ,  199 
 United Kingdom ,  65 ,  147 ,  168 
 United Nations (U.N.) ,  81 ,  145 ,  230 ,  231 ,  242 , 
 261 ,  271 ,  276–278 
 United Nations Educational, Scientifi c and 
Cultural Organization (UNESCO) ,  247 
 United Nations Relief and Works Agency 
(UNRWA) ,  305 
 United States ,  20 ,  22 ,  30 ,  39–41 ,  44 ,  45 , 
 47–51 ,  54 ,  61 ,  63 ,  67 ,  75 ,  84 ,  85 ,  137 , 
 147 ,  148 ,  150 ,  158 ,  160 ,  163 ,  164 ,  168 , 
 218 ,  221 ,  222 ,  242 ,  245 ,  261 ,  267 ,  275 , 
 280 ,  315 
 Universal access ,  23 ,  122 ,  301 
 Universal Declaration on Bioethics and 
Human Rights ,  251 
 Universal Declaration on the Human Genome 
and Human Rights ,  251 
 Unprotected water sources ,  195 
 UNRWA . See  United Nations Relief and 
Works Agency (UNRWA) 
 U.N. Universal Declaration of Human Rights 
(UDHR) ,  99 ,  230 ,  248 ,  286 
 U.N. Vienna Declaration and Programme of 
Action ,  249 
 U.S. Advisory Committee on Immunization 
Practices ,  126 
 U.S. Department of Health and Human 
Services ,  18 ,  20 ,  21 ,  48 ,  49 ,  140 ,  281 , 
 286 ,  288 ,  290 
Index
329
 U.S. Department of Homeland Security 
(DHS) ,  126 
 Use of incentives for research ,  263 
 User fees ,  301 ,  302 
 U.S. Food and Drug Administration (FDA) , 
 126 ,  260 
 U.S. Institute of Medicine (IOM) ,  6 ,  154 ,  294 
 U.S. Public Health Service ,  21 ,  38 ,  44–50 ,  280 
 U.S. Public Health Service Syphilis Study at 
Tuskegee ,  21 ,  281 
 Utilitarianism ,  15 ,  17 ,  91 ,  181 . 
See also  Utility 
 Utility ,  17 ,  26 ,  27 ,  29 ,  93 ,  123 ,  141 ,  143 ,  181 , 
 247 ,  282 
 V 
 Vaccination ,  6 ,  40–42 ,  73 ,  92 ,  277 
 Vaccine(s) ,  20 ,  39–41 ,  80 ,  270 ,  275 ,  277 
 Vaccine coverage ,  104–106 ,  127 
 Values ,  4 ,  7–13 ,  18 ,  19 ,  25–27 ,  31 ,  32 ,  37 ,  38 , 
 43 ,  53 ,  54 ,  63 ,  64 ,  71 ,  73 ,  78 ,  82 ,  88 , 
 91 ,  93 ,  141 ,  144 ,  150 ,  168 ,  170 ,  175 , 
 246 ,  265 ,  278 
 Vertical transmission ,  109 
 Vibrio cholera ,  269 ,  272 ( see also  Cholera and 
outbreak ) 
 Victim blaming ,  140 
 Voluntary ,  18 ,  30 ,  40 ,  140 ,  142 ,  148 ,  155 ,  159 , 
 252 ,  257 ,  258 ,  281 
 Voluntary counseling and testing and HIV ,  122 
 Voluntary  vs . mandatory evacuation ,  102 
 Vulnerability (defi nition of) ,  204 ,  209 
 Vulnerability ,  252 
 Vulnerable ,  180 ,  181 ,  187 ,  188 ,  199 . See also 
 Vulnerability 
 groups ,  48 
 and marginalized groups ,  162–165 
 and marginalized populations ,  133 
 populations ,  44 ,  47 ,  49 ,  134 ,  149 ,  180 , 
 228 ,  278 ,  292 ,  293 ,  295 ,  297 ,  301 , 
 314–317 
 W 
 Waivers of informed consent ,  290 
 War and warfare ,  126 ,  277 
 Water contamination ,  196 
 Water fl uoridation ,  150 ,  167–170 
 Waterhouse, B. ,  40 
 Water quality testing ,  197 
 Water Safety Plan (WSP) ,  196 
 Well construction ,  181 ,  182 ,  195–198 
 Western ,  3 ,  22 ,  222 ,  231 ,  243 ,  257 ,  258 , 
 271 ,  276 
 WHO ,  173 
 WIP . See  Working Party on Infection 
Prevention (WIP) 
 Working Party on Infection Prevention (WIP) , 
 192–194 
 Workplace hazards ,  178 
 World Bank ,  137 ,  172 ,  187 ,  188 ,  242 , 
 261 ,  301 
 World Health Organization (WHO) ,  5 ,  49 ,  75 , 
 80 ,  84 ,  90 ,  91 ,  137 ,  154 ,  158 ,  168 ,  173 , 
 196 ,  199 ,  242 ,  263 ,  267 ,  269 ,  271 ,  275 , 
 276 ,  280 ,  281 ,  286 
 World Health Organization Framework 
Convention on Tobacco Control ,  173 
 WSP . See  Water Safety Plan (WSP) 
 Y 
 Youth ,  149 ,  153–157 ,  297 ,  307 ,  308 
 Z 
 Zucht  v . King ,  43 
Index
